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ABSTRACT 
Research indicates that eating disorders and anxiety disorders frequently co-occur.  The 
prevalence of anxiety disorders amongst anorexia nervosa and bulimia nervosa samples 
has been reported in a number of investigations. Despite the significant number of 
research papers investigating the comorbidity between eating disorders and anxiety 
disorders, many are plagued by methodological problems, limiting the usefulness of 
findings. Furthermore, there is a significant lack of research examining the prevalence of 
eating disorders among anxiety patients, and as a result, the frequency of eating disorder 
pathology among patients presenting to specialty anxiety clinics is unclear. The current 
research investigated the prevalence of comorbid eating and anxiety disorders amongst 
152 women presenting for either eating disorder treatment or anxiety disorder treatment. 
The prevalence of anxiety disorders was determined from a sample of 100 women 
presenting for inpatient and outpatient eating disorder treatment. The prevalence of eating 
disorders was determined from a sample of 52 women presenting for outpatient treatment 
of an anxiety disorder. The current study found that 65% of women with eating disorders 
also met criteria for at least one comorbid anxiety disorder. Furthermore, 69% reported 
the onset of the anxiety disorder to precede the onset of the eating disorder. Of the 
anxiety disorders diagnosed, Social Phobia was most frequently diagnosed (42%) 
followed by PTSD (26%), GAD (23%), OCD (5%), Panic/Ag (3%) and Specific Phobia 
(2%). We also found that 13.5% of women presenting for anxiety treatment also met 
criteria for a comorbid eating disorder. The results of this study suggest that the 
prevalence of eating and anxiety disorder comorbidity is high.  It is hoped that the present 
research will have significant etiological and therapeutic implications and further the 
understanding of the development and maintenance of eating disorder pathology.  
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OVERVIEW 
 
The present research endeavours to investigate the prevalence of comorbid eating 
disorders and anxiety disorders. Chapter 1 provides a general overview of the eating 
disorders, Anorexia Nervosa, Bulimia Nervosa and Eating Disorder Not Otherwise 
Specified, as well as the available literature investigating eating disorders, including 
diagnosis, assessment, comorbidity, treatment and outcome. Chapter 2 provides a general 
overview of the anxiety disorders including core features and a review of the literature 
regarding diagnosis, assessment, comorbidity, and treatment of anxiety disorders. 
Chapters 3 and 4 provide a detailed literature review of the research investigating 
comorbidity between anxiety and eating disorders. These chapters also pay special 
attention to the methodological limitations inherent in much of the research investigating 
this area to date. Chapter 5 outlines the aims and objectives for the current study. The 
methodology for the current study is described in Chapter 6. Chapter 7 outlines the 
characteristics of the samples. Chapter 8 outlines the results obtained from the current 
study. Chapter 9 consists of a discussion of the results obtained, as well as a discussion 
on the strengths and limitations of the current study and directions for future research in 
the area of eating disorder and anxiety disorder comorbidity.   
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CHAPTER 1 
INTRODUCTION TO THE EATING DISORDERS 
 
An eating disorder diagnosis describes the observational pattern of clinical symptoms 
which, broadly defined, reflect a severe disturbance in issues concerning body weight and 
shape. The diagnostic criteria for an eating disorder incorporates the presence of 
behaviours specifically designed to influence body weight and shape (American 
Psychiatric Association, 2000). To date, there is a large body of research investigating the 
etiology, course, treatment and outcome of eating disorders. This chapter will provide an 
overview of the core features of eating disorders as well as the literature investigating 
assessment, treatment and outcome of eating disorders.  
1.1 Anorexia Nervosa: Core Features
Anorexia Nervosa (AN) is characterised by severe disturbances in eating behaviour. 
Specifically, an individual with this disorder refuses to maintain a minimally normal 
body weight, is intensely fearful of gaining weight and exhibits a significant disturbance 
in their perception of their shape and size (American Psychiatric Association, 2000; see 
Table 1.1). In addition, the Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV, American Psychiatric Association, 2000) includes amenorrhea in post menarchal 
females as a diagnostic feature of this disorder.  
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Table 1.1 
DSM-IV-TR diagnostic criteria for Anorexia Nervosa (American Psychiatric Association, 
2000) 
DSM-IV-TR Diagnostic Criteria for Anorexia Nervosa 
A. Refusal to maintain body weight at or above a minimally normal weight for age 
and height (e.g., weight loss leading to maintenance of body weight less than 85% 
of that expected; or failure to make expected weight gain during period of growth, 
leading to body weight less than 85% of that expected. 
B. Intense fear of gaining weight or becoming fat, even though underweight. 
C. Disturbance in the way in which one’s body weight or shape is experienced, 
undue influence of body weight or shape on self-evaluation, or denial of the 
seriousness of the current low body weight.  
D. In postmenarcheal females, amenorrhea, i.e., the absence of at least three 
consecutive menstrual cycles. (A woman is considered to have amenorrhea if her 
periods occur only following hormone, e.g., estrogen administration.) 
Specify Type:  
Restricting Type: during the current episode of Anorexia Nervosa, the person has 
not regularly engaged in binge-eating or purging behaviour (i.e., self-induced 
vomiting or the misuse of laxatives, diuretics, or enemas) 
Binge-Eating/Purging Type: during the current episode of Anorexia Nervosa, the 
person has regularly engaged in binge-eating or purging behaviour (i.e., self-
induced vomiting or the misuse of laxatives, diuretics, or enemas) 
 
  
The inclusion of amenorrhea as a diagnostic criterion has been criticised, as it is 
considered unreliable due to the frequency with which individuals with AN are 
prescribed contraceptive medication to regulate menses (Bulik, Reba, Siega-Riz & 
Reichborn-Kjennerud, 2005). Furthermore, research has found that there do not appear to 
be meaningful differences between those individuals with AN who have amenorrhea and 
those who do not (Watson & Andersen, 2003). Specifically, individuals meeting all 
criteria for AN except the amenorrhea condition, appear to have few statistically 
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significant differences in terms of demographics, psychiatric comorbidity, family history 
or early experiences (Garfinkel, Lin, Goering, Spegg, Goldbloom, Kennedy, Kaplan & 
Woodside, 1996), or illness history and treatment response (Watson & Andersen, 2003).  
In addition to the above concerns regarding the amenorrhea criterion, researchers have 
also called for the inclusion of patients with eating restraint but without shape and weight 
concerns to be included under the diagnosis of AN (Fairburn & Bohn, 2005; Palmer, 
1993, 2005; Rieger, Touyz, Swain & Beumont, 2001). This proposal has stemmed from 
several authors questioning the necessity of including both weight phobia and body-
image disturbance in the diagnosis of AN (Casper, 1983; Habermas, 2005; van Deth & 
Vandereycken, 1991). The reported absence of body-weight phobia and body image 
disturbance in non-Western patients with low body weight adds strength to this proposal 
(Lee, Ho & Hsu, 1993).  
The DSM-IV distinguishes between two subtypes of AN: the restricting type (ANR) and 
the binge eating/purging type (ANBP). The restricting type has presentations in which 
weight loss is achieved primarily through dieting, fasting or excessive exercise 
(American Psychiatric Association, 2000). During this period, the individual has not 
regularly engaged in binge eating or purging. In contrast, the binge eating/purging type is 
used to describe individuals who have regularly engaged in binge eating and or purging 
during the present episode.  
Generally, most individuals with AN who binge eat also purge through the use of self 
induced vomiting, and or the misuse of laxatives, diuretics or enemas. Some individuals 
in this subtype do not engage in binge eating, but will regularly purge after the 
consumption of a small amount of food. Although it would appear that individuals with 
binge eating/purging type will engage in these behaviours at least weekly, the DSM-IV 
(American Psychiatric Association, 2000) does not apply a minimum frequency of such 
behaviours.  
Support for the DSM-IV based subtypes of AN has been limited. The AN subtypes were 
originally differentiated based on observations that women with AN with binge purge 
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symptoms displayed increased comorbid psychopathology and distress than did the 
women with AN restricting subtype (DaCosta & Halmi, 1992; Herzog, Keller, Sachs, 
Yeh & Lavori, 1992). More recent research has failed to find differences between the 
restricting and binge/purge subtypes of AN in terms of co-morbid psychopathology, 
recovery, relapse or mortality rates (Herzog, Dorer, Keel, Selwyn, Ekeblad, Flores, 
Greenwood, Burwell & Keller, 1999; Keel, Dorer, Eddy, Franko, Charatan & Herzog, 
2003; Keel, Dorer, Franko, Jackson & Herzog, 2005).  
AN appears to be far more prevalent in industrialised countries, and more than 90% of 
cases are observed in females (American Psychiatric Association, 2000). The prevalence 
of AN amongst women is approximately 0.5% - 1% in Western Cultures (Hsu, 1996; 
Wilson & Pike, 2001). The observed course of AN appears to suggest that the disorder 
typically begins in mid to late adolescence, and onset is rarely observed in females over 
the age of 40 years (American Psychiatric Association, 2000).   
1.2 
The core features of Bulimia Nervosa (BN) are binge eating and inappropriate 
compensatory methods to prevent weight gain. Similarly to AN, the individual’s self-
evaluation is excessively influenced by body shape and weight. The DSM-IV (American 
Psychiatric Association, 2000; see table 1.2) specifies that the binge eating and 
compensatory behaviour must occur on average, at least twice a week for a 3 month 
period.  
 
 
 
 
 
Bulimia Nervosa: Core Features 
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Table 1.2 
DSM-IV-TR diagnostic criteria for Bulimia Nervosa (American Psychiatric Association, 
2000) 
DSM-IV-TR Diagnostic Criteria for Bulimia Nervosa 
A. Recurrent episodes of binge eating. An episode of binge eating is characterised by 
both of the following:  
(1) eating, in a discrete period of time (e.g., within any 2-hour period), an 
amount of food that is definitely larger than most people would eat during 
a similar period of time and under similar circumstances 
(2) a sense of lack of control over eating during the episode (e.g., a feeling 
that one cannot stop eating or control what or how much one is eating) 
B. Recurrent inappropriate compensatory behaviour in order to prevent weight gain, 
such as self-induced vomiting; misuse of laxatives, diuretics, enemas, or other 
medications; fasting; or excessive exercise. 
C. The binge eating and inappropriate compensatory behaviours both occur, on 
average, at least twice a week for 3 months.  
D. Self evaluation is unduly influenced by body shape and weight.  
E. The disturbance does not occur exclusively during episodes of Anorexia Nervosa. 
Specify Type:  
Purging Type: during the current episode of Bulimia Nervosa, the person has 
regularly engaged in self-induced vomiting or the misuse of laxatives, diuretics, 
or enemas  
Nonpurging Type: during the current episode of Bulimia Nervosa, the person has 
used other inappropriate compensatory behaviours, such as fasting or excessive 
exercise, but has not regularly engaged in self-induced vomiting or the misuse of 
laxatives, diuretics, or enemas 
 
 
The DSM-IV defines a binge as eating an amount of food larger than what most 
individuals would eat under similar circumstances, in a discrete period of time (usually 
less than two hours). In terms of assessment, clinicians use their own judgement of what 
would be considered a normal quantity of food to determine whether this criterion is 
satisfied. In addition, an episode of binge eating also includes a sense of losing control 
over one’s eating. Specifically, individuals will report a feeling that they are unable to 
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stop eating or control how much they are consuming. Recurrent inappropriate 
compensatory behaviour to avoid weight gain is also a key characteristic of BN. Such 
behaviour may include the use of self-induced vomiting, misuse of laxatives or diuretics, 
fasting or excessive exercise.  
Critics of the diagnostic criteria for BN have called for the twice-weekly threshold for 
binge eating and purging to be reduced (Herzog, Norman, Rigotti & Pepose, 1986; 
Wilson & Eldredge, 1991; Garfinkel, Kennedy & Kaplan, 1995; Fairburn & Bohn, 2005). 
This proposal has stemmed from evidence that individuals with once-weekly binge eating 
episodes demonstrate similar co-existing psychopathology and clinical outcome to those 
who binge more often (Garfinkel, Kennedy & Kaplan, 1995). Furthermore, the definition 
of what constitutes a binge episode has been difficult to operationalise which has also led 
to criticism (Pratt, Niego & Agras, 1998; Rossiter & Agras, 1990). The concept that the 
binge is time limited is not empirically based and there is no evidence suggesting that 
differentiating between the duration of binge episodes has clinical utility (Franco, 
Wonderlich, Little & Herzog, 2004).     
The DSM-IV distinguishes between two subtypes of this disorder: the purging type and 
the non-purging type (American Psychiatric Association, 2000). The purging type 
includes those individuals who have regularly engaged in self-induced vomiting or the 
misuse of laxatives, diuretics or enemas. The non-purging type refers to those individuals 
who have used other inappropriate behaviours such as fasting or excessive exercise, but 
have not regularly engaged in self-induced vomiting or the misuse of laxatives, diuretics 
or enemas. 
Research indicates that BN typically begins in late adolescence or early adult life 
(American Psychiatric Association, 2000).  The binge eating typically begins during or 
after a period of dieting, and indeed the restrictive dietary behaviours often observed in 
BN are not only recognised as triggers for binge eating but also a maintaining factor 
associated with this disorder. As with AN, BN is most often observed in industrialised 
countries, and at least 90% of individuals with BN are female (American Psychiatric 
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Association, 2000). The prevalence of BN amongst women is approximately 1% - 3% in 
Western cultures (Wilson & Pike, 2001).  
1.3 
The EDNOS category is reserved for individuals considered to have a clinically 
significant eating disorder, whilst not meeting the specified criteria for AN or BN (see 
Table 1.3). This category includes the provisional diagnostic category of binge eating 
disorder.  
Table 1.3 
DSM-IV-TR diagnostic criteria for Eating Disorder Not Otherwise Specified (American 
Psychiatric Association, 2000) 
DSM-IV-TR Diagnostic Criteria for Eating Disorder Not Otherwise Specified 
Eating Disorders Not Otherwise Specified (EDNOS): Core Features  
1. For females, all the criteria for AN are met except that the individual has regular 
menses.  
2. All the criteria for AN are met except that, despite significant weight loss, the 
individual’s current weight is within normal limits. 
3. All of the criteria for BN are met except that the binge eating and inappropriate 
compensatory behaviours occur at a frequency of less than twice a week or for a 
duration of less than 3 months.  
4. The regular use of inappropriate compensatory behaviour by an individual of 
normal body weight after eating small amounts of food.  
5. Repeatedly chewing and spitting out, but not swallowing, large amounts of food.  
6. Binge-eating disorder: recurrent episodes of binge eating in the absence of the 
regular use of inappropriate compensatory behaviours characteristic of BN.  
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Although the EDNOS category was intended to classify individuals with disorders 
residual to the specific categories subsumed under AN and BN, recent studies have found 
that EDNOS is the most common eating disorder diagnosis made in outpatient settings 
(Martin, Williamson & Thaw, 2000; Ricca, Mannucci, Mezzani, Di Bernado, Zucchi, 
Paionni, Placidi, Rotella, & Faravello, 2001; Turner & Bryant-Waugh, 2004). This 
situation is concerning, given the possibility that EDNOS diagnoses may be considered 
less severe than a diagnosis of AN or BN. Consequently, researchers have argued for a 
review of the classification system. Furthermore, although EDNOS is a common eating 
disorder diagnosis seen by clinicians, it has often been overlooked by researchers, 
particularly in regard to efficacious treatment approaches (Grave & Calugi, 2007). 
Furthermore, little is known about the incidence and prevalence of Binge Eating Disorder 
(BED), which is included under the EDNOS diagnostic criteria of the DSM-IV (Hsu, 
1996). It is estimated that the prevalence of BED in the general population is 
approximately 4% (Wilfley, Agras, Telch, Rossiter, Schneider, Cole, Sifford & Raeburn, 
1993).  
1.4 Assessment  
The current classification system for eating disorders also has limitations. Firstly, 
empirical studies of the current DSM-IV classification have raised several concerns 
including, the individual diagnostic criteria for the eating disorders, the validity of the 
1.4.1 DSM-IV Classification  
The present DSM-IV classification system for the diagnosis of eating disorders has 
several strengths. Firstly, it enables reliable diagnosis through the use of semi-structured 
and clinical interviews (Peterson & Miller, 2005). Secondly, as AN and BN appear to 
demonstrate different longitudinal patterns with regard to recovery (Herzog, Dorer, Keel, 
Selwyn, Ekeblad, Flores, Greenwood, Burwell & Keller, 1999) and mortality (Keel et al., 
2003), diagnostic validity can be inferred (Wonderlich, Joiner, Keel, Williamson & 
Crosby, 2007).  
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AN and BN subtype distinctions, and questions about the validity of the AN, BN and 
EDNOS diagnoses themselves (Franco et al., 2004).  
There is conflicting opinions in the literature concerning the overall relationship between 
the AN, BN and residual EDNOS categories. It is unclear whether each category 
represents a distinct disorder, or whether they are merely a perceived reflection of 
severity. It is clear that patients may frequently move from one diagnosis to another over 
the course of their eating disorder (Zipfel, Lowe, Reas, Deter & Herzog, 2000; Fairburn 
& Harrison, 2003). Indeed it is not uncommon for chronic restrictive AN patients to 
develop binge eating and purging behaviours over time and eventually display symptoms 
consistent with a diagnosis of BN (American Psychiatric Association, 2000).  The present 
structure of the DSM-IV effectively enables diagnosis between an AN and BN category 
to be distinguished by way of an individual’s weight falling below 85% of what would be 
expected. By definition, an individual with AN is below normal weight, individuals with 
BN range from normal to obese and individuals with EDNOS may range from 
underweight to obese. Essentially, a diagnosis of AN overrides a diagnosis of BN which 
in turn overrides a diagnosis of EDNOS. The DSM-IV diagnostic criteria is based on the 
present views regarding AN and BN, which suggest that these disorders are related 
conditions with similar maintenance processes.  
In terms of the criteria for AN, concerns have been raised about the fear of weight gain 
criterion, on the grounds that it may be culturally specific (Wonderlich et al., 2007), 
although this has also been debated (Habermas, 1989; Katzman & Lee, 1997). The 
amenorrhea criterion has been questioned, due to its unreliability as an indicator of 
weight status and its utility for providing comorbidity or outcome information (Garfinkel 
et al., 1996; Anderson, Bowers & Watson, 2001; Herzog & Delinsky, 2001). 
Furthermore, there do not appear to be meaningful differences between individuals with 
AN with and without menses (Watson & Anderson, 2003).  
The criteria for BN has also been criticised for a number of reasons. The definition of a 
binge as being a consumption of food definitely larger than what most people would 
consume has been extremely difficult to operationalise (Rossiter & Agras, 1990; Pratt et 
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al., 1998). Furthermore, the idea that the binge is time limited is not based on empirical 
testing, and the evidence is unclear on whether differentiating between longer or shorter 
binge episodes has any clinical utility (Franko et al., 2004). Finally the criterion that the 
bulimic symptoms must occur twice a week for a three month period has also failed to 
receive empirical support in a number of investigations (Kendler, Maclean, Neale, 
Kessler, Heath & Eaves, 1991; Crow, Agras, Halmi, Mitchell & Kraemer, 2002).  
Another limitation of the DSM-IV classification system is the subtyping within AN 
(binge-purge vs. restricting) and BN (purging vs. non purging).  Early research suggested 
differences between binge-purge and restricting anorexic women, in that the women with 
binge-purge symptoms displayed more co-morbid psychopathology and distress than did 
the restricting only group (DaCosta & Halmi, 1992; Herzog, Keller, Sacks, Yeh & 
Lavori., 1992). However, recent prospective and longitudinal research studies have failed 
to find convincing evidence for differences between the AN subtypes in terms of co-
morbid psychopathology, recovery, relapse or mortality rates (Herzog et al., 1999; Keel 
et al., 2003; Keel et al., 2005). Furthermore, it is well reported that individuals with 
restricting type AN are likely to report some binge – purge behaviours over time (Bulik, 
Sullivan, Fear & Pickering, 1997; Eddy, Keel, Dorer, Delinsky, Franco & Herzog, 2002). 
In terms of the subtyping of individuals with BN, there are very few studies providing 
any support to the validity of these subtypes (Wonderlich et al., 2007).  
In terms of the overall utility of the DSM-IV classification system, recent data has 
suggested that approximately 60% of individuals with eating disorders do not meet 
criteria for either AN or BN (Fairburn & Bohn, 2005; Wade, Crosby & Martin, 2006), 
and instead meet criteria for EDNOS. This is problematic, as the EDNOS category is 
designed to capture a residual group. Furthermore, the disorders within the EDNOS 
group tend to be no less clinically severe than AN or BN (Fairburn & Bohn, 2005). One 
study has suggested that approximately 70% of EDNOS patients move to either AN or 
BN over a 30-month follow up period (Milos, Spindler, Schnyder & Fairburn, 2005). 
Wonderlich et al. (2007) point out that this variation may be better explained by 
fluctuating body weight and symptom severity as opposed to actual transitions from one 
illness to another. Of concern is the potential that individuals with clinically significant 
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eating disorders are diagnosed with EDNOS simply because they fail to meet one of the 
diagnostic criterion.  
These issues raise the possibility that the DSM-IV classification system for eating 
disorders is not functioning as intended. Furthermore, the limitations with the current 
classification system discussed above suggest that there is a need for a more empirically 
based classification of eating disorders to better assist with assessment and treatment 
procedures.  
Reliable and valid diagnostic and outcome assessment of eating disorders is essential to 
defining and describing the course and outcome of AN, BN and EDNOS. Therefore, it is 
clear that eating disorder assessments have a significant impact on clinical care, research 
and social policy. Consequently, standardised assessments are vital for a number of 
reasons including, providing consistent and comprehensive diagnosis, facilitating reliable 
monitoring of course and outcome and providing norms for comparison of clinical status 
and severity (Pike, 2005).  
Unfortunately much of the available eating disorder research utilises self-report 
assessment procedures which form the basis for much of the criticism of such studies. In 
comparison to a self-report assessment, the main disadvantage of a structured interview is 
its time consuming nature and the need for expertise and training to properly conduct 
such an assessment (Pike, 2005). 
1.4.2  Assessment Instruments  
In psychiatric research, it is generally agreed that interview assessments have the 
potential to provide the most accurate data (Pike, 2005). Conducting assessments by way 
of a structured interview enables complex constructs to be thoroughly assessed (e.g., 
definitions of restraint and binge eating) and constructs for which everyday usage differ 
from diagnostic definitions (e.g., dieting and body shape concerns) (Pike, 2005). 
Furthermore, it enables the application of clinical judgement to assess the accuracy and 
reliability of the individual’s report (Pike, 2005), which is often a criticism of self-report 
based questionnaires for diagnosis. 
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In terms of useful structured interviews for the diagnosis of eating disorders, the 
Structured Clinical Interview for DSM-IV (SCID; First, Spitzer, Gibbon & Williams, 
1997) is commonly utilised for diagnosis. However, as the SCID does not provide 
continuous assessment of severity of eating disorder pathology, it should be used in 
conjunction with other instruments to achieve a more thorough assessment (Pike, 2005). 
A more comprehensive interview assessment for the eating disorders is the Eating 
Disorder Examination (EDE; Fairburn & Cooper, 1993). The EDE provides both 
descriptive and continuous data of eating pathology and provides operationally defined 
DSM-IV eating disorder diagnoses (Pike, 2005). Although not as widely utilised, the 
Interview for Diagnosis of Eating Disorders (IDED; Williamson, 1990) and the 
Structured Interview for Anorexic and Bulimic Disorders (SIAB; Fichter, Eleton, Engel, 
Meyer, Mall & Poustka, 1991) also provide categorical and continuous data for the 
assessment of eating disorders (Pike, 2005).  
There are a number of self-report measures with acceptable psychometric properties that 
may be utilised to complement an interview based assessment. Self-report instruments are 
particularly useful in generating continuous data on eating pathology, including binge 
eating, purging and dietary restriction, and attitudinal dimensions such as body shape and 
weight concerns (Pike, 2005). They are also beneficial in assessing clinical status over 
time, and capturing meaningful changes that may not be reflected by clinical diagnosis 
(Pike, 2005). In terms of self-report instruments useful for providing a diagnosis of 
general eating pathology, the Eating Disorder Diagnostic Scale (EDDS; Stice, Telch & 
Rizvi, 2000) is recognized as a good measure as it provides DSM eating disorder 
diagnoses based on self-report data and demonstrates good internal consistency and 
construct validity. The Eating Disorder Examination Questionnaire (EDE-Q; Fairburn & 
Beglin, 1994), is a self-report version of the Eating Disorder Examination (EDE; Fairburn 
& Cooper, 1993) and is recognised as another good measure for identifying general 
eating pathology. The EDE-Q assesses the same attitudinal and behavioural aspects of 
eating disorders as the EDE, over a 28 day time period. 
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The Eating Attitudes Test (EAT-40; Garner & Garfinkel, 1979) and the EDI-3 (Garner, 
2004) are also good measures of eating disorder psychopathology. In terms of self-report 
instruments for measuring dietary restraint, the Dutch Eating Behaviour Questionnaire 
(DEBQ; van Strien, Frijters, Bergers & Defares, 1986) and the Three Factor Eating 
Questionnaire (TFEQ-R; Stunkard & Messick, 1985) are recognized as reasonably sound 
instruments in terms of their psychometric properties.  
 
Self-report instruments for measuring body dissatisfaction and body image disturbance 
include the Body Shape Questionnaire (BSQ; Cooper, Taylor, Cooper & Fairburn, 1987) 
and the Body Image Avoidance Questionnaire (BIAQ; Rosen, Srebnik, Salzberg & 
Wendt, 1991). Finally, in terms of specific self-report measures for binge eating, the 
Binge Eating Scale (BES; Gormally, Black, Daston & Rardin, 1982) demonstrates 
reasonable test-retest reliability and validity.  
 
The use of assessment measures is of particular importance when addressing issues 
relating to comorbidity.  
 
1.5 Comorbidity of Mental Disorders  
Psychiatric comorbidity amongst individuals suffering from eating disorders is extremely 
common. In the last few decades there has been increased research investigating the 
prevalence of comorbidity amongst the eating disorders. The findings from this research 
indicated that identifying comorbid psychiatric illnesses is extremely important in terms 
of the etiological perspectives of eating disorders and also in driving evidenced based 
treatment approaches. Of the common comorbid psychiatric illnesses, mood disorders, 
anxiety disorders and personality disorders are most frequently implicated (Carroll, 
Touyz & Beumont, 1996; Råstam, Gillberg & Gillberg, 1995). As the comorbidity 
between eating and anxiety disorders is discussed extensively in chapters 3 and 4, the 
comorbidity with mood, substance abuse and personality disorders is discussed below.  
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Research into comorbidity amongst the eating disorders has found that mood disorders 
are frequently diagnosed. The lifetime prevalence of affective disorders in patients with 
eating disorders has been estimated to be approximately 70% (Råstam et al., 1995; Halmi 
et al, 1991). Furthermore, it has been suggested that major depression is the most 
common comorbid psychiatric condition in both AN and BN (O’Brien & Vincent, 2003).  
In an AN sample, Råstam (1992) reported that 40% met criteria for a current diagnosis of 
major depressive disorder, and this figure went up to 90% for a lifetime mood disorder.  
In BN samples, clinical depression has been identified in between 20 – 40% of subjects 
(Brewerton et al., 
1.5.1 Mood Disorders 
1995; Garfinkel, Lin, Goering, Spegg, Goldbloom, Kennedy, Kaplan & 
Woodside, 1995).  
Studies consistently report that individuals with eating disorders frequently report 
comorbid substance abuse disorders. This is particularly evident amongst the binge/ 
purge subtypes of AN and BN (Holderness, Brooks-Gunn, & Warren, 
1.5.2 Substance-Abuse Disorders  
1994; O’Brien & 
Vincent, 2003). One study found that 61 – 67% of their BN sample reported hazardous 
levels of alcohol consumption, compared with approximately 36% of the control group 
(Kozyk, Touyz & Beumont, 1998). Interestingly, eating disorder symptoms have also 
been reported to be higher than expected in females with substance abuse disorders 
(Schukit, Tipp, Anthenelli, Bucholz, Hesselbrock, & Nurnberger, 1996).  
Axis II comorbidity amongst eating disorder patients is reported to be high, with one 
study reporting Axis II comorbidity in over 30% of a BN sample compared with less than 
7% of controls (Carroll et al., 1996). A meta-analysis of 28 studies (Rosenvinge, 
Martinussen, & Ostensen, 
1.5.3 Personality Disorders  
2000) found that 58% of eating-disordered women met criteria 
for a personality disorder compared with 28% of comparison women. Furthermore, they 
reported that BN patients demonstrated higher proportions of Cluster-B personality traits 
(44% overall) compared with AN patients or controls (Rosenvinge et al., 2000). Cluster 
A personality disorders were equivalent in both AN and BN groups.   
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Gartner, Marcus, Halmi & Loranger (1989) reported that 25.7% of their AN sample met 
diagnostic criteria for OCPD. Interestingly, none of their BN sample met criteria for 
OCPD leading to the speculation that this personality feature is more consistent with 
individuals with AN (Gartner et al., 1989). However, Rossiter, Agras, Telch & Schneider 
(1993) reported that 10% of their BN sample met criteria for OCPD. Thornton and 
Russell (1997) reported that 19% met criteria for comorbid OCPD, and this was almost 
exclusively found in the AN sample. Lilenfeld, Kaye, Greeno, Merikangas, Plotnicov, 
Pollice, Rao, Strober, Bulik & Nagy (1998) reported that AN probands had higher rates 
of OCPD lending support to reports of perfectionism and inflexibility among individuals 
with restricting type AN. Lilenfeld et al. (1998) also found that 31% of AN probands met 
criteria for OCPD and OCD, leading to the suggestion that individuals with OCPD may 
be more vulnerable to the development of OCD than those without this personality 
pattern.  
Given the well documented adverse effects of malnutrition upon personality functioning 
(Keys, Brozek, Henschel, Mickelson, & Taylor, 1950), it is extremely important for 
studies to distinguish between symptoms that are secondary to the eating disorder and 
those that reflect stable trait patterns. Several studies investigating recovered eating 
disorder patients for comorbid personality disorders found that personality disorders were 
still prevalent even after recovery and weight restoration (Nilsson, Gillberg, Gillberg, & 
Råstam, 1999; Matsaunaga, Kaye, McConaha, Plotnicov, Pollice, & Rao, 2000).  
 
The literature investigating comorbidity amongst eating disorders suggests that existing 
treatment approaches may fail to adequately address comorbid diagnoses, targeting only 
the eating disorder symptoms. This is particularly problematic when considering that 
comorbid diagnoses may have preceded the onset of the eating disorder and furthermore, 
may play a role in the maintenance of eating pathology. Although this will be addressed 
in proceeding chapters, it is necessary to first provide a brief overview of the current 
evidenced-based approaches for the treatment of eating disorders.   
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1.6 Treatment  
To date, family therapy is the most extensively researched treatment for AN, and the 
results have generally been encouraging. The best studied approach is a specific form of 
family therapy known as the Maudsley model (Dare & Eisler, 1997; Lock & Le Grange, 
2005). The Maudsley model was first tested as a means of preventing weight loss post 
hospitalisation in subgroups of AN patients (Russell, Szmukler, Dare & Eisler, 1987). 
The findings indicated that younger patients with more recent onset responded well to 
conjoint family therapy, with 90% symptom free at 5 years. Furthermore, this approach 
was far more effective than a dynamically oriented approach (Russell et al., 1987; Eisler, 
Dare, Hodes, Russell, Dodge & le Grange, 2000). For patients with a longer history of 
illness and older age at onset, neither approach appeared beneficial (Wilson et al., 2007). 
Despite the encouraging research results supporting a family therapy based approach for 
AN, several researchers suggest that these results have been widely misunderstood 
(Fairburn, 2005; Vitousek & Gray, 2005). One criticism stems from the possibility that 
the favourable results may simply reflect the characteristics of the samples to which this 
approach has been delivered (Fairburn, 2005; Vitousek & Gray, 2005). Furthermore, in 
both the controlled and naturalistic studies, outcomes for young adolescents have been 
much more promising than the aggregate 50% recovery rate cited for all patients with AN 
1.6.1 Anorexia Nervosa 
The available research investigating the effective treatments for AN is weak (Berkman, 
Bulik, Brownley & Lohr, 2006). Over the last two decades, as few as 15 comparative 
trials have been completed and published. The paucity of controlled treatment research in 
AN is attributable to several factors associated with the disorder, including its rarity, the 
presence of medical complications sometimes requiring management in an inpatient 
setting and the protracted treatment period often necessary for full remission of 
symptoms (Wilson, Grilo & Vitousek, 2007). Motivational factors also play a role in the 
difficulty researching this population (Agras, Brandt, Bulik, Dolan-Sewell, Fairburn, 
Halmi, Herzog, Jimerson, Kaplan, Kaye, le Grange, Lock, Mitchell, Rudorfer, Street, 
Striegel-Moore, Vitousek, Walsh & Wilfley, 2004).  
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(Steinhausen, 2002; Nilsson & Hagglof, 2005). Much of the research has also suggested 
that symptom duration is a strong predictor of response to family therapy, where patients 
with a 16 month or longer history respond more poorly than those with an 8 month 
history (Eisler et al., 2000).  
The final criticism comes from the evidence of two randomised controlled trials 
comparing the conjoint format with a separated version, in which the anorexic child and 
parents attend different sessions (le Grange, Eisler, Dare & Russell, 1992; Eisler et al., 
2000). Despite both trials finding a favourable trend towards the theoretically less 
preferred separated format, the treatment manual strongly recommends the conjoint 
model for treatment (Wilson et al., 2007).   
Cognitive behaviour therapy (CBT) is the most frequently investigated individual 
treatment for AN, however, results are difficult to interpret due to the methodological 
limitations of these studies (Wilson et al., 2007). A cognitive behavioural framework for 
conceptualising and treating AN was initially described by Garner & Bemis (1982 & 
1985) and Garner, Vitousek & Pike (1997). Since the original postulation of this 
framework, there have been many variations of this approach (Kleifield, Wagner & 
Halmi, 1996; Wolff & Serpell, 1998; Fairburn, Shafran & Cooper, 1999; Fairburn, 
Cooper & Shafran, 2003), however they all broadly overlap with respect of their 
theoretical framework and strategies.  Generally, all CBT approaches stress the 
importance of motivational issues, the problems associated with starvation and the need 
for weight gain (Garner et al., 1997).   
Three studies have compared CBT with one or more alternative psychotherapies 
(Channon, de Silva, Hemsley & Perkins, 1989; Ball & Mitchell, 2004; McIntosh, Jordan, 
Carter, Luty, McKenzie, Bulik, Frampton & Joyce, 2005). In each of these studies, no 
clear differences were found between CBT and comparison conditions (Wilson et al., 
2007). It is noted that the methodological limitations of these studies limit the general 
application of the results. Unfortunately, another three randomised controlled trials also 
had methodological limitations, specifically the use of a non psychological comparative 
condition, which limits the ability to assess the efficacy of the CBT condition (Wilson et 
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al., 2007). Two of these studies compared CBT to nutritional counselling (Serfaty, 
Turkington, Heap, Ledsham & Jolley, 1999; Pike, Walsh, Vitousek, Wilson & Bauer, 
2003) whilst the other compared CBT with fluoxetine and a combined treatment group 
(Halmi, Agras, Crow, Mitchell, Wilson, Bryson & Kraemer, 2005).  
Finally, as research and clinical practice suggests, AN can be a notoriously difficult 
population to treat. Due to their resistance to treatment, AN patients have been likened to 
patients with substance abuse problems (Vitousek, Watson & Wilson, 1998). 
Consequently, research has focussed on the inclusion of motivational approaches used in 
the field of addictions to treat eating disorders. Specifically, Motivational Enhancement 
Therapy (MET) is derived from integrating the transtheoretical model of change 
(Prochaska & DiClemente, 1992) with the skills of motivational interviewing (Miller & 
Rollnick, 1991). There is increasing support for the use of interventions designed to 
enhance readiness to change amongst individuals with eating disorders (Garner & Bemis, 
1982; Vitousek, 1995; Pike, Loeb & Vitousek, 1996; Garner et al., 1997; Killick & Allen, 
1997; Levy, 1997; Strober, 1997; Treasure & Ward, 1997; Vitousek et al., 1998). 
Nevertheless, there remains a lack of well controlled research to review the use of MET 
in this treatment population. One pilot study found that motivational enhancement may 
improve engagement and result in behaviour change and early weight gain in adolescents 
with AN (Gowers & Smyth, 2004).  
1.6.2 Bulimia Nervosa 
Antidepressant medications and CBT have become well established as effective 
treatments for BN (Shafran, Keel, Haedt & Fairburn, in press). Manual based cognitive 
therapy (MBCT) is the most researched evidence-based treatment for BN and 
interpersonal psychotherapy has also received some empirical support (Wilson et al., 
2007). Most of the research in BN involves outpatient populations, as generally the vast 
majority of patients can be treated in this setting, unless these are contraindications such 
as suicidality or self harm (Wilson et al., 2007).  
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MBCT is based on the cognitive model for BN, implicating over-concern with body 
shape and weight as the core pathology leading to eating disorder behaviours (Fairburn, 
Marcus & Wilson, 1993). Typically treatment involves enhancing motivation for change, 
replacing dysfunctional dieting with a regular and flexible pattern of eating, decrease in 
the concern with body shape and weight and relapse prevention (Wilson et al., 2007). 
Treatment usually consists of between 16 to 20 individual sessions, however group 
therapy has also been successful (Chen, Touyz, Beumont, Fairburn, Griffiths, Butow, 
Russell, Schotte, Gertler & Basten, 2003; Nevonen & Broberg, 2006). MBCT for adults 
has been shown to be superior to other psychological treatments, at least in the short term 
(Wilson & Fairburn, 2002).  
Other approaches to the treatment of BN include interpersonal psychotherapy (IPT), 
which was originally developed for the treatment of depression (Klerman, Weissman, 
Rounsaville & Chevron, 1984). The rationale for the use of this therapeutic approach 
stems from the observation that an eating disorder often develops during late adolescence 
and early adulthood, during which time, interpersonal difficulties are prevalent (Crafti, 
2002). Subsequently, it has been hypothesised that binge eating is not only triggered by, 
but becomes a coping strategy for the negative affect elicited by interpersonal problems 
(Klerman et al., 1984).  Fairburn, Jones, Peveler, Hope & O’Connor (1993), adapted this 
treatment approach for BN, the emphasis of which is on identifying and modifying the 
interpersonal problems that are hypothesised to be maintaining the eating disorder. This 
treatment tends to be both non-directive and non-interpretive and does not directly focus 
on the eating disorder symptoms (Wilson et al., 2007).  
One study has reported that interpersonal psychotherapy was inferior to CBT at post 
treatment but equally effective at one and six year follow-ups (Fairburn, Jones, Peveler, 
Hope & O’Connor, 1993). Similar results have been reported by Agras, Walsh, Fairburn, 
Wilson & Kraemer (2000), where manual based CBT was found to be significantly 
superior to interpersonal psychotherapy at post-treatment, however at one year follow up 
there was no statistical difference. Crafti (2002) combined CBT with interpersonal 
components in a group setting and found significant improvements in binge eating and 
purging symptoms compared with a wait list control group.   
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Finally, given the evidence that links bulimic symptoms with negative emotions (Polivy 
& Herman, 1993; Telch & Agras, 1996; Agras & Telch, 1998), there has been increased 
interest in treatment specifically developed to target these difficulties with affect 
regulation strategies in BN (Esplen, Garfinkel, Olmsted, Gallop & Kennedy, 1998) and 
binge eating disorder (Telch, Agras & Linehan, 2000). Dialectical behaviour therapy 
(DBT; Linehan, 1993a & 1993b), was developed as a treatment for borderline personality 
disorder and is currently regarded as the most comprehensive and empirically validated 
affect regulation treatment (Safer, Telch & Agras, 2001). Generally the research 
investigating the use of DBT for BN has returned positive results, and specific strategies 
of DBT have been incorporated within CBT for BN (Wilson et al., 2007). In particular, 
training in mindfulness, distress tolerance and emotional regulation appear to be useful 
for addressing the high levels of negative affect that are frequently observed in BN (Stice 
& Agras, 1999; Fairburn, Stice, Cooper, Doll, Norman & O’Connor 2003). Safer et al. 
(2001) found that the use of DBT was associated with a decrease in bingeing and purging 
behaviours. Although this study was limited by the small number of participants, the 
results are nevertheless promising, and suggest that further research is necessary to 
determine the effectiveness of DBT for the treatment of BN.   
Fairburn, Cooper & Shafran (2003) developed an enhanced manual for the treatment of 
the full range of eating disorders, expanding on their previous body of work which 
identified the mechanisms involved in the maintenance of BN, on which the original CBT 
(Fairburn, Marcus & Wilson, 1993) was based. Furthermore, Ghaderi (2006) has 
1.6.3 Eating Disorders Not Otherwise Specified  
As previously discussed, the EDNOS category consists of variations of BN, AN and 
binge eating disorder, for which the provisional criteria are available (American 
Psychiatric Association, 2000).  Despite the prevalence and clinical severity of EDNOS, 
there is a paucity of published controlled treatment trials, with the exception of the binge 
eating disorder category (Wilson et al., 2007). It would appear however, that the existing 
evidence based treatment approaches may also be useful for the full range of eating 
disorders (Wilson et al., 2007). 
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suggested that a broader, more individualised CBT approach is superior to a more 
focussed, standardised CBT treatment for BN.  
In contrast to BN, there have been very few well controlled studies on the treatment of 
binge eating disorder. Research interventions have more recently stemmed from the 
approaches used to treat BN, such as CBT and interpersonal psychotherapy (Wilson et 
al., 2007). CBT for binge eating disorder (Fairburn, Marcus & Wilson, 1993) uses an 
adapted version of the cognitive model of BN, however there is increasing evidence to 
suggest that the eating pattern observed in binge eating disorder is much less restrictive 
than in BN (Masheb & Grilo, 2000). Overall the controlled trials for binge eating disorder 
support the use of CBT, as reductions in binge eating and other associated problems 
(except weight loss) have been reported to be significantly superior to those of controls 
(Wilfley et al.,  1993). Furthermore, studies have also indicated that gains are maintained 
at 12 month follow up (Agras, Telch, Arnow, Eldredge & Marnell, 1997; Wilfley, Welch, 
Stein, Spurrell, Cohen, Saelens, Dounchis, Frank, Wiseman & Matt, 2002).  
In terms of alternative psychological approaches, interpersonal therapy has also proven 
effective, as studies have reported outcomes identical to those for CBT (Wilfley et al., 
1993 & 2002). DBT has also demonstrated efficacy (relative to wait list controls) and 
impressive outcome results, with 56% remission rates observed at 6 month follow up 
(Telch, Agras & Linehan, 2001).  
The literature investigating the treatment of eating disorders gives rise to the importance 
of considering outcome studies in eating disorder populations. This is briefly addressed 
below.  
1.7 
Follow up studies of the eating disorders suggest varied outcomes ranging from recovery 
to death (Berkman, Lohr & Bulik, 2007; Keel, Mitchell, Davis, Fieselman & Crow, 
2000). Relapse rates range from 22% to 51% across outcome studies of AN and BN 
(Keel et al., 2005). A recent study found that at 10 years follow up, 11% of AN and 10% 
of BN patients met recovery criteria, and at 15 years this increased to 16% for AN and 
Outcome  
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25% for BN (von Holle, Poyastro Pinheiro, Thornton, Klump, Berrettini, Brandt, 
Crawford, Crow, Fichter, Halmi, Johnson, Kaplan, Keel, LaVia, Mitchell, Strober, 
Woodside, Kaye & Bulik, 2008). Interestingly, this study also found that the BN group 
had three times the rate of recovery at 10 – 14 years than the AN group (von Holle et al., 
2008).  There have been a number of studies investigating outcome in the eating 
disorders. However, differences in approach and method across these studies have made 
it difficult to compare and draw inferences from them.  Methodological differences 
across studies include the duration and method of follow up, assessment procedures used, 
sample size and attrition rate of the participants (Herzog, Nussbaum & Marmor, 1996).  
Importantly, many studies have utilised different definitions of outcome, or recovery 
presumably at least partly due to a lack of consensus in the eating disorders field on what 
constitutes recovery (Walsh, 2008). More recently, studies have tended to utilise 
consistent criteria to measure outcome, such as those of Morgan & Russell (1975). 
Across the eating disorders, there appear to be several predictors of poor outcome that are 
consistently supported by research. Among these predictors are very low body weight, 
long duration of illness, premorbid developmental or clinical abnormalities, bulimic 
symptoms (including the use of purgatives) and disturbed family relationships (Herzog, 
Nussbaum & Marmor, 1996). Furthermore, Baran, Weltzin & Kaye (1995) found that 
low weight at discharge was a significant indicator of poor outcome.  
The course and outcome of AN is highly variable. The research appears to suggest that 
some individuals will obtain a complete recovery, some display a fluctuating pattern of 
weight gain and relapse and others will exhibit a chronically deteriorating course of 
illness over many years (American Psychiatric Association, 2000). Remission rates for 
AN range from 31% to 76% (Strober, Freeman & Morrell, 1997; Herzog et al., 1999; 
Carter, Blackmore, Sutandar-Pinnock & Woodside, 2004; Clausen, 2004; Keel et al., 
2005; Couturier & Lock, 2006; Fichter, Quadflieg & Helund, 2006). Although research 
outcomes are varied, it is clear that once symptoms of AN have persisted for several 
years, the course of the illness appears to be relatively unremitting (Steinhausen, 2002).  
1.7.1 Anorexia Nervosa  
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In terms of research studies investigating longer term outcome in eating disorders, a 
prospective cohort study found at 5 year follow up that 59% of patients with AN were 
considered recovered (Gillberg, Råstam & Gillberg, 1994a; Gillberg, Råstam & Gillberg, 
1994b; Råstam, Gillberg & Gillberg, 1995). However the AN group were significantly 
less likely than controls to have been at normal body weight during the previous 6 
months. Furthermore, they also displayed significantly higher scores on measures of 
eating disorder symptomatology. At 10 years follow up, 27% still met criteria for an 
eating disorder and they continued to display more eating disorder symptomatolgy than 
the control group (Nilsson et al., 1999; Wentz, Gillberg, Gillberg & Råstam, 2001; 
Råstam, Gillberg & Wentz, 2003). Another study reported 30% recovery rate of AN 
patients at 12 year follow up, and similarly they reported that regardless of eating 
disorder status, all AN groups continued to display worse eating related outcomes than 
controls (Sullivan, Bulik, Fear & Pickering, 1998; Bulik, Sullivan, Fear & Pickering, 
2000).  A US study found similar results after 10 year follow up, with approximately 
27% of their AN group no longer meeting diagnostic criteria for an eating disorder 
(Halmi et al., 1991).  
Several studies have identified risk factors for poor outcome in AN which include, an 
extreme compulsive drive to exercise and a history of poor social relationships prior to 
onset of illness (Strober et al., 1997). Conversely, predictors of a more favourable 
outcome include less purging behaviour (Deter, Schellberg, Kopp, Friederich & Herzog, 
2005) and fewer social disturbances (Deter & Herzog, 1994). Furthermore, recovered 
patients were less likely to have major affective disorder or anxiety disorders (Eckert, 
Halmi, Marchi, Grove & Crosby, 1995). Not surprisingly, a shorter duration of the AN 
episode significantly predicted recovery after 4 years (Herzog, Field, Keler, West, 
Robbins, Staley & Colditz, 1996) and 8 years (Herzog et al., 1999). In terms of 
psychological risk factors, one study reported that the absence of a mood disorder was 
significantly associated with resolution of the eating disorder (Gillberg et al., 1994b).  
In terms of psychological outcomes, one study found at 5 year follow up that the AN 
group were significantly more likely to have personality disorders (in particular avoidant, 
dependent & obsessive-compulsive) and greater rates of OCD, Asperger’s syndrome and 
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any autistic like condition, compared with the comparison group (Gillberg, Råstam & 
Gillberg, 1995). Similar findings have been reported after 10 years follow up (Wentz, 
Gillberg, Gillberg & Råstam 2000; Wentz et al., 2001; Råstam et al., 2003). AN has also 
been associated with a lifetime prevalence of depression (Ivarsson, Råstam, Wentz, 
Gillberg & Gillberg, 2000).  
One study comparing individuals with BN with a no illness control group found at 12 
year follow up that the BN group (including those who had recovered) were significantly 
more symptomatic than the comparison group (Fichter & Quadflieg, 2004). Nevertheless, 
at follow up, 67% of the BN group did not meet criteria for an eating disorder. Studies 
with no comparison groups have yielded mixed results. At 5 year follow up BN patients 
had improved on a variety of measures including a reduction in objective binge episodes 
and purging behaviours (Fairburn, Norman, Welch, O’Connor, Doll & Peveler, 1995; 
Fairburn, Cooper, Doll, Norman & O’Connor, 2000; Fairburn, Stice, Cooper, Doll, 
Norman & O’Connor, 2003; Stice & Fairburn, 2003). In a US study, at 7 years follow up, 
73% had remained symptom free for a period of 8 consecutive weeks (Herzog et al., 
1999). The US study also reported that after testing predictors of outcome, such as 
1.7.2 Bulimia Nervosa  
The course and outcome of BN appears to be more favourable than that of AN with many 
individuals displaying a decrease in symptoms at long term follow up. Periods of 
remission of longer than 1 year are generally associated with a better long term prognosis 
(American Psychiatric Association, 2000). The course of BN may be chronic or 
intermittent, with periods of remission alternating with recurrences of binge eating 
(American Psychiatric Association, 2000). Estimates of remission for BN range between 
21% and 75% (Field, Herzog, Keller, West, Nussbaum & Colditz, 1997; Herzog et al., 
1999; Keel, Mitchell, Miller, Davis & Crow, 1999; Clausen, 2004; Fichter & Quadflieg, 
2004; Keel et al., 2005; Olmsted, Kaplan & Rockert, 2005). Generally, individuals with 
BN appear to derive benefit from antidepressant medication and psychotherapy, and 
continue to recover from their illness over time (Keel & Mitchell, 1997; Fairburn, 
Cooper, Doll, Norman & O’Connor, 2000).  
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duration of illness, age at onset, weight, binge/purge frequency and co-morbid psychiatric 
conditions) none were significant. Fichter & Quadflieg (2004) found that lifetime 
psychiatric comorbidity predicted a significantly higher probability of having any eating 
disorder at 2 and 6 years, but not 12 years. Fichter & Quadflieg (1997 & 2004) also 
reported that psychiatric comorbidities were only associated with the BN group and not 
the comparison group. Furthermore, this study found that at 12 years, 41% had a 
psychiatric disorder in the month prior to assessment, with 50% of those suffering from 
major depression and 36% meeting criteria for an anxiety or substance use disorder 
(Fichter & Quadflieg, 2004).  
1.8 
1.7.3 Eating Disorder Not Otherwise Specified  
In terms of outcome studies investigating binge eating disorder, there are several case 
series studies, one involving a comparison group, from which outcome results may be 
inferred. In a German study, at 6 year follow up, 78% had no eating disorder diagnosis, 
6% continued to meet criteria for binge eating disorder and a minority had developed BN 
over the follow up interval (Fichter, Quadflieg & Gnutzmann, 1998). This study also 
reported an improvement in depression, anxiety and obsessionality measures. Another 
study reported a poorer outcome at 1 year follow up, in terms of a greater number of 
reported binge days, for individuals with cluster B personality disorders (Wilfley, 
Friedman, Dounchis, Stein, Welch & Ball, 2000).  
Future models of eating disorder classification and assessment will have enormous 
implications on the empirical research and treatment development available for this 
serious psychopathology. It is clear that the present system for eating disorder 
classification, the DSM-IV, whilst significantly better than its predecessors, has inherent 
problems limiting its effectiveness and subsequently clinical utility. Ultimately the 
development of more effective eating disorder treatments will depend not only on 
improved classification and assessment systems, but also a better understanding of the 
mechanisms by which psychological treatments produce therapeutic change (Kraemer, 
Summary  
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Wilson, Fairburn & Agras, 2002). In terms of the assessment instruments used to 
diagnose eating disorders both in clinical practice and research, it is clear from the 
literature, that the use of a structured clinical interview is vital for obtaining reliable 
diagnoses. Although self-report questionnaires are favoured due to their ease of 
administration and less time consuming nature, they should not be relied upon for 
diagnostic purposes and should only be used in conjunction with a clinical interview.  
It is clear from the literature, that comorbid psychiatric illnesses are prevalent amongst 
the eating disorders. In particular, mood and anxiety disorders, substance abuse disorders 
and personality disorders, feature prominently. Subsequently, assessment procedures 
must also take into account the possibility of comorbid psychiatric illnesses, and in 
particular the temporal and functional relationships between comorbid disorders.  The 
issue of comorbidity will be addressed in greater detail in the following chapters.  
In terms of evidence based treatment approaches, whilst the research for efficacious 
treatments for AN is variable, generally family therapy and cognitive therapy obtain more 
favourable outcomes. For BN and binge eating disorder, the research tends to favour the 
use of CBT, IPT and DBT. It is clear across all eating disorder groups that the use of 
motivational therapy is vital regardless of the therapeutic approach. In terms of outcome, 
there are difficulties associated with drawing inferences from the available literature due 
to the varied methodological approaches utilised. Nevertheless, the outcomes of 
individuals with BN tend to be more consistently favourable than those for AN. It is clear 
that further research is essential in this area.  
As outlined in this chapter, the issue of psychiatric comorbidity amongst the eating 
disorders has received a great deal of interest to date. The purpose of the current study is 
to explore this area in greater depth. The following chapter provides a summary of the 
current literature concerning assessment and treatment of anxiety disorders, as well as 
providing an outline of the core features of anxiety disorders and psychiatric comorbidity 
associated with each disorder. Chapter 2 is important in providing background to the 
following chapters discussing the comorbidity between eating disorders and anxiety 
disorders.   
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CHAPTER 2 
INTRODUCTION TO THE ANXIETY DISORDERS 
As discussed in the previous chapter, the comorbidity between eating disorders and other 
Axis I disorders has been well established. In particular, anxiety disorders have more 
recently been implicated. Prior to discussing comorbidity between eating and anxiety 
disorders, a review of the current anxiety disorder literature, including a brief review of 
the DSM-IV diagnostic criteria for each of the anxiety disorders, is presented in this 
chapter.  
 
Anxiety is a universal phenomenon experienced by most human beings within the course 
of their lifetime (Di Tomasso & Gosch, 2002). Barlow & Cerny (1988) define anxiety as 
an unpleasant affective experience marked by a significant degree of apprehensiveness 
about the potential of future aversive or harmful events. It has been estimated that 
approximately 15% of the population are affected by an anxiety disorder at some point 
throughout their lifetime (Brown & Barlow, 1992). It is important to distinguish between 
the experience of anxiety in one’s life, and what characterises an anxiety disorder, and 
furthermore, to clearly delineate between primary anxiety symptomatology and those 
symptoms secondary to other Axis I disorders.  
 
Essentially an anxiety disorder diagnosis necessitates a frequency, intensity, severity, 
breadth and mix of symptoms, which are significant enough to adversely impact on 
social, occupational or other areas of functioning of an individual’s life (American 
Psychiatric Association, 2000). The DSM IV classification system for anxiety disorders 
is comprised of panic disorder, panic disorder with agoraphobia, specific phobia, social 
phobia, generalized anxiety disorder, post traumatic stress disorder, acute stress disorder 
and anxiety disorder not otherwise specified. Each of these disorders are discussed below.  
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2.1 
 (8) feeling dizzy, unsteady, lightheaded, or faint 
Panic Disorder and Agoraphobia: Core Features  
The essential feature of panic disorder is the presence of recurrent, unexpected panic 
attacks followed by at least one month of persistent concern about having another panic 
attack (American Psychiatric Association, 2000; see Table 2.1.1). Individuals with this 
disorder will also report concerns about the possible implications or consequences of the 
panic attacks (such as death, collapse or madness), and or display significant behavioural 
change as a result of these attacks. It is important to note that the DSM-IV specifies that 
for panic disorder to be present, the panic attacks must be unexpected, that is, the 
individual does not immediately associate it with a situational trigger, and it is perceived 
as occurring “out of the blue” (American Psychiatric Association, 2000, p434). 
Nevertheless, as a result of the experience of anxiety, people may begin to associate the 
experience with a particular situation or context, such as driving a car, or attending a 
shopping centre.  
Table 2.1.1 
DSM-IV-TR criteria for Panic Attack (American Psychiatric Association, 2000) 
DSM-IV-TR Criteria for Panic Attack   
A discrete period of intense fear or discomfort, in which four (or more) of the following 
symptoms developed abruptly and reached a peak within 10 minutes:  
 (1) palpitations, pounding heart, or accelerate heart rate 
 (2) sweating  
 (3) trembling or shaking 
 (4) sensations of shortness of breath or smothering  
 (5) feeling of choking 
 (6) chest pain or discomfort  
 (7) nausea or abdominal distress  
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Table 2.1.1 (continued) 
 (9) derealisation (feelings of unreality) or depersonalisation (being detached from 
oneself)  
 (10) fear of losing control or going crazy  
(11) Fear of dying  
(12) Paresthesias (numbness or tingling sensations)  
(13) Chills or hot flushes  
 
 
Additional features associated with the diagnosis of Panic Disorder include assessment 
for the presence of Agoraphobia (see Table 2.1.2). The essential feature of Agoraphobia 
is anxiety about being in public places or situations, from where escape or receiving 
assistance may be unavailable in the event of an individual having a panic attack. 
Subsequently, this anxiety leads to pervasive avoidance of a variety of situations and 
places. Some individuals, who do expose themselves to these situations, do so with 
intense dread and discomfort. The DSM-IV allows for the coding of Panic Disorder with 
or without agoraphobia (American Psychiatric Association, 2000; see Table 2.1.3 and 
Table 2.1.4). Agoraphobia may also be associated with a more limited form of panic 
called limited symptom attacks, which does not meet the diagnostic criteria for panic 
disorder (Di Tomasso & Gosch, 2002). Furthermore, The DSM-IV provides diagnostic 
criteria for agoraphobia without a history of panic disorder (see Table 2.1.5).  
 
The age of onset for Panic Disorder varies considerably, but onset is typically between 
late adolescence and the mid-30’s (American Psychiatric Association, 2000). 
Furthermore, the DSM-IV notes that there may be a bimodal distribution, with one peak 
in late adolescence and a second peak in the mid-30’s. Although rare, a small number of 
cases may begin in childhood or onset after age 45 years (American Psychiatric 
Association, 2000).  
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According to the DSM-IV, lifetime prevalence rates of Panic Disorder (with or without 
Agoraphobia) in community samples have been reported to be between 1 – 3.5%. One 
year prevalence rates are between 0.5 – 1.5%. The prevalence rates in clinical samples 
are considerably higher, and may be around 10% in mental health settings (American 
Psychiatric Association, 2000). In an Australian study surveying the rates of DSM-IV 
disorders in a large mixed gender sample, Panic Disorder with and without Agoraphobia 
had a 12 month prevalence rate of 1.1%, whilst Agoraphobia without Panic Disorder had 
a 12 month prevalence rate of 0.5% (Andrews, Henderson & Hall, 2001).  
Table 2.1.2 
DSM-IV-TR criteria for Agoraphobia (American Psychiatric Association, 2000) 
DSM-IV-TR Criteria for Agoraphobia   
A. Anxiety about being in places or situations from which escape might be difficult 
(or embarrassing) or in which help may not be available in the event of having an 
unexpected or situationally predisposed Panic Attack or panic-like symptoms. 
Agoraphobic fears typically involve characteristic clusters of situations that 
include being outside the home alone; being in a crowd or standing in a line; 
being on a bridge; and travelling in a bus, train or automobile.  
B.  The situations are avoided (e.g., travel is restricted) or else are endured with 
marked distress or with anxiety about having a Panic Attack or panic-like 
symptoms, or require the presence of a companion.  
C. The anxiety or phobic avoidance is not better accounted for by another mental 
disorder, such as Social Phobia, Specific Phobia, Obsessive-Compulsive Disorder, 
Posttraumatic Stress Disorder, or separation Anxiety Disorder.  
 
 
 54 
Table 2.1.3 
DSM-IV-TR diagnostic criteria for Panic Disorder Without Agoraphobia (American 
Psychiatric Association, 2000) 
DSM-IV-TR Diagnostic Criteria for Panic Disorder Without Agoraphobia   
A. Both (1) and (2):  
(1) recurrent unexpected Panic Attacks  
(2) at least one of the attacks has been followed by 1 month (or more) of one (or 
more) of the following:  
(a) persistent concern about having additional attacks  
(b) worry about the implications of the attack or its consequences 
(e.g., losing control, having a heart attack, and “going crazy”) 
(c) a significant change in behaviour related to the attacks  
B. Absence of Agoraphobia  
C. The panic Attacks are not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or a general medical condition (e.g., hyperthyroidism).  
D. The Panic Attacks are not better accounted for by another mental disorder such as 
Social Phobia, Specific Phobia, Obsessive-Compulsive Disorder, Posttraumatic Stress 
Disorder, or separation Anxiety Disorder.  
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Table 2.1.4 
DSM-IV-TR diagnostic criteria for Panic Disorder With Agoraphobia (American 
Psychiatric Association, 2000) 
DSM-IV-TR Diagnostic Criteria for Panic Disorder With Agoraphobia   
A. Both (1) and (2):  
(1) recurrent unexpected Panic Attacks  
(2) at least one of the attacks has been followed by 1 month (or 
more) of one (or more) of the following:  
(a) persistent concern about having additional attacks  
(b) worry about the implications of the attack or its consequences 
(e.g., losing control, having a heart attack, and “going crazy”) 
(c) a significant change in behaviour related to the attacks  
B. The presence of Agoraphobia  
C. The panic Attacks are not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or a general medical condition (e.g., hyperthyroidism).  
D. The Panic Attacks are not better accounted for by another mental disorder such as 
Social Phobia, Specific Phobia, Obsessive-Compulsive Disorder, Posttraumatic Stress 
Disorder, or separation Anxiety Disorder.  
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Table 2.1.5 
DSM-IV-TR diagnostic criteria for Agoraphobia Without a History of Panic Disorder 
(American Psychiatric Association, 2000) 
DSM-IV-TR Diagnostic Criteria for Agoraphobia Without a History of Panic 
Disorder 
A. The presence of Agoraphobia related to a fear of developing panic–like symptoms 
(e.g., dizziness or diarrhoea).  
B. Criteria have never been met for Panic Disorder 
C. The disturbance is not due to the direct physiological effects of a substance (e.g., 
a drug of abuse, a medication) or a general medical condition  
D. If an associated general medical condition is present, the fear described in 
Criterion A is clearly in excess of that usually associated with the condition.  
 
 
2.2 
The essential feature of Specific Phobia is marked and persistent fear of certain objects or 
situations (American Psychiatric Association, 2000; see Table 2.2.). These situations or 
objects may include (but are not limited to): animals, heights, storms, water, 
blood/injection/injury, air travel, enclosed spaces, driving or dental/medical procedures. 
Exposure to the phobic stimulus almost always invokes an immediate anxiety response 
(which may include a situational bound panic attack). The diagnosis of this disorder is 
only appropriate if the avoidance, fear or anxious anticipation of encountering the phobic 
stimulus interferes with the individual’s functioning (daily routine, occupational 
functioning or social life). The DSM-IV further codes specific phobias into five distinct 
subtypes including animal type, natural environment type, blood-injection-injury type, 
situational type or other type. The DSM-IV highlights that although phobias are common 
in the general population, they rarely result in sufficient impairment or distress to warrant 
a diagnosis of specific phobia. In community samples, current prevalence rates range 
from 4 – 8.8% and lifetime rates range from 7.2 – 11.3% (American Psychiatric 
Association, 2000). In terms of age of onset, the first symptoms of a specific phobia tend 
Specific Phobia: Core Features   
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to occur in childhood or early adolescence and may occur at a younger age for women 
than men (American Psychiatric Association, 2000). The age at onset tends to vary 
depending on the type of phobia, with situational type phobias tending to be bimodally 
distributed with a peak in childhood and a second peak in the mid-20’s. Natural 
environment type phobias tend to begin primarily in childhood, although the development 
of height phobia in early adulthood is not uncommon (American Psychiatric Association, 
2000). The age of onset for animal and blood- injection-injury type phobias tend to be in 
childhood.  
Table 2.2 
DSM-IV-TR diagnostic criteria for Specific Phobia (American Psychiatric Association, 
2000) 
DSM-IV-TR Diagnostic Criteria for Specific Phobia 
A. Marked and persistent fear that is excessive or unreasonable, cued by the presence or 
anticipation of a specific object or situation (e.g., flying, heights, animals, receiving an 
injection, seeing blood).  
B. Exposure to the phobic stimulus almost invariably provokes an immediate anxiety 
response, which may take the form of a situationally bound or situationally predisposed 
Panic Attack.  
C. The person recognises that the fear is excessive or unreasonable  
D. The phobic situation(s) is avoided or else endured with intense anxiety or distress 
E. The avoidance, anxiety anticipation, or distress in the feared situation(s) interferes 
significantly with the person’s normal routine, occupational (or academic) functioning, or 
social activities or relationships, or there is marked distress about having the phobia.  
F. In individuals under age 18 years, the duration is at least 6 months.  
G. The anxiety, Panic Attacks or phobic avoidance associated with the specific object or 
situation are not better accounted for by another mental disorder such as Obsessive-
Compulsive Disorder, Posttraumatic Stress Disorder, Separation Anxiety Disorder, Social 
Phobia, Panic Disorder with Agoraphobia, or Agoraphobia Without a history of Panic 
Disorder.  
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Table 2.2 (continued) 
Specify Type:   
Animal Type 
Natural Environment Type (e.g., heights, storms, water) 
Blood-Injection-Injury type  
Situational Type (e.g., airplanes, elevators, enclosed places) 
Other Type (e.g., fear of choking, vomiting or contracting an illness) 
 
 
2.3 Social Phobia: Core Features   
An individual is diagnosed with Social Phobia when they display a marked and persistent 
fear of social or performance situations in which embarrassment may occur. Exposure to 
such situations invariably provokes an immediate anxiety response (American Psychiatric 
Association, 2000; see Table 2.3). Usually, the social or performance based situation is 
avoided, however at times an individual will confront the situation and endure it with 
dread. Epidemiological and community based studies have reported a lifetime prevalence 
of social phobia ranging from 3% to 13% (American Psychiatric Association, 2000). In 
an Australian study social phobia had a 12 month prevalence rate of 1.3% (Andrews et 
al., 2001). Social phobia typically has an onset in the mid-teens, however some 
individuals report an onset early childhood.   
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Table 2.3 
DSM-IV-TR diagnostic criteria for Social Phobia (American Psychiatric Association, 
2000) 
DSM-IV-TR Diagnostic Criteria for Social Phobia 
A. Marked and persistent fear of one or more social or performance situations in which 
the person is exposed to unfamiliar people or to possible scrutiny by others. The 
individual fears that he or she will act in a way (or show anxiety symptoms) that will be 
humiliating or embarrassing.  
B. Exposure to the feared social situation almost invariably provokes anxiety, which may 
take the form of a situationally bound or situationally predisposed Panic Attack.  
C. The person recognises that the fear is excessive or unreasonable.  
D. The feared social or performance situations are avoided or else are endured with 
intense anxiety or distress. 
E. The avoidance, anxious anticipation, or distress in the feared social or performance 
situation(s) interferes significantly with the person’s normal routine, occupational (or 
academic) functioning, or social activities or relationships, or there is marked distress 
about having the phobia.  
F. In individuals under age 18 years, the duration is at least 6 months.  
G. The fear or avoidance is not due to the direct physiological effects of a substance (e.g., 
a drug of abuse, a medication) or a general medical condition and is not better accounted 
for by another mental disorder (e.g., Panic Disorder With or Without Agoraphobia  
Obsessive-Compulsive Disorder, Separation Anxiety Disorder, Body Dysmorphic 
Disorder, a Pervasive developmental Disorder, or Schizoid Personality Disorder) 
H. If a general medical condition or another mental disorder is present, the fear in 
Criterion A is unrelated to it, e.g., the fear is not of stuttering, trembling in Parkinson’s 
disease, or exhibiting abnormal eating behaviour in Anorexia Nervosa or Bulimia 
Nervosa.  
Specify if:   
Generalised: if the fears include most social situations (also consider the 
additional diagnosis of Avoidant Personality Disorder)  
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2.4 Obsessive Compulsive Disorder (OCD): Core Features   
The essential features of OCD include recurrent obsessions or compulsions. Obsessions 
relate to persistent ideas, thoughts, impulses or images that are experienced as intrusive 
or inappropriate and cause marked distress or anxiety (American Psychiatric Association, 
2000; see Table 2.4). Importantly, these obsessions are often referred to as ego-dystonic, 
meaning that the individual regards the content of the obsession as “alien, not within his 
or her own control, and not the kind of thought that he or she would expect to have” 
(American Psychiatric Association, 2000, p457). Common obsessions include thoughts 
about contamination, repeated doubts, a need to have things in a particular order, 
aggressive or horrific impulses and sexual imagery. As a result of the obsessions, the 
individual usually feels compelled to ignore, suppress or neutralize them in order to 
reduce the anxiety and distress.  
 
Compulsions refer to the repetitive behaviours or mental acts the individual engages in to 
prevent or reduce anxiety or distress. It is important to note that the performance of these 
acts are not completed to provide pleasure or gratification (American Psychiatric 
Association, 2000).  
 
OCD typically begins in adolescence or early adulthood, however it may begin in 
childhood. Modal age of onset tends to be lower in males (6 – 15 years) than females (20 
– 29 years) (American Psychiatric Association, 2000).  
 
In terms of prevalence rates, the DSM-IV cites community studies estimating a lifetime 
prevalence of 2.5% and a 1 year prevalence of between 0.5 – 2.1% in adults. It is noted 
that methodological problems with assessment tools raise the possibility that true 
prevalence rates may be much lower (American Psychiatric Association, 2000). The 12 
month prevalence rate for OCD across an Australian sample was found to be 0.7% 
(Andrews et al., 2001).  
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Table 2.4 
DSM-IV-TR diagnostic criteria for Obsessive-Compulsive Disorder (American 
Psychiatric Association, 2000) 
DSM-IV-TR Diagnostic Criteria for Obsessive-Compulsive Disorder 
A. Either obsessions or compulsions:  
 Obsessions as defined by (1), (2), (3), and (4):  
(1) Recurrent and persistent thoughts, impulses or images that are experienced, at some 
time during the disturbance, as intrusive and inappropriate and that cause marked anxiety 
or distress 
(2) The thoughts, impulses, or images are not simply excessive worries about real life 
problems  
(3) The person attempts to ignore or suppress such thoughts, impulses, or images, or to 
neutralise them with some other thought or action  
(4) The person recognises that the obsessional thoughts, impulses, or images are a 
product of his or her own mind (not imposed from without as in thought insertion)  
Compulsions as defined by (1) and (2):  
(1) Repetitive behaviours (e.g., hand washing, ordering, checking) or mental acts (e.g., 
praying, counting, repeating words silently) that the person feels driven to perform in 
response to an obsession, or according to rules that must be applied rigidly 
(2) The behaviours or mental acts are aimed at preventing or reducing distress or 
preventing some dreaded event or situation; however, these behaviours or mental acts 
either are not connected in a realistic way with what they are designed to neutralise or 
prevent or are clearly excessive  
B. At some point during the course of the disorder, the person has recognised that the 
obsessions or compulsions are excessive or unreasonable.  
C. The obsessions or compulsions cause marked distress, are time consuming (take more 
than 1 hour a day), or significantly interfere with the person’s normal routine, 
occupational (or academic) functioning, or usual social activities or relationships. 
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Table 2.4 (continued)  
D. If another Axis I disorder is present, the content of the obsessions or compulsions is 
not restricted to it (e.g., preoccupation with food in the presence of an Eating Disorder; 
hair pulling in the presence of Trichotillomania; concern with the appearance in the 
presence of Body Dysmorphic Disorder; preoccupation with drugs in the presence of  
Substance Use Disorder; preoccupation with sexual urges or fantasies in the presence of 
Hypochondriasis; preoccupation with sexual urges or fantasies in the presence of a 
Paraphilia; or guilty ruminations in the presence of Major Depressive Disorder).  
E. The disturbance is not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or a general medical condition   
Specify if:   
With Poor insight: if, for most of the time during the current episode, the person 
does not recognise that the obsessions and compulsions are excessive or 
unreasonable.   
 
 
2.5 Post Traumatic Stress Disorder (PTSD) and Acute Stress Disorder (ASD): Core 
Features   
PTSD refers to the development of characteristic symptoms following exposure to an 
extreme traumatic stressor involving direct personal experience of an event that involves 
actual or threatened death or injury; or witnessing an event involving actual or threatened 
death or injury; or learning about the unexpected violent death, serious harm, or threat of 
death or injury experienced by a family member or close associate (American Psychiatric 
Association, 2000; see Table 2.5.1). An individual’s response to such an event involves 
intense fear, helplessness or horror.  
 
The characteristic symptoms resulting from exposure to a trauma as described above 
include persistent re-experiencing of the event, persistent avoidance of stimuli associated 
with the event and numbing of general responsiveness, and persistent symptoms of 
increased arousal.  
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Although the perception of what constitutes a traumatic event may differ from person to 
person, such events may include: military combat, violent personal assault (mugging, 
sexual assault), kidnapping, hostage situations, terrorist attack, torture, incarceration, 
natural or manmade disasters, car accidents, or being diagnosed with a life threatening 
illness (American Psychiatric Association, 2000). The DSM-IV notes that the disorder is 
likely to be especially severe or long lasting when the trauma is of human design, such as 
torture or sexual assault (American Psychiatric Association, 2000).  
 
The defining characteristic of PTSD and ASD is the experiencing or witnessing of a 
traumatic or life threatening event during which the individual has experienced a sense of 
helplessness or horror. What distinguishes ASD from PTSD is the duration of the 
problem. Specifically, a diagnosis of ASD is assigned when the individual experiences 
the disturbance outlined above for a minimum of two days and a maximum of four 
weeks, and occurs within four weeks of the traumatic event (American Psychiatric 
Association, 2000; see Table 2.5.2).  
 
In terms of prevalence rates for PTSD, community-based studies reveal a lifetime 
prevalence of approximately 8% of the US adult population (American Psychiatric 
Association, 2000). The prevalence of ASD in the general population is unknown, 
however in the few available studies, rates ranging from 14 – 33% have been reported in 
individuals exposed to severe trauma (American Psychiatric Association, 2000). The 12 
month prevalence rate for PTSD across an Australian sample was found to be 1.3% 
(Andrews et al., 2001). Onset for PTSD can occur at any age, including childhood 
(American Psychiatric Association, 2000).  
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Table 2.5.1 
DSM-IV-TR diagnostic criteria for Post traumatic Stress Disorder (American Psychiatric 
Association, 2000) 
DSM-IV-TR Diagnostic Criteria for Post Traumatic Stress Disorder 
A. The person has been exposed to a traumatic event in which both of the following 
were present:  
(1) The person experienced, witnessed, or was confronted with an event or 
events that involved actual or threatened death or serious injury, or a threat 
to the physical integrity of self or others  
(2) The person’s response involved intense fear, helplessness, or horror.  
B. The traumatic event is persistently reexperienced in one (or more) of the following 
ways:  
(1) recurrent and intrusive distressing recollection of the event, including images, 
thoughts, or perceptions 
(2) recurrent distressing dreams of the event 
(3) Acting or feeling as if the traumatic event were recurring (includes a sense of 
reliving the experience, illusions, hallucinations, and dissociative flashback 
episodes, including those that occur on awakening or when intoxicated).  
(4) Intense psychological distress at exposure to internal or external cues that 
symbolise or resemble an aspect of the traumatic event 
(5) Physiological reactivity on exposure to internal or external cues that symbolise or 
resemble an aspect of the traumatic event 
C. Persistent avoidance of stimuli associated with the trauma and numbing of general 
responsiveness (not present before the trauma), as indicated by three (or more) of the 
following:  
(1) efforts to avoid thoughts, feelings, or conversations associated with the trauma 
(2) efforts to avoid activities, places, or people that arouse recollections of the trauma 
(3) inability to recall an important aspect of the trauma 
(4) markedly diminished interest or participation in significant activities  
(5) feeling of detachment or estrangement from others 
(6) restricted range of affect (e.g., unable to have loving feelings) 
(7) sense of a foreshortened future (e.g., does not expect to have a career, marriage, 
children, or a normal life span) 
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Table 2.5 (continued)  
D. Persistent symptoms of increased arousal (not present before the trauma), as indicated 
by two (or more) of the following:  
(1) difficulty falling asleep or staying asleep  
(2) irritability or outbursts of anger 
(3) difficulty concentrating 
(4) hypervigilance  
(5) exaggerated startle response  
E. Duration of the disturbance (symptoms in Criteria B, C, and D) is more than 1 month.  
F. The disturbance causes clinically significant distress or impairment in social, 
occupational, or other important areas of functioning  
Specify if:  
Acute: if duration of symptoms is less than 3 months 
Chronic: if duration of symptoms is 3 months or more 
Specify if:  
With Delayed Onset: if onset of symptoms is at least 6 months after the 
stressor  
 
 
Table 2.5.2 
DSM-IV-TR diagnostic criteria for Acute Stress Disorder (American Psychiatric 
Association, 2000) 
DSM-IV-TR Diagnostic Criteria for Acute Stress Disorder 
A. The person has been exposed to a traumatic event in which both of the following were 
present:  
(1) The person experienced, witnessed, or was confronted with an event or events 
that involved actual or threatened death or serious injury, or a threat to the 
physical integrity of self or others  
(2) The person’s response involved intense fear, helplessness, or horror.  
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Table 2.5.2 (continued)  
B. either while experiencing or after experiencing the distressing event, the individual 
has three (or more) of the following dissociative symptoms:  
(1) a subjective sense of numbing, detachment, or absence of emotional 
responsiveness 
(2) a reduction in awareness of his or her surroundings (e.g., “being in a daze”)  
(3) derealisation  
(4) depersonalisation  
(5) dissociative amnesia (i.e., inability to recall an important aspect of the trauma)  
C. The traumatic event is persistently reexperienced in one (or more) of the following 
ways: recurrent images, thoughts, dreams, illusions, flashback episodes, or a sense of 
reliving the experience; or distress on exposure to reminders of the traumatic event 
D. Marked avoidance of stimuli that arouse recollections of the trauma (e.g., thoughts, 
feelings, conversations, activities, places, and people).  
E. Marked symptoms of anxiety or increased arousal (e.g., difficulty sleeping, 
irritability, poor concentration, hypervigilance, exaggerated startle response, motor 
restlessness). 
F. The disturbance causes clinically significant distress or impairment in social, 
occupational, or other important areas of functioning or impairs the individual’s 
ability to pursue some necessary task, such as obtaining necessary assistance or 
mobilising personal resources by telling family members about the traumatic 
experience.  
G. The disturbance lasts for a minimum of 2 days and a maximum of 4 weeks and occurs 
within 4 weeks of the traumatic event.  
H. The disturbance is not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or a general medical condition, is not better accounted 
for by Brief Psychotic Disorder, and is not merely an exacerbation of a pre-existing 
Axis I or Axis II disorder.  
 
 
 67 
2.6 Generalised Anxiety Disorder (GAD): Core Features   
The essential feature of GAD is excessive anxiety and worry occurring on more days than 
not for a period of at least 6 months. The anxiety and worry relates to a number of events 
or activities in the individual’s life, and the worry is perceived as uncontrollable. In 
addition, the anxiety and worry are accompanied by at least three additional symptoms 
including restlessness, being easily fatigued, concentration impairment, irritability, 
muscle tension, and disturbed sleep (American Psychiatric Association, 2000; see Table 
2.6). Although individuals may not always regard the worry as excessive, they will report 
subjective distress resulting from the constant worry, have difficulty controlling the 
worry, or experience related impairment in social, occupational or daily functioning. It is 
important to note that the DSM-IV specifies that the intensity, duration or frequency of 
the worry is significantly out of proportion with the actual likelihood or impact of the 
feared event. Typical areas of worry include minor matters, work or educational 
commitments, family, finances, social/interpersonal, health (self or others) or community 
or world affairs. It is typical for worries to shift focus from one concern to another over 
the course of this disorder (American Psychiatric Association, 2000). 
 
In terms of prevalence rates, in a community sample, the 1-year prevalence rate was 
approximately 3% and the lifetime rate was 5% (American Psychiatric Association, 
2000). The 12 month prevalence rate for GAD across an Australian sample was found to 
be 2.6% (Andrews et al., 2001). 
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Table 2.6 
DSM-IV-TR diagnostic criteria for Generalised Anxiety Disorder (American Psychiatric 
Association, 2000) 
DSM-IV-TR Diagnostic Criteria for Generalised Anxiety Disorder 
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than 
not for at least 6 months, about a number of events or activities (such as work or 
school performance).  
B. The person finds it difficult to control the worry  
C. The anxiety or worry are associated with three (or more) of the following six 
symptoms (with at least some symptoms present for more days than not for the past 6 
months):   
(1) Restlessness or feeling keyed up or on edge 
(2) Being easily fatigued 
(3) Difficulty concentrating or mind going blank 
(4) Irritability  
(5) Muscle tension 
(6) Sleep disturbance (difficulty falling asleep or staying asleep, or restless, 
unsatisfying sleep)  
D. The focus of the anxiety and worry is not confined to features of an Axis I disorder, 
e.g., the anxiety or worry is not due to Panic Disorder, Social Phobia, Obsessive-
Compulsive Disorder, Separation Anxiety disorder, Anorexia Nervosa, Somatization 
Disorder, Hypochondriasis, or Posttraumatic Stress Disorder.  
E. The anxiety, worry, or physical symptoms cause clinically significant distress or 
impairment in social, occupational, or other important areas of functioning.  
F. The disturbance is not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or a general medical condition (e.g. hyperthyroidism) 
and does not occur exclusively during a Mood Disorder, a Psychotic Disorder, or a 
Pervasive Developmental Disorder.  
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2.7 Assessment  
The interest in assessment procedures is of particular relevance in the comorbidity 
literature, and unfortunately has been a source of recurrent criticism.  Although this will 
discussed in greater detail later, the differentiation between a comorbid anxiety disorder 
and symptoms secondary to other Axis I disorders is crucial, and relies on the assessment 
measures and procedures used to draw this distinction. A brief overview of current 
measures and procedures recommended for the assessment of anxiety disorders is 
provided below. 
 
Assessment of anxiety disorders for clinical and research purposes, utilise a number of 
different methods including interviews, questionnaire measurements, observational 
techniques and self- monitoring (Wells, 1997). The interview is recognized as the most 
frequently utilized assessment method, and may be conducted as either a standardized 
diagnostic interview or a clinical assessment interview (Wells, 1997). Essentially, the 
assessment serves to identify the problem(s), elicit information for case formulation, 
determine the level of past and present functioning and monitor treatment outcome 
(Wells, 1997). The aim of the initial assessment is also to provide a diagnostic 
understanding of the presenting problem, which may assist with evidenced based 
treatment planning.   
  
The current DSM-IV diagnostic system for anxiety disorders represents a significant 
improvement in the process of diagnosis, compared with its previous versions. It is clear 
that the introduction of diagnostic systems, such as the DSM and the International 
Classification of Diseases (ICD) has been extremely important in assisting the 
development of evidence based treatment approaches. Nevertheless, inherent problems 
remain, such as the error variance within the classification system, limited reliability in 
cross diagnosis, and difficulties when presented with individuals meeting criteria for 
more than one disorder (Kendall & Clarkin, 1992). Furthermore, this is particularly 
salient when considering the prevalence of comorbidity amongst Axis I disorders, and the 
possibility that our present diagnostic system and assessment procedures may contribute 
2.7.1 DSM-IV Classification  
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to false comorbidity rates. Subsequently, the issue of comorbidity is inextricably tied to 
the diagnostic classification system used to diagnose the disorders.  
 
2.7.2 Assessment Instruments  
Structured diagnostic instruments have been designed to improve the reliability of the 
clinical judgment in regards to whether a patient meets the diagnostic criteria (Andrews, 
Creamer, Crino, Hunt, Lampe & Page, 2003) and to allow accurate distinction between 
different diagnoses. These interviews are useful due to the standardisation of questioning 
leading to greater validity. However as Andrews et al., (2003) note, validity will be 
limited to the validity of the diagnostic criteria upon which the interview was based, and 
how efficiently the interview can elicit the cognitions, emotions and behaviours contained 
within the diagnostic criteria. There are a number of assessment instruments specific to 
anxiety symptomatology, including structured and semi-structured interviews as well as 
questionnaire based assessment tools. Some of these will be discussed in greater detail in 
chapter 6.  
 
The current literature concerning anxiety disorder comorbidity with mood, substance 
abuse and personality disorders is detailed below. The comorbidity between anxiety and 
eating disorders is discussed in detail in proceeding chapters.  
 
2.8 Comorbidity of Mental Disorders   
Assessment of comorbid disorders amongst individuals presenting with an anxiety 
disorder is extremely important given the reported high rates of comorbid psychiatric 
illness, including additional anxiety disorders, mood disorders, substance abuse disorders 
and personality disorders. These will be discussed briefly below.  
 
Previous research has found that individuals presenting with anxiety disorders often 
display symptoms consistent with an additional anxiety disorder or mood disorder 
diagnosis. One study reported that as many as 50% of participants with a principal 
anxiety disorder had at least one clinically significant additional anxiety or mood disorder 
2.8.1 Mood Disorders  
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(Moras, DiNardo, Brown & Barlow, 1991). Furthermore, GAD and social phobia at 
clinically significant levels were found to be the most commonly diagnosed comorbid 
anxiety disorder (Moras et al., 1991).  
 
2.8.2 Substance Abuse Disorders  
A number of previous research studies have reported high comorbidity rates between 
anxiety and substance abuse disorder. Most of these studies have examined the rates of 
anxiety disorders amongst substance abuse samples, finding lifetime prevalence rates of 
anxiety disorders to range between 25 – 45% (Bowen, Cipywnyk, D’Arcy & Keegan, 
1984; Hesselbrock, Meyer & Keener, 1985; Chambless, Cherney, Caputo & Rheinstein, 
1987). Studies examining rates of alcohol use disorders amongst anxiety disorder 
outpatient samples have found that approximately 15% – 25% meet criteria for a current 
or past diagnosis of alcohol abuse or dependence (Bibb & Chambless, 1986; Thyer, 
Parrish, Himle, Cameron, Curtis & Nesse, 1986). Another study reported that substance 
abuse was the most common comorbid diagnosis in a male sample of Vietnam veterans 
with PTSD (Kulka, Schlenger, Fairbank, Hough, Jordan, Marmar & Weiss, 1990).  
 
Finally, the comorbidity between Axis I and II disorders is particularly problematic when 
considering evidenced based treatment approaches available for people with multiple 
diagnoses.  Unfortunately, there are a number of problems associated with the use of 
2.8.3 Personality Disorders  
Comorbidity between anxiety disorders and personality disorders has been investigated in 
a number of studies. Much of the literature focuses on the prevalence of personality 
disorders amongst individuals with Panic Disorder, suggesting that between 27% - 65% 
of patients demonstrate evidence of a comorbid personality disorder (Koenigsberg, 
Kaplan, Gilmore & Cooper, 1985; Mavissakalian & Hamann, 1986; Friedman, Shear & 
Frances, 1987; Reich, Noyes & Troughton, 1987; Green & Curtis, 1988). Two studies 
examining the rates of comorbid personality disorders in GAD (Sanderson & Wetzler, 
1991) and OCD (Steketee, 1990) both reported that 50% met criteria for a personality 
disorder.  
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diagnosis to drive treatment approaches. Although clearly the use of a diagnostic system 
such as the DSM-IV is useful for determining the selection of evidenced based 
treatments, limitations stem from the fact that many people present with multiple 
diagnoses (Brown, Campbell, Lehman, Grisham & Mancill, 2001) or their anxiety 
features do not meet full symptom criteria for a particular anxiety disorder (Antony & 
Rowa, 2005).  Subsequently, evidenced based treatment guidelines say little about how 
best to treat such individuals (Antony & Rowa, 2005). As will be discussed later, 
treatment of multiple diagnoses may involve modification of current approaches, to 
ensure that all symptoms are addressed, particularly where there is a relationship between 
the disorders. A brief overview of current treatment approaches for the anxiety disorders 
is discussed below.  
 
2.9 
Cognitive explanations have also been used to explain the underlying mechanisms 
involved in exposure based treatment programs (Meadows & Phipps, 2002). Foa & 
Treatment  
Treatment for anxiety disorders have been influenced by Mowrer’s (1939) two-factor 
theory, which combines classical and operant conditioning, and forms the basis for much 
of behaviour therapy (Meadows & Phipps, 2002). Subsequent cognitive–behavioural 
models of anxiety disorders and their treatments have incorporated the idea that 
avoidance learning is central to the maintenance of anxiety disorders and therefore 
reducing avoidance behaviour is crucial in disrupting the anxiety cycle.  
 
Although initially, behaviour therapists did not focus on the role of cognitions in 
maintaining anxiety disorders, the work of Ellis and Beck throughout the 1960’s 
emphasized the importance of cognitions impacting upon emotional states and behaviours 
(Meadows & Phipps, 2002). Beck’s cognitive theory (1967) stated that humans do not 
respond to events directly, but to our interpretation of these events. Subsequently it was 
postulated that by challenging our interpretations and erroneous beliefs, we could replace 
them with more rational or adaptive ones, leading to more adaptive emotions and 
behaviours (Meadows & Phipps, 2002).  
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Kozak (1986) postulated that exposure involves the introduction of corrective 
information which leads to a decrease in fear, rather than simply the disruption of 
associations between a situation and the ensuing anxious state.  
 
More recently new combinations of CBT treatments have begun to emerge, which 
attempt to integrate elements of other therapeutic approaches into standard CBT 
interventions (Bates, 2007). Some examples of these ‘enhanced’ treatment packages 
include incorporating mindfulness techniques (Linehan, 1993a) and psychodynamic 
methods (Ryle, 2004).  
 
Within the cognitive behavioural treatment paradigm, problem–solving therapy (PST) has 
emerged as an empirically supported treatment approach for anxiety disorders (Felgoise, 
Nezu & Nezu (2002). PST focuses on the emotional, cognitive and behavioural processes 
that interfere with an individual’s ability to cope with problems in daily living (Felgoise 
et al, 2002). The main focus of PST is on the social and interpersonal context in which 
problems and problem solving often occur. Furthermore, this approach states that 
maladaptive psychological and physical responses are the result of an individual’s 
inability to cope with negative mood states and stressful life events (Felgoise et al, 2002).  
A number of research studies have suggested that effective problem solving may 
moderate the effects of the stress-distress relationship, specifically with regard to anxious 
and depressive states (Nezu & Ronan, 1985 & 1988; Nezu, Nezu, Saraydarian, Kalman & 
Ronan, 1986; Kant, D’Zurilla & Maydeau-Olivares, 1997). PST has been reported to be 
effective for the treatment of social phobia (DiGiuseppe, Simon, McGowan & Gardner, 
1990).  
 
Another treatment approach gaining support in the treatment of anxiety disorders is 
Acceptance and Commitment Therapy (ACT). ACT is a contextual behavioural 
psychotherapy (Hayes, Strosahl & Wilson, 1999) sharing its philosophical roots with 
constructivism, narrative psychology, dramaturgy, social constructionism, feminist 
psychology, Marxist psychology, and other contextulistic approaches (Hayes, Luoma, 
Bond, Masuda & Lillis, 2006). Essentially, ACT views psychopathology as a relatively 
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frequent and normal side effect of human language processes (Hayes, Pankey & Gregg, 
2002). Verbal processes are seen as driving suffering, in so much as individuals, through 
language are able to think, reason and problem solve, and similarly able to amplify 
suffering (Hayes et al, 2002). ACT therefore focuses on reducing experiential avoidance, 
deconstructing language representations, teaching acceptance and willingness towards 
unwanted private events, assisting in maintaining contact with a transcendent sense of 
self, clarifying life values and directions, assisting with directing behaviour in line with 
chosen life values (Hayes et al, 2002). An increasing body of literature supports the 
empirical value of ACT (Hayes et al., 1999; Hayes et al., 2006). In a randomized 
controlled study investigating the treatment of workplace anxiety and stress, ACT was 
found to be useful (Bond & Bunce, 2000). ACT was also found to be effective in the 
treatment of GAD (Roemer & Orsillo, 2002).  
 
Interpersonal Psychotherapy (IPT) is another therapeutic approach which has been 
receiving greater attention as a treatment for anxiety disorders. IPT, originally developed 
for the treatment of depression, is a focused, time-limited treatment approach, 
concentrating on interpersonal as opposed to the cognitive-behavioural aspects of an 
individual’s life (Goldstein & Gruenberg, 2002). The IPT model proposes to address 
anxious and depressive symptoms, by specifically focusing on an individual’s current 
stressors in interpersonal relationships in combination with the stress response associated 
with those relationships (Goldstein & Gruenberg, 2002). Interpersonal therapy (IPT) has 
proven efficacious for major depression (Elkin, Shea, Watkins, Imber, Sotsky, Glass,  
Pilkonis, Leber & Docherty, 1989; Weissman, Markowitz, & Klerman, 2000) and for 
bulimia (Fairburn et al.,1995). Although there is some research indicating that IPT may 
be an effective treatment for Social Phobia (Lipsitz, Markowitz & Cherry, 1999; Borge, 
Hoffart, Sexton, Clark, Markowitz & McManus, 2007), there is a need for further 
research in this area, particularly with regard to specific phobia and GAD (Goldstein & 
Gruenberg, 2002).  
 
Pharmacological approaches have also been implicated in the treatment of anxiety 
disorders, namely benzodiazepines and antidepressant medications. Over the last few 
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decades there have been a number of studies confirming the efficacy of benzodiazepines 
in the treatment of GAD (Leonard, 1998). Unfortunately, tolerance and dependence may 
occur with prolonged use of benzodiazepine medication, and Consequently, there have 
been criticisms surrounding its use as a frontline treatment for anxiety disorders. 
Furthermore, as previously indicated, a key component of many of the psychotherapeutic 
approaches is a reduction in avoidance based coping strategies, which does not 
necessarily fit with the prescription of medication designed to reduce anxiety symptoms 
without cognitive or behavioural change. The use of benzodiazepines may also interfere 
with the generalization of skills learnt during therapy (Andrews et al., 2003).    
 
Antidepressant medication, however, appears to be different, and has been effectively 
been used in the treatment of anxiety and comorbid anxiety and depression (Feighner, 
1999). To date, the research has supported the efficacy of SSRI’s and tricyclic 
antidepressants in the treatment of anxiety disorders. Although they do not contain the 
same reinforcing properties and subsequent dependence issues identified with 
benzodiazepine class medications, there may still be the risk that treatment gains or 
improvements are attributed to the antidepressant and not changes made by the 
individual.  
 
2.10 
Although the current DSM-IV diagnostic system for anxiety disorders represents a 
significant improvement in the process of diagnosis, compared with its previous versions, 
nevertheless, inherent problems remain. These limitations prove problematic for 
Summary  
This chapter has provided a brief summary of issues relating to the assessment and 
treatment of Anxiety Disorders. The core features of each of the anxiety disorders have 
been discussed, and whilst each has its own specific diagnostic criteria, it is clear that a 
key characteristic across all of the disorders is the experience of anxious apprehension 
(Barlow & Cerney, 1988). Other commonalities across all of the disorders are the 
marked, persistent and excessive nature of symptoms experienced and their subsequent 
impact on an individual’s ability to function.  
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clinicians and researchers, in regards to diagnostic and treatment issues.  Comorbidity is 
an area that has frequently been complicated by the present diagnostic system. Given the 
clear evidence that comorbid psychiatric disorders feature prominently in anxiety 
disorder samples, this is of particular concern.  
 
Psychiatric comorbidity amongst Axis I and II disorders is common, and in particular, 
anxiety disorders are frequently associated with eating disorders. Despite the fact that 
anxiety disorders are frequently implicated in eating disorder populations, there is little 
research regarding the prevalence of eating disorders amongst anxiety populations. Such 
research is needed to improve the understanding of the relationship between eating and 
anxiety disorders. The following two chapters provide a detailed summary of the 
literature concerning the comorbidity of eating disorders and anxiety disorders, as well as 
a critical analysis of the research to date. That analysis is the background to the 
development of the current research project.    
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CHAPTER 3 
LITERATURE REVIEW: THE COMORBIDITY BETWEEN 
EATING DISORDERS AND ANXIETY DISORDERS – A REVIEW  
European Eating Disorders Review
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256 J. M. Swinbourne and S. W. Touyzs Aet al., 1990) to 75% (Schwalberg et al., 1992) in BN
and from 23% (Laessle et al., 1987) to 75% (Deep
et al., 1995) in AN.
Several studies have shown that, inmost cases, the
onset of an anxiety disorder precedes the onset of an
eating disorder (Brewerton et al., 1995; Bulik, 2003;
Deep et al., 1995; Godart et al., 2003; Schwalberg
et al., 1992) (see Table 1 for summary). These
findings have led some researchers to speculate that
early onset anxiety disorders may represent a
potential genetically mediated pathway toward
the development of an eating disorder (Kaye
et al., 2004), and at the very least it suggests that
early onset anxiety disorders may in some way
predispose individuals to the development of an
eating disorder (Bulik et al., 1996).
Of the anxiety disorders, obsessive-compulsive
disorder and social phobia have been found to have
the highest co-morbidity with eating disorders.
Table 2 provides a summary of the research
findings investigating comorbid eating disorders
and anxiety disorders. The prevalence rates of
anxiety disorders also differs amongst the eating
disorder subtypes a summary of which can be seen
in Table 3 and Table 4 for AN and BN, respectively.
Whilst most studies have focused on the preva-
lence of anxiety disorders in eating disorder
populations, significantly less research has
examined the prevalence of eating disorders among
anxiety patients (Bulik, 1995). As a result, there is a
general lack of information as to frequency of eating
disorder pathology among patients presenting to
specialty anxiety clinics, and it is unclear whether
eating disorders are more commonly associated
with some anxiety disorders as compared to others
(Black Becker et al., 2004). This raises the possibility
that eating disorders may go unidentified and
untreated, particularly given that eating disorder
assessment and treatment is often viewed as a
clinical specialty and subsequently many clinicians
in anxiety clinics may not be adept at detecting
eating disorder symptomatology (Black Becker
et al., 2004). The only study we have found which
investigates eating disorder rates amongst women
presenting to an anxiety clinic is that by Black
Becker et al. (2004). They found that 12% of 257
women presenting to an anxiety clinic met criteria
for a possible eating disorder. Other studies have
investigated eating disorder rates amongst specific
anxiety disorders (Brewerton et al., 1993; Lipschitz
et al., 1999) or amongst individuals with sexual
abuse trauma (Pribor and Dinwiddie, 1992; Far-
avelli et al., 2004) and war veterans (Striegel-Moore
et al., 1999).ssociation. Eur. Eat. Disorders Rev. 15, 253–274 (2007)
DOI: 10.1002/erv
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disorder and anxiety comorbidity is whether a
comorbid anxiety disorder has implications for the
treatment and outcome of an eating disorder. It is
clear that individuals with comorbid conditions often
display more severe symptoms and subsequently
may be at greater risk for a poorer treatment outcome.
Research findings however, are inconsistent. Some
studies have suggested that comorbid anxietymay be
one indicator for poor outcome (Fichter and Quad-
flieg, 2004; Gleaves and Eberenz, 1994; Goodwin and
Fitzgibbon, 2002; Halmi et al., 1973; Herpertz-
Dahlmann et al., 1996; Procopio, Holm-Denoma,
Gordon, & Joiner, 2006; Thompson–Brenner and
Westen, 2005; von Ranson et al., 1999), however other
studies have not found this to be the case (Bulik et al.,
1996; Halmi et al., 1991 and Thiel et al., 1998)
(A summary of these studies and their findings can be
seen in Table 5).
Despite the significant number of research papers
investigating the comorbidity between eating dis-
orders and anxiety disorders, many are plagued by
methodological problems, limiting the usefulness of
findings (the limitations have been summarised in
Tables 1–5). This paper aims to critically review the
available literature examining the co-morbidity
between eating disorders and anxiety disorders.OBSESSIVE COMPULSIVE
DISORDER (OCD)
A relationship between AN, BN and OCD has been
suggested by clinical observation and, increasingly,
by empirical investigation. A number of studies
have reported significant comorbidity between
individuals with eating disorders andOCD (Fornari
et al., 1992; Godart et al., 2000; Halmi et al., 1991;
Hudson et al., 1983, 1987; Iwasaki et al., 2000;
Kaye et al., 2004; Laessle et al., 1989; Lilenfeld et al.,
1998; Matsunaga et al., 1999; Milos et al., 2002;
Ra˚stam et al., 1995; Speranza et al., 2001; Thornton
and Russell, 1997) (see Table 2 for summary).
Thornton and Russell (1997) showed that OCD
usually predated the onset of an eating disorder,
suggesting that OCD may be a risk factor for
developing an eating disorder. Milos et al. (2002)
reported that individuals with OCD co-morbidity
have a longer history of an eating disorder and are
likely to have developed the eating disorder at an
earlier age.
AN has a considerable overlap with obsessive–
compulsive disorder (OCD) and this may reflect
common neurobiological, genetic, or psychologicalCopyright # 2007 John Wiley & Sons, Ltd and Eating Disorders Aelements. Early descriptive studies suggested that
50%–100% of patients with AN showed obsessional
or compulsive features. More recent studies have
found a lower but still significant level of obsessions
and compulsions among patients with AN (Halmi
et al., 1991, 2003; Matsunaga et al., 1999; Pollice
et al., 1997; Ra˚stam et al., 1995) (see Table 3 for a
summary of AN and OCD comorbidity findings).
Fornari et al. (1992) and Speranza et al. (2001)
found a significant difference in the OCD
lifetime prevalence between purging AN and
restrictive AN, where purging AN patients exhib-
ited higher prevalence of OCD than the restricting
AN patients.
There is some argument that the pattern of
obsessions and compulsions most commonly pre-
sent in AN is different from that found in OCD.
Therefore, it is important to distinguish those
behaviours that are not directly related to food,
weight and shape. The lack of clear evidence
regarding these mechanisms means that it is
difficult to draw clear causal conclusions. However
at a functional level, an important issue is that
compulsive behaviours reduce anxiety levels. It can
be hypothesized that the same function is served in
the eating disorders, given the affect regulation
function of restriction and bulimic behaviours
(Lockwood et al., 2004). This however, does not
explain the difference between the ego-dystonic
nature of OCD and the ego-syntonic nature of eating
disorders. This important distinction does need to
be addressed.
Holden (1990) noted that the obsessions and
compulsions of OCD patients are ego-dystonic
whereas the preoccupations and rituals of AN
patients are largely ego-syntonic. Mazure et al.
(1994) suggested that phobic thoughts of food and
weight repeatedly enter the mind of AN patients,
but not necessarily against their will. Although
these thoughts or preoccupations may be distres-
sing, they are not regarded as senseless. This is in
contrast to typical obsessions and compulsions
unrelated to eating, which also may occur in AN
patients (Bastiani et al., 1996).
One of the most common concerns raised in the
current debate is whether people with AN display
‘typical’ or ‘true’ OCD symptoms as seen in patients
diagnosed with primary OCD, or whether their
symptoms are secondary to weight loss and
malnutrition, or a combination of these. These
concerns arise due to evidence that in conditions of
semistarvation, psychologically ‘normal’ adults can
develop a range of obsessional features. Keys et al.
(1950) illustrated how obsessions and compulsions,ssociation. Eur. Eat. Disorders Rev. 15, 253–274 (2007)
DOI: 10.1002/erv
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and consumption of food, develop under conditions
of food restriction. This study also provides
evidence for the possibility that the obsessive and
compulsive symptoms observed in people with AN
may at least partly be the result of their malnour-
ished state, and not evidence of a true OCD. Some
evidence for this comes from the discrepancy
between inpatient and outpatient AN OCD rates,
whereby lower rates have been reported in the latter
group (Serpell et al., 2002).
Studies that have compared rates of OCD in AN
and BN have usually found higher co-morbidity in
AN. However, two Japanese studies found a
significant number of BN participants met criteria
for OCD (Iwasaki et al., 2000; Matsunaga et al.,
1999), even after excluding the OCD-like symptoms
typical of eating disorders. Matsunaga et al. (1999)
also reported that BN subjects with concurrent OCD
weremore likely than subjects without OCD to have
more severe mood and core eating disorder
psychopathology. Among BN subjects with con-
current OCD, symptoms related to symmetry and
order were most frequently identified, followed by
contamination and aggressive obsessions, and
checking and cleaning/washing compulsions (Mat-
sunaga et al., 1999).
Perfectionism and Obsessive Compulsive
Personality Disorder (OCPD)
As discussed above, the research into OCD and
eating disorders reveals a significant relationship,
and several researchers have reported that non food
related obsessions and compulsions, including
significantly more cleanliness, orderliness, perfec-
tionism, rigidity, miserliness, scrupulosity have
been identified in patients with eating disorders
(Brumberg, 1988; Kasvikis et al., 1986; Rothenberg,
1986; Solyom et al., 1982). This has fuelled sugges-
tions that distinct personality traits may be
important in the development and maintenance
of an eating disorder. The literature also suggests
that perfectionism and dichotomous thinking may
mediate the relationship between extreme concerns
about shape and weight and rigid and intense
dieting (Fairburn, 1997). Furthermore, Fairburn
(1997) suggests that perfectionism and dichotomous
thinking may mediate the relationship between
intense, rigid dieting and binge eating. This has lead
to significant interest in investigating the prevalence
of personality disorders in the eating disorders and
subsequently, there have been a number ofCopyright # 2007 John Wiley & Sons, Ltd and Eating Disorders Astructured investigations into Axis II diagnosis
amongst eating disorder patients.
Gartner, Marcus, Halmi, and Loranger (1989)
used the PDE to assess inpatient ED subjects and
reported that 25.7% met diagnostic criteria for
OCPD. None of the BN sample met criteria for
OCPD leading to the speculation that this person-
ality feature is more consistent with individuals
with AN. However, Rossiter, Agras, Telch, and
Schneider (1993) reported that 10% of their BN
samplemet criteria for OCPD. Thornton and Russell
(1997) reported that 19% met criteria for comorbid
OCPD, and this was almost exclusively found in the
AN sample. Lilenfeld et al. (1998) reported that AN
probands had higher rates of OCPD lending
support to reports of perfectionism and inflexibility
among individuals with restricting type AN.
Lilenfeld et al. (1998) also found that 31% of AN
probands met criteria for OCPD and OCD, leading
to the suggestion that individuals with OCPD may
be more vulnerable to the development of OCD
than those without this personality pattern.Social Phobia
Whilst the link between eating problems and
obsessive-compulsive pathology has been clearly
established (O’Brien and Vincent, 2003), other
manifestations of fear, such as social phobia,
agoraphobia and panic, have received less research
attention (Hinrichson et al., 2004).
A number of studies show that social phobia is
common in patients with eating disorders (Brewer-
ton et al., 1995; Godart et al., 2000; Halmi et al., 1991;
Hinrichson, Wright, Waller, &Meyer, 2003; Iwasaki
et al., 2000; Kaye et al., 2004; Laessle et al., 1987,
1989; Lilenfeld et al., 1998; Piran et al., 1985; Powers
et al., 1988; Schwalberg et al., 1992) (see Tables 2–4
for a summary of findings). Several studies suggest,
that social anxiety may be a more common
co-morbid condition with eating disorders than
OCD, and some researchers have speculated that
social anxiety may play a role in the aetiology of
eating disorders (Black Becker et al., 2004).
Hinrichson et al. (2003) demonstrated that levels of
social phobia in patients with AN and BN are
significantly elevated compared to control women,
and that social phobia is associatedwith higher levels
of eating psychopathology in bulimic individuals.
The prevalence rate of social phobia and eating
disorders has differed across studies. In AN,
prevalence rates of between 16% (Kaye et al.,ssociation. Eur. Eat. Disorders Rev. 15, 253–274 (2007)
DOI: 10.1002/erv
268 J. M. Swinbourne and S. W. Touyz2004) and 88.2% (Hinrichson et al., 2003) have been
reported and between 17% (Brewerton et al., 1995;
Powers et al., 1988) and 67.8% (Hinrichson et al.,
2003) in BN. Lilenfeld et al. (1998) also reported that
social phobia is significantly more frequent in AN
than in controls. Two controlled follow-up studies
of AN found differing results, one found a
significantly higher rate of social phobia in AN
than normal controls (Halmi et al., 1991), whilst the
second found no difference (Ra˚stam et al., 1995).Agoraphobia
Studies investigating ED and agoraphobia have
found varying results. In AN, lifetime prevalence of
agoraphobia ranges from 0% (Laessle et al., 1989) to
3% (Godart et al., 2000) in restricting subgroups,
wheras a study of binge/purge AN found a 20%
rate (Laessle et al., 1989). In follow up studies of AN,
significantly higher lifetime prevalence rates of
agoraphobia have been reported in the AN group
compared to controls (Halmi et al., 1991), however a
study by Ra˚stam et al. (1995) reported no difference.
The lifetime prevalence of agoraphobia in BN
varies from 0% (Schwalberg et al., 1992) to 17.4%
(Laessle et al., 1989). In the community, lifetime
prevalence of agoraphobia in BN varies from 27%
(Bushnell et al., 1994) to 34.5% (Garfinkel et al.,
1995).Panic Disorder
The findings of panic disorder co-morbidity
amongst eating disorder samples is also varied
with one study reporting between 9% and 11%
prevalence (Kaye et al., 2004) and another finding
between 42% and 52% preavlence (Piran et al.,
1985). Bulimic samples have been varied, ranging
from 0% (Schwalberg et al., 1992) to 39% (Hudson
et al., 1983). Several studies have found the lifetime
prevalence rates of panic disorder ranges from 4%
(Lilenfeld et al., 1998) to 7% (Godart et al., 2000) in
AN–R and is estimated to 15% in AN- B/P (Laessle
et al., 1989). Two AN controlled outcome studies
have estimated that the lifetime prevalence of panic
disorder is 8.1%, and 6 month prevalence between
2% and 11.8% (Halmi et al., 1991; Ra˚stam et al.,
1995). Walters and Kendler (1995) reported that
in a community study, individuals with ‘possible
anorexia’ have the risk of panic disorder increased
by 3.4.Copyright # 2007 John Wiley & Sons, Ltd and Eating Disorders ASpecific Phobia
The reported lifetime prevalence of specific phobias
amongst individuals with eating disorders varies
considerably, ranging from 0% (Piran et al., 1985) to
34% (Godart et al., 2000) in AN and from 10%
(Schwalberg et al., 1992) to 46% (Laessle et al., 1987)
in BN. Follow up studies have reported that there is
no difference between AN and controls (Lilenfeld
et al., 1998) however, in a community study, the risk
for phobia is increased by 2 to 4 in AN subjects
(Kendler et al., 1991;Walters and Kendler, 1995) and
by 2.37 in BN subjects (Kendler et al., 1991).Post Traumatic Stress Disorder (PTSD)
Although a history of trauma, particularly child-
hood sexual abuse, is considered to be a non-specific
risk factor for the development of an eating
disorder, surprisingly few studies have examined
co-morbidity of PTSD with eating disorders (Black
Becker et al., 2004). Studies investigating PTSD
co-morbidity among eating disordered individuals
have reported rates ranging from 11% to 52%
(Gleaves et al., 1998; Turnbull et al., 1997). Faravelli
et al. (2004) found that women who had been
sexually assaulted were significantly more likely to
report an eating disorder compared with women
who had not been assaulted. This is supported by
the literature reporting themost frequently reported
psychiatric consequences of sexual abuse in women
are PTSD, mood disorders, substance abuse dis-
orders, eating disorders and sexual disorders
(Putnam & Trickett, 1997; Dahl, 1989; Thompson
et al., 2003).
A number of studies have demonstrated a
positive association between child sexual assault
(CSA) and clinical eating disorders (Johnson et al.,
2002; Steiger & Zanko, 1990; Vize & Cooper, 1995;
Welch & Fairburn, 1994). A meta-analysis by
Smolak & Murnen (2002) found a relationship
between CSA and eating disorders, such that CSA is
associated with an increased likelihood of eating
disorder symptomatology. Furthermore, Jacobi
et al. (2004) reported that therewas a high likelihood
that sexual abuse preceded the eating disorder.
However, there have also been a number of studies
that have not found a relationship between CSA and
eating disorders (Pribor & Dinwiddie, 1992; Rorty
et al., 1994).
When considering the eating disorder subtypes,
Dansky et al. (1997) reported current and lifetime
rates of PTSD in women with BN to be high andssociation. Eur. Eat. Disorders Rev. 15, 253–274 (2007)
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subjects were considered to be at 3.36 times the risk
of developing BN. Tozzi et al. (2003) report that
several studies have shown that psychological
stress or stressful life events can trigger the onset
of AN. However, the nature and identity of these
stressors remain poorly defined (Beumont et al.,
1978; Casper & Jabine, 1986; Pyle, Mitchell, &
Eckert, 1981; Strober, 1984). Kaye et al. (2004)
observed that PTSD was approximately three times
more frequent in individuals with BN as opposed to
those with AN.
Generalised Anxiety Disorders (GAD)
Considerably less research has considered the
relationship between eating disorders and GAD,
however Godart et al. (2000) and Lilenfeld et al.
(1998) estimate the lifetime prevalence of GAD in
AN to be 31% and 24%, respectively. Studies
reviewing the relationship between GAD and BN
have found that lifetime prevalence varies between
10% (Powers et al., 1988) and 55% (Schwalberg et al.,
1992). Kaye et al. (2004) identified GAD in their AN
and BN sample of 13% and 7%, respectively, which
is significantly lower than the 45.6% and 31.4%,
respectively, reported by Godart et al. (2003).
Iwasaki et al. (2000) reported that 13% of their
AN and BN subjects met the criteria for GAD, and
interestingly, their findings indicate that GAD was
more prevalent amongst the purging subtypes of
both AN and BN subjects, although this difference
did not reach significance.
Bulik et al. (2000) reported that the maternal
perception of greater childhood anxiety was
supported by the twin self report, with the affected
twin being at a greater risk for lifetime GAD. They
suggested that because the age of onset for GAD
was reported to be prior to or concurrent with the
onset of BN in 75% of the cases, it is possible that the
anxiety may be a predisposing factor rather than a
sequelae of BN. These results support a growing
body of literature that has reported elevated rates of
premorbid anxiety disorders in women with BN
(Bulik et al., 1997; Deep et al., 1995).Eating Disorders Amongst Individuals
With Anxiety Disorders
There is less research available examining the
prevalence of eating disorders amongst individuals
with anxiety disorders. Of the studies that have
considered this, they have generally examined ratesCopyright # 2007 John Wiley & Sons, Ltd and Eating Disorders Aof eating disorders concurrent with one particular
anxiety disorder, usually OCD (Bulik, 1995).
Among female OCD patients, eating disorder
co-morbidity estimates have ranged from 11% to
42% depending on the type of eating disorder and
the method of assessment (Bulik, 1995). Brewerton
et al. (1993) reported that 20% of women with social
phobia met the criteria for an eating disorder.
Lipschitz et al. (1999) reported that 25% of an
adolescent mixed-gender PTSD inpatients met the
criteria for an eating disorder. Black Becker et al.
(2004) indicates that although the number of studies
is limited, estimates of the prevalence of eating
disorders amongst anxiety disorder patients is high.
Reported rates are markedly higher than the
estimated prevalence of AN or BN among young
females.LIMITATIONS IN THE RESEARCH
Many studies investigating the co-morbidity
between eating and anxiety disorder suffer from
general methodological limitations (Mitchell et al.,
1991; Schwalberg et al., 1992; Godart et al., 2002;
Micali and Heyman, 2006; Godart et al., 2006). The
variability between estimated co-morbidity of
anxiety disorders and eating disorders amongst
the available research is a significant limitation
when considering the prevalence of co-morbid
disorders. A number of factors may contribute to
this variability.
Sample Sources and Selection
Research into ED and AD often include samples
from various sources including inpatients, out-
patients and community samples. Unfortunately
this may bias the sample, as one could expect that
an inpatient sample may be more likely to have
multiple diagnoses and may not be representative
of all patients with the disorder (Godart et al., 2002).
Furthermore, some researchers have used exclusion
criteria that may limit the frequency of comorbid
AD. Keck et al. (1990) excluded all subjects with
comorbid substance abuse, despite patients with
AD often reporting comorbid substance abuse
(Bulik et al., 1996). Several studies excluded subjects
taking psychoactive medication (Bulik et al., 1996;
Bulik et al., 1997; Deep et al., 1995; Keck et al., 1990)
and subsequently may have diminished the rates of
AD identified.ssociation. Eur. Eat. Disorders Rev. 15, 253–274 (2007)
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General methodological limitations included: (1) In
many of the studies reviewed in this paper, the
sample sizes were small, often including at least one
group of less than 30 subjects; (2) Some studies
include both males and females, while it is
recognised that women have more lifetime AD
than men (Wittchen and Essau, 1993) and that ED
are rare in men (Godart et al., 2002); (3) Few studies
are controlled, and often those that are controlled
have larger control groups than ED groups and are
not matched for age or other characteristics; (4) The
definition of current prevalence varies across
studies, referring to either 6-month (Herpertz-
Dahlmann et al., 1996; Ra˚stam et al., 1995) or 1-year
prevalence (Halmi et al., 1991).
Diagnostic Criteria for Eating Disorders and
Anxiety Disorders
Changes in diagnostic criteria for ED and AD over
the past 15 years [e.g. Feighner criteria (1972),
Research Diagnostic Criteria (RDC) (1977), DSM-III
(APA, 1980), DSM-III-R (APA, 1987), DSM-IV (APA,
1994)] have clearly had an impact on the prevalence
findings. Even in more recent studies, it is some-
times unclear whether they have utilised the
DSM-IV or ICD-10 criteria to diagnose ED (e.g.
Goodwin and Fitzgibbon, 2002). Changes in AD
diagnostic criteria may also have impacted on the
findings of studies over time. For example In the
RDC (1977) and the DSM-III (1980) it was not
possible to diagnose a depressive disorder and AD
simultaneously, which may have influenced the
prevalence of AD reported in some studies (Godart
et al., 2002). It is possible that certain anxiety
disorders may have been over reported due to the
changes in diagnostic criteria between the DSM-III
and the DSM-III-R. Specifically OCD and Social
phobia DSM-III-R criteria stipulates both disorders
cannot be diagnosed if the obsessions and compul-
sions or the social anxiety are exclusive to food
related concerns. Whilst some researchers already
incorporated this in addition to DSM-III criteria it
may provide an explanation as to higher rates of
both of these disorders in earlier studies. Finally, the
number of anxiety disorders assessed often differs
between the studies and will obviously affect the
prevalence rates. A number of the studies reported
in this paper excluded certain AD from the
assessment, which is a significant limitation when
drawing conclusions about prevalence rates of AD
and ED. Significantly, it is not uncommon in theCopyright # 2007 John Wiley & Sons, Ltd and Eating Disorders Aresearch to exclude PTSD from the anxiety assess-
ment, and this presents a limitation when consider-
ing the suggestion that a history of trauma,
particularly CSA is a non-specific risk factor for
the development of an eating disorder (Black Becker
et al., 2004).
Diagnostic Instruments
Diagnostic instruments used to assess both eating
disorders and anxiety disorders have also varied
across studies and present a significant limitation
when drawing conclusions about ED and AD
comorbidity (Micali and Heyman, 2006; Godart
et al., 2006). Unfortunately, many of the studies
presented in this paper have failed to use well-
standardised, internationally accepted diagnostic
instruments to identify eating disorders, limiting
the usefulness of their findings. Similarly, some of
the research has used inadequate diagnostic instru-
ments or criteria to identify anxiety disorders. This
is particularly important to enable one to dis-
tinguish between eating disorder and anxiety
symptomatology. For example considering the high
but also variable rates of reported OCD in eating
disorder populations, one may conclude that some
research has insufficiently distinguished between
obsessive compulsive symptoms that are secondary
to malnutrition and the ED and those which may
reflect a true OCD. Furthermore, as mentioned by
Bulik et al. (1996), GAD in the SCID (with DSM-III-R
criteria) is skipped for subjects with a current mood
disorder. A number of the studies reported in this
paper have used the SCID (e.g. Brewerton et al.,
1995; Bulik et al., 1997; Powers et al., 1988; Ra˚stam
et al., 1995; Walters and Kendler, 1995) and
therefore the rates of GADmay be an underestimate
in these studies.SUMMARY AND RESEARCH
IMPLICATIONS
It is clear from the research that anxiety disorders
are significantly more frequent in subjects with
eating disorders than the general community. The
available research investigating the prevalence of
anxiety disorders amongst eating disordered indi-
viduals presents strikingly inconsistent findings.
Whilst there are a large number of studies research-
ing this area, the inconsistencies complicate the
understanding of eating disorder and anxiety co-
morbidity. This presents the need for researchers to
usewell-standardised, internationallyaccepted instru-
ments to identify and investigate both eating disordersssociation. Eur. Eat. Disorders Rev. 15, 253–274 (2007)
DOI: 10.1002/erv
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into the prevalence of eating disorders amongst
individuals presenting for anxiety treatment,
despite indications that prevalence may be high,
suggests the need for greater research in this area.
A study currently being undertaken by the
authors endeavours to examine the comorbidity
between eating disorders and anxiety disorders
using well standardised, internationally accepted
diagnostic instruments and questionnaires. The
current literature would suggest that further
investigation into the co-morbidity between anxiety
and eating disorders may have significant aetiolo-
gical and therapeutic implications.REFERENCES
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CHAPTER 4 
EATING DISORDER AND ANXIETY DISORDER COMORBIDITY 
 
This chapter is an extended version of the preceding chapter, providing a comprehensive 
and critical review of the literature to date, concerning the comorbidity between eating 
disorders and anxiety disorders.   
4.1 Introduction to Research 
Klerman (1990) proposed three definitions for establishing comorbidity and identifying 
primary versus secondary diagnoses. The first is chronological, to identify the temporal 
relationship between the two disorders, where the disorder that appeared first would be 
classified as the primary disorder. A second approach is to establish a causal link between 
the disorders, to determine whether one disorder promoted the development of the other. 
The final approach is symptomatic, to consider the severity and level of impairment 
generated by both disorders, and defining the primary disorder as the one causing the 
greatest level of impairment (Klerman, 1990). It is clear that all three approaches may be 
4.1.1 Defining Comorbidity   
Comorbidity has been defined as the simultaneous occurrence of two separate disorders 
within the same person at a given point in time or all of the diagnoses for which an 
individual has ever met diagnostic criteria over a given period of time (Brown & Barlow, 
1992). Widiger, Frances, Harris, Jacobsberg, Fryer & Manning (1991) suggested that 
comorbidity can involve the co-occurrence of two independent disorders, with a common 
underlying etiology or two disorders having a causal relation between them. Comorbidity 
may be examined cross-sectionally, where one records the co-occurrence of disorders at a 
given point in time, or longitudinally, where all diagnoses are assessed over a specified 
time frame, such as over a lifetime (Brown & Barlow, 1992).  
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useful in providing a greater understanding of the etiological basis of identified disorders, 
as well as providing an impetus for the selection of treatment approaches.  
 
4.1.2 Background to the comorbidity between eating disorders and anxiety  
 
Research considering the etiological aspects of eating disorders often refers to the 
developmental, social and biological processes which are thought to influence the 
development of eating pathology (Garner, 1993; Treasure & Campbell, 1994). Cultural 
attitudes toward body weight and shape are critical, yet insufficient to account for 
pathogenesis (Kaye, Devlin, Barbarich, Bulik, Thornton, Bacanu, Fichter, Halmi, Kaplan, 
Strober, Woodside, Bergen, Crow, Mitchell, Rotondo, Mauri, Cassano, Keel, Plotnicov, 
Pollice, Klump, Lilenfelf, Ganjei, Quadflieg and Berrettini, 2004). Research has sought 
to investigate the possible genetic factors influencing the development of eating 
pathology, and subsequent family and twin studies have provided support for the 
hypothesis of heritability in eating disorders (Bulik, Sullivan & Kendler, 1998). It is not 
surprising therefore, that research into psychiatric comorbidity amongst the eating 
disorders has also increased over the last decade.  
 
Research to date has consistently demonstrated that anxiety disorders and eating 
pathology often co-occur.  However, limitations in the research in this area has impaired 
the utility of the results. Briefly, those limitations include: 1) the problems establishing 
the accurate prevalence rates for eating and anxiety disorder comorbidity, due to much of 
the previous research focusing on AN and BN, despite the indication that the residual 
category of EDNOS is at least as common in clinical practice (Fairburn & Walsh, 2002; 
Fairburn & Harrison, 2003); 2) The focus of much of the research on only a few of the 
anxiety diagnoses, often excluding PTSD despite the suggestion that trauma is a non 
specific risk factor for the development of eating pathology; and 3) the tendency of 
research to utlise insufficient diagnostic instruments, such as self-report questionnaires, 
possibly affecting rates of diagnosis.  
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Notwithstanding these methodological limitations, the role of anxiety in the eating 
disorders has been clearly described by a number of authors. Furthermore, eating disorder 
patients have reported that eating binges are more likely to be triggered by anxiety and 
anger states, than depression (Arnow, Kennedy & Agras, 1992).  
Several conceptual models have been proposed to account for the observed comorbidity 
between eating pathology and anxiety. A number of authors have suggested that AN 
could represent a variant of OCD, based on clinical (Hollander & Wong, 1995) and 
biological (Kennedy & Garfinkel, 1992) observations. However, this theory has largely 
been discredited (Holden, 1990; Hsu, Kaye & Weltzin, 1993). Another theory has 
suggested that the eating pathology may be secondary to the anxiety symptoms and serve 
to reduce it (Godart et al., 2000). This theory suggests that many of the behaviours that 
characterise the eating disorders (e.g. restriction, bingeing, purging and body checking) 
may be considered safety behaviours, reducing the immediate level of anxiety through 
the blocking of awareness of that emotional state (Pallister & Waller, 2008). In particular, 
research in this area has reported that anxiety has been associated with vomiting (Carter 
& Duncan, 1984), laxative abuse (Weltzin, Bulik, McConaha & Kaye, 1995) and 
restriction (Chesler, 1995). In exactly the same way that safety behaviours are viewed in 
the anxiety disorder literature, the eating disorder behaviours, whilst initially reducing the 
level of arousal, serve to maintain and even increase anxiety levels in the long term 
(Waller, 2008). This theory has been investigated in a number of BN samples.  
In one study, researchers found that the frequency of bingeing and purging behaviours 
was correlated to the severity of anxiety, as rated by a clinician (Piran, Kennedy, 
Garfinkel & Owens, 1985). Another study hypothesised that the frequency of GAD and 
social phobia reported in BN could be accounted for by individuals attempting to reduce 
anxiety through focus on shape and weight, followed by strict dieting and subsequent 
bulimic behaviours (Mitchell, Speckert & de Zwaan, 1991). Researchers have also 
suggested a link between PTSD and the development of an eating disorder. One theory 
has suggested that as PTSD tends to increase anxiety and vigilance overall, this may 
exacerbate or trigger a pre-existing diathesis to develop an eating disorder (Black Becker, 
DeViva & Zayfert, 2004). Other theories have implicated the role of eating disordered 
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behaviours such as restriction, bingeing and purging, in a reduction of anxiety and 
distress as a result of PTSD symptoms.  
Biological theories implicate the common functional abnormalities observed in the 
anxiety and eating disorder, namely the pattern serotonergic dysfunction inherent in both 
disorders (Brewerton, 1995). Abnormalities with the serotonin system have not only been 
implicated in the anxiety disorders, but also depression and personality disorders which 
are also frequently associated with the eating disorders (Godart et al., 2000). The obvious 
difficulty with this theory is in terms of providing a causal account for the development 
of comorbid eating and anxiety disorders, as serotonin is also likely to be affected as a 
result of these disorders. Strober, Freeman, Lampert & Diamond (2007) recently 
suggested that individuals with AN inherit neural circuitry that is predisposed towards 
anxiety and fear reactions. Consequently, such individuals will regard novel situations 
and experiences as threatening and will use compulsive behaviours to ensure 
predictability. These observations have led several authors to propose that eating 
disorders be subsumed into the anxiety disorder diagnostic category (Strober et al., 2007; 
Waller, 2008). In his recent article, Waller (2008) incorporates this idea into a schematic 
model (see figure 4.1), using only a few of the anxiety disorder diagnoses to demonstrate 
where the eating disorders could sit if they were categorised with the anxiety disorders.  
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Figure 4.1 Eating Disorders incorporated into a wider model of disorders 
characterised by anxiety and concomitant safety behaviours (Waller, 2008) 
 
 
Amongst the Axis I disorders, research indicates that eating disorders and anxiety 
disorders frequently co-occur (Herzog, Keller, Sachs, Yeh & Lavori, 1992; Milos, 
Spindler & Schnyder, 2004).  Studies have consistently shown that a significant number 
of patients with AN or BN experience one or more anxiety disorders (Kaye, Bulik, 
Thornton, Barbarich, Masters & the Price Foundation Collaborative Group, 2004). 
Herzog, Keller, Sachs, Yeh & Lavori, (1992) reported that 73% patients with AN 
restricting type (ANR), 82% with AN binge/purge type (ANBP) and 60% with BN had 
one or more concurrent Axis I comorbidities.  
Disorders characterized by non-specific anxiety and 
vulnerability cognitions  
Anxiety and safety 
behaviours focused 
on danger of 
negative evaluation 
by others  
 
 
 
Anxiety and safety 
behaviours focused 
on food, eating, 
weight and shape   
 
 
 
Anxiety and safety 
behaviours focused 
on personal 
responsibility for 
negative outcomes   
Anxiety and safety 
behaviours focused on danger 
of overarousal and physical 
injury / death   
No Anxiety Disorder  
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The prevalence of anxiety disorders amongst BN samples has been reported in a number 
of investigations (Hudson, Pope, Jonas & Yurgelun-Todd, 1983; Piran et al., 1985; 
Walsh, Roose, Glassman, Gladis & Sadik, 1985; Hudson, Pope, Yurgelun-Todd, Jonas & 
Frankenburg, 1987; Powers, Coovert, Brightwell & Stevens 1988; Laessle, Wittchen, 
Fichter & Pirke, 1989; Schwalberg, Barlow, Alger & Howard, 1992; Brewerton, Lydiard, 
Herzog, Brotman, O’Neil & Ballenger, 1995; Bulik, Wade & Kendler, 2000). Similarly, 
prevalence amongst AN samples has also been investigated (Laessle, Kittl, Fichter, 
Wittchen & Pirke, 1987; Halmi, Eckert, Marchi, Sampugnaro, Apple & Cohen, 1991; 
Deep, Nagy, Weltzin, Rao & Kaye, 1995; Herpertz-Dahlmann, Wewetzer, Schulz & 
Remschmidt, 1996) (see Table 4.1).  Lifetime prevalence rates of at least one anxiety 
disorder varies from 25% (Keck at al., 1990) to 75% (Schwalberg et al., 1992) in BN and 
from 23% (Laessle et al., 1987) to 83% (Godart et al., 2000) in AN.  
Several studies have shown that, in most cases, the onset of an anxiety disorder precedes 
the onset of an eating disorder (Schwalberg et al., 1992; Brewerton et al., 1995; Bulik, 
2003; Deep et al., 1995; Godart, Flament, Curt, Perdereau, Lang, Venisse, Halfon, 
Bizouard, Loas, Corcos, Jeammet & Fermanian, 2003) (see Table 4.1 for summary). 
These findings have led some researchers to speculate that early onset anxiety disorders 
may represent a potential genetically mediated pathway toward the development of an 
eating disorder (Kaye, Bulik, Thornton, Barbarich, Masters & the Price Foundation 
Collaborative Group, 2004), and at the very least it suggests that early onset anxiety 
disorders may in some way predispose individuals to the development of an eating 
disorder (Bulik, Sullivan, Carter & Joyce, 1996).   
 
Unfortunately methodological limitations evident in many of the studies investigating 
anxiety and eating comorbidity may account for the striking variability amongst 
prevalence rates reported. Despite these discrepancies, it is clear that anxiety and eating 
disorders consistently demonstrate a high comorbidity, generally two to three times 
higher than those reported in the community (Laessle et al., 1989; Mitchell et al., 1991 & 
Fornari et al., 1992).  
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Of the anxiety disorders, obsessive-compulsive disorder and social phobia have been 
found to have the highest comorbidity with eating disorders. Table 4.2 summarises the 
findings of research investigating comorbid eating disorders and anxiety disorders. The 
prevalence rates of anxiety disorders also differs amongst the eating disorder subtypes, a 
summary of which can be seen in Table 4.3 and Table 4.4 for AN and BN respectively.  
 
Finally, it is impossible to discuss the comorbidity between eating and anxiety disorders 
without further addressing the familial relationship that has been discussed in the 
literature. In terms of the consideration of an etiological relationship between these 
disorders, research has included twin studies and family design studies to further test this 
relationship. To date well designed research in this area is limited, however Lilenfeld et 
al., (1998) reported that relatives of AN and BN probands had significantly increased 
rates of GAD and panic disorder, compared with normal controls.  Similarly, Wade, 
Bulik, Prescott & Kendler (2004) reported a shared familial risk factor between GAD and 
BN. Furthermore, a multivariate twin study found evidence for a shared genetic 
vulnerability between BN and anxiety disorders (panic disorder and phobias) (Kendler, 
Walters, Neale, Kessler, Heath & Eaves, 1995). Similarly, Keel et al., (2005) utilising a 
discordant monozygotic twin design, found support for a shared transmission between 
anxiety and eating disorders. Nevertheless, they did not elaborate on the nature of this 
shared diathesis. Thus, it is clear that further research in this area is crucial. 
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Table 4.1.  
Lifetime and Current prevalence of anxiety disorders in patients with eating disorders 
Reference  & 
Country 
Subjects N Diagnostic 
Criteria & 
Instruments 
Summary of 
Results 
Limitations of Research 
Brewerton et al. 
(1995)   
USA  
BN 59 DSM-III-R; SCID 36% reported at least 1 AD 
71% anxiety preceded BN 
No specific ED diagnostic instrument; No control 
group  
Bulik et al. (1996)  
New Zealand 
BN 114 DSM-III-R; SCID; SCID 
II; SADS; HDRS; GAFS 
64% reported at least 1 
AD. AD had a mean onset 
of 8 yr and BN mean age 
of onset 20yr  
No specific ED diagnostic instrument; Sample not 
representative (exclusion criteria); No control group; 
Comorbid lifetime alcohol dependence in 48% of 
sample; No Ax PTSD  
Bulik, Wade & 
Kendler (2000)  
USA  
BN Monozyg 
twins  
20 
pairs  
DSM-III-R; SCID  BN twin more likely to 
report lifetime GAD & 
mother report more 
anxious as child 
Small sample size; No specific ED diagnostic 
instrument; No control group  
Deep et al. (1995)  
USA  
AN  
L/T recovered 
24 
 
DSM-III-R; SADS-L 75%  prevalence of 1 AD  
79% AD preceded ED 
Small sample size; Sample not representative 
(exclusion criteria); No control group; No specific ED 
diagnostic instrument 
Fornari et al. (1992)  
USA  
AN 
BN 
42 
21 
DSM-III-R; SADS-L 45.8%of AN had at least 1 
lifetime AD 
PTSD and SP not assessed; Small sample size; No 
specific ED diagnostic instrument; No control group; 
Males and females included 
Godart et al. (2000)  
France  
ANR 
BN 
29 
34 
DSM-IV; DSM-III-R for 
AD; CIDI 
71% AN-R at least 1 AD 
65% BN at least 1 AD 
Small sample size; No control group; No specific ED 
diagnostic instrument; Retrospective diagnosis; 
Males and females included 
Godart et al. (2003)  
France  
AN 
BN 
NC 
166 
105 
271 
DSM-IV; MINI  71%  prevalence AD in ED  
41.8–53.3% AD preceded 
ED 
Sample may not be representative (more severe ED) 
Retrospective diagnosis; Small numbers in BN-NP 
group 
Halmi et al.(1991)  
USA 
AN 
NC 
62 
62 
DSM-III-R; DIS; RDC-FH 62.9% at least 1 lifetime 
AD in AN  
1 year prevalence in AN:  
OCD:11.3% ; PD: 4.8% ; 
Ph:24.2%  
No specific ED diagnostic instrument; No Ax PTSD 
Herpertz-Dahlmann 
et al. (1996)  
Germany  
AN 
Adolescents  
34 DSM-III-R; Morgan 
Russell  
SIAB-P; CIDI; BDI; ANIS; 
SCL-90 R 
6 month prevalence: 
41% at least 1 AD 
53% reported AD 
preceding ED 
Standardised measures not used at each time period; 
Small sample size and varying ages of sample; No 
control group; Males and females included 
Hudson et al. 
(1983) 
USA 
AN 
BN 
AN+BN 
16 
49 
25 
DSM-III ; DIS; EDS 54% ED group at least 1 
AD 
No specific ED diagnostic instrument; Inclusion of an 
AN + BN group; Small sample size and groups 
unequal  
Hudson et al.(1987)  
USA 
BN  
Hx BN 
Depression  
NC 
51 
19 
24 
28 
DSM-III ; DIS; ADDS ; 
EDS for ED 
43% BN sample at least 1 
AD 
No specific ED diagnostic instrument; No Ax PTSD, 
SP and phobias; Apart from BN group, small sample; 
Males and females included 
Iwasaki et al.(2000)  
Japan  
AN 
BN 
98 
73 
DSM-IV; SCID-P 41% ED group at least 1 
AD 
Exclusion of EDNOS; No control group; No specific 
ED diagnostic instrument; Hospital sample more 
severe 
Kaye, Bulik, 
Thornton, 
Barbarich, Masters 
& the PFCG, 2004)  
USA 
AN 
BN 
AN+BN 
97 
282 
293 
DSM-IV; SCID; YBOCS; 
STAI; FMPS; TCI 
63.5% ED group at least 1 
AD 
Modified ED criteria; AD diagnosed when 
subthreshold  
EDNOS excluded; No control group; No specific ED 
diagnostic instrument; Query  representativeness of 
sample 
Keck et al. (1990)  
USA 
BN 
Bulimia  
DC 
NC 
69 
50 
24 
28 
DSM-III-R; DSM-III ; 
SCID 
25% Prevalence of at least 
1 AD in BN  
higher than NC though non 
sig 
Sample not representative (exclusion criteria); No Ax 
of PTSD; No specific ED diagnostic instrument; Small 
control group 
Laessle et al.(1989)  
Germany 
AN R 
ANBP 
BN 
BN – Hx AN 
21 
20 
27 
23 
DSM-III ; CIDI 33.3% At least 1 AD in AN-
R 
55% At least 1 AD in AN-
BP 
70.4% At least 1 AD BN 
65.2% At least 1 AD BN-
Hx AN 
No Ax GAD & PTSD; No specific ED diagnostic 
instrument; Small sample size; No control group 
Laessle et al.(1987)  
Germany 
AN 
AN+Bulimia 
BN 
DC 
13 
26 
13 
47 
DSM-III ; CIDI; EDI ; EAT 23%  prevalence of 1 AD 
in AN 
Small sample size; No specific ED diagnostic 
instrument  
No Ax for PTSD; GAD; Males and females included 
Powers et al. (1988) 
USA 
BN 30 DSM-III-R; SCID 53% At least 1 AD No Ax PTSD; Small sample size; No specific ED 
diagnostic instrument 
Schwalberg et al. 
(1992) USA  
BN 20 DSM-III-R ; ADIS-R 75%  prevalence of 1 AD   
59.3% AD precededED 
Small sample size; No control group; No specific ED 
diagnostic instrument 
 
 
 108 
Table 4.2  
Summary of research papers investigating eating disorder comorbidity with anxiety disorders  
Reference  & 
Country 
Subject N Diagnostic Criteria 
& Instruments 
Summary of Results Limitations of Research 
Fornari et al. (1992)  
USA 
ANR 
ANBP 
BN 
24 
18 
21 
DSM-III-R; SADS-L Lifetime OCD ANR (25%) and ANBP (66%) (sig difference). BN OCD 
(42.9%).  
No Ax PTSD and SP; Small sample size; No specific ED 
diagnostic instrument; No control group; Males and females 
included 
Gleaves et al. 
(1998)  
USA 
AN 
BN 
EDNOS 
121 
103 
70 
DSM-III-R; BULIT-
R; EAT; DES; TSC-
40 ; 
 TSC-40-ANX; PSS 
AN: 47% PTSD / BN: 62% PTSD 
EDNOS: 74% reported traumatic event; 52%  met criteria for PTSD 
No control group; Type of trauma identified in less than 10% of 
sample 
Use of self-reportmeasure to diagnose PTSD 
Godart et al. (2000)   
France  
ANR 
BN 
29 
34 
DSM-IV; DSM-II-R 
for AD CIDI 
AN-R: SP55%; Ph34%; GAD24%; OCD21%; PD7%; AG3%  
BN: SP59%; OCD0%; GAD23%; AG6%; PD15%; Ph21% 
Small sample size; No control group; No specific ED diagnostic 
instrument 
Retrospective diagnostic procedure; Males and females included 
Godart et al. (2003)  
France 
AN 
BN 
NC 
166 
105 
271 
DSM-IV; MINI  AN GAD 45.6%; ANR: OCD 17.5%; ANBP OCD 21.8 
BN GAD 31.4% 
Sample may not be representative (severe ED); Retrospective 
diagnosis of past disorders; Small numbers in BNNP group 
Hinrichson et al. 
(2003)  
UK 
ANR 
ANBP 
BN 
NC 
21 
34 
59 
50 
DSM-IV ; BITE ; 
DES-II ; FNE 
ANR: SP 71.4% 
ANBP: SP 88.2% 
BN: SP 67.8% 
NC: SP 30% 
No specific ED and AD diagnostic instrument 
Hudson et al. (1983)   
USA 
AN 
BN 
AN+BN 
16 
49 
25 
DSM-III ; DIS; EDS AN: OCD69%; PD38%; AG13%; Ph25%; 
BN: PD39%; OCD24%; phobia12%; AG10% 
AN + BN: PD44%; OCD44%; AG24%;  Ph4%;  
No specific ED diagnostic instrument; Inclusion of an AN + BN 
group  
Small sample size and groups unequal; No Ax  for SP  
Iwasaki et al.(2000)  
Japan 
ANR 
ANBP 
BNP 
BNNP 
62 
36 
57 
16 
DSM-IV; SCID-P In all subjects, OCD was most prev (19%); followed by SP (18%), PD 
(16%) and GAD (13%); 43% of sample met criteria for AD and lifetime 
prev GAD more prev amongst ANBP and BNP than ANR 
Exclusion of EDNOS; No control group; No specific ED diagnostic 
instrument; Hospital sample may be more severe 
Kaye, Bulik, 
Thornton, 
Barbarich, 
Masters & the 
PFCG, 2004)  
USA 
AN 
BN 
AN+BN 
 
97 
282 
293 
 
DSM-IV ; SCID; 
YBOCS; STAI; 
FMPS; TCI 
Prevalence of OCD, PD, SP, AG and GAD did not differ significantly 
across ED subtypes 
OCD (35 – 44%) ; SP (16 – 23%) ; Ph (12 – 18%); GAD (8 – 13%) ; PD 
(9-11%) ; AG (2 – 4%) ; PTSD x3 more frequent in BN (13%) than AN 
(5%)  
Modified ED criteria; AD diagnosed when subthreshold; EDNOS 
excluded 
No control group; No specific ED diagnostic instrument; Sample 
may not be not representative 
Laessle et al. (1987)  
Germany 
AN 
AN+BN 
BN 
DC 
13 
26 
13 
47 
DSM-III ; CIDI; EDI ; 
EAT 
AN: SP 23%; Ph: 15%; OCD 15%; AG 0% 
AN + BN: SP 50%; Ph: 19%; OCD 15% AG 15% 
BN: Ph: 46%; SP 31%; OCD 8% Ag 8% 
 
Small sample size; No specific ED diagnostic instrument; No Ax 
for PTSD, GAD and PD 
Laessle et al. (1989)  
Germany 
ANR 
ANBP 
BN 
BN (Hx AN) 
21 
20 
27 
23 
DSM-III ; CIDI; EAT ANR: SP 23.8%; Ph14.3%;OCD 9.5%;PD 4.8%;AG 0%  
ANBP: SP 40%; AG 20%; Ph 15%; OCD 10%; PD 5% 
BN: SP 48%; phob 37%; OCD 18.5%; AG 14.8%; PD 11% 
BN (Hx AN): SP 56.5%; AG 17.4%; OCD 13%; Ph 8.7%; PD 4.3% 
No Ax for GAD & PTSD; No specific ED diagnostic instrument; 
Small sample size; No control group 
Lilenfeld et al. 
(1998)  
USA 
ANR 
BN 
CW 
26 
47 
44 
DSM-III-R; SADS; 
KSADS  
Eating Disorder 
Family History 
Interview. 
ANR: OCD 62%; SP 31%; GAD 31%; Ph 27%; PTSD 7%; PD 4%  
BN: PTSD 30%; OCD 21%; Ph 19%; SP15%; GAD 13%;  PD 4% 
CW: Ph 7%; PTSD 7%; SP 5%; OCD 5%;  GAD 2%;  PD 0%   
SP more frequent in ANR vs controls  
No Ax for AG; Small AN sample; Unbalanced sample sizes 
Milos et al.  (2002) 
Switzerland 
AN 
BN 
84 
153 
DSM-IV ; SCID-I 29% OCD in ED; no diff between AN and BN; Comorbid OCD assoc with 
longer hx of ED & earlier onset  
Self-report retrospective data on ED course; No specific ED 
diagnostic instrument; No control group 
Piran et al. (1985)  
Canada 
AN 
BN 
14 
33 
DSM-III ; SADS; 
DST; BDI; MMPI; 
HSCL; HDS; HAS 
Lifetime:  
AN: SP 53.8%; PD 42.8%; OCD 14%; AG 0%; Ph 0% 
BN: PD 52.7%; SP 48.7%; AG 3%; Ph 3%; OCD 0% 
No Ax PTSD; No specific ED diagnostic instrument; No control 
group 
 
Speranza et al. 
(2001)  
France 
AN 
BN 
CW 
58 
31 
89 
DSM-IV ; MINI ; 
YBOCS 
Current and lifetime prev of OCD sig higher ED (15.7% and 19%) than in 
general population (0% and 1.1%).  
AN current (19%) and lifetime (22.4%) 
BN current (9.7%) and lifetime (12.9%) 
ANBP higher prev than ANR and BN 
Anxiety preceded ED in 65% of cases 
 
Small sample size of ED subtypes; AN inpatients vs BN 
outpatients may differ in severity of illness 
Stiger & Zanko 
(1990)  
Canada 
ANR 
ANBP 
BN 
NC 
PC 
16 
12 
45 
24 
21 
DSM-III-R ; EAT; 
DSQ 
30% of ED women report CSA. CSA more prevalent among BP group 
than ANR. Only 8% of NC reported trauma  
 
Modified ED criteria; NC group may have been comprised of well 
functioning individuals (hospital staff etc)  and therefore not 
representative of the normal population; small sample size; No 
specific ED diagnostic instrument 
Thornton & Russell 
(1997)  
Australia  
AN 
BN 
35 
33 
DSM-III-R; CIDI ; 
Personality 
Disorders Inventory 
AN: 37% OCD 
BN: 3% OCD 
21% of ED reported OCD; OCD usually predated ED 
19% had premorbid OCPD 
Inpatients only, therefore maybe more severe and not 
representative of population; No specific ED diagnostic instrument; 
No control group  
Turnbull et al. 
(1997)  
UK 
AN 
BN 
EDNOS 
90 
54 
20 
ICD-10; DSM-III-R ; 
SCID 
Childhood adversity 
and trauma 
interview 
No differences between AN, BN and EDNOS groups: Lifetime and 
current rates of PTSD were 18% and 11% respectively. Comorbid PTSD 
was not associated with greater severity of illness.  
The onset of PTSD in relation to ED not assessed; No specific ED 
diagnostic instrument 
No control group 
Vize & Cooper 
(1995) 
UK 
AN 
BN 
NC 
DC 
40 
60 
40 
40 
DSM-III-R ; 
interview based on 
EDE; SADS; PDQ-
R; BDI; CECA 
Sexual abuse of any form was identified in 52.5% of AN group, 35% of 
BN group and 12% of control group  
Groups not equal in numbers; Results may underestimate sexual 
abuse given participants were only given one opportunity to 
disclose abuse.  
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Table 4.3  
Summary of research papers investigating AN and AD comorbidity 
Reference  &  
Country 
Subjec
t 
N Diagnostic 
Criteria & 
Instruments 
Summary of Results Limitations of Research 
Halmi et 
al.(1991)  
USA 
AN 
NC 
62 
62 
DSM-III-R; DIS; 
RDC-FH 
AN:SP33.9%; OCD25.8%; AG14.5%; Ph12.9%;PD8.1% 
NC:Ph14.5%; PD8.1%; OCD6.5%; AG3.2%; SP3.2% 
Higher lifetime AG in AN vs NC  
No specific ED diagnostic instrument; No Ax PTSD  
Halmi et al. 
(2003)  
USA 
ANR 
ANBP 
OCD  
147 
177 
116 
DSM-IV ; SIAB ; 
YBOCS 
AN-R: 68% lifetime OCD 
AN-BP: 79.1% lifetime OCD 
 
Modified criteria for AN; Sample may not be representative (family cases) 
Herpertz-
Dahlmann et 
al. (1996)  
Germany  
AN 
Adolesc
ents  
 
34 DSM-III-R; 
Morgan Russell ; 
SIAB-P; CIDI; 
BDI; ANIS; SCL-
90  
SP21%; Ph17.6%; PD11.8%; AG5.9%; OCD0% 
12% of sample had obsessive compulsive behaviour 
without meeting DSM-III criteria for OCD 
Standardised measures not used at each time period; Small sample size and 
varying ages of sample; No control group; Males and females included 
Matsunaga et 
al. (1999)  
Japan 
ANR 
OCD  
53 
23 
DSM-III-R; DSM-
IV ; MAS for AD; 
SDS; SCID-II; 
SCID-P 
40% met criteria for OCD after excluding OC symptoms 
typical of ED; Comorbid OCD assoc with more severe ED 
symptoms 
Small sample size; No specific ED diagnostic instrument 
 
Pollice et al. 
(1997)  
USA 
 
AN  
NC 
48  
18  
DSM-III-R; HRSD; 
BDI; HARS; STAI; 
YBOCS; YBOCS-
ED 
Anxiety and obsessionality most severe in underweight 
state, symptoms reduced after short term and long term 
weight restoration.  
Small sample; Mixed longitudinal and cross sectional design; No specific ED 
diagnostic instrument 
 
Rastam et al. 
(1995)  
Sweden  
AN  
NC 
51 
51 
DSM-III-R ; SCID-
II 
Sig more AN subjects (31%) met criteria for lifetime OCD 
compared with NC (8%). 20% of the AN group continued 
to meet OCD diagnosis at follow up compared with 6% of 
NC. Other than OCD there was No sig diff b/w AN and 
NC in AD prevalence  
PTSD not assessed ; No specific ED diagnostic instrument 
 
Table 4.4  
Summary of research papers investigating BN and AD comorbidity 
Reference  
&  Country 
Subject N Diagnostic Criteria & 
Instruments 
Summary of Results Limitations of Research 
Brewerton et 
al.(1995)   
USA 
BN 59 DSM-III-R; SCID SP17%; GAD12%; PD10%; PTSD 3%; OCD3% No specific ED diagnostic instrument 
No control group 
No Ax for AG 
Bulik et 
al.(1996)  
New 
Zealand 
BN 114 DSM-III-R; SCID; SCID 
II; SADS; HDRS; GAFS 
Lifetime prevalence: SP: 30%; Ph: 30%; PD: 10%; 
OCD: 4%; AG without PD: 2%; GAD: 2%  
No specific ED diagnostic instrument; Sample not representative (exclusion 
criteria); No control group; Comorbid lifetime alcohol dependence in 48% of 
sample; No Ax PTSD 
Bulik, Wade 
& Kendler 
(2000) USA 
BN 
Monozy 
twins 
20 
pairs  
DSM-III-R; SCID  75% reported GAD prior to ED  Small sample size; No specific ED diagnostic instrument; No control group 
Dansky et 
al. (1997)  
USA 
BN  
 
CW 
72 
 
2929 
DSM-IV BN Current PTSD 21.4%  
BN Lifetime PTSD 36.9% 
CW Current PTSD 4.2%  
CW Lifetime PTSD 11.8% 
Sig difference b/w BN and CW 
Telephone screening ; No diagnostic instruments used for ED or AD  
Hudson et 
al. (1987)  
USA 
BN  
Hx BN 
51 
19 
DSM-III; DIS; ADDS ; 
EDS for ED 
BN: OCD33%; PD/AG14% 
Hx BN: OCD32%; PD/AG26% 
No specific ED diagnostic instrument; No Ax for PTSD, SP and phobias ; Apart 
from BN group, small sample; Males and females included 
Powers et 
al.(1988) 
USA 
BN 30 DSM-III-R ; SCID-P Ph: 20%; SP: 17%; AG: 13%; GAD: 10%; OCD: 3% No Ax for PTSD and PD; Small sample size; No specific ED diagnostic 
instrument 
Rorty et al. 
(1994)  
USA 
BN 
BN Hx 
NC 
40 
40 
40 
DSM-III-R; Proposed 
DSM-IV; SCID-P; 
SCID-II; EAT-SADS-L ; 
EDQ ; SAEQ; AEIII; 
PSY 
No sig diff between BN group and NC in reported 
sexual abuse – BN (28.8%) v NC (20%) 
Non sexual abuse more prevalent in BN group vs 
NC.  
Sample may not be representative due to recruitment through advertisement; 
Problem associated with retrospective study – reliance on recollection  
Schwalberg 
et al.(1992)  
USA  
BN 20 DSM-III-R ; ADIS-R GAD: 55%; SP: 45%; OCD: 15%; Ph: 10%; PTSD: 
10%; AG: 0%; PD: 0%; 
 
Small sample size; No control group; No specific ED diagnostic instrument 
Welch & 
Fairburn 
(1994)  
UK 
BN  
NC 
PC 
100 
100 
50 
DSM-III-R ; EDE; SCID Sexual abuse reports were similar in BN groups vs 
control groups.  
Retrospective design; Interviewers not blind to the case status of subjects 
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Table 4.5  
Summary of research papers investigating treatment response and outcome of individuals 
with comorbid ED and AD  
Reference  & 
Country 
Subjects N Diagnostic Criteria 
& Instruments 
Summary of Results Limitations of Research 
Bulik et al. (1996) 
New Zealand 
BN 11
4 
DSM-III-R; SCID; 
SADS-L; HRDS 
Comorbid AD not associated with differences in 
BN symptoms. However, an AD was associated 
with a Hx AN and earlier age of onset of drug 
and alcohol dependence 
No specific ED diagnostic instrument; Sample not representative (exclusion 
criteria); No control group; Comorbid lifetime alcohol dependence in 48% of 
sample; No Ax PTSD 
Fichter & Quadflieg 
(2004)  Germany 
BN (Ax pre 
and post Tx 
and 2yr, 6yr 
and 12 yr 
F/U) 
19
6 
DSM-III; DSM-III-R; 
DSM-IV; SIAB-S; 
EDI; HSCL 
Lifetime anxiety found in 36% & comorbidity 
was the strongest predictor of unfavourable 
outcome 
Telephone interviews; Inpatients only therefore may be more severe; 
Retrospective assessment – bias; No control group 
Gleaves & Eberenz 
(1994)  USA 
BN 46
4 
DSM-III-R; self-
reportquestionnaire 
based on DSED-R 
71% reporting a Hx of sexual abuse also had 
indicators of poor prognosis 
Insufficient assessment of sexual abuse; possible underestimate of sexual 
abuse due to non disclosure; No control group 
Goodwin & 
Fitzgibbon (2002) 
USA 
AN or BN 28 EDI; BORI for SP Individuals who did not enter treatment had 
significantly higher levels of social anxiety than 
those who engaged with treatment 
Small sample size; The diagnostic criteria for ED and AD unclear; No specific 
ED or AD diagnostic instruments; No control group 
Halmi et al. (1973) 
USA 
AN 42 Feighner et al More severe non ED OC behaviours assoc with 
poor outcome. moderate to severe anxiety 
symptoms were frequent in those who did and 
did not recover 
The diagnostic criteria for AD unclear; No specific ED or AD diagnostic 
instruments; No control group 
Halmi et al. (1991) 
USA 
AN (10 yr 
F/U) 
NC 
62 
62 
DSM-III-R; DIS; 
RDC-FH 
Recovered patients had the same prevalence of 
lifetime psychiatric dx as those with persisting 
ED symptoms 
No specific ED diagnostic instrument; No Ax PTSD 
Herpertz-
Dahlmann et al. 
(1996) 
Germany 
AN 
Outcome 
study 
Adolescents 
34 DSM-III-R; Morgan 
Russell; SIAB-P; 
CIDI; BDI; ANIS; 
SCL-90 R 
41% at initial assessment met criteria for AD. At 
7 years follow up 38% met criteria for AD. 
Patients with poor outcome show higher levels 
of psychopathology. 
Standardised measures not used at each time period; Small sample size and 
varying; ages of sample; No control group; Males and females included 
Pollice et al. (1997) 
USA 
 
 
AN 
(underweight 
and at 
S/Trecovery) 
AN (at 
L/Trecovery) 
NC 
22 
 
26 
18 
DSM-III-R; HRSD; 
BDI; HARS; STAI; 
YBOCS; YBOCS-ED 
Anxiety and obsessionality most severe in 
underweight state, symptoms reduced after 
short term and long term weight restoration. 
Small sample; Mixed longitudinal and cross sectional design; No specific ED 
diagnostic instrument 
 
Procopio et al. 
(2006) 
USA 
Bulimic 
symptom 
 
Two Ax over 
2.5 years 
15
0 
EDI; RSE; BDI; BAI The level of anxiety symptoms significantly 
predicted the level of bulimic symptoms 2.5 
years later 
No specific ED or AD diagnostic instruments; Sample not classified as per DSM-
IV BN criteria; No control group 
Rastam et al. 
(1995) 
Sweden 
AN 
NC 
51 
51 
DSM-III-R; SCID-II; 
Morgan-Russell; 
EAT 
20% of the An group continued to meet OCD 
diagnosis at follow up compared with 6% of NC. 
No Ax PTSD; No specific ED diagnostic instrument 
 
 
Srinivasagam et al. 
(1995) 
USA 
Recovered 
AN 
NC 
20 
16 
EDI; FMPS AN sample had higher perfectionism scores 
and greater symmetry and exactness scores 
than controls 
Small sample size; Inclusion of women in recovery at least 1 year, therefore 
unclear whether some had longer recovery times which may impact on results 
Thompson Brenner 
& Westen (2005)   
USA 
Bulimic 
Symptoms 
14
5 
DSM-IV; SWAP 200 Comorbidity was systematically related to 
treatment length and outcome, such that the 
comorbid patients tended to have longer and 
less successful treatments by clinician report. 
Patients with and without DSM-IV BN included; Retrospective clinician reports; 
Different therapeutic approaches; Selective response rate – bias; No specific ED 
and AD diagnostic instruments; No control group 
Thiel et al. (1988) 
Germany 
AN 
BN 
(Ax pre Tx 
and at 30 
month F/U) 
27 
48 
DSM-IV; YBOCS; 
EDI; Hamburg OCI 
At assessment 37% met criteria for OCD; no sig 
diff between ED diagnosis and OCD status; 
Dropout was not related to OCD status; Poorer 
prognosis for BN and comorbid OCD; patients 
with most improved ED showed highest 
reduction in obsessions and compulsions 
Significant drop out rate (19%); Small sample size; No specific ED diagnostic 
instruments; No control group  
 
Toner, Garfinkel & 
Garner (1988) 
Canada 
AN (14 year 
F/U) 
 
CW 
47 
 
 
26 
Feigner et al ; DSM 
III ; DIS 
 
Symptomatic and improved AN group were sig 
higher in AD than CW. Symptomatic group had 
sig higher incidence of AD prior to onset of AN 
relative to asymptomatic group (83% vs 55% 
respectively) 
No Ax PTSD and GAD; Retrospective recall in assessment of anxiety and 
depression 
von Ranson et al. 
(1999) 
USA 
BN 
Recovered 
BN 
NC 
31 
29 
19 
DSM-III-R; SADS-L; 
YBOCS; HDRS; 
HARS; EDI 
YBOCS scores for BN and recovered BN 
groups were similar and were significantly 
higher than NC group 
OCD not diagnosed in BN group; Cross sectional design; Small sample size; No 
specific ED diagnostic instruments 
 
 
Note. ED: Eating Disorder; AN: Anorexia Nervosa; ANR: Anorexia Nervosa Restricting type; ANBP: Anorexia Nervosa Binge Purge type; BN: Bulimia Nervosa; BNP: Bulimia Nervosa Purging type; BNNP: Bulimia 
Nervosa Non Purging type; EDNOS: Eating disorder not otherwise specified; AD: Anxiety Disorder; CW: Control Women; NC: Normal Controls; DC: Depressed Controls; PC: Psychiatric controls; SP: Social 
Phobia; GAD: Generalised Anxiety Disorder; OCD: Obsessive Compulsive Disorder; PTSD: Post Traumatic Stress Disorder; AG: Agoraphobia; Ph: phobia; PD: Panic Disorder; Hx: History of; Ax: Assessment; 
CSA: Child Sexual Assault; L/T: long term; S/T: short term; Tx: treatment; follow up: F/U 
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4.2 Eating Disorder Comorbidity with Anxiety Disorders 
4.2.1 Obsessive Compulsive Disorder (OCD) 
A relationship between AN, BN and OCD has been suggested by clinical observation 
and, increasingly, by empirical investigation. A number of studies have reported 
significant comorbidity between individuals with eating disorders and OCD (Hudson et 
al., 1983; Hudson et al., 1987; Laessle et al., 1989; Halmi et al., 1991; Fornari et al., 
1992; Råstam et al., 1995; Thornton and Russell, 1997; Lilenfeld et al., 1998; Matsunaga 
et al., 1999; Godart et al., 2000; Iwasaki et al., 2000; Speranza et al., 2001; Milos et al., 
2002; Godart et al., 2003; Kaye, Bulik, Thornton, Barbarich, Masters & the Price 
Foundation Collaborative Group, 2004) (see Table 4.2 for summary). Thornton and 
Russell (1997) showed that OCD usually predated the onset of an eating disorder, 
suggesting that OCD may be a risk factor for developing an eating disorder. Milos et al. 
(2002) reported that individuals with OCD comorbidity have a longer history of an eating 
disorder and are likely to have developed the eating disorder at an earlier age.  
AN has a considerable overlap with obsessive–compulsive disorder (OCD) and this may 
reflect common neurobiological, genetic, or psychological elements. Early descriptive 
studies suggested that 50% to 100% of patients with AN showed obsessional or 
compulsive features. More recent studies have found a lower but still significant level of 
obsessions and compulsions among patients with AN (Halmi et al., 1991; Råstam et al., 
1995; Pollice et al., 1997; Matsunaga et al., 1999; Halmi et al., 2003) (see Table 4.3 for a 
summary of AN and OCD comorbidity findings). Fornari et al. (1992) and Speranza et al. 
(2001) found a significant difference in the OCD lifetime prevalence between purging 
AN and restrictive AN, where purging AN patients exhibited higher prevalence of OCD 
than the restricting AN patients. Godart et al. (2003) found significantly higher lifetime 
rates of OCD in women with AN compared with controls (24.3% for ANR and 23.6% for 
ANBP), however this difference was not found in their BN sample. A similar pattern of 
results was also reported by Bulik, Sulivan, Fear & Joyce (1997).  
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Arguably, the pattern of obsessions and compulsions most commonly present in AN is 
different from that found in OCD. Therefore, it is important to distinguish those 
behaviours that are not directly related to food, weight and shape. The lack of clear 
evidence regarding these mechanisms means that it is difficult to draw clear causal 
conclusions. However at a functional level, an important issue is that compulsive 
behaviours reduce anxiety levels. It can be hypothesized that the same function is served 
in the eating disorders, given that restriction and bulimic behaviours act to regulate affect 
(Lockwood et al., 2004). This however, does not explain the difference between the ego-
dystonic nature of OCD and the ego-syntonic nature of eating disorders. This important 
distinction needs to be addressed.  
 
Holden (1990) noted that the obsessions and compulsions of OCD patients are ego-
dystonic whereas the preoccupations and rituals of AN patients are largely ego-syntonic. 
Mazure et al. (1994) suggested that phobic thoughts of food and weight repeatedly enter 
the mind of AN patients, but not necessarily against their will. Although these thoughts or 
preoccupations may be distressing, they are not regarded as senseless. This is in contrast 
to typical obsessions and compulsions unrelated to eating, which also may occur in AN 
patients (Bastiani et al., 1996). 
One of the most common concerns raised in the current debate is whether people with 
AN display ‘typical’ or ‘true’ OCD symptoms as seen in patients diagnosed with primary 
OCD, or whether their symptoms are secondary to weight loss and malnutrition, or a 
combination of these. These concerns arise due to evidence that in conditions of         
semi-starvation, psychologically ‘normal’ adults can develop a range of obsessional 
features. Keys et al. (1950) illustrated how obsessions and compulsions, particularly 
those concerned with the preparation and consumption of food, develop under conditions 
of food restriction. This study also provides evidence for the possibility that the obsessive 
and compulsive symptoms observed in people with AN may at least partly be the result 
of their malnourished state, and not evidence of a true OCD. Some evidence for this 
comes from the discrepancy between inpatient and outpatient AN OCD rates, whereby 
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lower rates have been reported in the latter group (Serpell Livingstone, Neiderman & 
Lask, 2002).  
Studies that have compared rates of OCD in AN and BN have usually found higher 
comorbidity in AN, for example, Blinder, Cumella & Sanathara (2006) found that their 
ANR and ANBP sample was twice as likely to have OCD compared with BN and 
EDNOS patients. However, two Japanese studies found a significant number of BN 
participants met criteria for OCD (Matsunaga et al., 1999; Iwasaki et al., 2000), even 
after excluding the OCD-like symptoms typical of eating disorders. Matsunaga et al. 
(1999) also reported that BN subjects with concurrent OCD were more likely than 
subjects without OCD to have more severe mood and core eating disorder 
psychopathology. Among BN subjects with concurrent OCD, symptoms related to 
symmetry and order were most frequently identified, followed by contamination and 
aggressive obsessions, and checking and cleaning/washing compulsions (Matsunaga et 
al., 1999).  
A number of studies show that social phobia is common in patients with eating disorders 
(Piran et al., 1985; Laessle et al., 1987; Laessle et al., 1989; Halmi et al., 1991; 
Schwalberg et al., 1992; Garfinkel, Lin, Goering, Spegg, Goldbloom, Kennedy, Kaplan 
& Woodside, 1995; Brewerton et al., 1995; Lilenfeld et al., 1998; Powers et al., 1998; 
Godart et al., 2000; Iwasaki et al., 2000; Godart et al., 2003; Hinrichson et al., 2003; 
Kaye, Bulik, Thornton, Barbarich, Masters & the Price Foundation Collaborative Group, 
2004) (see Table 4.2, 4.3 and 4.4 for a summary of findings). Several studies suggest that 
social anxiety may be a more common co-morbid condition with eating disorders than 
4.2.2 Social Phobia 
Whilst the link between eating problems and obsessive-compulsive pathology has been 
clearly established (O’Brien & Vincent, 2003), other manifestations of fear, such as 
social phobia, agoraphobia and panic, have received less research attention (Hinrichson et 
al., 2004).  
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OCD, and some researchers have speculated that social anxiety may play a role in the 
etiology of eating disorders (Black Becker et al., 2004). 
The prevalence rate of social phobia and eating disorders has differed across studies. 
Halmi et al. (1991) reported significantly higher lifetime rates of social phobia in their 
eating disorder group (33.9%) compared with controls (3.2%). Furthermore, Godart et al. 
(2003) found similarly high rates of social phobia in their eating disorder sample. In AN, 
prevalence rates of between 16% (Kaye, Bulik, Thornton, Barbarich, Masters & the  
Price Foundation Collaborative Group, 2004) and 88.2% (Hinrichson et al., 2003) have 
been reported and between 17% (Powers et al., 1988; Brewerton et al., 1995) and 67.8% 
(Hinrichson et al., 2003) in BN. Lilenfeld, et al. (1998) reported that social phobia is 
significantly more frequent in AN than in controls. However Bulik, Sulivan, Fear & 
Joyce (1997) did not find a significant difference between their AN sample and controls. 
Two controlled follow-up studies of AN found differing results, one finding a 
significantly higher rate of social phobia in AN than normal controls (Halmi et al., 1991), 
whilst the second found no difference (Råstam et al., 1995).  
Hinrichson et al. (2003) demonstrated that levels of social phobia in female patients with 
AN and BN are significantly elevated compared to control women, and that social phobia 
is associated with higher levels of eating psychopathology in bulimic individuals.  
Garfinkel, Lin, Goering, Spegg, Goldbloom, Kennedy, Kaplan & Woodside (1995) 
observed significantly higher prevalence rates of social phobia amongst women with 
clinical and subthreshold BN compared with controls. Bulik, Sulivan, Fear & Joyce 
(1997) supported this finding with a significantly higher rate of social phobia reported 
amongst their BN sample (30.2%) compared with normal controls (6.1%). Furthermore, 
Godart et al. (2003) found that of the anxiety disorders, social phobia was the most 
prevalent amongst their BN sample. 
It must be noted that prevalence rates for social phobia amongst the eating disorders may 
be inconsistent due to the observation that many women with eating pathology avoid 
social situations and consequently the lower rates of social anxiety may reflect a lack of 
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social interactions as opposed to a lack of social anxiety per se (Bulik, Sulivan, Fear & 
Joyce, 1997).  
4.2.3 Agoraphobia  
Studies investigating ED and agoraphobia have found varying results. Godart et al. 
(2002) report that comorbidity rates for agoraphobia vary from 0% to 34.5% and findings 
in this area are limited and contradictory. In AN, lifetime prevalence of agoraphobia 
ranges from 0% (Laessle et al., 1989) to 3% (Godart et al., 2000) in restricting subgroups, 
whereas a study of binge/purge AN found a 20% rate (Laessle et al., 1989). A later study 
by Godart et al. (2003), reported significantly higher lifetime rates of agoraphobia in 
women with AN (19.8% for ANR and 27.3% for ANBP) compared with matched 
controls (7.3%). In follow up studies of AN, significantly higher lifetime prevalence rates 
of agoraphobia have been reported in the AN group compared to controls (Halmi et al., 
1991), however a study by Råstam et al. (1995) reported no difference.  
The lifetime prevalence of agoraphobia in BN varies from 0% (Schwalberg et al., 1992) 
to 17.4% (Laessle et al, 1989). In the community, lifetime prevalence of agoraphobia in 
BN varies from 27% (Bushnell et al., 1994) to 34.5% (Garfinkel, Lin, Goering, Spegg, 
Goldbloom, Kennedy, Kaplan & Woodside, 1995). Furthermore, Garfinkel, Lin, Goering, 
Spegg, Goldbloom, Kennedy, Kaplan & Woodside (1995) and Godart et al. (2003), found 
significantly higher lifetime rates of agoraphobia in their BN samples compared to their 
control groups (7.5% and 17.4%).  
The findings of panic disorder comorbidity amongst eating disorder samples is also 
varied with one study reporting between 9 - 11% prevalence (Kaye, Bulik, Thornton, 
Barbarich, Masters & the Price Foundation Collaborative Group, 2004) and another 
finding between 42 – 52% prevalence (Piran et al., 1985). Bulimic samples have been 
varied, ranging from 0% (Schwalberg et al., 1992) to 39% (
4.2.4 Panic Disorder  
Hudson et al., 1983). Several 
studies have found the lifetime prevalence rates of panic disorder ranges from 4% 
(Lilenfeld et al., 1998) to 7% (Godart et al., 2000) in ANR and is estimated to be around 
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15% in ANBP (Laessle et al., 1989). Two AN controlled outcome studies have estimated 
that the lifetime prevalence of panic disorder is 8.1%, and 6 month prevalence between 
2% and 11.8% (Halmi et al., 1991; Råstam et al., 1995). Walters & Kendler (1995) 
reported that in a community study, individuals with “possible anorexia” have the risk of 
panic disorder increased by 3.4.  
4.2.5 Specific Phobia 
The reported lifetime prevalence of specific phobias amongst individuals with eating 
disorders varies considerably, ranging from 0% (Piran et al., 1985) to 34% (Godart et al,. 
2000) in AN and from 10% (Schwalberg et al.,1992) to 46% (Laessle et al., 1987) in BN.  
Bulik at al. (1996) reported that 30% of their BN sample met a lifetime diagnosis of 
specific phobia. Lilenfeld et al. (1998) found that whilst 19% of their BN sample met 
criteria for specific phobia, this was not significantly different to their controls (7%). 
Conversely, Lilenfeld et al. (1998) found a significant difference between prevalence 
rates between their AN sample (27%) and controls. Furthermore, a community study 
reported that the risk for phobia is increased by 2 to 4 in AN subjects (Kendler et al., 
1991; Walters & Kendler, 1995) and by 2.37 in BN subjects (Kendler et al., 1991).  
In terms of follow up studies, Halmi et al. (1991) found no significant difference in 
lifetime prevalence of specific phobia in women with a history of AN compared to 
controls. Garfinkel, Lin, Goering, Spegg, Goldbloom, Kennedy, Kaplan & Woodside 
(1995) found significantly higher lifetime rates of specific phobia in women with clinical 
and subthreshold BN (40 – 40.9% respectively) compared to controls (11.4%).   
There has been considerable interest in the relationship between eating disorders and 
trauma (Vanderlinden & Vandereycken, 1997). Although a history of trauma, particularly 
childhood sexual abuse, is considered to be a non-specific risk factor for the development 
of an eating disorder, surprisingly few studies have examined comorbidity of PTSD with 
eating disorders (Black Becker et al., 2004). A study conducted by Godart et al. (2000) 
indicated that one of their objectives was to assess the comorbidity of all anxiety 
4.2.6 Post Traumatic Stress Disorder (PTSD) 
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disorders amongst their eating disorder sample. However, they did not include PTSD in 
the assessment. Studies investigating PTSD comorbidity among eating disordered 
individuals have reported rates ranging from 11% to 52% (Turnbull et al., 1997; Gleaves 
et al., 1998). Faravelli et al. (2004) found that women who had been sexually assaulted 
were significantly more likely to report an eating disorder compared with women who 
had not been assaulted. This is supported by the literature reporting the most frequently 
reported psychiatric consequences of sexual abuse in women are PTSD, mood disorders, 
substance abuse disorders, eating disorders and sexual disorders (Dahl, 1989; Putnam & 
Trickett, 1997; Thompson et al., 2003). Striegel-Moore, Garvin, Dohm & Rosenheck 
(1999) reported that 25% of their eating disorder sample met criteria for PTSD. Black 
Becker et al. (2004) also found support for a link between PTSD and eating disorders in 
their clinical population.  
 
A number of studies have demonstrated a positive association between child sexual 
assault (CSA) and clinical eating disorders (Root & Fallon, 1989; Steiger & Zanko, 1990; 
Welch & Fairburn, 1994; Vize & Cooper, 1995; Fallon & Wonderlich, 1997; Johnson et 
al., 2002). Links have also been proposed between a history of child sexual assault and 
specific eating disorder symptoms, specifically, bingeing, vomiting and negative body 
image (Waller, 1992; Waller, Hamilton, Rose, Sumra & Baldwin, 1993). It has also been 
suggested that abuse may act as a moderator between a range of causal factors and eating 
disorder pathology (van Gerko, Hughes, Hamill & Waller, 2005).  
A meta-analysis by Smolak & Murnen (2002) found a relationship between CSA and 
eating disorders, such that CSA is associated with an increased likelihood of eating 
disorder symptomatology. Furthermore, Jacobi, Hayward, de Zwaan, Kraemer & Agras, 
(2004) reported that there was a high likelihood that sexual abuse preceded the eating 
disorder. However, there have also been a number of studies that have not found a 
relationship between CSA and eating disorders (Pribor & Dinwiddie, 1992; Rorty et al., 
1994). Furthermore, the prevalence of childhood sexual abuse varies considerably across 
the studies, due to differences in definitions, methodologies and measures used (Welch & 
Fairburn, 1994).  
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When considering the eating disorder subtypes, Dansky et al. (1997) reported current and 
lifetime rates of PTSD in women with BN to be high and Mantero and Crippa (2002) 
reported that PTSD subjects were considered to be at 3.36 times the risk of developing 
BN. Tozzi et al. (2003) report that several studies have shown that psychological stress or 
stressful life events can trigger the onset of AN. However, the nature and identity of these 
stressors remain poorly defined (Beumont et al., 1978; Pyle, Mitchell, & Eckert, 1981; 
Strober, 1984; Casper & Jabine, 1986). Kaye, Bulik, Thornton, Barbarich, Masters & the 
Price Foundation Collaborative Group (2004) observed that PTSD was approximately 
three times more frequent in individuals with BN as opposed to those with AN. Blinder et 
al. (2006) reported that ANBP patients were twice as likely to have PSTD compared with 
ANR, BN and EDNOS. When considering child sexual abuse, the prevalence of this type 
of trauma is consistently low in ANR, but high in women with binge/purge 
symptomatology (Steiger & Zanko, 1990; Waller, Halek & Crisp, 1993). One reason for 
this observation is that bingeing and purging behaviours may assist with regulating 
disturbing cognitions and emotions that may arise from a history of abuse (Root & 
Fallon, 1989). It is interesting to note that the literature does not appear to implicate 
restrictive and non-purgative compensatory behaviour such as exercise, to a history of 
abuse (van Gerko et al., 2005).  
 
Considerably less research has considered the relationship between eating disorders and 
GAD, and there are wide variations in the estimated prevalence of GAD across eating 
disorder studies (Godart, Flament, Perereau, Jeammet, 2002). Lilenfeld et al. (1998) and 
Godart et al. (2000) estimated the lifetime prevalence of GAD in AN to be 31% and 24% 
respectively. Studies reviewing the relationship between GAD and BN have found that 
lifetime prevalence varies between 10% (Powers et al., 1988) and 55% (Schwalberg et 
al., 1992). Kaye, Bulik, Thornton, Barbarich, Masters & the Price Foundation 
Collaborative Group (2004) identified GAD in their AN and BN sample of 13% and 7% 
respectively, which is significantly lower than the 45.6% and 31.4% respectively, 
reported by Godart et al. (2003). Furthermore, Lilenfeld et al. (1998) found that 13% of 
4.2.7 Generalised Anxiety Disorder (GAD)  
 
 119 
their BN patients had a lifetime prevalence of GAD, which was not significantly different 
to the prevalence amongst controls (2%).  Iwasaki et al. (2000) reported that 13% of their 
AN and BN subjects met the criteria for GAD, and interestingly, their findings indicate 
that GAD was more prevalent amongst the purging subtypes of both AN and BN 
subjects, although this difference did not reach significance. Garfinkel, Lin, Goering, 
Spegg, Goldbloom, Kennedy, Kaplan & Woodside (1995) found that the lifetime rate of 
GAD amongst a community sample of women with BN (10.9%) was significantly higher 
than that of their comparison sample (2.5%).  
 
Bulik, Wade & Kendler (2000) reported that the maternal perception of greater childhood 
anxiety was supported by the twin self report, with the affected twin being at a greater 
risk for lifetime GAD. They suggested that because the age of onset for GAD was 
reported to be prior to or concurrent with the onset of BN in 75% of the cases, it is 
possible that the anxiety may be a predisposing factor rather than a sequelae of BN. 
These results support a growing body of literature that has reported elevated rates of 
premorbid anxiety disorders in women with BN (Deep et al., 1995; Bulik, Sulivan, Fear 
& Joyce, 1997).  
 
4.3 
As discussed above, the research into OCD and eating disorders reveals a significant 
relationship, and several researchers have reported that non food related obsessions and 
compulsions, including significantly more cleanliness, orderliness, perfectionism, 
rigidity, miserliness, scrupulosity have been identified in patients with eating disorders 
(Solyom, 1982; Kasvikis et al., 1986; Rothenberg, 1986; Brumberg, 1988; Bastiani, Rao, 
Weltzin & Kaye, 1995; Halmi, Sunday, Strober, Kaplan, Woodside, Fichter, Treasure, 
Berrettini & Kaye 2000; Lilenfeld, Stein, Bulik, Strober, Plotnicov, Pollice, Rao, 
Merikangas, Nagy & Kaye, 2000; Bulik, Tozzi, Anderson, Mazzeo, Aggen & Sullivan, 
2003; Sutandar-Pinnock, Blake, Carter, Olmsted & Kaplan, 2003). Furthermore, 
perfectionism has been identified as a risk factor for the development of an eating 
disorder, as supported by Fairburn, Cooper, Doll & Welch (1999) who found that 
Perfectionism and Obsessive Compulsive Personality Disorder (OCPD) 
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perfectionistic tendencies tended to predate the onset of an eating disorder. There is also 
evidence that perfectionistic traits may persist following recovery from an eating disorder 
(Bastiani et al., 1995; Srinivasagam, Kaye, Plotnicov, Greeno, Weltzin & Radhika, 1995; 
Kaye, Greeno, Moss, Fernstrom, Fernstrom, Lilenfeld, Weltzin & Mann, 1998; Sutandar-
Pinnock et al., 2003). This has fuelled suggestions that distinct personality traits may be 
important in the development and maintenance of an eating disorder.  
The literature also suggests that perfectionism and dichotomous thinking may mediate the 
relationship between extreme concerns about shape and weight and rigid and intense 
dieting (Fairburn, 1997). Furthermore, Fairburn (1997) suggests that perfectionism and 
dichotomous thinking may mediate the relationship between intense, rigid dieting and 
binge eating. This has led to significant interest in investigating the prevalence of 
personality disorders in the eating disorders and subsequently, there have been a number 
of structured investigations into Axis II diagnosis amongst eating disorder patients. 
The prevalence rates of OCPD amongst individuals with eating disorders has varied 
significantly amongst the studies, ranging from 3% - 60% (Piran, Lerner, Garfinkel, 
Kennedy & Brouilette, 1988; Gartner et al., 1989; Wonderlich, Swift, Slotnick & 
Goodman, 1990; Herzog, Keller, Lavori, Kenny & Sacks, 1992; Rossiter et al., 1993; 
Thornton & Russell, 1997; Lilenfeld et al., 1998).  
Gartner et al. (1989) used the PDE to assess inpatient ED subjects and reported that 
25.7% met diagnostic criteria for OCPD. None of the BN sample met criteria for OCPD 
leading to the speculation that this personality feature is more consistent with individuals 
with AN. However, Rossiter et al. (1993) reported that 10% of their BN sample met 
criteria for OCPD. Thornton and Russell (1997) reported that 19% met criteria for 
comorbid OCPD, and this was almost exclusively found in the AN sample. Lilenfeld et 
al. (1998) reported that AN probands had higher rates of OCPD lending support to 
reports of perfectionism and inflexibility among individuals with restricting type AN. 
Lilenfeld et al. (1998) also found that 31% of AN probands met criteria for OCPD and 
OCD, leading to the suggestion that individuals with OCPD may be more vulnerable to 
the development of OCD than those without this personality pattern.  
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4.4 
This area has been notoriously difficult to investigate due to the inherent problems 
associated with prospective studies of at risk populations (Serpell et al., 2002). A number 
of studies have considered the temporal relationship between eating disorders and anxiety 
disorders (Toner et al., 1988; Schwalberg et al., 1992; Brewerton et al., 1995; Bulik et al., 
1996; Thornton & Russell, 1997; Godart et al., 2000; Milos et al. (2002); Godart et al., 
2003 and Sanci, Coffey, Olsson, Reid, Carin & Patton, 2008). Of these studies, all but 
one (Sanci et al., 2008) were retrospective. The retrospective research has focused 
reporting the temporal relationship between the onset of both disorders and drawing 
inferences about etiological links (Pallister & Waller, 2008). The methodological 
limitations associated with assessing the age of onset of psychiatric diagnoses by 
retrospective recall have been raised by a number of authors (Toner et al., 1988; Godart 
et al., 2000; Godart et al., 2003). The limitations associated with retrospective studies 
include memorization or reconstruction biases that may affect the ability for someone to 
recognise the symptoms of a disorder and recall the time of onset and difficulties 
associated with interpreting the appearance chronology of anxiety and eating pathology 
(Godart et al., 2000). Furthermore, there are often inconsistencies in the determination of 
the age of onset, which sometimes refers to the age when the first symptom occurred and 
sometimes to the age when all criteria for the disorder were met (Wittchen & Essau, 
Temporal Relationship Between Eating Disorders and Anxiety Disorders   
The research to date clearly indicates that individuals with eating disorders frequently 
exhibit anxiety symptoms. Furthermore, there is the suggestion that eating pathology may 
occur in response to a pre-existing anxiety disorder (Johnson & Larson, 1982). Although 
the specific nature of the relationship between eating disorders and anxiety is still 
unclear, some researchers have suggested that anxiety disorders may contribute to the 
onset and maintenance of eating disorders (Fornari et al., 1992). Godart et al. (2003) 
implicate three possible explanations for the observed comorbidity between eating and 
anxiety pathology. Firstly, that anxiety may be a risk factor for the development of an 
eating disorder. Secondly, that anxiety may be secondary to eating pathology and thirdly 
that both disorders may share common vulnerability factors.  
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1993). Certainly prospective studies have the benefit of fewer potential sources of bias 
and confounding than retrospective studies, however there are few available prospective 
studies investigating the comorbidity between anxiety and the onset of eating pathology.  
Whilst retrospective data must be interpreted with caution, the results may nevertheless 
provide extremely useful information about the vulnerability factors that may be 
associated with the development of an eating disorder.  
 
Notwithstanding the limitations associated with researching the temporal pattern of onset 
between eating and anxiety pathology, some research has interestingly suggested that 
there may be a relationship between early onset (childhood) anxiety disorders and the 
later development of an eating disorder. Whilst this pattern of onset may simply reflect 
the natural course of the two disorders (Silberg & Bulik, 2005), some researchers have 
speculated that early onset anxiety disorders may represent a potential genetically 
mediated pathway toward the development of an eating disorder (Kaye, Bulik, Thornton, 
Barbarich, Masters & the Price Foundation Collaborative Group, 2004), or, at the very 
least suggests that early onset anxiety disorders may in some way predispose individuals 
to the development of an eating disorder (Bulik et al., 1996).   
 
Whilst clinical studies investigating the comorbidity between eating disorders and anxiety 
may identify associations that do not exist in the community because of differential 
referral (Berkson, 1946), epidemiological studies provide estimates of comorbidity that 
are not confounded by treatment seeking (Silberg & Bulik, 2005). Walters & Kendler 
(1995) reported from a retrospective population-based sample of over 2000 twins, that 
the presence of AN significantly increased the risk of suffering from a comorbid anxiety 
disorder, in particular, GAD, phobias and panic disorder. Similar findings have been 
reported in a BN sample, suggesting that early onset anxiety disorders may represent an 
etiological risk factor for BN (Schwalberg et al., 1992; Bulik et al., 1996; Kaye, Bulik, 
Thornton, Barbarich, Masters & the Price Foundation Collaborative Group, 2004). 
Multivariate twin models exploring the structure of the genetic relationship between 
anxiety disorders, mood disorders and substance abuse, have identified shared genetic 
factors among BN, phobias and panic disorder (Kendler, Walters, Neale, Kessler, Heath 
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& Eaves, 1995). Furthermore, Silberg & Bulik (2005) reported results from a large 
juvenile twin study, indicating that a common genetic factor influenced vulnerability 
towards anxiety, depression and eating disorder pathology.  
 
A number of research papers considering the temporal relationship between eating 
disorders and anxiety have shown that, in most cases, the onset of anxiety disorders 
precedes the onset of an eating disorder (Bulik, 2003). Godart et al. (2003) reported that 
between 41.8 and 53.3% of co-morbid cases had an anxiety disorder preceding the onset 
of the eating disorder. In particular Godart et al. (2003) reported that social phobia 
commonly occurred first. Kaye, Bulik, Thornton, Barbarich, Masters & the Price 
Foundation Collaborative Group (2004) found that a number of anxiety disorders (OCD, 
social phobia, specific phobia and GAD) typically began in childhood, their onset 
typically preceding that of the eating disorder. Bulik, Wade & Kendler (2000) set out to 
address this further by investigating monozygotic twins discordant for BN. They found 
that mothers retrospectively recalled the affected twin as having been more shy and 
fearful as children and this was supported by the twin self report. Subsequently, they 
hypothesised that this could suggest that early anxiety could play a role in the 
development of BN. They also reported markedly higher obsessive-compulsive scores in 
affected twins, which supports the literature suggesting a shared diathesis between BN 
and obsessive-compulsive disorder.  
 
Similar findings have been reported in retrospective studies in BN populations. 
Schwalberg et al. (1992) found that in 59% of women with a lifetime diagnosis of an 
anxiety disorder, the anxiety preceded the eating disorder. Brewerton et al. (1995) found 
that 71% of their sample reported the onset of anxiety prior to the development of BN. 
Godart et al. (2000) reported that 88% of their BN sample had at least one anxiety 
disorder prior to the onset of the eating disorder. These results support a growing body of 
literature that has reported elevated rates of premorbid anxiety disorders in women with 
BN (Deep et al., 1995; Bulik, Sulivan, Fear & Joyce, 1997). 
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In AN, the findings are similar, with one retrospective study reporting that 79% of their 
female sample had the onset of anxiety before the onset of AN (Deep et al., 1995). 
Godart et al. (2000) reported that 75% of their AN sample had at least one anxiety 
disorder prior to the onset of the eating disorder. 
 
Studies investigating the onset of specific comorbid anxiety disorders with eating 
pathology have reported a similar pattern. In two small studies, Brewerton et al. (1993) 
reported that social phobia preceded the eating disorder in all of their BN participants, 
whilst Braun, Sunday & Halmi (1994) found that the anxiety disorder predated the eating 
disorder in 79% of their AN and BN participants. In another small sample investigating 
the prevalence of OCD and AN, Kasvikis et al. (1986) reported that 40% reported the 
onset of the OCD to predate the onset of the AN. In a large casenote study investigating 
the prevalence of eating pathology amongst OCD patients, patients with comorbid eating 
and anxiety pathology reported the onset of both disorders at the same time and the age of 
onset was lower than for those without comorbid AN (Fahy, Osacar & Marks, 1993).  
 
A prospective Australian study investigating the link between child sexual assault before 
the age of 16 years and later onset of bulimia and anorexia nervosa symptoms in females 
found that childhood sexual abuse seems to be a risk factor for the development of 
bulimic syndromes, not necessarily mediated by psychiatric morbidity or severe dieting 
(Sanci, Coffey, Olsson, Reid, Carin & Patton, 2008).  
 
It is important to note that anxiety disorders do not always precede the onset of eating 
pathology. Godart et al. (2003) found that OCD, GAD and panic disorder typically 
occurred simultaneously or following the onset of the eating disorder. Kaye, Bulik, 
Thornton, Barbarich, Masters & the Price Foundation Collaborative Group (2004) also 
reported from their sample that PTSD, panic disorder and agoraphobia tended to have an 
onset simultaneous or later than the eating disorder. These findings lead to speculation 
that eating disorders may lead to or exacerbate anxiety symptomatology (Pallister & 
Waller, 2008). Once again, this gives rise to the possibility that anxiety symptomatology 
may be secondary to eating disorder pathology, such as malnutrition, rather than a 
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distinct anxiety disorder diagnosis. This hypothesis was demonstrated in the Keys et al. 
(1950) study and has since been discussed by several authors since (Pollice et al., 1997; 
Serpell et al., 2002).  Consequently, research in this area must be careful to clearly 
delineate between the anxiety symptoms related to eating pathology and those that 
represent a distinct anxiety disorder.  
 
Understanding the relationship between eating disorders and anxiety pathology becomes 
more complicated when one considers the possibility that both may result from common 
vulnerability factors (Wonderlich & Mitchell, 1997; Godart et al., 2003). This theory 
proposes that early negative experiences may give rise to risk factors for the development 
of both disorders. Pallister & Waller (2008) describe this model in detail, suggesting that 
underlying vulnerability cognitions lead to harm avoidance cognitions which result in the 
implementation of safety behaviours comprising disordered eating and anxiety 
behaviours.  
 
The suggestion that childhood anxiety may play an etiological role in the development of 
eating disorders has stemmed from the possibility that excessive fear about certain events 
or situations may lead into excessive concerns about eating, shape and weight and 
subsequently lead to the development of eating pathology (Pallister & Waller, 2008). It is 
clear that further research needs to be conducted into the interaction between anxiety and 
specific prodromal symptoms of eating disorders (Jacobi et al., 2004).   
 
4.5 
In order to clearly understand the pattern of comorbidity between eating and anxiety 
disorders, it is important to not only consider the prevalence of anxiety amongst 
individuals with eating pathology, but also the prevalence of eating disorders amongst 
people with anxiety disorders (Pallister & Waller, 2008). However, whilst most studies 
have focused on the prevalence of anxiety disorders in eating disorder populations, 
significantly less research has examined the prevalence of eating disorders among anxiety 
patients (Bulik, 1995). As a result, there is a general lack of information as to frequency 
of eating disorder pathology among patients presenting to specialty anxiety clinics, and it 
Eating Disorders amongst Anxiety Disorder Populations  
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is unclear whether eating disorders are more commonly associated with some anxiety 
disorders as compared to others (Black Becker et al., 2004). This raises the possibility 
that eating disorders may go unidentified and untreated, particularly given that eating 
disorder assessment and treatment is often viewed as a clinical specialty and subsequently 
many clinicians in anxiety clinics may not be adept at detecting eating disorder 
symptomatology (Black Becker et al., 2004). The absence of formal eating disorder 
assessment in anxiety treatment settings is also indicated by the lack of eating disorder 
assessment items in assessment instruments for the anxiety disorders. The best example 
of this is the ADIS-IV, arguably one of the best structured interviews available for the 
assessment of anxiety disorders, which does not include an assessment of eating 
pathology in the sections that screen for all other Axis I disorders.  
 
The only study the author found which investigates eating disorder rates amongst women 
presenting to an anxiety clinic is that by Black Becker et al. (2004). They found that 12% 
of 257 women presenting to an anxiety clinic met criteria for a possible eating disorder. 
Furthermore, although the rates of probable eating disorders across the anxiety diagnoses 
did not differ significantly, social phobia had unique variance in the regression analysis 
(Black Becker et al., 2004). Interestingly, despite the research implicating a link between 
eating disorders and OCD, Black Becker et al. (2004) did not find that OCD contributed 
to the unique variance in their regression analysis. They suggested that apparent 
relationships between OCD and eating pathology may be due to other comorbid anxiety 
disorders. Other studies have investigated eating disorder rates amongst specific anxiety 
disorders (Brewerton et al., 1993; Lipschitz et al., 1999) or amongst individuals with 
sexual abuse trauma (Pribor and Dinwiddie, 1992; Faravelli et al., 2004) and war veterans 
(Striegel-Moore et al., 1999). 
 
Of the studies that have investigated eating disorders amongst anxiety patients, they have 
generally examined rates of eating disorders concurrent with one particular anxiety 
disorder, usually OCD (Bulik, 1995). Among female OCD patients, eating disorder 
comorbidity estimates have ranged from 11 to 42% depending on the type of eating 
disorder and the method of assessment (Bulik, 1995). Fahy et al. (1993) found that 11% 
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of their OCD patients also had co-morbid AN. Brewerton et al. (1993) reported that 20% 
of women with social phobia met the criteria for an eating disorder. Lipschitz et al. 
(1999) reported that 25% of adolescent mixed-gender PTSD inpatients met the criteria for 
an eating disorder. Wittchen, Stein & Kessler (1999) investigated rates of social phobia 
and related comorbidities amongst a large mixed gender sample. They reported 
significantly higher rates of eating disorders (generally EDNOS) amongst individuals 
with social phobia (15%) compared to those without (2.6%).  
 
Black Becker et al. (2004) indicates that although the number of studies is limited, 
estimates of the prevalence of eating disorders amongst anxiety disorder patients is high. 
Reported rates are markedly higher than the estimated prevalence of AN or BN among 
young females.  
 
4.6 
It is clear that generally individuals with comorbid conditions often display more severe 
symptoms and subsequently may be at greater risk for a poorer treatment outcome. 
Similarly, psychiatric comorbidity may increase eating disorder severity, chronicity and 
treatment resistance (Blinder, Chaitlin & Goldstein, 1988; Bulik, 2002). Eating disorder 
patients with psychiatric comorbidity may require specialised treatment protocols 
(Herzog, Field, Keler, West, Robbins, Staley & Colditz, 1996; Saccomani, Savoini, 
Cirrincione, Vercellino & Ravera, 1998; Woolsey, 2002). For example, in the case of co-
morbid obsessive compulsive disorder, they may require an exposure and response 
prevention component (Boutelle, 1998). Research findings however, are inconsistent. 
Implications for Treatment and Outcome 
A further point of interest in the area of eating disorder and anxiety comorbidity is 
whether a comorbid anxiety disorder has implications for the treatment and outcome of 
an eating disorder. A number of authors have discussed the importance of considering 
comorbidity in the formulation and treatment of eating pathology (Braun et al., 1994; 
Serpell et al., 2002; O’Brien & Vincent, 2003). Unfortunately, despite the increasing 
body of literature discussing the prevalence of anxiety in the eating disorders, few studies 
to date have investigated the impact of comorbid anxiety on treatment.  
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Some studies have suggested that co-morbid anxiety may be one indicator for poor 
outcome (Halmi et al., 1973; Gleaves and Eberenz., 1994; Weltzin et al., 1995; Herpertz 
Dahlmann et al., 1996; von Ranson et al., 1999; Goodwin and Fitzgibbon., 2002; Fichter 
and Quadfleig., 2004; Thompson-Brenner and Westen, 2005; Procopio et al., 2006), 
however other studies have not found this to be the case (Halmi et al., 1991; Bulik et al., 
1996; Thiel et al., 1998) (A summary of these studies and their findings can be seen in 
Table 4.5).  
 
Torem and Curdue (1988) presented a series of case reports of 4 women with eating 
disorder symptomatology and a previously undiagnosed PTSD diagnosis. They reported 
that following treatment focusing on the resolution of the trauma symptoms, each of the 
women showed an overall improvement in their general wellbeing as well as their eating 
disorder symptoms. Furthermore, Torem and Curdue (1988) noted that for each of their 
patients, vomiting was regarded as important not only for regaining a sense of self-
control, but also as a means of cleansing themselves.  
 
4.7 Methodological Limitations in the Research  
Despite the significant number of research papers investigating the comorbidity between 
eating disorders and anxiety disorders, many of these studies suffer from general 
methodological limitations (Mitchell et al., 1991; Schwalberg et al., 1992, Godart et al., 
2002; Godart, Berthoz, Perereau & Jeammet, 2006; Godart, Berthoz, Rein, Perereau, 
Lang, Venisse, Halfon, Bizouard, Loas, Corcos, Jeammet, Flament & Curt, 2006; Micali 
and Heyman, 2006). These limitations have been summarised in Tables 4.1 – 4.5. The 
variability between estimated comorbidity of anxiety disorders and eating disorders 
amongst the available research is a significant limitation when considering the prevalence 
of co-morbid disorders. A number of factors may contribute to this variability and are 
discussed below.  
 
Research into ED and AD often include samples from various sources including 
inpatients, outpatients and community samples. Unfortunately this may bias the sample, 
4.7.1 Sample Sources and Selection 
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as one could expect that an inpatient sample may be more likely to have multiple 
diagnoses and may not be representative of all patients with the disorder (Godart et al., 
2002). Furthermore, some researchers have used exclusion criteria that may limit the 
frequency of comorbid AD. Keck et al. (1990) excluded all subjects with comorbid 
substance abuse, despite patients with AD often reporting comorbid substance abuse 
(Bulik et al., 1996). Several studies excluded subjects taking psychoactive medication 
(Keck et al., 1990; Deep et al., 1995; Bulik et al., 1996; Bulik, Sulivan, Fear & Joyce, 
1997) which may have diminished the rates of AD identified.  
 
4.7.2 General Methodological Limitations  
General methodological limitations included:  
1) In many of the studies reviewed in this paper, the sample sizes were small, often 
including at least one group of less than 30 subjects;  
2) Some studies include both males and females, while it is recognised that women have 
more lifetime AD than men (Wittchen and Essau, 1993) and that ED are rare in men 
(Godart et al., 2002);  
3) Few studies are controlled, and often those that are controlled have larger control 
groups than ED groups and are not matched for age or other characteristics;  
4) The definition of current prevalence varies across studies, referring to either 6-month 
(Herpertz- Dahlmann et al., 1996; Råstam et al., 1995) or 1-year prevalence (Halmi et al., 
1991).  
 
Changes in diagnostic criteria for ED and AD over the past 15 years [e.g. Feighner 
criteria (1972), Research Diagnostic Criteria (RDC) (1977), DSM-III (American 
Psychiatric Association, 1980), DSM-III-R (American Psychiatric Association, 1987), 
DSM-IV-TR (American Psychiatric Association, 2000) have clearly had an impact on the 
prevalence findings. Even in more recent studies, it is sometimes unclear whether they 
have utilised the DSM-IV or ICD-10 criteria to diagnose ED (e.g. Goodwin and 
Fitzgibbon, 2002). Changes in AD diagnostic criteria may also have impacted on the 
findings of studies over time. For example, In the RDC (1977) and the DSM-III (1980) it 
4.7.3 Diagnostic Criteria for Eating Disorders and Anxiety Disorders  
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was not possible to diagnose a depressive disorder and AD simultaneously which may 
have influenced the prevalence of AD reported in some studies (Godart et al., 2002). It is 
possible that certain anxiety disorders may have been over reported due to the changes in 
diagnostic criteria between the DSM-III and the DSM-III-R. Specifically OCD and Social 
phobia DSM-III-R criteria stipulates both disorders cannot be diagnosed if the obsessions 
and compulsions or the social anxiety are exclusive to food related concerns. Whilst some 
researchers already incorporated this in addition to DSM-III criteria, it may provide an 
explanation as to higher rates of both of these disorders in earlier studies. Finally, the 
number of anxiety disorders assessed often differs between the studies and will obviously 
affect the prevalence rates. A number of the studies previously reported excluded certain 
AD from the assessment, which is a significant limitation when drawing conclusions 
about prevalence rates of AD and ED. Significantly, it is not uncommon in the research 
to exclude PTSD from the anxiety assessment, and this presents a limitation when 
considering the suggestion that a history of trauma, particularly CSA, is a non-specific 
risk factor for the development of an eating disorder (Black Becker et al., 2004). 
 
Diagnostic instruments used to assess both eating disorders and anxiety disorders have 
also varied across studies and present a significant limitation when drawing conclusions 
about ED and AD comorbidity (Godart, Berthoz, Perereau & Jeammet, 2006; Godart, 
Berthoz, Rein, Perereau, Lang, Venisse, Halfon, Bizouard, Loas, Corcos, Jeammet, 
Flament & Curt, 2006; Micali and Heyman, 2006). Unfortunately, many of the studies 
previously presented have failed to use well standardised, internationally accepted 
diagnostic instruments to identify eating disorders, limiting the usefulness of their 
findings. Similarly, some of the research has used inadequate diagnostic instruments or 
criteria to identify anxiety disorders. This is particularly important to enable one to 
distinguish between eating disorder and anxiety symptomatology. For example, 
considering the high but also variable rates of reported OCD in eating disorder 
populations, one may conclude that some research has insufficiently distinguished 
between obsessive compulsive symptoms that are secondary to malnutrition and the ED 
and those which may reflect a true OCD.  Furthermore, as mentioned by Bulik et al. 
4.7.4 Diagnostic Instruments 
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(1996), GAD in the SCID (with DSM-III-R criteria) is skipped for subjects with a current 
mood disorder. A number of the studies previously reported have used the SCID (e.g. 
Powers et al., 1988; Brewerton et al., 1995; Råstam et al., 1995; Walters and Kendler, 
1995; Bulik, Sulivan, Fear & Joyce, 1997) and therefore the rates of GAD may be an 
underestimate in these studies.  
 
4.8 Summary and Research Implications  
 
It is clear from the research that anxiety disorders are significantly more frequent in 
subjects with eating disorders than the general community. However, the available 
research investigating the prevalence of anxiety disorders amongst eating disordered 
individuals presents strikingly inconsistent findings. Whilst there are a large number of 
studies researching this area, the inconsistencies complicate the understanding of eating 
disorder and anxiety comorbidity. It should be noted that many of the studies presented in 
this thesis involve clinical samples, and as such, comorbidity may be overrepresented. Du 
Fort, Newman and Bland (1993) cited the phenomenon of Berkson’s Bias, whereby 
individuals with comorbid diagnoses are more likely to seek treatment than those with a 
single diagnosis. Nevertheless, there is a clear need for researchers to use well 
standardised, internationally accepted instruments to identify and investigate eating 
anxiety disorder comorbidity. Furthermore, the lack of research into the prevalence of 
eating disorders amongst individuals presenting for anxiety treatment, despite indications 
that prevalence may be high, suggests the need for greater research in this area.  It is this 
clear need for further research in this area that provided the impetus for the development 
of the current research. The next chapter provides a detailed overview of the aims and 
objectives for the current study.    
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CHAPTER 5 
AIMS AND OBJECTIVES FOR THE CURRENT STUDY  
 
5.1 Background  
Eating disorders are amongst the most debilitating of psychiatric illnesses (Klein & 
Walsh, 2003) and responsible for the highest mortality rate of any of the psychiatric 
conditions. As earlier discussed, there are significant limitations in a number of the 
studies investigating comorbidity between eating disorders and anxiety disorders. These 
limitations affect the conclusions that can be extrapolated from those studies.  A number 
of authors have highlighted the general methodological limitations found in research 
investigating eating and anxiety comorbidity including Mitchell et al., 1991; Schwalberg 
et al., 1992, Godart et al., 2002; Micali & Heyman, 2006; Godart, Berthoz, Perereau & 
Jeammet, 2006 and Godart, Berthoz, Rein, Perereau, Lang, Venisse, Halfon, Bizouard, 
Loas, Corcos, Jeammet, Flament & Curt, 2006. A number of factors arguably 
contributing to the limitations in the research resulting from the variability of its findings  
was discussed earlier at Chapter 4.7.  
 
It is both the lack of research on prevalence of eating disorders in anxiety populations and 
the inherent methodological limitations in comorbidity research generally, that has led to 
the development of the present study. There are several key studies which have led to the 
development of the aims and objectives for the current study, including Godart et al. 
(2000), Godart et al. (2003), Black-Becker et al. (2004) and Kaye, Bulik, Thornton, 
Barbarich, Masters & the Price Foundation Collaborative Group (2004). 
 
The current literature would suggest that further investigation into the comorbidity 
between anxiety and eating disorders may have significant etiological and therapeutic 
implications. To date, there continues to be limitations involved in the successful 
treatment of eating disorder pathology (particularly in respect of AN), and outcome 
research is varied. It is clear that research identifying etiological factors associated with 
eating disorders may assist in the provision of effective evidenced based treatment for 
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eating pathology. These factors have also provided impetus for the aims and hypotheses 
tested in the present research.  
 
5.2 Aims of the Current Study  
A key objective of the present study was to investigate the prevalence of comorbid eating 
disorders and anxiety disorders using well standardised, internationally accepted 
measures in order to accurately determine diagnoses, assess various hypotheses 
commensurate with the current literature, and avoid replicating methodological errors 
observed in previous research.  
 
The present study was designed to investigate the prevalence of anxiety disorders 
amongst an eating disorder population, comparing prevalence rates amongst an inpatient 
sample and an outpatient sample. In order to investigate whether eating disorders were 
also prevalent amongst individuals presenting for anxiety disorder treatment, an area 
previously lacking in research, this study also completed eating disorder assessments with 
individuals seeking treatment from an anxiety disorder outpatient unit. To this end, the 
researchers were also interested in comparing the eating disorder group with anxiety 
disorders and anxiety group with eating disorders, specifically with regards to the 
severity of eating disorder and anxiety symptomatology. This comparison was considered 
clinical relevant in furthering our understanding of why individuals with comorbid 
disorders present for specific treatment.  
 
The present study had several aims  
1. To examine the prevalence of anxiety disorders in an eating disorder population and to 
examine the prevalence of eating disorders in an anxiety disorder population. The present 
study drew from several key studies in this area (including Kaye, Bulik, Thornton, 
Barbarich, Masters & the Price Foundation Collaborative Group, 2004 and Godart et al., 
2003) finding a high prevalence of anxiety disorders amongst women with eating 
disorders. Subsequently the present study aimed to further explore the question of 
whether anxiety disorders are prevalent amongst eating disorder populations. The interest 
in investigating the prevalence of eating disorders amongst an anxiety population 
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stemmed from the fact that there is a distinct lack of research studies in this area. 
Research conducted by Black Becker et al. (2004) found that 12% of their anxiety sample 
also met criteria for an eating disorder, suggesting that this was an area in need of greater 
research.   
2. To examine the temporal relationship between comorbid eating disorders and anxiety 
disorders. This aim was derived from research by Godart et al. (2003) who also found 
that the anxiety pathology commonly preceded the onset of the eating disorder. The 
present research aimed to investigate whether individuals with co-morbid eating disorders 
and anxiety disorders would retrospectively report the onset of the anxiety disorder to be 
prior to the onset of the eating disorder. 
3. To make an overall comparison between eating disorder group with anxiety disorders 
and anxiety group with eating disorders. Consider the severity of eating disorder 
symptomatology and anxiety symptomatology in both groups. This aim was contingent 
upon finding enough people in the anxiety group with a co-morbid eating disorder to 
draw comparisons. To this end, the researchers were also interested in comparing the 
eating disorder group with anxiety disorders and anxiety group with eating disorders, 
specifically with regards to the severity of eating disorder and anxiety symptomatology. 
This comparison was considered clinical relevant in furthering our understanding of why 
individuals with comorbid disorders present for specific treatment. 
4. To make an overall comparison between the inpatient eating disorder group and 
outpatient eating disorder group in terms of the prevalence rates of co-morbid anxiety 
disorders. This research aim stemmed from the Godart et al. (2002) paper highlighting 
the limitations with previous research investigating comorbidity amongst inpatient 
samples only, and therefore this led to the aim to investigate whether anxiety disorders 
would be more prevalent amongst the inpatient eating disorder sample than the outpatient 
sample. 
 
5.3 Objectives for the Current Study  
  5.3.1 Objectives regarding the Eating Disorder sample  
The present study drew from several key studies in this area (including Kaye, Bulik, 
Thornton, Barbarich, Masters & the Price Foundation Collaborative Group, 2004 and 
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Godart et al., 2003) finding a high prevalence of anxiety disorders amongst women with 
eating disorders. Subsequently the present was an extension of previous research aiming 
to further explore the question of whether anxiety disorders are prevalent amongst eating 
disorder populations, and which of the anxiety disorders were most prevalent. The 
present research also aimed to investigate whether individuals with co-morbid eating 
disorders and anxiety disorders would retrospectively report the onset of the anxiety 
disorder to be prior to the onset of the eating disorder, replicating the work of Godart et 
al. (2003). Finally, Godart et al. (2002) highlighted the limitations with previous research 
investigating comorbidity amongst inpatient samples only, and therefore to explore this 
issue, the present research aimed to investigate whether anxiety disorders would be more 
prevalent amongst the inpatient eating disorder sample than the outpatient sample.  
  
 5.3.2 Objectives regarding the Anxiety Disorder sample 
The research of Black Becker et al. (2004) highlighted the need to further investigate the 
prevalence of eating disorders amongst anxiety populations. Due to the paucity of 
research in this area, the present study aimed to replicate the study undertaken by Black 
Becker et al. (2004), by exploring the prevalence of eating disorders amongst anxiety 
disorder populations. Furthermore, in line with previous research on the temporal 
relationship between eating and anxiety disorders, this research hypothesized that 
individuals with co-morbid eating disorders and anxiety disorders would retrospectively 
report the onset of the anxiety disorder to be prior to the onset of the eating disorder. 
 
 5.3.3 Objectives regarding the Anxiety Disorder Diagnoses  
Previous research has found that of the anxiety disorders OCD and social phobia tend to 
be the most prevalent amongst eating disorder populations. Subsequently, in participants 
meeting criteria for both an eating disorder and anxiety disorder, the present study 
hypothesized that of the anxiety disorders, OCD and social phobia would be the most 
prevalent. Nevertheless, we were interested in extending on previous research in this area 
which often excluded certain anxiety disorders from the assessment.  
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           CHAPTER 6 
METHOD 
 
This chapter outlines the methodology for the current study, including the study design, 
ethics approval, participants, recruitment and assessment procedure. Details of all 
assessment instruments utilised is also described in detail.  
  
6.1 Study Design  
Eating disorder and anxiety disorder pathology was assessed in two samples, an eating 
disorder sample and an anxiety disorder sample. The method of assessment included 
structured interviews and the completion of several self-report questionnaires. The 
findings from these assessments then enabled calculation of prevalence of comorbid 
anxiety and eating disorder symptomatology in both samples.  
 
In order to obtain an eating disorder sample reflecting a range of severity and character of 
eating disorder psychopathology, participants were recruited from both inpatient eating 
disorder treatment units and outpatient eating disorder treatment services (see 6.3.1 and 
6.3.2 for details of the treatment sites).   
 
6.2 Ethics Approval  
This study was approved by the University of Sydney Human Research Ethics 
Committee (see Appendix D), the Sydney West Area Health Service Human Research 
Ethics Committee (see Appendix E), the Westmead Health Scientific Advisory 
Committee (see Appendix E), the Northside Clinic Ethics Committee (see Appendix F) 
and by the executive committee of Wesley Private Hospital, Ashfield. As several 
amendments were made over the course of this study, each of the corresponding ethics 
approval letters are also included in Appendices D, E and F.  All participants gave written 
consent and were provided with an information sheet outlining the background and 
procedures involved in the study. Copies of the information sheets and consent forms 
used are provided in Appendices A, B and C.  
 
 137 
 
6.3 Participants 
A total of 198 women presenting for treatment of an eating disorder or an anxiety 
disorder, who met study criteria, were approached to participate in the current study. A 
total of 152 women were recruited for this study.  The subsequent sample represents 
76.8% of patients who were approached to participate. Reasons given for not consenting 
for participation in the current study included an unwillingness to participate in research 
(n=40), an inability to find the time due to work or other commitments (n=3). 1 
participant was excluded for completing questionnaires incorrectly, and 2 eating disorder 
participants following assessment, met criteria for BED, and were subsequently excluded 
from the study.  A further 41 patients were deemed unsuitable for participation in this 
study due to being under 18 years of age (n=27), acute suicidality (n=8), absconding from 
the treating unit (n=1) and not meeting a DSM-IV diagnosis for an eating disorder or an 
anxiety disorder (n=5).  
 
Inclusion criteria for participants with eating disorders were a current DSM-IV diagnosis 
of AN, BN or EDNOS, aged 18 years or over and not subject to serious medical 
complications resulting from their eating disorder.  
 
Inclusion criteria for participants with anxiety disorders were a current DSM-IV 
diagnosis of an anxiety disorder and aged 18 years or over. Details of each sample are 
described below.   
 
The present study did not assess for additional comorbid disorders, such as depressive 
disorders, substance abuse or personality disorders and subsequently, did not exclude 
individuals who may have met criteria for these disorders.  
 
6.3.1 Eating Disorder Inpatient Sample  
Consecutive female patients entering the inpatient unit of the Peter Beumont Centre for 
Eating Disorders (PBCED) at Wesley Private Hospital, and the Eating Disorder Unit at 
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Northside Clinic (NSC), who met the noted inclusion criteria, were approached to 
participate in the current study. A total of 50 inpatients were recruited for this study.  
 
6.3.2 Eating Disorder Outpatient Sample  
Patients entering the outpatient unit of the PBCED at Wesley Private Hospital, the 
SWAHS Eating Disorder Day Treatment program, the University of Sydney Psychology 
Clinic or accessing private psychiatry or psychology treatment services in the Sydney 
Metropolitan area who met the noted inclusion criteria, were approached to participate in 
the current study. A total of 50 outpatients were recruited for this study.  
 
6.3.3 Anxiety Disorder Outpatient Sample  
Consecutive patients entering the Westmead Anxiety Disorder Treatment and Research 
Unit and the University of Sydney Psychology Clinic who met the noted inclusion 
criteria, were approached to participate in the current study. A total of 52 anxiety disorder 
outpatients were recruited for this study.  
 
6.4 Assessment Measures 
Copies of all assessment measures used in this study are contained in Appendix G.  
6.4.1 Eating Disorder Assessment Measures  
The eating disorder measures utilised in this study had several purposes. Firstly, two self 
report measures were used to screen for eating disorder symptomatology amongst 
individuals presenting for treatment of an anxiety disorder. The rationale for utilizing two 
self report measures was to ensure that eating disorder symptomatolgy was sufficiently 
screened, to minimize the possibility of missing cases. Both self-report measures are 
brief, and can be easily administered, therefore minimising participant burden. A 
diagnostic interview was used to confirm eating disorder diagnoses amongst individuals 
presenting for treatment of an eating disorder, and to confirm diagnoses amongst women 
presenting for anxiety treatment whose self-reports measures were indicative of an eating 
disorder. Each of these measures will be discussed below.  
 
 139 
i) Eating Disorder Examination (EDE; Cooper & Fairburn, 1987; Fairburn & 
Cooper, 1993) 
The EDE was used to evaluate the eating disorder specific psychopathology and to elicit 
the clinical DSM-IV eating disorder diagnoses. All EDE interviews were completed by a 
3rd year Doctoral level student (the present author, JMS), who had been trained in the 
administration of the EDE by Christopher Fairburn.  The EDE is a standardised, 
investigator based interview, considered to be the “gold standard” in the assessment of 
eating disorders (Garner, 1995). The EDE assesses the frequency of key behavioural and 
attitudinal aspects of eating disorders during the preceding 28 days. The EDE evaluates 
the major areas of eating disorder psychopathology on four subscales: Restraint, Eating 
Concern, Shape Concern and Weight Concerns. Interrater reliability for the Global EDE 
score has been estimated to be 0.97 – 0.99 (Wilson & Smith, 1989). Furthermore, the four 
subscales have good discriminant validity in distinguishing between individuals with 
eating disorders and controls (Cooper, Cooper & Fairburn, 1989; Fairburn & Cooper, 
1993). The Weight and Shape Concern subscales also have good discriminant validity in 
distinguishing between individuals with eating disorders and restrained eaters (Wilson & 
Smith, 1989).  
 
ii) Eating Disorder Examination – Questionnaire (EDE-Q; Fairburn & Beglin, 
1994) 
Eating disorder symptomology was screened using the EDE-Q, which is a self-report 
version of the EDE (Fairburn & Cooper, 1993). The EDE-Q assesses the same attitudinal 
and behavioural aspects of eating disorders as the EDE, over a 28 day time period. The 
EDE-Q consists of the same four subscales utilised in the EDE, including shape concern, 
weight concern, dietary restraint and eating concern. The EDE-Q yields scores on each of 
these subscales as well as a Total Scale score. These subscales have demonstrated 
excellent test-retest reliability over a two week period with co-efficients ranging from 
0.81 to 0.94 (Luce & Crowther, 1999). It also contains items enabling the assessment of 
binge eating and compensatory behaviours in terms of the number of days each behaviour 
occurred and the number of distinct episodes on each day. The EDE-Q appears to be 
useful as a screening measure for eating disorder pathology, and its generally good 
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convergent validity with the EDE, suggests that it may be used as a substitute for the 
EDE (Fairburn & Beglin, 1994). Nevertheless, given that it may indicate a higher 
frequency of problematic eating disorder symptoms, it was decided that this measure 
alone would not be utilised to identify eating disorder diagnoses. Subsequently, this 
measure was purely used to identify any eating disorder pathology, and where indicated, 
the EDE was then utilised to confirm diagnoses.   
 
iii) Eating Attitudes Test (EAT-40; Garner & Garfinkel, 1979) 
The EAT-40 was originally developed to assess attitude and behaviour characteristics of 
individuals with AN. It not only discriminates AN samples from controls, it also 
discriminates BN samples from control groups (Gross, Rosen, Leitenberg & Willmuth, 
1986). The EAT-40 may be most appropriately used as an assessment of the severity of 
concerns typically observed amongst individuals with eating disorders, namely drive for 
thinness, fear of weight gain and restrictive eating patterns (Williamson, 1990). The 
EAT- 40 has three subscales: dieting, bulimia/food preoccupation, and oral control, 
which are highly correlated with each other (Garner, Olmsted, Bohr & Garfinkel, 1982). 
The EAT-40 also demonstrates good psychometric properties. The EAT-40 was 
administered with the EDE-Q to screen for possible eating disorder pathology.  
 
iv) Eating Disorder Inventory -3 (EDI-3; Garner, 2004) 
The EDI-3 is a revised version of a widely utlised self-report measure of psychological 
traits and constructs demonstrated to be clinically relevant in individuals with eating 
disorders (Garner, 2004). This measure consists of 91 items organized into 12 primary 
scales, with higher scores reflecting greater levels of pathology. The subscales include 
drive for thinness, bulimia, body dissatisfaction, low self esteem, personal alienation, 
interpersonal insecurity, interpersonal alienation, interoceptive deficits, emotional 
dysregulation, perfectionism, asceticism and maturity fears. 
 
Items are presented in a 6-point Likert scale, in which respondents rate whether the item 
applies to them always, usually, often, sometimes, rarely, or never. The reliability 
(internal consistency [α = 0.83-0.93] and test-retest reliability [α = 0.67 – 0.85]) and 
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validity (content, construct, concurrent validity and discriminant validity) of the EDI and 
its revisions have been demonstrated (Garner, Olmsted & Polivy,1983). 
 
This measure was included in the current study to further assess a wide range of eating 
disorder pathology. It was anticipated that this measure could be used to investigate any 
possible differences between eating pathology and severity amongst the comorbid and 
non-comorbid groups.  
 
6.4.2 Anxiety Disorder Assessment Measures  
i) Anxiety Disorder Interview Schedule - IV (ADIS-IV; Brown et al., 1994)  
The ADIS-IV was used to assess for current anxiety symptoms and to determine whether 
a DSM-IV anxiety disorder diagnosis was met.  The ADIS-IV is designed to identify the 
following anxiety disorders: panic disorder, agoraphobia, social phobia, OCD, GAD, 
PTSDr, ASD and specific phobia. The ADIS-IV, is a semi-structured clinician 
administered interview that yields DSM-IV diagnoses. Although this interview is 
extremely thorough, and provides a detailed and reliable assessment, its time consuming 
administration means that it is better suited to small scale clinical research projects 
(Andrews et al., 2003). The ADIS-IV has demonstrated favourable levels of diagnostic 
reliability (Grishham, Brown & Campbell, 2004), making it a popular measure for 
diagnosing anxiety disorders in research settings. 
 
6.4.3 Depression Assessment Measure   
i) Depression Anxiety and Stress Scale (DASS-21; Lovibond & Lovibond, 1995) 
The DASS-21 is a short form of Lovibond and Lovibond’s (1995) 42-item measure of 
depression, anxiety and stress. It consists of three 7-item self-report scales taken from the 
full version of the DASS. There is evidence the DASS scales do constitute valid 
measures of the constructs they were intended to represent (Lovibond & Lovibond, 1995; 
Crawford & Henry, 2003; Henry & Crawford, 2005). The DASS-21 has a number of 
advantages over the full length DASS. As it is shorter than its full length counterpart, it is 
more acceptable for clients, whilst still demonstrating adequate reliability and omits items 
from the full DASS that have been identified as problematic (Henry & Crawford, 2005). 
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The DASS-21 was used to identify depression, anxiety and stress symptoms experienced 
in the preceding 7 days.   
 
6.4.4 Socio-Demographic Questionnaire  
A socio demographic questionnaire including date of birth, ethnic origin, marital status, 
number of children (if any), occupational history, highest level of education obtained and 
medications of each participant was completed on assessment.  
 
6.4.5  Height and Weight Measurements  
Anxiety participants provided their height and current weight measurements, in order for 
the researchers to calculate body mass index (BMI) scores. Although self-report height 
and weight measurements are not considered optimal, as reported by Black Becker et al. 
(2004), research has shown that self report weights are reasonably accurate (Stunkard & 
Albaum, 1981). For eating disorder participants, height and weight measurements were 
taken from clinical records upon entry into treatment.  
 
6.4.6 Excluded Measures  
A number of additional measures were initially included in the first phase of this study, 
however it was found that the time pressures on participants to complete these was too 
great, and therefore they were excluded from the study. A number of the measures were 
discontinued after the first 30 participants were assessed, with the response rate at less 
than 60% for completing all questionnaires. Subsequently, the ANSOCQ, EDBQ & 
Anxiety self –report measures were excluded from the study. These are described briefly 
below and copies are contained in Appendix H.  
 
i) Beck Depression Inventory II (BDI-II; Beck, Steer & Brown, 1996) 
The BDI-II is a 21-item self-report instrument intended to assess the existence and 
severity of symptoms of depression as listed in the DSM-IV (American Psychiatric 
Association, 2000).  This new revised edition replaces the BDI and the BDI-1A, and 
includes items intending to index symptoms of severe depression, which would require 
hospitalization. In the BDI-II items have been revised to indicate increases or decreases 
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in sleep and appetite, items labeled body image, work difficulty, weight loss, and somatic 
preoccupation were replaced with items labeled agitation, concentration difficulty and 
loss of energy, and many statements were reworded resulting in a substantial revision of 
the original BDI and BDI-1A. When presented with the BDI-II, a patient is asked to 
consider each statement as it relates to the way they have felt for the past two weeks, to 
more accurately correspond to the DSM-IV criteria. The BDI has been reported to be 
highly reliable regardless of the population. It was decided that instead of using the BDI-
II, this study would utilise the DASS-21 (Lovibond and Lovibond, 1995). The main 
reason for making this change was so that the researchers would also be able to examine 
the differences between samples on general levels of anxiety, as well as screening for 
depression. 
 
ii) Anorexia Nervosa Stages Of Change Questionnaire (ANSOCQ; Rieger, Touyz, 
Schotte, Beumont, Russell, Clarke, Kohn & Griffiths, 2000) 
The ANSOCQ is a 20-item self-report measure assessing symptomatology relevant to 
AN, specifically in terms of eating behaviours, body shape and weight concerns and 
weight control strategies, problematic personality characteristics and interpersonal 
difficulties. It was designed to measure readiness to change, based on the stages of 
change model proposed by DiClimente and Prochaska (1998).  Furthermore, the 
ANSOCQ has demonstrated good internal consistency in adult (Rieger et al., 2000) and 
adolescent AN samples (Serrano, Castro, Ametller, Martinez & Toro, 2004). Initially this 
questionnaire was included, as the authors thought that it might be interesting to consider 
any differences between readiness to change for individuals with and without an anxiety 
disorder. As this questionnaire was developed for use in an AN population, it was not 
suitable for the BN & EDNOS participants who were included in the study. Furthermore, 
due to the lengthy nature of the assessment procedure, it was decided that this 
questionnaire was too time consuming to include in addition to the other self-report 
items.  
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iii) Eating Disorder Belief Questionnaire (EDBQ; Cooper, Cohen-Tovee, Todd, 
Wells & Tovee, 1997)  
The EDBQ is a 32 item self-report questionnaire designed to assess assumptions and 
beliefs associated with eating disorders. This measure assesses core beliefs rating to four 
dimensions, including, negative self-beliefs, weight and shape as a means to acceptance 
by others, weight & shape as a means to self-acceptance and control over eating. 
Participants indicate the strength with which they hold a particular belief, using a scale 
ranging from 0 to 100, with responses being analysed under each of the four dimensions 
(Cooper et al, 1997). In the development phases for the current research, it was initially 
thought that an interesting aspect would be to explore any differences between core 
beliefs for individuals with and without comorbid anxiety disorders. Although in the 
early stages of this research, this questionnaire was included in the self-report battery 
given to participants, a number of participants did not complete this measure. It was 
determined that due to the time intensive nature of the initial assessment, the expectation 
for participants to also complete this questionnaire was too great. Subsequently, this 
questionnaire was removed from the assessment battery.  
 
iv) Anxiety Questionnaires 
A number of anxiety specific self-report questionnaires were also included in the initial 
design of this research. The purpose of including these questionnaires was so that 
comparisons could be drawn between participants with comorbid anxiety and eating 
disorders presenting for anxiety treatment versus eating disorder treatment. Specifically, 
the authors were interested in whether there was an observable difference between the 
specific anxiety disorder symptoms experienced (as measured by the self-report 
questionnaires) between these groups. This analysis in the research was always dependent 
on identifying sufficient numbers of comorbid cases in each group. As will be detailed in 
the following chapter, only a small number of participants presenting for anxiety 
treatment also met diagnosis for a current eating disorder, and subsequently, there were 
insufficient numbers to draw comparisons. As previously highlighted, the time 
consuming nature of the initial assessment meant that participants were reluctant to 
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complete further questionnaires. The completion rate for the anxiety specific self-report 
questionnaires was very low. The following anxiety self-report measures were initially 
incorporated in the assessment procedure:  
 
Generalised Anxiety Disorder  
• Metacognitions questionnaire (MCQ; Cartwright-Hatton & Wells, 1997) 
• Penn State Worry questionnaire (PSWQ; Meyer, Miller, Metzger and Borkovec, 
1990) 
The MCQ is 65-item measure of beliefs about worrying thoughts, attitudes and processes 
associated with cognition. The scale consists of 5 factor-derived subscales including 
positive beliefs; beliefs about uncontrollability and danger of thoughts; cognitive 
confidence; need for control, responsibility and punishment and cognitive self-
consciousness (Wells, 1997). The subscales demonstrate adequate to good internal 
consistencies and adequate to very good test-retest reliabilities (Roemer, 2001).  
 
The PSWQ is a 16-item self-report measure of worry. Each item is rated on a 5-point 
scale (1 = "not at all typical" to 5 = "very typical"). Several studies indicate that the 
PSWQ provides a reliable and valid measure of general worry in patient and nonpatient 
samples (Brown, Antony & Barlow, 1992; Ladouceur, Freeston, Dumont, Letarte, 
Rheaume, Gagnon & Thibodeau, 1992; Brown, Moras, Zinbarg & Barlow, 1993; Davey, 
1993). 
 
Social phobia  
• Social interaction anxiety scale (SIAS; Mattick & Clark, 1989)  
• Social phobia scale (SPS; Mattick & Clark, 1989) 
• Fear of negative evaluation scale (FNE; Watson & Friend, 1969) 
 
The SIAS and SPS are 20 item scales designed to assess social anxiety in situations 
involving social interaction (SIAS) and situations involving observation by others (SPS).  
Both the SPS and SIAS have demonstrated good reliability and discriminative validity 
(McNeil, Ries & Turk, 1995).  
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The FNE scale measures the cognitive and affective/behavioural aspects of social anxiety 
(Watson & Friend, 1969). Although this scale has been used extensively in clinical and 
research settings, some limitations exist. These limitations including having reversed 
items, which may cause confusion in responses and the ‘True/False’ format which 
impairs the potential sensitivity of the scale (Wells, 1997). Generally however, the FNE 
scale is considered to be valuable in the assessment and treatment of social phobia, and a 
number of studies support its validity (McNeil et al., 1995).  
  
Panic Agoraphobia 
• Agoraphobic cognitions questionnaire (ACQ; Chambless, Caputo, Bright & 
Gallagher, 1984) 
• Body sensations questionnaire (BCQ; Chambless, Caputo, Bright & Gallagher, 
1984) 
The ACQ and the BSQ are twin scales based on the fear of fear model proposed by 
Goldstein & Chambless (1978). The ACQ is a 14 item measure of thoughts about 
negative consequences of anxiety. The BSQ is a 17 item measure of an individual’s fear 
of bodily sensations associated with high arousal and panic states. The ACQ and BSQ are 
recognized as extremely important tools in the assessment and treatment of panic disorder 
and agoraphobia (Wells, 1997). 
 
Obsessive Compulsive Disorder 
• Yale – Brown obsessive compulsive scale (Y-BOCS; Goodman, Price, 
Rasmussen, Mazure, Fleishmann, Hill, Heninger & Charney, 1989 & Goodman, 
Price, Rasmussen, Mazure, Fleishmann, Hill, Heninger & Charney, 1989) 
• Padua Inventory - Washington State University Revision (PI-WSUR; Burns, 
Keortge, Formea & Sternberger, 1996)  
• Maudsley Obsessional Compulsive inventory (MOCI; Hodgson & Rachman, 
1977) 
The Y-BOCS is a semi-structured interview designed to assess the presence and severity 
of symptoms found in patients with OCD. Initially a symptom checklist for both 
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obsessions and compulsions is generated for both current and lifetime symptoms. 
Following this, the clinician assesses the severity and clinical significance of the 
symptoms. The Y-BOCS reliability and validity has been well established (Goodman, 
Price, Rasmussen, Mazure, Fleishmann, Hill, Heninger & Charney, 1989; Goodman, 
Price, Rasmussen, Mazure, Fleishmann, Hill, Heninger & Charney, 1989). Initially this 
measure was going to be used in addition to the ADIS-IV to further assess for obsessive 
and compulsive symptomatology. However, it was subsequently decided by the authors 
that the ADIS-IV OCD assessment section was sufficient, and as previously mentioned, 
the already time consuming nature of the initial assessment meant that the authors needed 
to be cognisant of the time pressures placed on participants.  
 
The PI-WSUR is a 39-item self-report measure of obsessions and compulsions. Each 
item is rated on a 5-point scale according to the degree of disturbance caused by the 
thought or behavior. This measure is separated into five subscales: (1) contamination, 
obsessions and washing compulsions, (2) dressing/grooming compulsions, (3) checking 
compulsions, (4) obsessional thoughts of harm to self/others, and (5) obsessional 
impulses to harm self/others. The PI-WSUR has good reliability and good test-retest 
reliability (Burns et al., 1996).  The revised version was designed to limit the overlap 
between worry and obsessions observed in the original PI (Sanavio, 1988). Despite this 
overlap having been reduced, significant overlap still remains (Wells & Papageorgiou, 
1998). 
 
The MOCI is a 30-item self-report questionnaire with four subscales consisting of 
checking, cleaning, slowness and doubting. The measure has been shown to be valid in 
identifying obsessions and compulsions in both clinical and non-clinical samples 
(Sternberger & Burns, 1990). The MOCI also has good reliability and validity (Myers & 
Wells, 2005). 
 
Post Traumatic Stress Disorder  
• Post Traumatic Diagnostic Scale (PDS; Foa, Cashman, Jaycox & Perry, 1997)  
• Impact of Events Scale Revised (IES-R; (Weiss & Marmar, 1997) 
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The PDS assessment is designed to aid in the diagnosis of PTSD (PTSD) and with the 
quantification of the severity of symptoms. The PDS is a 49-item self-report 
questionnaire designed to parallel the DSM-IV diagnostic criteria for PTSD. The PDS 
has demonstrated excellent internal consistency overall and very good internal 
consistency for the symptom subscales. The validity of this scale has also been 
demonstrated to be sound (Orsillo, 2001).  
The Impact of Events Scale (IES; Horowitz, Wilner & Alvarez, 1979; Zilberg, Weiss & 
Horowitz, 1982; Weiss & Marmar, 1997) is a 15-item scale designed to assess subjective 
distress for any specific life event. As the original IES was developed prior to the 
inclusion of PTSD in the DSM, the IES-R was designed to parallel the DSM-IV criteria 
for PTSD. Thus, while the IES only assesses intrusion and avoidance symptoms, the IES-
R includes questions assessing hyperarousal symptoms. Generally the psychometric 
properties of the IES-R appear sound and Weiss and Marmar (1997) reported that the 
internal consistency of the 3 subscales was very high.  
6.5 Procedure 
6.5.1 Eating Disorder Participants 
 i) Inpatient Sample 
Consecutive referrals of patients attending the inpatient units for eating disorder 
treatment were invited to participate in the current study (see Section 6.3.1 for details of 
the inpatient treatment units involved). Of the 50 participants assessed, the author (JMS), 
completed all of these assessments. The assessment consisted of conducting the EDE, in 
order to confirm an eating disorder diagnosis, and then completion of the ADIS-IV 
(Anxiety Disorders Section Only) to identify comorbid anxiety disorder diagnoses. 
Participants were also given a socio-demographic questionnaire, the DASS-21 and the 
EDI-3 to complete. As discussed in Section 6.4.6, initially some additional eating 
disorder and anxiety self-report questionnaires were also given to participants, however 
these were subsequently discontinued.   
 
All eating disorder participants received detailed information about the procedures and 
aims of the study, and gave written consent.  
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ii) Outpatient Sample 
Attending patients referred to outpatient services for eating disorder treatment were 
invited to participate in the current study (see Section 6.3.2 for details of the outpatient 
treatment services involved). Of the 50 participants assessed, the author (JMS), 
completed all of these assessments. The assessment consisted of conducting the EDE, in 
order to confirm an eating disorder diagnosis, and then completion of the ADIS-IV 
(Anxiety Disorders Section Only) to identify comorbid anxiety disorder diagnoses. 
Participants were also given a socio-demographic questionnaire, the DASS-21 and the 
EDI-3 to complete. As discussed in Section 6.4.6, initially some additional eating 
disorder and anxiety self-report questionnaires were also given to participants, however 
these were subsequently discontinued.   
 
All eating disorder participants received detailed information about the procedures and 
aims of the study, and gave written consent.  
 
6.5.2 Anxiety Participants  
Patients attending the generalist or specialist units for anxiety treatment were invited to 
participant in the current study (see Section 6.3.3 for details of the outpatient treatment 
services involved). All participants who agreed to participate were assessed for current 
anxiety disorder diagnoses using the ADIS-IV (complete). The ADIS-IV assessments 
were all completed by the author (JMS) and by Doctoral Students in their 2nd or 3rd year 
of clinical training, who had been trained by Clinical Psychologists in the use of the 
ADIS-IV. Participants were also given two eating disorder self-report questionnaires to 
complete (the EDE-Q and the EAT-40) as well as the DASS-21 and a socio-demographic 
questionnaire. As discussed in Section 6.4.6, initially some additional eating disorder and 
anxiety self-report questionnaires were also given to participants, however these were 
subsequently discontinued.   
 
Participant responses on the EDE-Q and the EAT-40, enabled the researchers to 
determine the presence of a possible eating disorder. Based on the eating disorder self-
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report measures, participants obtaining scores indicative of eating disorder pathology 
were invited back for a more comprehensive eating disorder assessment using the EDE 
(the EDE assessments were all completed by the author, JMS). This further assessment 
enabled an eating disorder diagnosis to be confirmed. Participants with confirmed eating 
disorder diagnoses were also given the EDI-3 to complete.   
 
All anxiety participants received detailed information about the procedures and aims of 
the study, and gave written consent.  
 
6.5.3 Age at Onset  
For participants reporting that the anxiety disorder was present during childhood “for as 
long as I could remember”, the age of onset was set at 5 years of age based on the 
assumption that childhood recollections may be limited prior to this age, in line with 
previous research in this area (Kaye, Bulik, Thornton, Barbarich, Masters & the Price 
Foundation Collaborative Group, 2004).  For each eating disorder and anxiety disorder 
diagnosed, the researchers determined the age of onset as defined by the age at which all 
the symptoms necessary to make an eating or anxiety disorder diagnosis were present 
concurrently. This was based on the recollection of the participant only, and no additional 
measures were used to determine this. From this information the researchers were able to 
determine the temporal relationship between the onset of comorbid diagnoses, 
specifically whether the onset of one disorder was prior to, concurrent or following the 
onset of the comorbid disorder.   
 
6.6 Statistical Analysis   
 6.6.1 Data Screening  
All statistical analyses were performed using Statistical Package for the Social Sciences 
(SPSS, 2006) for Windows (Version 15.0). The data set was thoroughly screened prior to 
commencing analyses, and the accuracy of the data file was ensured by double-checking 
all entries and screening for the presence of missing data.  
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6.6.2 Statistical Analyses 
The data analysis was performed using SPSS (v15.0, 2006). In order to investigate the 
prevalence of comorbid anxiety and eating disorders much of the information collected in 
the current study was summarised with percentages. The information regarding the 
temporal relationship between disorders was also summarised with percentages. 
Comparisons across the sample were made using chi-square analyses, t-tests, ANOVA 
and logistic regression. Specifically, significant mean group differences for parametric 
variables were analysed using t-tests and one-way analysis of variance (ANOVA) 
statistical procedures. In place of t-tests, Mann-Whitney tests were conducted in cases 
where the t test normality assumption was violated (determined by skewness and 
kurtosis) and sample sizes were small. Chi-Square (χ²) tests were used for categorical 
independent variables. Furthermore, Fisher’s exact test was used when the minimum 
expected cell size was 5 or less and Craméres V was used when independent variables 
had more than 2 categories (Hills, 2008). A logistical regression analysis was also 
conducted for the comparison of EDE scores across the sample. For all statistical 
analyses reported, the alpha was set at p<.05, unless otherwise indicated. All tests 
performed were two-tailed. For all SPSS output files refer to Appendix I.  
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CHAPTER 7 
SAMPLE CHARACTERISTICS 
 
This chapter is an overview of the participant recruitment and sample characteristics at 
assessment for the current study. Demographic characteristics are reported, as well as 
participants’ scores on self-report measures. The demographic characteristics for the 
eating disorder sample were similar to those reported in similar studies (Godart et al., 
2003, Kaye, Bulik, Thornton, Barbarich, Masters & the Price Foundation Collaborative 
Group, 2004, Blinder et al., 2006) as were the demographic characteristics for the anxiety 
sample (Black Becker et al., 2004). The depressive symptoms as measured by the DASS 
in the present study appear similar to Mood Disorder rates reported by Blinder et al., 
(2006) across their eating disorder sample.  
 
7.1 Recruitment of the Eating Disorder Sample  
A total of 100 eating disorder participants were recruited for the current study. This 
included 50 participants from inpatient eating disorder units and 50 patients from 
outpatient treatment services.  
 
7.1.1 Inpatient ED Sample  
A total of 78 eating disorder inpatients who appeared to meet inclusionary criteria were 
invited to participate in the study. The aim was to see all participants as soon after 
admission as possible (within the first week). All eating disorder assessments investigated 
the 28 day period prior to admission into treatment. The subsequent inpatient sample 
represents 64% of patients who were approached to participate. Most participation 
refusals were encountered at one of the treatment sites (NSC), where only 3 (16%) of the 
18 patients approached consented. The main reason for refusal appeared to be that 
patients were already involved in a number of research projects being undertaken in the 
unit. Subsequently, it was decided to cease recruitment at NSC and continue recruitment 
through the PBCED at Wesley Hospital.  
 
 153 
Of the patients who were deemed unsuitable for participation, 26 were unsuitable due to 
being under 18 years of age, 4 were unsuitable due to acute suicidality and self harm 
attempts (three were reported to have a comorbid PTSD diagnosis), and 1 had absconded 
from the hospital just after admission.  
 
7.1.2 Outpatient ED Sample 
A total of 58 eating disorder outpatients who appeared to meet inclusionary criteria were 
invited to participate in the study. The subsequent outpatient sample represents 86.2% of 
patients who were approached to participate. Reasons given for not consenting for 
participation in the current study included an unwillingness to participate in research 
(n=5) and an inability to find the time due to work commitments (n=1). Two patients 
(n=2) were also excluded as they met criteria for EDNOS (Binge Eating Disorder), as this 
study was investigating anxiety amongst patients with AN, BN and subthreshold 
diagnoses of these disorders.  
 
Of the patients who were deemed unsuitable for participation (n=8), 1 was unsuitable due 
to being under 18 years of age, 4 were unsuitable due to acute suicidality and the 
remaining 3 did not meet DSM-IV criteria for an eating disorder on assessment.  
 
7.2 Recruitment of the Anxiety Disorder Sample 
A total of 52 anxiety disorder participants were recruited for the current study. All 
participants were recruited through outpatient treatment units. A total of 62 anxiety 
disorder outpatients who appeared to meet inclusionary criteria were invited to participate 
in the study. The subsequent outpatient sample represents 83.9% of patients who were 
approached to participate. Reasons given for not consenting for participation in the 
current study included unwillingness to participate in research (n=7) and an inability to 
find the time due to work or other commitments (n=2).  
 
One participant was excluded from the study due to completing the questionnaires 
incorrectly.  
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Of the patients who were deemed unsuitable for participation (n=2), both were unsuitable 
due to not meeting criteria for a DSM-IV anxiety disorder.  
 
Of the 23% (n=12) of women identified as having a potential eating disorder (as indicated 
by the self-report questionnaires) only 3 participants were unable to complete a further 
eating disorder assessment to confirm diagnosis.  Two of these participants were unable 
to be contacted, and the other declined to participate in a further interview.   
 
7.3 Characteristics of the Eating Disorder Sample 
7.3.1 Inpatient Sample  
All 50 female participants met DSM-IV (American Psychiatric Association, 2000) 
criteria for an eating disorder, including 66% (n=33) for AN (38% (n=19) for restricting 
subtype and 28% (n=14) for binge purging subtype); 12% (n=6) for BN; and 22% (n=11) 
for EDNOS. Of the participants diagnosed with EDNOS, 54.5% (n=6) presented with 
subthreshold BN and 45.5% (n=5) presented with subthreshold AN.  
 
All diagnoses were made by the author (JMS) following an assessment using the EDE.  
The mean (± sd) estimated duration for eating disorder pathology was 88 months (± 78.5 
months). The range was from a minimum of 3 months to a maximum of 276 months. The 
mean age of onset of eating disorder pathology was 17.9 years (± 6.3), with onset ranging 
from age 11 through to age 43 years.  
 
Regarding bingeing and purging behaviours in the preceding 28 days, 38% (n= 19) 
reported at least one objective binge episode; 50% (n=25) reported to have engaged in 
self induced vomiting on at least one occasion and 24% (n=12) reported laxative abuse in 
the preceding month. 44% (n=22) reported having engaged in excessive exercise in the 
preceding 28 days. See Table 7.2 for a summary of eating disorder characteristics of 
participants and Table 7.3 for a summary of demographic and clinical characteristics by 
ED subtype.   
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At assessment, the mean (± sd) body mass index (BMI in kg/m²) for all participants was 
17.3 kg/m² (± 3.2) with the mean for AN (n=33) being 15.4 (±1.0), for BN (n=6) the 
mean was 20.7 (±2.7) and for EDNOS (n=11) the mean was 20.95 (±3.2). Across the 
entire sample, the minimum BMI was 12.5 kg/m² and the maximum was 25.5 kg/m².  
 
The mean age for participants was 25 years (± 8.3), with an age range of 18-56 years of 
age. The mean level of education for the sample was 14.2 years (± 2) with the minimum 
level of education being 11 years and the maximum 20 years. In respect of employment 
status, at the time of the assessment, 46% (n=23) of the sample were employed, 30% 
(n=15) were unemployed and 24% (n=12) were involved in full time study. In terms of 
marital status, at the time of the assessment, 72% (n=36) of the sample were single, 10% 
were married (n=5), 12% (n=6) had a partner and 6% (n=3) were separated or divorced. 
Furthermore, 92% (n=46) reported not having any children, whilst the remaining 8% 
(n=4) reported having 1 or more children. In antidepressant medications, 74% (n=37) 
reported currently taking antidepressant medications, whilst the remaining 26% (n=13) 
denied taking current medications.  
 
Regarding depression levels, as measured by the DASS scores, 48% (n=24) obtained 
scores in the severe to extremely severe range, 28% (n=14) were in the mild to moderate 
range, and 12% (n=6) obtained scores in the normal range. The remaining 12% (n=6) did 
not return the questionnaire, and therefore their depression scores were unable to be 
calculated. See Table 7.1 for a summary of the demographic profile of participants. 
 
7.3.2 Outpatient Sample  
All 50 female participants met DSM-IV (American Psychiatric Association, 2000) 
criteria for an eating disorder, including 58% (n=29) for EDNOS; 30% (n=15) for BN; 
and 12% (n=6) for AN (10% (n=5) for restricting subtype and 2% (n=1) for binge 
purging subtype). Of the participants diagnosed with EDNOS, 58.6% (n=17) presented 
with subthreshold AN and 41.4% (n=12) presented with subthreshold BN.  
 
All diagnoses were made by the author (JMS) following an assessment using the EDE.  
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The mean (± sd) estimated duration for eating disorder pathology was 99.1 months (± 
76.8 months). The range was from a minimum of 6 months to a maximum of 336 months. 
The mean age of onset of eating disorder pathology was 16.8 years (± 4.7), with onset 
ranging from age 9 through to age 34 years. In terms of bingeing and purging behaviours 
in the preceding 28 days, 54% (n= 27) reported at least one objective binge episode; 52% 
(n=26) reported to have engaged in self-induced vomiting on at least one occasion and 
4% (n=2) reported laxative abuse in the preceding month. 38% (n=19) reported having 
engaged in excessive exercise in the preceding 28 days. See Table 7.2 for a summary of 
eating disorder characteristics of participants and Table 7.3 for a summary of 
demographic and clinical characteristics by ED subtype. 
 
At assessment, the mean (± sd) body mass index (BMI in kg/m²) for all participants was 
20.4 kg/m² (± 3.2) with the mean for AN (n=6) being 16.58 (±0.5), for BN (n=15) the 
mean was 21.7 (±2.9) and for EDNOS (n=29) the mean was 20.6 (±3.1). Across the 
entire sample, the minimum BMI was 15.4 kg/m² and the maximum was 28.9 kg/m².  
 
The mean age for participants was 25.0 years (± 6.4), with an age range of 18-45 years of 
age. The mean level of education for the sample was 13.6 years (± 2.1) with the 
minimum level of education being 10 years and the maximum 19 years. In respect of 
employment status, at the time of the assessment, 36% (n=18) of the sample were 
employed, 22% (n=11) were unemployed and 42% (n=21) were involved in full time 
study. Regarding marital status, at the time of the assessment, 60% (n=30) of the sample 
were single, 22% (n=11) had a partner, 14% were married (n=7) and 4% (n=2) were 
separated or divorced. Furthermore, 80% (n=40) reported not having any children, whilst 
the remaining 20% (n=10) reported having 1 or more children. In terms of antidepressant 
medications, 60% (n=30) denied taking current medications, whilst the remaining 40% 
(n=20) reported currently taking antidepressant medications.  
 
In respect of depression levels, as measured by the DASS scores, 46% (n=23) obtained 
scores in the severe to extremely severe range, 32% (n=16) were in the mild to moderate 
range, and 20% (n=10) obtained scores in the normal range. A further 2% (n=1) did not 
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return the questionnaire, and therefore their depression scores were unable to be 
calculated. See Table 7.1 for a summary of the demographic profile of participants. 
 
7.4 Characteristics of the Anxiety Disorder Sample 
All 52 female participants met DSM-IV (American Psychiatric Association, 2000) 
criteria for an anxiety disorder: 28.8% (n=15) for social phobia, 23.1% (n=12) for OCD, 
17.3% (N=9) for GAD, 17.3% (N=9) for Panic with Agoraphobia, 5.8% (N=3) for 
specific phobia, 5.8% (N=3) for PTSD and 1.9% (n=1) for ASD. Secondary anxiety 
disorder diagnoses were also diagnosed in 25% (n=13), 2 of these participants met 
diagnosis for 2 secondary anxiety disorders and one met criteria for 3 secondary anxiety 
disorder diagnoses.  
 
A total of 23% (n=12) of participants obtained scores on the EAT-40 and EDE-Q 
indicative of the presence of eating disorder pathology. Of these 12 cases, 9 participants 
completed a further assessment interview to establish the presence or absence of an 
eating disorder diagnosis. Of the 3 who did not complete a further assessment, 1 declined 
and  2 were unable to be contacted by the researcher. Following a further eating disorder 
assessment, 7 participants (13.5% of the whole anxiety disorder sample) were diagnosed 
as meeting DSM-IV (American Psychiatric Association, 2000) criteria for an eating 
disorder (EDNOS). Of the participants diagnosed with EDNOS, 3 presented with 
subthreshold BN, n=2 with subthreshold AN and 2 with Binge Eating Disorder.  All 
confirmed eating disorder diagnoses were made by the author (JMS) following an 
assessment using the EDE.  
 
In terms of individuals meeting criteria for both an anxiety disorder and an eating 
disorder (n=7), the mean (± sd) age was 31.3 (± 12.8) and mean (± sd) level of education 
was 13 years (± 1.2). Regarding marital status, 57.1% (n=4) reported being single, whilst 
42.9% (n=3) reported being either married or having a partner. In terms of children, 
57.1% (n=4) reported having no children, whilst the remaining 42.9% (n=3) reported 
having between 1 and 3 children. Of this sample, 57.1% (n=4) were employed, 28.6% 
(n=2) were full time students and the remaining 14.3% (n=1) were unemployed. The 
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mean (± sd) estimated duration for anxiety disorder pathology was 197.1 months (± 161.1 
months). The range was from a minimum of 24 months to a maximum of 504 months. 
The mean (± sd) age of onset for anxiety disorders was 14 years (±9.2), ranging from 
onset at age 5 to age 32 years. The mean (± sd) estimated duration for eating disorder 
pathology was 147.4 months (± 105.9 months). The range was from a minimum of 72 
months to a maximum of 348 months. In relation to the age of onset for eating disorder 
pathology, the mean (± sd) was 19 years (± 9.9), with onset ranging from age 9 years to 
age 40 years. Regarding bingeing and purging behaviours in the preceding 28 days, 
71.4% (n= 5) reported engaging in at least one objective binge episode; 14.3% (n=1) 
reported engaging in self induced vomiting on at least one occasion and 100% (n=7) 
denied laxative abuse in the preceding month. A further 42.9% (n=3) reported having 
engaged in excessive exercise in the preceding 28 days. See Table 7.2 for a summary of 
eating disorder characteristics of participants. 
 
At assessment, the mean (± sd) body mass index (BMI in kg/m²) for participants with an 
eating disorder diagnosis was 27.7 kg/m² (±12.4), with the minimum BMI being 17.6 
kg/m² and the maximum 51.2 kg/m². In terms of antidepressant medication, 71.4% (n=5) 
reported not currently taking an antidepressant, whilst the remaining 28.6% (n=2) 
reported that they were. Finally, of this sample, 42.9% (n=3) reported severe to extremely 
severe levels of depression, 28.6% (n=2) reported moderate levels of depression and 
28.6% (n=2) obtained scores in the normal range for depression.  
 
For the entire sample, the mean age for participants was 34.9 (± 12.3), with an age range 
of 18 – 70 Years of age. The mean level of education for the sample was 13.45 years (± 
2.4) with the minimum level of education being 7 years and the maximum 21 years. 
However, 15.4% (n=8) participants failed to record their level of education and therefore 
this calculation is based on the information from 84.6% (n=44) participants who recorded 
this information. In terms of employment status, at the time of the assessment, 48.1% 
(n=25) of the sample were employed, 32.7% were unemployed (n=17), 13.5% (n=7) were 
involved in full time study and 1.9% (n=1) reported being retired. Regarding marital 
status, at the time of the assessment, 50% (n=26) of the sample were single, 21.2% were 
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married (n=11), 21.2% (n=11) had a partner, 5.7% (n=3) were separated or divorced and 
1.9% (n=1) reported being widowed. Furthermore, 57.7% (n=30) reported not having any 
children, whilst the remaining 42.3% (n=22) reported having 1 or more children. In 
respect of antidepressant medications, 69.2% (n=36) denied taking current medications, 
whilst the remaining 30.8% (n=16) reported currently taking antidepressant medications. 
In terms of depression levels, as measured by the DASS scores, 34.6% (n=18) obtained 
scores in the severe to extremely severe range, 25% (n=13) were in the mild to moderate 
range, and 40.4% (n=21) obtained scores in the normal range. See Table 7.1 for a 
summary of the demographic profile of participants. 
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Table 7.1 Demographic profile of participants     
                                                                         Eating Disorder Unit                  Anxiety Disorder Unit 
Characteristic Inpatient 
(n=50)  
Outpatient 
(n=50)  
Entire Sample 
(n=52)  
ED Only 
(n=7)  
Age  (Years)  
Mean (± sd) 
 
25.4 (± 8.3) 
 
25 (± 6.4) 
 
34.9 (± 12.3)  
 
31.3 (± 12.8) 
Education (Years) 
Mean (± sd)  
 
14.2 (±2)  
 
13.6 (± 2.1)  
 
13.45 (± 2.4)  
 
13 (± 1.2)  
Employment Status  
% (n) 
Employed  
Unemployed 
F/T Student  
Retired  
 
 
46 (23)  
30 (15) 
24 (12)  
0 (0)   
 
 
36 (18)  
22 (11)  
42 (21)  
0 (0)  
 
 
48.1 (25)  
32.7 (17)  
13.5 (7)  
1.9 (1)  
 
 
57.1 (4)  
14.3 (1)  
28.6 (2) 
0 (0)   
Marital Status  
% (n) 
Married / Partner  
Single  
Separated/Divorced 
Widowed 
 
 
22 (11) 
72 (36) 
6 (3) 
0 (0)  
 
 
36 (18)  
60 (30)  
4 (2)  
0 (0) 
 
 
42.4 (22) 
50 (26)  
5.7 (3)  
1.9 (1)   
 
 
49.9 (3)  
57.1 (4)  
0 (0)  
0 (0)  
Children ( 1 or more)  
% (n) 
 
8 (4) 
 
20 (10) 
 
42.3 (22) 
 
42.9 (3) 
Antidepressant Medication  
% (n) 
 
74 (37)*  
 
40 (20)  
 
30.8 (16)  
 
28.6 (2)  
Depression Level  
% (n) 
Normal  
Mild – Moderate  
Severe – Ex Severe  
 
 
12 (6)  
28 (14)  
48 (24)  
 
 
20 (10)  
32 (16)  
46 (23)  
 
 
40.4 (21)  
25 (13)  
34.6 (18)  
 
 
28.6 (2)  
28.6 (2)  
42.9 (3)  
*P<0.05 v Outpatient ED (χ² test) 
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Table 7.2 Eating disorder characteristics of participants  
                                                                             Eating Disorder Unit  Anxiety Disorder Unit  
Characteristic Inpatient 
(n=50)  
Outpatient 
(n=50)  
ED Only 
(n=7)  
AN  
% (n) 
 
66 (33) 
 
12 (6)  
 
0 (0)  
 BN  
% (n) 
 
12 (6)  
 
30 (15) 
 
0 (0)  
EDNOS  
% (n) 
 
22 (11) 
 
58 (29)  
 
100 (7) 
Duration of ED (Months)  
Mean (± sd) 
 
88.3 (± 78.5)  
 
99.1 (±76.8) 
 
147.4 (± 105.9) 
Onset of ED (Years)  
Mean (± sd) 
 
17.9 (± 6.3)  
 
16.8 (± 4.7) 
 
19 (±9.9)  
BMI (kg/m²) 
Mean (± sd) 
 
17.3 (± 3.2) *  
 
20.4 (± 3.2)  
 
27.7 (± 12.4)  
Objective Bingeing  
% (n)  
 
38 (19) 
 
54 (27)  
 
71.5 (5)  
Self Induced Vomiting  
% (n) 
 
50 (25) 
 
52 (26)  
 
14.3 (1)  
Laxative Abuse ª 
% (n) 
 
24 (12) †  
 
4 (2)  
 
0 (0) 
Excessive Exercise  
% (n) 
 
44 (22)  
 
38 (19)  
 
42.9 (3)  
* P<0.01 v outpatient ED  
† P<0.01 v outpatient ED  
ª Some cells had an expected count less than 5, in these cases a Fisher’s exact significance test was selected 
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Table 7.3 Demographic and clinical characteristics of eating disorder subtypes 
(Eating Disorder Units Only)   
Characteristic AN  
(n=39) 
BN  
(n=21) 
EDNOS 
(n=40)  
Whole Sample  
(n=100) 
Age (Years) ** 
Mean (± sd) 
 
26.3 (± 9.1) 
 
23.7 (±4.4) 
 
25 (±6.72) 
 
25.2 (±7.3) 
Education (Years) 
Mean (± sd) 
 
14.1 (±2.0) 
 
13.9 (±1.8) 
 
13.7 (±2.2) 
 
25.2 (±7.3) 
Employment Status  % (n) ª 
Employed  
Unemployed 
F/T Student  
Retired 
 
43.6 (17)  
33.3 (13) 
23.1 (9)  
0 (0) 
 
47.6 (10) 
19 (4)  
33.3 (7)  
0 (0) 
 
35 (14)  
22.5 (9)  
42.5 (17)  
0 (0) 
 
41 (41)  
26 (26)  
33 (33)  
0 (0)  
Marital Status  % (n)  
Married / Partner  
Single  
Separated/Divorced 
Widowed 
 
25.6 (10) 
64.1 (25) 
10.2 (4) 
0 (0)  
 
23.8 (5)  
71.4 (15)  
4.8 (1)  
0 (0) 
 
35 (14) 
65 (26) 
0 (0) 
0 (0) 
 
29 (29)  
66 (66)  
5 (5)  
0 (0) 
Children ( 1 or more)  % (n) 15.4 (6) 0 (0) 20 (8)  14 (14)  
Depression Level  % (n) a 
Normal  
Mild – Moderate  
Severe – Ex Severe 
 
12.8 (5)  
28.2 (11)  
48.7 (19)  
 
14.3 (3)  
33.4 (7)  
52.4 (11)  
 
20 (8)  
30 (12)  
42.5 (17)  
 
16 (16)  
30 (30)  
47 (47)  
Duration of ED (Months)  
Mean (± sd) 
 
89.1(±6.9) 
 
87.33 (±54.8) 
 
101.8 (±84.9) 
 
93.7 (±77.4) 
Onset of ED (Years)  
Mean (± sd) 
 
18.8 (±6.9) 
 
16.4 (±2.9) 
 
16.4 (±4.9) 
 
17.4 (±5.6) 
BMI (kg/m²) ** 
Mean (± sd) 
 
15.6 (±1.1)† 
 
21.4 (±2.8) 
 
20.7 (±3.1) 
 
18.8 (±3.6) 
Objective Bingeing  % (n)  20.5 (8)  100 (21) 42.5 (17) 46 (46) 
Self  Induced Vomiting  % (n) 38.5 (15) 85.7 (18) 45 (18) 51 (51) 
Laxative Abuse % (n) ª 15.4 (6) 14.3 (3) 12.5 (5) 14 (14)  
Excessive Exercise  % (n) 38.5 (15) 23.8 (5) § 52.5 (21) 41 (41) 
** Levene’s test for equality of variances was significant, so equal variances were not assumed 
 † P<0.01 v BN & EDNOS 
§ P<0.05 vAN & EDNOS 
ª Some cells had an expected count less than 5, in these cases a Fisher’s exact significance test was selected 
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7.5 Sample Comparisons  
Pearson’s Chi-square tests and independent t-tests were conducted to examine any 
differences between the inpatient and outpatient ED samples. The data presented in tables 
7.1 and 7.2 indicates that there were no significant differences between the samples 
N=100 (p<0.05), for age, education and N=99 (p<0.05) for illness duration and illness 
age of onset. A chi-square analysis revealed no significant differences between  
employment status, marital status (married or single), number of children, depression 
scores, the presence of bingeing, vomiting and excessive exercise between inpatient and 
outpatient ED samples. Significantly more inpatients reported taking antidepressant 
medications than the outpatient ED sample (χ² (1, N=57) = 5.1, p<0.05). Furthermore, 
significantly more of the inpatient ED sample reported laxative abuse than the outpatient 
sample (χ² (1, N=14) = 7.1, p<0.01).  The inpatient ED sample also had significantly 
lower BMI scores than those in the outpatient ED sample (t(98)= -4.91, p=0.00).  
  
Pearson’s Chi-square tests and one way Analysis of Variance (ANOVA) analyses were 
also conducted to examine any differences between the AN, BN and EDNOS samples 
across the entire inpatient and outpatient ED sample. Due to small participant numbers, 
the subgroups within each of the ED diagnoses were not analysed separately. The data 
presented in table 7.3 indicates that there were no significant differences between the 
samples N=100 (p<0.05), for age and education and N=99 (p<0.05) for illness duration 
and illness age of onset. There was a significant difference between BMI scores across 
the samples (F(2,97)= 58.8, p=0.00, η²= 0.55) and a Games-Howell post Hoc comparison 
revealed the AN sample had significantly lower BMI scores than those in the BN or 
EDNOS samples. There was no significant difference found between BMI scores in the 
BN sample and EDNOS sample.  
 
A chi-square analysis revealed no significant differences between employment status, 
marital status (married or single), number of children, depression scores, the presence of 
bingeing, vomiting and laxative abuse between the AN, BN and EDNOS samples. There 
was a statistically significant difference in the use of excessive exercise between samples 
(χ² (2, N=41) = 9.6, p<0.01), with the EDNOS sample reporting the most use of excessive 
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exercise (21, 52.5%), while the least use was reported by the BN sample (5, 23.8%). 
Excessive exercise amongst the AN sample was reported by 15 (38.5%) of the 
participants. A further chi square analysis revealed no statistically significant difference 
between the use of excessive exercise amongst the EDNOS and AN sample.  
 
For the purpose of statistical analysis and to ensure adequate power, martial status was 
recorded as a dichotomous variable, single or partnered. Individuals who reported having 
been previously divorced or separated but were currently in a relationship were coded as 
partnered and those who reported not currently being in a relationship were coded as 
single.  
 
 165 
 
CHAPTER 8 
RESULTS 
 
This chapter presents the analyses conducted to address the aims, objectives and 
hypotheses of the current study, and the results obtained from these analyses.  All 
statistical analyses were performed using SPSS for Windows (Version 15.0).  
 
8.1 The Prevalence of Comorbid Anxiety and Eating Disorders  
One of the primary aims of this study was to investigate the prevalence of comorbid 
eating and anxiety disorders amongst an eating disorder sample and anxiety disorder 
sample. This aim also included establishing which of the anxiety disorders were most 
prevalent. The results have been summarised and presented for the inpatient & outpatient 
eating disorder samples, the entire eating disorder sample and the anxiety disorder 
sample.  
 
8.1.1 Inpatient Eating Disorder Sample  
In relation to anxiety disorder diagnoses, 74% (n= 37) of the inpatient ED sample (n=50) 
met DSM-IV criteria for a current primary DSM-IV anxiety disorder diagnosis, whilst the 
remaining 26% (n=13) did not. Secondary anxiety disorders were also identified in 42% 
(n=21) of the inpatient sample. Of the secondary anxiety disorders diagnosed, social 
phobia was the most frequent (48%, n=10), followed by GAD (33%, n=7), OCD (9.5%, 
n=2), PTSD (4.8%, n=1) and panic disorder with agoraphobia (4.8%, n=1). Furthermore, 
subthreshold anxiety disorders were also identified in 12% (n=6) of the sample, with 
subthreshold OCD identified in 3 participants, subthreshold specific phobia in 2 
participants and subthreshold GAD in 1 of the participants.  
 
Table 8.1 shows the current prevalence of at least one primary anxiety disorder in each of 
the eating disorder subgroups across the entire inpatient ED sample.  
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Figure 8.1 shows the frequencies of primary anxiety disorder diagnoses in the comorbid 
anxiety and eating disorder sample.  
 
Of the inpatient sample (n=50), 32% (n=16) reported having experienced at least one 
trauma in their lifetime. Furthermore, of the women who disclosed having experienced a 
trauma, 25% (n=4) were unable to continue the PTSD assessment, due to their distress, 
and therefore the presence of PTSD as a diagnosis was not confirmed. 6% (n=3) of the 
inpatient sample met DSM-IV criteria for a possible diagnosis of OCPD.  
 
An independent sample t-test analysis was also conducted to examine any differences 
between the clinical characteristics of the comorbid eating disorder and anxiety group and 
the eating disorder only group across the inpatient sample. Due to small participant 
numbers, the subgroups within each of the ED diagnoses were not analysed separately. 
The data presented in Table 8.2 indicates that there were no significant differences 
between the samples N=50 (p<0.05), for illness duration and illness age of onset, BMI, 
bingeing and purging episodes per month or use of excessive exercise. For the purpose of 
obtaining sufficient statistical power, a total purgative abuse score was calculated 
comprising the number of people who reported engaging in self-induced vomiting as well 
as laxative abuse for both the comorbid eating disorder and anxiety sample and the eating 
disorder only sample. Significantly more of the comorbid eating disorder and anxiety 
sample reported purgative abuse than the eating disorder only sample (χ² (1, N=37) = 
22.7, p<0.001).    
 
Due to small participant numbers, no statistical analyses were undertaken to consider the 
differences between anxiety diagnoses amongst the AN, BN and EDNOS diagnostic 
categories.  
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Table 8.1 Current prevalence of anxiety disorders across the inpatient ED sample 
Disorder AN 
(n=33) 
BN 
(n=6)  
EDNOS 
(n=11)  
Whole 
Sample 
(n=50) 
Any Anxiety Disorder  69.7 (23) 100 (6) 72.7 (8) 74 (37) 
Social Phobia 27.3 (9) 33.3 (2) 27.3 (3) 28 (14) 
PTSD 18.2 (6) 16.7 (1) 27.3 (3) 20 (10) 
GAD 12.1 (4) 50 (3) 9.1 (1) 16 (8) 
OCD 6.1 (2) 0 (0) 0 (0) 4 (2) 
Specific Phobia 3 (1) 0 (0) 0 (0) 2 (1) 
Panic with 
Agoraphobia 
3 (1) 0 (0) 0 (0) 2 (1) 
Panic without 
Agoraphobia 
0 (0) 0 (0) 9.1 (1) 2 (1) 
ASD 0 (0) 0 (0) 0 (0) 0 (0) 
Note: Values are expressed as the percentage %(n) 
 
Figure 8.1 Prevalence of primary anxiety disorders diagnosed across the inpatient 
ED comorbid sample (N=37)  
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Table 8.2 Summary of clinical characteristics of comorbid ED and ED only group 
across the inpatient sample (N=50)  
Characteristic Comorbid ED and AD 
(n=37)  
ED Only  
(n=13)  
AN  
% (n) 
 
62.2 (23) 
 
76.9 (10) 
 BN  
% (n) 
 
16.2 (6) 
 
0 (0) 
EDNOS  
% (n) 
 
21.6 (8) 
 
23.1 (3) 
Duration of ED (Months)  
Mean (± sd) 
 
92.5 (±77.7) 
 
75.3 (±82.9) 
Onset of ED (Years)  
Mean (± sd) 
 
17.95 (±6.5) 
 
18 (±6.1) 
BMI (kg/m²) 
Mean (± sd) 
 
17.6 (±3.3) 
 
16.4 (±3.1) 
Objective binge episodes / month 
Mean (± sd) 
 
14.4 (±31.8) 
 
10.7 (±19.4) 
Self Induced Vomiting episodes 
/month 
Mean (± sd) 
 
39.5 (±81.4) 
 
27.2 (±45.9) 
Laxative Abuse 
% (n) 
 
32.4 (12) 
 
0 (0) 
Purgative Abuse Total 
% (n) ª 
 
89.2 (33)* 
 
30.8 (4) 
Excessive Exercise Minutes / day 
Mean (± sd) 
 
61.4 (±93.3)  
 
25.4 (±42.2) 
ª Some cells had an expected count less than 5, in these cases a Fisher’s exact significance test was selected 
* P<0.001 v ED only group  
 
 169 
8.1.2 Outpatient Eating Disorder Sample   
In terms of anxiety disorder diagnoses, 56% (n= 28) of the outpatient ED sample (n=50) 
met DSM-IV criteria for a current primary DSM-IV anxiety disorder diagnosis, whilst the 
remaining 44% (n=22) did not. Secondary anxiety disorders were also identified in 26% 
(n=13) of the outpatient sample. Of the secondary anxiety disorders diagnosed, social 
phobia was the most frequent (61.5%, n=8), followed by GAD (23.1%, n=3), OCD 
(7.7%, n=1) and panic disorder without agoraphobia (7.7%, n=1). Subthreshold anxiety 
disorders were also identified in 18% (n=9) of the sample, with subthreshold GAD 
identified in 3 participants, subthreshold social phobia, panic disorder with agoraphobia 
and OCD were each identified in 2 participants.  
 
Table 8.3 shows the current prevalence of at least one primary anxiety disorder in each of 
the eating disorder subgroups across the entire outpatient sample. Figure 8.2 shows the 
frequencies of primary anxiety disorder diagnoses in the comorbid anxiety and eating 
disorder sample.  
 
Of the outpatient sample (n=50), 32% (n=16) reported having experienced at least one 
trauma in their lifetime. Furthermore, of the women who disclosed having experienced a 
trauma, 12.5% (n=2) were unable continue the PTSD assessment, due to their distress, 
and therefore the presence of PTSD as a diagnosis was not confirmed. In relation to 
OCPD, 6% (n=3) of the outpatient sample met DSM-IV criteria for a possible diagnosis 
of OCPD.  
 
An independent sample t-test and Mann-Whitney test was also conducted to examine any 
differences between the clinical characteristics of the comorbid eating disorder and 
anxiety group and the eating disorder only group across the outpatient sample. Due to 
small participant numbers, the subgroups within each of the ED diagnoses were not 
analysed separately. The data presented in Table 8.4 indicates that there were no 
significant differences between the samples where N=50 (p<0.05) for illness duration and 
illness age of onset, BMI, purging episodes per month or use of excessive exercise. There 
was a significant difference between these samples on reported episodes of objective 
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bingeing per month z(N=50) = 2.4, p=0.15, r²=0.1. The mean number of reported 
episodes of bingeing was lower in the comorbid eating disorder and anxiety sample 
(M=9.8, SD=18.4) than in the ED only sample (M=21.9, SD=24.3). For the purpose of 
obtaining sufficient statistical power, a total purgative abuse score was calculated 
comprising the number of people who reported engaging in self induced vomiting as well 
as laxative abuse for both the comorbid eating disorder and anxiety sample and the eating 
disorder only sample. There was no significant difference found between reported 
purgative abuse for both samples.  
 
Due to small participant numbers, no statistical analyses were undertaken to consider the 
differences between anxiety diagnoses amongst the AN, BN and EDNOS diagnostic 
categories.  
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Table 8.3 Current prevalence of anxiety disorders across the outpatient ED sample 
Disorder AN 
(n=6) 
BN 
(n=15)  
EDNOS 
(n=29)  
Whole 
Sample 
(n=50) 
Any Anxiety Disorder  66.6 (4) 60 (9) 51.7 (15) 56 (28) 
Social Phobia 16.6 (1) 33.3 (5) 24.1 (7) 26 (13)  
PTSD 16.6 (1)  13.3 (2) 13.8 (4) 14 (7)  
GAD 33.3 (2)  13.3 (2) 10.3 (3) 14(7) 
OCD 0 (0)  0 (0) 3.4 (1) 2 (1)  
Specific Phobia 0 (0) 0 (0) 0 (0) 0 (0)  
Panic with 
Agoraphobia 
0 (0) 0 (0) 0 (0) 0 (0) 
Panic without 
Agoraphobia 
0 (0) 0 (0) 0 (0) 0 (0) 
ASD 0 (0) 0 (0) 0 (0) 0 (0) 
Note: Values are expressed as the percentage %(n) 
 
Figure 8.2 Prevalence of primary anxiety disorders diagnosed across the outpatient 
ED comorbid sample (N=28)  
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Table 8.4 Summary of clinical characteristics for the comorbid ED and ED only 
groups across the outpatient sample (N=50)  
Characteristic Comorbid ED and AD 
(n=28)  
ED Only  
(n=22)  
AN  
% (n) 
 
14.3 (4) 
 
9 (2)  
 BN  
% (n) 
 
32.1 (9) 
 
27.3 (6)  
EDNOS  
% (n) 
 
53.6 (15) 
 
63.6 (14) 
Duration of ED (Months)  
Mean (± sd) 
 
116 (±86.9) 
 
77.5 (±56.4) 
Onset of ED (Years)  
Mean (± sd) 
 
16.6 (±4.7) 
 
16.95 (±4.8) 
BMI (kg/m²) 
Mean (± sd) 
 
20.4 (±2.7) 
 
20.4 (±3.7) 
Objective binge episodes / month 
Mean (± sd) 
 
9.8 (±18.4)* 
 
21.9 (±24.3) 
Self Induced Vomiting episodes /month 
Mean (± sd) 
 
16.3 (±25.5) 
 
30.6 (±62.5) 
Laxative Abuse 
% (n) 
 
7.1 (2) 
 
0 (0) 
Purgative Abuse Total 
% (n) 
 
57.1 (16) 
 
54.5 (12) 
Excessive Exercise Minutes / day 
Mean (± sd) 
 
32.1 (±50.9)  
 
22.5 (±29.9) 
* P<0.05 v ED only group 
 
8.1.3 Entire Inpatient and Outpatient Eating Disorder Sample   
Regarding anxiety disorder diagnoses, 65% (n= 65) of the entire ED sample (N=100) met 
DSM-IV criteria for a current primary DSM-IV anxiety disorder diagnosis, whilst the 
remaining 35% (n=35) did not. Secondary anxiety disorders were also identified in 34% 
(n=34) of the entire ED sample. Of the secondary anxiety disorders diagnosed, social 
phobia was the most frequent (52.9%, n=18), followed by GAD (29.4%, n=10), OCD 
(8.8%, n=3), panic disorder with and without agoraphobia (5.9%, n=2) and PTSD (2.9%, 
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n=1). Furthermore, subthreshold anxiety disorders were also identified in 15% (n=15) of 
the sample, with subthreshold OCD identified in 5 participants, subthreshold GAD in 4 of 
the participants, subthreshold social phobia, specific phobia and panic disorder with 
agoraphobia were each identified in 2 participants. Table 8.5 shows the current 
prevalence of anxiety disorders in each of the eating disorder subgroups of at least one 
primary anxiety disorder and across the entire inpatient and outpatient sample. Figure 8.3 
shows the frequencies of primary anxiety disorder diagnoses in the comorbid anxiety and 
eating disorder sample.  
 
Of the entire sample (N=100), 32% (n=32) reported having experienced at least one 
trauma in their lifetime. Furthermore, of the women who disclosed having experienced a 
trauma, 18.8% (n=6) were unable continue the PTSD assessment, due to their distress, 
and therefore the presence of PTSD as a diagnosis was not confirmed. In terms of the 
experience of trauma across the eating disorder subtypes, 30.8% (n=12) of AN, 23.8% 
(n=5) of BN and 37.5% (n=15) of the EDNOS participants reported having experienced 
at least one trauma. There were no significant differences found between the reported 
experience of trauma across the ED subtypes. Regarding OCPD, 6% (n=6) of the entire 
sample met DSM-IV criteria for a possible diagnosis of OCPD, and across the eating 
disorder subtypes this included 7.7% (n=3) of the AN sample and 7.5% (n=3) of the 
EDNOS sample.  
 
An independent sample t-test and chi-square analysis was also conducted to examine any 
differences between the clinical characteristics of the comorbid eating disorder and 
anxiety group and the eating disorder only group across the entire inpatient and outpatient 
sample. Due to small participant numbers, the subgroups within each of the ED diagnoses 
were not analysed separately. The data presented in Table 8.6 indicates that there were no 
significant differences between the groups where N=100 (p<0.05) for illness duration and 
illness age of onset, BMI, depression scores, bingeing  and purging episodes per month. 
Using the t-test for unequal variance because of violation of the assumption of 
homogeneity of variance, a statistically significant difference between these groups on 
reported episodes of excessive exercise was found (t(98) = 2.22, p<0.05). The mean 
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number of reported episodes excessive exercise was higher in the comorbid eating 
disorder and anxiety group (M=48.8, SD=78.8) than in the ED only group (M=23.6, 
SD=34.4). For the purpose of obtaining sufficient statistical power, a total purgative 
abuse score was calculated comprising the number of people who reported engaging in 
self induced vomiting as well as laxative abuse for both the comorbid eating disorder and 
anxiety group and the eating disorder only group. Significantly more of the comorbid 
eating disorder and anxiety group reported purgative abuse than the eating disorder only 
group (χ² (1, N=65) = 16.8, p<0.001).    
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Table 8.5 Current prevalence of anxiety disorders across the entire ED sample  
Disorder AN 
(n=39) 
BN 
(n=21)  
EDNOS 
(n=40)  
Whole 
Sample 
(N=100) 
Any Anxiety Disorder  69 (27) 71 (15) 57.5 (23) 65 (65) 
Social Phobia 26 (10) 33 (7) 25 (10) 27 (27) 
PTSD 18 (7) 14 (3) 17.5 (7) 17 (17) 
GAD 15 (6) 24 (5) 10 (4) 15 (15) 
OCD 5 (2) 0 (0) 2.5 (1) 3 (3) 
Specific Phobia 3 (1) 0 (0) 0 (0) 1 (1) 
Panic with 
Agoraphobia 
3 (1) 0 (0) 0 (0) 1 (1) 
Panic without 
Agoraphobia 
0 (0) 0 (0) 1 (1) 1 (1) 
ASD 0 (0) 0 (0) 0 (0) 0 (0) 
Note: Values are expressed as the percentage %(n) 
 
Figure 8.3 Prevalence of primary anxiety disorders diagnosed across the entire 
comorbid ED sample (N=65)  
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Table 8.6 Summary of clinical characteristics of comorbid ED and ED only group 
across the entire ED sample (N=100)  
Characteristic Comorbid ED and AD 
(n=65)  
ED Only  
(n=35)  
AN  % (n) 41.5 (27) 34.3 (12) 
 BN  % (n) 23.1 (15) 17.1 (6) 
EDNOS  % (n) 35.4 (23) 48.6 (17) 
Duration of ED (Months)  
Mean (± sd) 
 
102.6 (±81.96) 
 
76.7 (±65.7) 
Onset of ED (Years)  
Mean (± sd) 
 
17.4 (±5.8) 
 
17.3 (±5.2) 
BMI (kg/m²) 
Mean (± sd) 
 
18.8 (±3.4) 
 
18.9 (±3.96) 
Objective binge episodes / month 
Mean (± sd) 
 
12.4 (±26.7) 
 
17.74 (±22.98) 
Self Induced Vomiting episodes /month 
Mean (± sd) 
 
29.5 (±64.2) 
 
29.31 (±56.2) 
Laxative Abuse 
% (n) 
 
21.5 (14) 
 
0 (0) 
Purgative Abuse Total 
% (n) 
 
75.4 (49)** 
 
45.7 (16) 
Excessive Exercise Minutes / day 
Mean (± sd) 
 
48.8 (±78.8)* 
 
23.6 (±34.4) 
Depression Level  % (n)  
Normal  
Mild – Moderate  
Severe – Ex Severe 
 
10.8 (7)  
26 (17)  
53.8 (35)  
 
25.7 (9)  
37 (13)  
34.3 (12)  
* P<0.05 v ED only group 
** P<0.001 v ED only group 
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An ANOVA was conducted comparing eating disorder symptom levels (BMI, duration of 
illness, onset of eating disorder, number of episodes of bingeing and vomiting an 
excessive exercise use) across participants with different anxiety disorder diagnoses. 
Unfortunately the low subject numbers (n<5) for some of the anxiety disorders (namely 
OCD, specific phobia and panic disorder) means that interpretation of those results is 
problematic due to insufficient statistical power. In any case, the results of these analyses 
were not significant.  
 
Figures 8.4 to Figure 8.8 demonstrate the differences between the anxiety disorders 
across the entire eating disorder sample.  For the purpose of obtaining sufficient statistical 
power, a total purgative abuse score was calculated for eating disorder participants with 
comorbid anxiety. This score comprised the number of people who reported engaging in 
self induced vomiting as well as laxative abuse across the entire ED sample (Figure 8.9 
shows the frequency of purgative abuse across the anxiety disorders). A chi-square 
analysis was performed to establish whether there were differences between purgative 
abuse across each of the anxiety disorder diagnoses. Due to insufficient statistical power, 
analyses were not conducted where the purgative total score was 1 or less, and this was 
the case for Panic Disorder, OCD and Specific Phobia. Results of this analysis revealed 
that there was no significant difference in purgative abuse between individuals with 
social phobia, PTSD and GAD.  
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8.1.4 Outpatient Anxiety Eating Disorder Sample   
In terms of eating disorder diagnoses, 13.5% (n=7) were diagnosed as meeting DSM-IV 
criteria for an eating disorder (EDNOS). Of the participants diagnosed with EDNOS, 
42.8% (n=3) presented with subthreshold BN, 28.6% (n=2) with subthreshold AN and 
28.6% (n=2) with Binge Eating Disorder.  The primary anxiety disorders for which 
participants sought treatment included OCD (n=3), social phobia (n=1), GAD (n=1), 
Specific Phobia (n=1) and PTSD (n=1). Regarding secondary diagnoses, there was only 1 
participant who was diagnosed with a secondary anxiety disorder (social phobia). There 
were no cases of subthreshold anxiety disorders identified in the comorbid anxiety and 
eating disorder group. The experience of at least 1 trauma was reported by 3 of the 
participants, however in only 1 of these cases was a diagnosis of PTSD met.  
 
Due to the small number of participants with eating disorders, further statistical analyses 
and comparisons were not conducted on this group.  
 
8.2 The Temporal Relationship between comorbid Anxiety and Eating Disorders  
Another aim of this study was to investigate the temporal relationship between the onset 
eating and anxiety disorders amongst individuals with comorbid diagnoses. The results 
for this aim have been summarised and presented for the inpatient & outpatient eating 
disorder samples, the entire eating disorder sample and the anxiety disorder sample.  
 
8.2.1 Inpatient Sample  
The majority (64.9%, n=24) of the comorbid anxiety and eating disorder sample reported 
the onset of the anxiety disorder to precede the onset of the eating disorder (see Figure 
8.10 for a summary of percentages for the reported onset of anxiety and eating disorder 
pathology and Table 8.7 for a summary of mean (± sd) length and age of onset for eating 
and anxiety disorders). Table 8.8 displays the mean (± sd) age of onset and range for all 
of the anxiety disorders across each of the eating disorder subtypes.  
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Figure 8.10 Temporal relationship between ED and anxiety disorder onset across 
the inpatient ED comorbid sample (N=37)  
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Table 8.7 Summary of eating disorder and anxiety disorder length and onset across 
the comorbid inpatient ED sample (N=37) 
Parameter  Eating Disorder Anxiety Disorder 
Length of Disorder (Months)  
Mean (± sd)  
 
92.5 (±77.7) 
 
126.6 (±80.5) 
Age of Onset (Years)  
Mean (± sd) 
 
17.95 (±6.5) 
 
15.2 (±9.0) 
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Table 8.8 Age of onset (years) of anxiety disorders across the inpatient ED sample 
Disorder 
AN 
(n=23) 
BN 
(n=6)  
EDNOS 
(n=8)  
Whole Sample 
(n=37) 
Any Anxiety 
Disorder  
15.3 ± 10.1  
(5 – 43)  
11± 3.6 
(6 – 15)  
18 ± 8.1 
(5 – 30)  
15.19 ± 9.0  
(5 – 43) 
Social Phobia 
10.89 ± 4.6  
(5 – 16)  
10 ± 5.7 
(6 - 14)  
20 ± 9.5 
(11 – 30) 
12.71 ±6.7  
(5 – 30) 
PTSD 
18.17 ± 8.7  
(10 – 34)  
10.0 ± 
(10 – 10)   
20 ± 6.2 
(15 – 27) 
17.9 ±7.7  
(10 – 34) 
GAD 
20.5 ± 16.1  
(5 – 43) 
12 ± 3.6 
(8 – 15)  
5.0 ± 0 
(5 – 5)  
15.38 ±12.3  
(5 – 43) 
OCD 
11.5 ± 7.8  
(6 – 17)  
 
- 
 
- 
11.5 ±7.8  
(6 – 17) 
Specific Phobia 
5.0 ± 0 
(5 – 5)  - - 
5.0 ± 0 
(5 – 5) 
Panic with 
Agoraphobia  
35.0 ± 0 
(35 – 35) 
 
- 
 
- 
35.0 ± 0 
(35 – 35) 
Panic without 
Agoraphobia  
 
- 
 
- 
19.0 ± 0 
(19 – 19) 
19.0 ± 0 
(19 – 19) 
ASD 
 
- 
 
- 
 
- 
 
- 
 
 
8.2.2 Outpatient Sample  
 
The majority (75%, n=21) of the comorbid anxiety and eating disorder sample reported 
the onset of the anxiety disorder to precede the onset of the eating disorder (see Figure 
8.11 for a summary of percentages for the reported onset of anxiety and eating disorder 
pathology and Table 8.9 for a summary of mean (± sd) length and age of onset for eating 
and anxiety disorders). Table 8.10 displays the mean (± sd) age of onset and range for all 
of the anxiety disorders across each of the eating disorder subtypes.  
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Figure 8.11 Temporal relationship between ED and anxiety disorder onset across 
the outpatient ED comorbid sample (N=28)  
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Table 8.9 Summary of eating disorder and anxiety disorder length and onset across 
the comorbid outpatient ED sample (N=28) 
Parameter  Eating Disorder Anxiety Disorder 
Length of Disorder (Months)  
Mean (± sd)  
 
116.04 (±86.9) 
 
169.7 (±90.2)  
Age of Onset (Years)  
Mean (± sd) 
 
16.6 (±4.7) 
 
12.3 (±7.2) 
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Table 8.10 Age of onset (years) of anxiety disorders across the outpatient ED sample 
Disorder 
AN 
(n=4) 
BN 
(n=9)  
EDNOS 
(n=15)  
Whole Sample 
(n=28) 
Any Anxiety 
Disorder  
19.5 ± 15.5 
(6 – 40) 
12.7 ± 4.7 
(5 – 17) 
10.1 ± 4.1 
(5 – 18) 
12.3 ± 7.3 
(5 – 40) 
Social Phobia 
6.0 ± 0 
(6 – 6) 
12.6 ± 4.4 
(6 – 17) 
11.9 ± 5.1 
(5 – 18) 
11.7 ± 4.7 
(5 – 18) 
PTSD 
9.0 ± 0 
(9 – 9) 
17.0 ± 0.0 
(17) 
10.0 ± 1.6 
(8 – 12) 
11.86 ± 3.7 
(8 – 17) 
GAD 
31.5 ± 12.0 
(23 – 40) 
8.5 ± 4.95 
(5 – 12) 
7.3 ± 2.5 
(5 – 10) 
14.6 ± 12.8 
(5 – 40) 
OCD - - 6.0 ± 0 
(6 – 6) 
6.0 ± 0 
( 6 – 6 ) 
Specific Phobia - - - - 
Panic with 
Agoraphobia  
 
- 
 
- 
 
- 
 
- 
Panic without 
Agoraphobia  
 
- 
 
- 
 
- 
 
- 
ASD 
 
- 
 
- 
 
- 
 
- 
Note: All values are the Mean ± sd (Range)  
 
 
 
8.2.3 Entire Inpatient and Outpatient Eating Disorder Sample   
The majority (69.2%, n=45) of the comorbid anxiety and eating disorder sample reported 
the onset of the anxiety disorder to precede the onset of the eating disorder (see Figure 
8.12 for a summary of percentages for the reported onset of anxiety and eating disorder 
pathology and Table 8.11 for a summary of mean (± sd) length and age of onset for 
eating and anxiety disorders). Table 8.12 displays the mean (± sd) age of onset and range 
for all of the anxiety disorders across each of the eating disorder subtypes. 
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Figure 8.12 Temporal relationship between ED and Anxiety Disorder Onset across 
the entire comorbid ED sample (N=65)  
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Table 8.11 Summary of eating disorder and anxiety disorder length and onset across 
the entire comorbid ED sample (N=65) 
Parameter  Eating Disorder Anxiety Disorder 
Length of Disorder (Months)  
Mean (± sd)  
102.6 (±81.96) 145.2 (±86.8) 
Age of Onset (Years)  
Mean (± sd) 
17.4 (±5.8) 13.9 (±8.4) 
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Table 8.12 Age of onset (years) of anxiety disorders across the entire ED sample 
Disorder 
AN 
(n=27) 
BN 
(n=15)  
EDNOS 
(n=23)  
Whole Sample 
(n=65) 
Any Anxiety 
Disorder  
15.9 ± 10.8 
(5 – 43)  
12.0 ± 4.2  
(5 – 17) 
16.4 ± 4.9  
(9 – 34) 
13.9 ± 8.4  
(5 – 43) 
Social Phobia 
10.4 ± 4.6 
(5 – 16) 
11.9 ± 4.5  
(6 – 17) 
18.5 ± 5.5 
(12 – 33) 
12.2 ± 5.8  
(5 – 30) 
PTSD 
16.9 ± 8.6 
(9 – 34) 
14.7 ± 4.0 
(10 – 17) 
12.9 ± 1.9  
(10 – 15) 
15.4 ± 6.9  
(8 – 34) 
GAD 
24.2 ± 14.7  
(5 – 43) 
10.6 ± 4.0  
(5 – 15) 
15.0 ± 2.8 
(11 – 17) 
15.0 ± 12.1  
(5 – 43) 
OCD 
11.5 ± 7.8 
(6 – 17) 
 
- 
15.0 ± 0 
(15 – 15) 
9.7 ± 6.4 
(6 – 17) 
Specific Phobia 
5.0± 0 
(5 – 5) 
 
- 
- 
5.0 ± 0 
(5 – 5) 
Panic with 
Agoraphobia  
35.0± 0 
(35 – 35) 
 
- 
 
- 
35.0 ± 0 
(35 – 35) 
Panic without 
Agoraphobia  
 
- 
 
- 
19.0 ± 0 
(19 – 19) 
19.0 ± 0 
(19 – 19) 
ASD 
 
- 
 
- 
 
- 
 
- 
Note: All values are the Mean ± sd (Range)  
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8.2.4 Outpatient Anxiety Eating Disorder Sample   
In terms of the temporal relationship between the onset of the anxiety and eating disorder 
pathology, 5 participants reported the onset of the anxiety to precede the onset of the 
eating disorder, whilst the remaining 2 participants reported the onset of the anxiety to 
have occurred after the onset of the eating disorder. A summary of eating disorder and 
anxiety disorder mean (± sd) length and age of onset can be seen in Table 8.13.  
 
Table 8.13 Summary of eating disorder and anxiety disorder length and onset  
across the outpatient anxiety sample (n=7) 
Parameter  Eating Disorder Anxiety Disorder 
Length of Disorder (Months)  
Mean (± sd)  
147.4 (±105.9) 197.1 (±161.1) 
Age of Onset (Years)  
Mean (± sd) 
19 (±9.9) 14.9 (±9.2) 
 
8.3 Comparisons Across the Comorbid and ED Only Sample 
The final aim of this study was to undertake comparisons across the comorbid sample 
with respect to the frequency of diagnosed anxiety disorders, the temporal onset, age of 
onset, illness duration and EDE scores. We were also interested in exploring potential 
differences on EDE scores across the entire ED sample (comorbid and ED only). 
Although the initial aim also included comparisons between comorbid groups in the 
eating disorder and anxiety sample, the small sample size in the anxiety sample was 
prohibitive in terms of meaningful analyses. Subsequently most of the analyses have only 
included comparison between the inpatient and outpatient samples, except for the EDE 
scores.  
 
8.3.1 Comparison of the frequency of diagnosed anxiety disorders across the ED 
sample  
Chi-square analyses revealed that there was no statistically significant difference in 
diagnosed anxiety disorders between the inpatient and outpatient eating disorder sample, 
χ²(1, N=65)=1.25, p=0.26. Furthermore, analyses were conducted on differences between 
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frequencies of each of the anxiety disorders diagnosed between inpatient and outpatient 
samples, and no statistically significant differences were found. Due to small participant 
numbers, analyses were not conducted on differences between specific phobia, and panic 
disorder with and without agoraphobia. Table 8.14 shows the frequencies of diagnosed 
anxiety disorders between inpatient and outpatient eating disorder groups.  
   
Table 8.14 Current prevalence of anxiety disorders across the inpatient and 
outpatient ED samples (N=100) 
Disorder Inpatient ED 
(n=50) 
Outpatient ED 
(n=50) 
Any Anxiety Disorder  74 (37) 56 (28) 
Social Phobia 28 (14) 26 (13) 
PTSD 20 (10) 14 (7) 
GAD 16 (8) 14(7) 
OCD 4 (2) 2 (1) 
Specific Phobia 2 (1) 0 (0) 
Panic with Agoraphobia 2 (1) 0 (0) 
Panic without Agoraphobia 2 (1) 0 (0) 
ASD 0 (0) 0 (0) 
Note: Values are expressed as the percentage %(n) 
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8.3.2 Comparison between anxiety and eating disorders temporal onset, age of 
onset and illness duration across the Inpatient and Outpatient ED sample 
With alpha set at 0.05, a two way chi-square analysis revealed that there was no statistical 
difference between the temporal relationship of anxiety disorder onset versus eating 
disorder onset between the inpatient and outpatient eating disorder sample, χ²(2, 
N=65)=0.96, p>0.05, Cramer’s V=0.12. Table 8.15 displays the frequencies of reported 
temporal relationship between eating and anxiety disorder across the eating disorder 
sample. Furthermore, a chi-square analysis revealed that there was no statistical 
difference between the temporal relationship between anxiety and eating disorder onset 
across eating disorder subtypes. Table 8.16 displays the frequencies of the reported 
temporal relationships between eating and anxiety disorders across the eating disorder 
subtypes. An independent sample t-test found no significant differences between 
comorbid inpatient and outpatient groups on eating disorder length and age of onset and 
anxiety disorder age of onset. However, a significant difference was found between these 
groups on anxiety disorder length (t(63)=-2.03, p<0.05), with the mean anxiety disorder 
duration in the outpatient group being greater than that of the inpatient sample. Table 
8.17 displays the mean (± sd) of anxiety and eating disorder length and age of onset 
across the inpatient and outpatient comorbid groups. A further chi-square analysis 
comparing the temporal onset of anxiety disorders compared with eating disorders across 
the ED subtypes did not find any statistically significant results (see Table 8.18 for a 
summary of frequencies for temporal onset across the ED sample).   
 
Table 8.15 Temporal relationship of anxiety and eating disorders across the ED 
sample (N=65) 
Temporal Relationship Inpatient Outpatient 
Anxiety before ED 64.9 (24) 75 (21) 
Anxiety same time as ED ª 18.9 (7) 10.7 (3) 
Anxiety after ED ª 16.2 (6) 14.3 (4) 
Note: Values are expressed as the percentage %(n) 
ª Some cells had an expected count less than 5, in these cases a Fisher’s exact significance test was selected 
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Table 8.16 Temporal relationship of anxiety and eating disorders across the ED 
subtypes (N=65) 
Temporal 
Relationship 
AN 
(n=27) 
BN 
(n=15) 
EDNOS 
(n=23) 
Anxiety before ED 77.7 (21) 60 (9) 65.2 (15) 
Anxiety same time as 
ED ª 
11.1 (3) 26.6 (4) 13 (3) 
Anxiety after ED ª 11.1 (3) 13.3 (2) 21.7 (5) 
Note: Values are expressed as the percentage %(n) 
ª Some cells had an expected count less than 5, in these cases a Fisher’s exact significance test was selected 
 
Table 8.17 Summary of eating disorder and anxiety disorder length and onset  
across inpatient and outpatient comorbid samples (N=65)  
Parameter  Inpatient  
(n=37) 
Outpatient  
(n=28) 
Length of Eating Disorder 
(Months)  
Mean (± sd)  
 
92.5 (± 77.7)  
 
116.04 (±86.9) 
Age of Onset Eating Disorder 
(Years)  
Mean (± sd) 
 
17.95 (± 6.5)  
 
16.6 (±4.7) 
Length of Anxiety Disorder 
(Months)  
Mean (± sd)  
 
126.6 (± 80.5)*  
 
169.7 (±90.2) 
Age of Onset Anxiety Disorder 
(Years)  
Mean (± sd) 
 
15.2 (± 9.0) 
 
12.3 (±7.2) 
 
* P<0.05 v Outpatient group 
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Table 8.18 Onset of anxiety disorders relative to the time of onset of eating disorders 
for comorbid ED and anxiety sample (N=65)  
                                                     
                                                  Inpatient  n=37                     Outpatient n=28                Entire Sample N=65 
Anxiety 
Diagnosis  
Temp 
Onset  
AN 
n=23    
BN 
n= 6 
EDNOS 
n= 8 
AN 
n= 4  
BN 
n=9 
EDNOS 
n= 15 
AN 
n=27   
BN 
n=15 
EDNOS 
n=23 
Any 
anxiety 
disorder 
Prior 
Same  
After 
78(18) 
13 (3) 
9 (2) 
67 (4) 
33 (2) 
- 
25 (2) 
25 (2) 
50 (4) 
75 (3) 
- 
25(1) 
56 (5) 
22 (2) 
22 (2) 
87 (13) 
7 (1) 
7 (1) 
78 (21) 
11 (3) 
11 (3) 
60 (9) 
27 (4) 
13 (2) 
65 (15) 
13 (3) 
22(5) 
Social 
Phobia 
Prior 
Same  
After 
35 (8) 
4 (1) 
- 
17 (1) 
17 (1) 
- 
13 (1) 
13 (1) 
13 (1) 
25(1) 
- 
- 
33 (3) 
22 (2) 
- 
40 (6) 
7 (1) 
- 
33 (9) 
4 (1) 
- 
27 (4) 
20 (3) 
- 
30 (7) 
9 (2) 
4 (1) 
PTSD 
Prior 
Same  
After 
22 (5) 
- 
4 (1) 
17 (1) 
- 
- 
- 
13 (1) 
25 (2) 
25(1) 
- 
- 
- 
- 
22 (2) 
20 (3) 
- 
7 (1) 
22 (6) 
- 
4 (1) 
7 (1) 
- 
13(2) 
13 (3) 
4 (1) 
13 (3) 
GAD 
Prior 
Same  
After 
9 (2) 
9 (2) 
- 
33 (2) 
17 (1) 
- 
13 (1) 
- 
- 
25(1) 
- 
25(1) 
22 (2) 
- 
- 
20 (3) 
- 
- 
11 (3) 
7 (2) 
4 (1) 
27 (4) 
7 (1) 
- 
17 (4) 
- 
- 
OCD 
Prior 
Same  
After 
9 (2) 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
7 (1) 
- 
- 
7 (2) 
- 
- 
- 
- 
- 
4 (1) 
- 
- 
Panic with 
AG 
Prior 
Same  
After 
- 
- 
4 (1) 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
4 (1) 
- 
- 
- 
- 
- 
- 
Panic w/o 
AG 
Prior 
Same  
After 
- 
- 
- 
- 
- 
- 
- 
- 
13 (1) 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
4 (1) 
Specific 
Phobia 
Prior 
Same  
After 
4 (1) 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
4 (1) 
- 
- 
- 
- 
- 
- 
- 
- 
ASD  
Prior 
Same  
After 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Note: all values are expressed as the whole percentage % (n)  
ª Some cells had an expected count less than 5, in these cases a Fisher’s exact significance test was selected 
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8.3.3 Summary and comparison of EDE scores across the entire sample  
Scores for the EDE subscales (including restraint concern, eating concern, shape concern, 
weight concern and a global score) were computed for all eating disorder participants 
across inpatient ED, outpatient ED and anxiety outpatient samples. The mean (± sd) 
scores are presented at Table 8.19. An ANOVA was conducted to compare differences 
between each of the groups on EDE scores. Due to the unequal subject numbers, an LSD 
post hoc comparison with p<0.01 was selected. ED inpatients scored significantly higher 
on the restraint concern subscale than the ED outpatients (F(2,104)= 4.25, p=0.01). Anxiety 
disorder participants scored significantly lower on the eating concern subscale than the 
ED inpatients or ED outpatients (F(2,104)= 4.54, p=0.01). Scores for the EDE subscales 
were compared for all eating disorder participants with an anxiety disorder and those 
without an anxiety diagnosis. Anxiety disorder unit participants with eating disorders 
were not included in these analyses. The mean (± sd) scores are presented in Table 8.20. 
No significant differences were found between these scores. Furthermore, a logistic 
regression analysis was conducted to assess whether these five variables significantly 
predicted whether or not an anxiety disorder was diagnosed, however none of these 
variables, either separately or together were found to be significant.  
 
Table 8.19  Summary of EDE scores across the ED sample (N=107) 
                                                                             Eating Disorder Unit  Anxiety Disorder Unit  
EDE Subscales  Inpatient 
(n=50)  
Outpatient 
(n=50)  
ED Only 
(n=7)  
Restraint Concern  
Mean (± sd) 
 
4.5 (± 0.9)* 
 
3.9 (± 1.1) 
 
3.7 (± 1.0) 
Eating Concern  
Mean (± sd) 
 
3.9 (± 1.1) 
 
3.9 (± 1.3) 
 
2.5 (± 1.4)§ 
Shape Concern 
Mean (± sd) 
 
4.4 (± 1.6) 
 
4.6 (± 1.2) 
 
3.97 (± 0.8) 
Weight Concern  
Mean (± sd) 
 
4.2 (± 1.6) 
 
4.6 (± 1.1) 
 
3.6 (± 0.6) 
Global Score  
Mean (± sd) 
 
4.3 (± 0.97) 
 
4.2 (± 1.0) 
 
3.5 (± 0.6) 
* P<0.01 v ED Outpatient group 
§ P<0.01 v ED Inpatient & Outpatient group 
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Table 8.20  Summary of EDE scores across the Comorbid ED and ED only groups (N=100) 
EDE Subscales  Comorbid ED and AD 
(n=65) 
ED only 
(n=35) 
Restraint Concern  
Mean (± sd) 4.3 (± 1.1) 4.0 (± 0.96) 
Eating Concern  
Mean (± sd) 3.9 (± 1.1) 3.8 (± 1.3) 
Shape Concern 
Mean (± sd) 4.6 (± 1.2) 4.5 (± 1.3) 
Weight Concern  
Mean (± sd) 4.4 (± 1.4) 4.4 (± 1.4) 
Global Score  
Mean (± sd) 4.3 (± 0.99) 4.2 (± 1.0) 
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CHAPTER 9 
DISCUSSION 
 
This final chapter provides an overview of the current study and discusses the results in 
relation to the previously outlined objectives and hypotheses. The results are also 
compared to the findings of several key papers in this area, including Godart et al. (2000), 
Godart et al. (2003), Black-Becker et al. (2004) and Kaye, Bulik, Thornton, Barbarich, 
Masters & the Price Foundation Collaborative Group (2004). The strengths and 
limitations of the current study as well as directions for future research are also discussed.  
 
9.1 Research Overview 
A thorough review of the literature revealed that the prevalence of anxiety disorders 
amongst individuals with eating disorders is high. Furthermore, many studies reported 
that the onset of an anxiety disorder tended to predate the onset of eating disorder 
pathology, which suggested that anxiety may play an important role in the etiology of 
eating disorders. That led some researchers to speculate that childhood anxiety may 
represent one important genetically mediated pathway towards the development of an 
eating disorder.  
 
Unfortunately, much of the available research in this area has been plagued with 
methodological limitations. These limitations may account for the striking variability in 
prevalence rates of anxiety and eating disorder comorbidity reported in the literature. The 
presence of such limitations certainly limit the usefulness of research findings, which is 
of concern given the potential value that this research has in furthering the assessment 
and evidence-based treatment procedures for eating disorders.  
 
Similarly, despite the recent interest in the comorbidity between eating and anxiety 
disorders, few studies have investigated the prevalence of eating pathology amongst 
individuals presenting for treatment of an anxiety disorder. This has led some researchers 
to suggest that eating pathology may be going unidentified and thus untreated in 
specialist anxiety treatment units.  
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As discussed in previous chapters, the interest in anxiety and eating disorder comorbidity 
has stemmed from the suggestion that anxiety may not only play a role in the etiology of 
eating pathology, but also in the maintenance of eating disorders. In particular, this link 
has been made between PTSD and eating pathology, whereby recurrent bingeing  and 
purging behaviours assist with the blocking out and avoidance of intrusive, painful 
memories. This suggestion is strengthened by the research reporting that trauma is a non-
specific risk factor for the development of an eating disorder. However, despite this, 
many of the investigations into the prevalence of anxiety disorders amongst patients with 
eating disorders have failed to include an assessment of PTSD or the experience of 
trauma. One may speculate therefore, that where an individual’s eating disorder serves to 
minimize anxiety symptoms, the treatment of eating pathology in the absence of 
addressing anxiety symptoms, may render treatment ineffective.  
 
As previously highlighted, much of the research into anxiety and eating disorder 
comorbidity has tended to focus heavily on several of the anxiety disorders, namely OCD 
and social phobia. Studies investigating the prevalence of OCD have generally found 
extremely high rates amongst individuals with eating disorders, particularly AN. Given 
the low prevalence rates of OCD reported in the community (between 0.5 – 2.5%; 
American Psychiatric Association, 2000), it is necessary to consider whether the 
diagnosis of obsessive and compulsive symptoms in the eating disorders is reflective of a 
true OCD as opposed to symptoms directly related to the eating pathology or secondary 
to malnutrition. Unfortunately in some instances, the research has failed to demonstrate 
that it has adequately drawn this distinction.  In particular, it is often unclear whether a 
distinction has been made between ego-syntonic and ego-dystonic obsessive and 
compulsive symptoms. Given the research indicating high rates of OCPD amongst 
individuals with eating disorders, this further complicates the picture, and again 
highlights the importance of utilising assessment measures and procedures that will 
clearly distinguish between OCD, OCPD and obsessions and compulsion either related to 
the eating pathology or secondary to malnutrition. In this regard, a semi-structured 
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interview may be useful as it enables clinicians to use their own clinical judgment to 
determine whether diagnoses are met, and to ask further questions if necessary. 
 
It is these considerations that led to the development of the current research. To the 
author’s knowledge, this is the first and largest study of its kind to be conducted on an 
Australian clinical population. There are also few studies worldwide that have 
investigated all anxiety disorders across all the eating disorder subtypes, as most exclude 
EDNOS diagnoses, and many exclude one or more of the anxiety disorders. As 
previously discussed, the EDNOS diagnostic category was included in the DSM-IV as a 
residual eating disorder category, however the research to date indicates that many 
individuals with eating disorders now fall into this category. Consequently, exclusion of 
such individuals may result in an inaccurate representation of the eating disorder clinical 
population. The less stringent exclusion criteria employed in the current study may mean 
that the present results are more clinically relevant than previous studies in this area.  
 
There were several objectives of the current study. The first aim was to investigate the 
prevalence of anxiety disorders amongst an inpatient and outpatient eating disorder 
sample, using well standardized measures to assess for all of the DSM-IV anxiety 
disorders and confirm diagnoses. The second aim was to clearly establish the temporal 
relationship between the onset of comorbid eating and anxiety disorders. The final aim 
was to investigate the prevalence of eating pathology amongst an outpatient anxiety 
disorder sample, and investigate the temporal relationship between the two disorders.   
 
9.2 Summary and Interpretation of the Results  
Our objective, to investigate the prevalence between comorbid anxiety and eating 
disorders, was achieved. The researchers hypothesized that anxiety disorders would be 
prevalent amongst our eating disorder sample, and this was supported. Our findings 
confirm the high prevalence of anxiety and eating disorders amongst both inpatient and 
outpatient eating disorder samples, and across all eating disorder subtypes. Furthermore, 
our results are consistent with previously published research in this area notwithstanding 
the methodological limitations inherent in many of these studies. The current study found 
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high rates of anxiety comorbidity amongst the eating disorders, comparable to previous 
studies in this area. Given that our study investigated all 8 of the DSM-IV anxiety 
disorders, compared with other studies, many of which included only  4-5 diagnoses, it is 
not surprising our rates are high. We found 74% of our inpatient ED sample and 56% of 
our outpatient ED sample met criteria for at least one anxiety disorder, and this difference 
did not reach statistical significance. Across the entire ED sample, 65% met criteria for at 
least one anxiety disorder, for AN 69%, for BN 71% and for EDNOS 57.5%. In a study 
conducted on an Australian community sample of 10,641 adult males and females, 12 
month prevalence of any anxiety disorder was 5.6% (Andrews et al, 2001). Across the 
female adult sample, the 12 month prevalence rate increased to 12.1% (Australian Bureau 
of Statistics, 1997). 
 
Although we anticipated finding a greater prevalence of anxiety disorders amongst the 
inpatient ED sample compared with the outpatient sample, the difference was not 
significant. Furthermore, the inpatient and outpatient samples did not differ significantly 
except in regards to reported antidepressant medications (higher in the inpatient sample), 
BMI (lower in the inpatient sample) and laxative abuse (greater in the inpatient sample). 
These differences are not surprising given the well documented observations that 
inpatient ED samples have a greater severity of symptoms than outpatient samples. 
Although depression scores were not significantly different between the inpatient and 
outpatient samples, this may be explained by the fact that the inpatient sample reported a 
higher frequency of prescribed antidepressant medications than the outpatient sample, 
thus perhaps reducing their depression scores in the preceding 7 days. It should be noted 
that as a clinical assessment for a mood disorder was not conducted, comorbid depression 
could not be confirmed across the sample.  
 
In respect of differences across the eating disorder subtypes for the entire sample, not 
surprisingly, the AN sample had significantly lower BMI scores than those in the BN or 
EDNOS samples. This is to be expected given that most of the participants with AN were 
in the inpatient sample. The EDNOS sample also reported a statistically greater amount 
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of excessive exercise use than those in the AN or BN sample.  No other significant 
differences were found amongst the ED subtypes.  
 
In terms of anxiety disorder diagnoses, 65% of the entire ED sample (74% of the 
inpatient ED sample and 56% of the outpatient ED sample) met DSM-IV criteria for a 
current primary DSM-IV anxiety disorder diagnosis. Similar rates of anxiety disorders 
were also observed across all the ED subtypes (69% of the AN sample, 71% of the BN 
sample and 57.5% of the EDNOS sample). A significant proportion of the sample also 
met criteria for secondary anxiety disorders (42% of the inpatient sample, 26% of the 
outpatient sample and 34% of the entire ED sample). Subthreshold anxiety disorders 
were also identified in 12-18% of the entire sample. It is important to note that our 
diagnoses excluded any possible anxiety symptoms related to the eating pathology. For 
example, in social phobia, a fear of eating and drinking in public, and in GAD, any 
excessive, uncontrollable worry related to food, weight or shape, or secondary to the 
eating disorder, such as health concerns as a result of the ED, were not considered to be 
part of an anxiety disorder.  
 
The research objective to explore the temporal relationship between the onset of eating 
and anxiety pathology was also achieved. Regarding the temporal onset of anxiety 
disorders, the majority (65%) of the inpatient sample and outpatient sample (75%) 
reported the onset of the anxiety disorder to precede the onset of the eating disorder. For 
the overall ED sample 69% reported the onset of the anxiety disorder to precede the onset 
of the eating disorder. In terms of eating disorder subtypes, the majority of the AN (78%), 
BN (60%) and EDNOS (65%) samples reported the onset of the anxiety disorder to 
proceed the onset of the eating disorder, and there was no significant difference found 
between the subtypes. These results are commensurate with those obtained in other 
studies investigating the temporal relationship between eating disorders and anxiety 
disorders (Toner et al., 1988; Brewerton et al., 1995; Bulik et al., 1996; and Godart et al., 
2000). 
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The research objective to identify which of the anxiety disorders was most prevalent was 
also achieved. As expected, the prevalence of social phobia was particularly high across 
the entire sample (42%) and across all ED subtypes. In fact, it was the most commonly 
diagnosed anxiety disorder across the entire sample (Inpatient: 38%; Outpatient 46%) and 
all ED subtypes (AN: 26%; BN: 33%; EDNOS: 25%). It must be noted that these 
diagnoses excluded any reported fears of eating or drinking in public or fears related to 
weight or shape concerns. Interestingly, this is up to 15 times higher than the 12 month 
prevalence rate for social phobia (3%) from a large Australian adult female community 
sample (Australian Bureau of Statistics, 1997). Our findings for AN tend to be on a par 
with those reported by Kaye, Bulik, Thornton, Barbarich, Masters & the Price Foundation 
Collaborative Group (2004), Laessle et al. (1987); Laessle et al. (1989) and Herpertz-
Dahlman (1996). Our findings for BN are consistent with social phobia rates reported by 
Laessle et al. (1987) and Bulik et al. (1996).    
 
The diagnosis of PTSD was also particularly high across the entire sample (26%), with 
just over a quarter of inpatients (27%) and 25% of the outpatients meeting criteria. Rates 
for PTSD across the ED subtypes were also comparable (AN: 18%; BN: 14%; EDNOS 
17.5%). This finding is particularly interesting given that PTSD has so frequently been 
excluded from previous studies. Furthermore, this prevalence rate is likely to be an 
underestimate of the true rates of PTSD given that almost 19% of women who reported 
having experienced a trauma were unable to continue the assessment due to their distress. 
This rate is up to 6 times higher than the 12 month prevalence rate (4.3%) of an 
Australian adult female community sample (Australian Bureau of Statistics, 1997).  
Notwithstanding the few available studies investigating PTSD in ED samples, our 
findings are comparable to those PTSD rates reported for AN, BN and EDNOS 
participants in the study by Turnbull et al. (1997).  There were no diagnoses of ASD 
across the entire sample. 
 
The diagnosis of GAD was also high amongst the entire ED sample (23%), with fairly 
similar rates being reported across the inpatient (22%) and outpatient (25%) samples and 
ED subtypes (AN: 15%; BN: 24%; EDNOS 10%). Our findings for GAD amongst our 
 203 
AN and BN sample are slightly higher than those reported by Kaye, Bulik, Thornton, 
Barbarich, Masters & the Price Foundation Collaborative Group (2004), however our 
findings for the EDNOS sample were comparable to that study. Our findings regarding 
rates of GAD across this sample is up to 6 times higher than the 12 month prevalence rate 
(3.7%) of an Australian adult female community sample (Australian Bureau of Statistics, 
1997). 
 
Interestingly, we found relatively low rates of Panic Disorder with and without 
Agoraphobia across the entire ED sample (3%) compared with those rates reported by 
Godart et al. (2000). Our findings are comparable to those reported by Lilenfeld et al. 
(1998) of 4% across their AN and BN sample. One reason for our low rates of reported 
panic disorder, was that we consistently excluded any panic symptoms related to food, 
weight or shape concerns. It was noted that most of the sample reported experiencing 
panic attacks, however upon further questioning in many cases they denied fearing the 
symptoms or future panic attacks, as would be expected for a diagnosis of panic disorder. 
Furthermore, Agoraphobia was not diagnosed if fears were related to food related 
situations (supermarkets, food courts etc) in the absence of fear about the actual 
symptoms. Our rates of Panic Disorder across the ED sample are comparable to the 12 
month prevalence rate (2%) of an Australian adult female community sample (Australian 
Bureau of Statistics, 1997). 
  
Similarly low rates of specific phobias were also reported across the entire sample (2%), 
which was surprising given the previously reported rates of between 12 – 45% for AN 
and 12 – 46% for BN (Hudson et al., 1983; Laessle et al., 1987; Lilenfeld et al., 1998; 
Godart et al., 2000). Our findings were comparable to those of an earlier study by Piran et 
al. (1985) of rates of phobias of between 0 – 3% across their AN and BN sample.   
 
Of interest were the rates of OCD found in our study. It was hypothesized that we would 
also find OCD to be prevalent amongst our sample, however this was not supported. In 
contrast to a number of previous studies reporting high rates of OCD amongst ED 
samples, we found only 5% of our entire ED sample met criteria for OCD. OCD rates did 
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not differ significantly across inpatient (5%) and outpatient (4%) samples. Most of the 
OCD cases were identified in the AN group (5%) and there was one diagnoses of OCD in 
the EDNOS sample (2.5%).  Interestingly, we did not find a single case of OCD amongst 
the inpatient or outpatient BN sample. Previous studies have reported rates of OCD for 
AN between 9.5 – 69% (Hudson et al., 1983; Piran et al., 1985; Laessle et al., 1987; 
Laessle et al., 1989; Fornari et al., 1992; Thornton & Russell, 1997; Godart et al., 2000; 
Iwasaki et al., 2000; Speranza et al., 2001; Milos et al., 2002; Godart et al., 2003; Kaye, 
Bulik, Thornton, Barbarich, Masters & the Price Foundation Collaborative Group, 2004), 
however our reported rate for AN is lower still. Furthermore, when considering the rate 
of OCD amongst AN (37%) reported in another Australian study (Thornton & Russell, 
1997), our rates appear extremely low. One explanation for this would be that previous 
studies may have over diagnosed rates of OCD, perhaps including obsessive and 
compulsive symptoms that are related to eating disorder pathology as opposed to true 
OCD diagnosis.  
 
Another possibility for this difference, given our reported rates of possible OCPD (6%), 
is that symptoms potentially related to obsessive compulsive personality constructs may 
have been diagnosed as OCD. Studies investigating the prevalence of OCPD amongst 
eating disorder samples have reported rates of between 3 – 83% (Kasvikis et al., 1986). 
Caution must be applied to the observation of OCPD in our study, given that no formal 
measures to assess for OCPD diagnoses were employed. Prevalence rates of OCPD in 
community samples are estimated to be around 1%, whilst estimates in mental health 
settings vary between 3 – 10% (American Psychiatric Association, 2000).  
 
Our findings for OCD prevalence rates amongst our BN and EDNOS sample are 
comparable to the lowest rates presented in previous studies. Studies investigating the 
prevalence of OCD amongst BN samples have reported between 0 – 44% (Hudson et al., 
1983; Piran et al., 1985; Laessle et al., 1987; Laessle et al., 1989; Fornari et al., 1992; 
Thornton & Russell, 1997; Lilenfeld et al., 1998; Godart et al., 2000; Speranza et al., 
2001; Milos et al., 2002; Kaye, Bulik, Thornton, Barbarich, Masters & the Price 
Foundation Collaborative Group, 2004). Furthermore, our rates of OCD across the BN 
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and EDNOS sample are comparable to the 12 month prevalence rate (0.4%) of an 
Australian adult female community sample (Australian Bureau of Statistics, 1997). 
 
Previous retrospective studies determining age of onset of psychiatric diagnoses have 
faced criticism as the reliability of the data based on participants’ recall may be 
questionable. Further, there are often inconsistencies in the determination of the age of 
onset, which sometimes refers to the age when the first symptom occurred and sometimes 
to the age when all criteria for the disorder were met (Wittchen & Essau, 1993). In the 
current study we recorded the earliest age of onset for a number of anxiety disorders as 5 
years of age1
For the entire ED sample, the average age of onset for any anxiety disorder was almost 
14 years compared with just over 17 years for the onset of the eating disorder pathology. 
, in line with previous research in this area (Kaye, Bulik, Thornton, 
Barbarich, Masters & the Price Foundation Collaborative Group, 2004), and only 
diagnosed onset when all criteria for the disorder were met.  
 
In the inpatient sample, the average age of onset for the anxiety disorders was 15 years 
compared with almost 18 years for the onset of the eating disorder pathology. This was 
slightly lower for the outpatient sample, with the average age of onset for the anxiety 
disorder being 12 years compared with almost 17 years for the onset of the eating 
disorder pathology. Although there was no significant difference between age of onset for 
anxiety disorder pathology for each of the specific anxiety disorders across the inpatient 
and outpatient samples, social phobia in the inpatient sample had a mean age of onset of 
just over 12 years, followed by GAD at 15 years and PTSD at almost 18 years. The mean 
age of onset for panic disorder (with and without agoraphobia) was 27 years, however 
there were only 2 participants diagnosed in this group. For the one participant diagnosed 
with specific phobia, age of onset was recorded at 5 years of age. For the outpatient 
sample, social phobia and PTSD had a mean age of onset of almost 12 years, followed by 
GAD at almost 15 years.  
 
                                                 
1 As discussed in section 6.5.3, the age of onset was set at 5 years of age when participants reported that the onset of the anxiety disorder was “for as long 
as I could remember”.  This was based on the assumption that childhood recollections may be limited prior to this age, in line with previous research in 
this area (Kaye, Bulik, Thornton, Barbarich, Masters & the PFCG, 2004). 
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Although there was no significant differences between age of onset of anxiety disorder 
pathology for each of the specific anxiety disorders across the entire sample, social 
phobia had a mean age of onset of just over 12 years, GAD had a mean age of onset of 15 
years and PTSD had a mean age of onset of just over 15 years. Although rates of OCD 
were small, the mean age of onset was just under 10 years of age. In respect of age of 
onset of anxiety disorders across the eating disorder subtypes, there were no significant 
differences found. The age of onset for each of the anxiety disorder diagnoses for 
participants with AN was just over 10 years of age for social phobia, almost 17 years of 
age for PTSD and just over 24 years of age for GAD. Although the prevalence rate for 
OCD was low, the mean age of onset was 11.5 years of age. For BN, the mean age of 
onset for social phobia was almost 12 years, for GAD the mean age was almost 11 years 
and for PTSD the mean age was almost 15 years. For EDNOS the mean age of onset for 
social phobia was 18.5 years, for GAD it was 15 years and for PTSD, almost 13 years of 
age.  
 
Finally, one of our hypotheses was that comorbid anxiety and eating disorder groups 
would differ from ED only groups in terms of clinical characteristics and severity of 
symptoms. In line with this hypothesis, we found that significantly more of the inpatient 
comorbid eating disorder and anxiety sample reported purgative abuse than the eating 
disorder only sample. This is consistent with previous findings confirming increased 
vomiting (Carter & Duncan, 1984) and laxative abuse (Weltzin, Bulik, McConaha & 
Kaye, 1995) amongst individuals with comorbid anxiety and eating pathology. 
Furthermore, across the entire ED sample, the mean number of reported episodes of 
excessive exercise was higher in the comorbid eating disorder and anxiety group than in 
the ED only group. Although there is an absence of research into the use of excessive 
exercise amongst individuals with ED and comorbid anxiety disorders, one might 
hypothesise that exercise could be used in a similar manner to other avoidance or self 
harm behaviours, that enable an individual to regulate affect.   
 
Surprisingly, amongst the outpatient sample, a greater number of reported episodes of 
objective binge eating was found in the ED only sample compared with the comorbid 
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anxiety and ED group. Although this difference only just met significance, it is 
nevertheless surprising given the literature suggesting that increased levels of bingeing 
behaviour have been observed in individuals with comorbid anxiety.  
 
These results must be interpreted with caution, due to the fact that our comorbid anxiety 
and eating disorder only groups contained individuals with AN, BN and EDNOS 
diagnoses. Thus, any significant differences in clinical ED symptoms (such as bingeing 
and purging) could be attributed to their ED diagnosis, and not necessarily to the 
presence or absence of anxiety pathology. In an attempt to control for this, we calculated 
individual EDE scores to compare eating pathology between comorbid and ED only 
groups. More recently, treatment for eating disorders has emphasised a transdiagnostic 
approach and, there have been some suggestions that research investigating anxiety 
presentations irrespective of eating disorder diagnosis may assist in broadening our 
current understanding of comorbidity between anxiety and eating disorders (Pallister & 
Waller, 2008).  
 
The rationale for investigating EDE scores across the groups was to eliminate the 
possibility that severity of eating pathology, as indicated by BMI, binge purge and 
exercise behaviours, may have been influenced by eating disorder diagnoses and 
therefore any differences could not reliably be attributed to the presence or absence of an 
anxiety disorder diagnosis. Furthermore, rather than conducting a series of analyses and 
increasing the possibility of committing a type I error, logistic regression was used to 
investigate whether any of the scores on the EDE subscale significantly predicted 
whether or not an anxiety disorder was diagnosed.  We found that none of these 
variables, either separately or together were found to be significant. Although it has 
previously been suggested that individuals with comorbid diagnoses display more severe 
clinical symptomatology, our findings, based on the EDE scores, did not support this.  
  
In relation to the rates of eating disorder pathology amongst the outpatient anxiety 
sample, we found that 13.5% of the sample met criteria for EDNOS, which included 
diagnoses of subthreshold AN, subthreshold BN and BED. It must be noted that this rate 
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may be an underestimate as 3 participants identified as having potential eating pathology 
were unable to be assessed further to confirm an eating disorder diagnosis. Unfortunately 
there is not a comparable Australian community sample to compare these rates with. 
However, our findings are comparable to the 12% of probable eating disorder cases 
reported by Black Becker et al (2004). Furthermore, our findings are far higher than the 
0.5% - 4% prevalence of AN, BN and BED reported in other studies (Wilfley, Agras, 
Telch, Rossiter, Schneider, Cole, Sifford & Raeburn, 1993; Hsu, 1996; Wilson & Pike, 
2001).  
 
The presentation of a range of anxiety diagnoses in our anxiety patient sample inhibits 
inferences being drawn regarding the prevalence of eating pathology amongst the specific 
anxiety disorders. Nevertheless, our findings are indicative of the presence of significant 
eating pathology amongst women presenting for anxiety treatment. A larger sample size 
across each of the anxiety disorder categories would improve statistical power and would 
potentially enable inferences to be drawn regarding the differences in clinical eating and 
anxiety symptoms between the anxiety participants with comorbid eating disorders and 
the eating disorder groups with comorbid anxiety.  
 
9.3 Recruitment and assessment procedures 
One of the difficulties faced in conducting this study was in terms of recruitment of 
participants. At one of the inpatient recruitment sites, only 3 (16%) of the 18 patients 
approached consented. The main reason for refusal was that patients were already 
involved in a number of research projects being undertaken in the unit. Subsequently it 
was decided to cease recruitment at this site due to concerns that the sample would not be 
sufficiently representative of the inpatient population. Furthermore, across all the sites 
many of the patients had already completed a number of questionnaires for other research 
studies and were therefore disinclined to participate in further research. In hindsight, 
collaboration with other researchers to share common assessment measures may have 
reduced the burden on participants and thus increased willingness to participate.  
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In addition, the lengthy nature of the assessment procedure in the current study (between 
1.5 – 4 hours) may have discouraged potential participants. At initial stages in this study, 
a package of self-report questionnaires, including the EDI-3, DASS-21 and several 
anxiety measures (discussed in previous chapters) were also given to participants to 
complete. Unfortunately, after completing 30 assessments, the response rate for the 
participants completing the full set of measures was less than 60%, with a number of 
participants failing to complete these prior to discharge from hospital.  Subsequently, the 
ANSOCQ, EDBQ & Anxiety self –report measures were excluded from the study. 
Feedback from participants also suggested that following participation in such a lengthy 
assessment interview, they were less inclined to spend up to an additional 1 hour 
completing self-report questionnaires, particularly as they had already completed some of 
these same questionnaires for other research studies. Subsequently the researchers 
decided to eliminate all questionnaires except for the DASS-21 (which could be 
completed in 5 minutes following the assessment) and the EDI-3 (which they could 
return at a later date). It is unlikely that discontinuing these questionnaires would have 
had any affect on the results, as the participants who completed the full set of measures, 
did so following the assessment interview. However, had we not discontinued these 
questionnaires, it is likely that participation would have been substantially affected. 
Furthermore, given that participants who were recruited from inpatient units were 
disinclined to complete the full set of questionnaires, it is likely that outpatients would 
have been even less likely to complete them.  
 
Although the researchers were interested in comparing EDI-3 results across the sample, 
the low completion rate for this questionnaire (< 40%) hindered adequate numbers for 
final analysis, and was subsequently excluded. Given the primary aim of the current 
research was to complete thorough assessments for both eating and anxiety pathology to 
determine diagnosis, the additional self-report measures (with the exception of the 
DASS-21 to assess depressive symptomatology) placed an unnecessary burden on 
participants.  
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9.4 Strengths of the current research  
A significant strength of the current study is that, to the best of the author’s knowledge, it 
is the first study of its kind to investigate anxiety and eating disorder comorbidity across 
an inpatient and outpatient eating disorder sample (including all ED diagnoses) as well as 
across an anxiety disorder sample (including all Anxiety diagnoses). It is also the largest 
study of its kind to be conducted on an Australian clinical population. Furthermore, the 
use of well standardised, internationally accepted diagnostic instruments for the 
assessment of anxiety and eating pathology is also a significant strength, as it has avoided 
the methodological limitations of previous research failing to employ adequate 
assessment measures.  
 
An unpublished study investigating the same inpatient eating disorder population as 
included in the current study found rates of diagnosed anxiety disorders in only 14% of 
patients, based on the admission assessment notes (Dean, 2006). This same study 
reported a higher rate of diagnosed mood disorders, with 38% of the sample meeting 
criteria for major depressive disorder and 14% meeting criteria for a subthreshold mood 
disorder (Dean, 2006). This is despite the current study finding a rate of 74% of any 
anxiety disorder diagnosis in the same population. This indicates that current eating 
disorder assessment procedures may focus primarily on eating and mood disorder 
pathology, perhaps only including an anxiety diagnosis if the symptoms are obvious. This 
is not surprising given the focus in the literature on comorbidity of mood disorders 
amongst individuals with eating disorders. However the research also suggests that a 
comorbid anxiety disorder may be related to poorer treatment response and outcomes in 
individuals with eating pathology.  Thus, a strength of the present research is in 
highlighting not only the prevalence of eating and anxiety comorbidity but the need for 
conducting a thorough assessment of anxiety disorders and establishing the temporal 
relationship between both disorders. It is also clear from this and previous research that a 
thorough understanding of the etiological and maintaining factors of eating pathology is 
crucial for developing a formulation and framework for treatment.  
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This study has also met its objective of identifying which anxiety disorders are most 
prevalent in an eating disorder population. In contrast to much of the previous research in 
this area, the current study assessed for all DSM-IV anxiety disorders. Consistent with 
previous research, social phobia was the most prevalent of the anxiety disorders. 
Interestingly, PTSD and GAD were also prevalent, despite often being excluded from 
assessment in other research. This research also sought to understand the relationship 
between OCD and eating disorders, and found that in contrast to many previous studies, 
OCD was not prevalent in the current sample. What was extremely clear from conducting 
the current research, was that many of the participants reported obsessions and 
compulsions, however these were, in the majority of cases, determined to be directly 
related to the eating disorder pathology, or a possible indication of personality traits 
consistent with a diagnosis of OCPD. A key difference between the obsessions and 
compulsions reported by participants with and participants without a diagnosis of OCD 
(excluding those purely related to food, shape and weight) was that for many, the 
obsessions and compulsions were ego syntonic. In this regard, many reported that they 
did not find the obsessions and compulsions distressing. Indeed, they found them helpful. 
This is in clear contrast to the typically distressing, time consuming and ego dystonic 
obsessions and compulsions reported in OCD.  The current study has clearly identified 
this difference.  
 
The few exclusion criteria the present research employed in recruitment of participants, 
was also a significant strength. All patients who were well enough to attend the 
assessment were included in this study. The only patients excluded from the present study 
were those with serious medical complications as a result of their eating disorder, or 
those who were acutely suicidal. Consequently, the current sample provides a good 
representation of the type of patients treated at the inpatient and outpatient units included 
in this study. While the inclusion of participants with all DSM-IV eating disorder 
diagnoses (except binge eating disorder in the eating disorder sample), varying treatment 
histories and duration of illness length, enables a greater generalization of the results. 
Furthermore, this study did not exclude participants with other comorbid conditions, such 
as alcohol abuse or personality disorders, due to the recognition that often individuals 
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with anxiety disorders will also have additional comorbid diagnoses. It is hoped that the 
less stringent exclusion criteria utilised in this study will increase the clinical efficacy of 
the current results.  
 
A final strength of this research was that only the author conducted all of the assessments 
on participants presenting with an eating disorder or potential eating disorder. Apart from 
fewer than 15 ADIS-IV assessments conducted on the anxiety sample (only those without 
possible or comorbid eating pathology), the author conducted all assessments on anxiety 
participants as well. This increased the likelihood that the assessments were conducted in 
a consistent manner, eliminating potential difficulties associated with clinician variables.   
 
9.5 Limitations of the current research  
Besides the absence of a community control group, there are a number of limitations 
which can be raised regarding the current research which are identified below.  
 
There were difficulties with participants completing self-report questionnaires. In the 
initial phase of the study, a number of additional self-report questionnaires examining 
eating and anxiety symptomatology were also included. At an early stage it became clear 
that there were far too many for participants to complete, and subsequently, these were 
excluded from the study. Furthermore, across the entire sample, completion rates for the 
EDI-3 were also low. There were several possible reasons for this including the time 
consuming nature of the assessment interview (between 1.5 – 4 hours), many participants 
already participating in other research projects requiring the completion of either the 
EDI-2 or the EDI-3, and therefore being less motivated to complete it again, and the 
researcher was unable to ask participants to complete the EDI-3 at the time of the 
interview due to the lengthy nature of this questionnaire. Participants were asked to return 
the questionnaire at a later date, and subsequently, motivation to do this was possibly 
low. In hindsight, collaborating with the other researchers to avoid overlapping 
questionnaires, may have increased completion rates. The information gained from these 
questionnaires would have been extremely valuable, especially with regards to symptom 
severity.  
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Participants were not followed up over time to assess anxiety symptoms post treatment. 
After commencing this study, we thought it would be interesting to investigate this 
aspect, by following up participants 6 months post assessment, to reassess anxiety and 
eating disorder symptomatology. Unfortunately, as we had not initially sought consent 
from participants to do this, it proved too difficult to obtain consent at a later stage, as 
many of the participants were either uncontactable, or did not consent to follow up. This 
is clearly an area for potential research in the future.  
 
The objectives of this study did not set out to include an analysis of differences of 
reported anxiety disorders amongst the eating disorder subtypes, nevertheless had the 
subject numbers been higher in each of these groups, this would have been an interesting 
analysis to consider. The fewer number of BN participants in the inpatient sample was 
not surprising, as individuals with BN are more likely to be treated in an outpatient 
setting. Furthermore, the higher number of EDNOS diagnoses (almost double) compared 
with BN diagnoses in the outpatient setting appears consistent with previous research 
reporting that EDNOS is the most frequently diagnosed of the eating disorder subtypes in 
outpatient settings (Martin et al., 2000; Ricca et al., 2001; Turner & Bryant-Waugh, 
2004).  
 
The researchers also chose to report the age at onset as the age at which all criteria for a 
DSM-IV anxiety or eating disorders were met. In some cases, individuals may have 
demonstrated subthreshold diagnoses at earlier ages. The present study also investigated 
the current diagnoses of eating and anxiety pathology. An investigation of lifetime 
diagnoses may have yielded higher prevalence rates, and this would have been an 
interesting investigation in terms of lifetime eating disorder diagnoses amongst the 
anxiety sample.  
 
The current study did not incorporate a measure to formally assess for OCPD. 
Unfortunately the decision to assess for possible DSM-IV OCPD diagnoses was decided 
after the study had commenced. Nevertheless, when possible OCPD symptoms were 
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highlighted in the course of the clinical interview, the researcher endeavored to closely 
assess these as per the DSM-IV diagnostic criteria. The use of a formal measure would 
have ensured greater consistency and reliability, which is why the researchers have been 
hesitant to assign a formal diagnosis and referred only to possible OCPD cases identified.  
 
Inherent to the design of the current study is the retrospective diagnostic procedure used 
to provide the time of onset for clinically significant anxiety and eating disorders. The 
obvious problems with this procedure, as noted in many previous studies, is the 
memorization biases that may have affected the ability for someone to recognize the 
symptoms of a disorder and recall the time of onset (Godart et al., 2000). Furthermore, as 
discussed in previous research, there are difficulties associated with interpreting the 
appearance chronology of anxiety and eating pathology (Godart et al., 2000).  
 
Although the DASS was administered to assess for depressive symptomatology, we did 
not formally assess for the presence of a comorbid mood disorder. Likewise, substance 
use disorders were also not assessed. Both of these disorders are clearly implicated in the 
eating disorders, and have been widely studied in this population. Given the already 
lengthy assessment process involved in the previous study, an additional interview to 
confirm mood and substance disorders may have been too great a burden on participants. 
Nevertheless, this is clearly a limitation of the present study.  
 
As criticisms of previous studies have stemmed from the exclusion of certain anxiety 
disorders when investigating comorbidity amongst the eating disorders, this study set out 
to include all DSM-IV diagnoses regardless of frequency of presentation. We found that 
13.5% of women presenting for anxiety disorder treatment also met criteria for a current 
eating disorder, and their primary anxiety diagnoses included all DSM-IV disorders 
except for Panic Disorder, Agoraphobia and Acute Stress Disorder. A significant 
limitation however, is the small number of participants with comorbid eating and anxiety 
disorders in each of the specific anxiety disorder groups. This precluded tests of effects 
within individual diagnostic categories, thus limiting the ability to compare and draw 
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conclusions. Subsequently, future research should replicate this study with larger sample 
sizes.  
 
Studies involving clinical samples may overestimate the rates of comorbidity as 
individuals with comorbid diagnoses may be more likely to seek treatment than those 
with only a single diagnosis. The present study attempted to reduce the possibility that 
comorbidity was a result of severity by including an inpatient and outpatient eating 
disorder sample. Nevertheless, it could be argued that the results from the present study 
may be limited in terms of their general application to community samples. 
Notwithstanding this potential limitation, the results from the current study are likely to 
provide an accurate reflection of the levels and temporal pattern of eating and anxiety 
comorbidity observed in clinical treatment settings.  
 
9.6 Clinical Implications arising from the research  
Over the last decade there has been an increase in the awareness that comorbidity in the 
eating disorders may have significant implications on the assessment and treatment 
procedures in this field. Despite this increased awareness, the research conducted in this 
area to date has been limited, and has suffered from methodological problems limiting 
ability to draw generalizations from the results.  
 
The current study clearly demonstrates that not only do many eating disorder patients 
have comorbid anxiety disorders, but up to 70% of patients with eating disorders have a 
pre-existing anxiety disorder. While other studies have found similarly high rates of 
comorbid anxiety, it is interesting that a similar high level of anxiety comorbidity was 
prevalent despite the low rates of OCD diagnosed across our sample. This knowledge is 
extremely important in the treatment of eating pathology, as it suggests that symptoms 
which previously have been understood as relating to the eating disorder (such as social 
withdrawal, fear in social situations) may instead be related to a pre-existing anxiety 
disorder. Conversely, symptoms previously identified as relating to a comorbid anxiety 
disorder (such as OCD), may actually, be secondary to the eating pathology or 
malnutrition.  
 216 
 
The speculation that anxiety may play a role in the onset and maintenance of eating 
pathology suggests that addressing eating disorder symptomatology in the absence of 
anxiety treatment, may reduce the overall efficacy of treatment outcomes. This raises the 
question as to whether it is possible for an eating disorder patient to achieve complete 
recovery in the absence of treatment for the anxiety symptoms. This is particularly salient 
if the eating disorder functions to assist with the management of anxiety 
symptomatology.  
 
The clinical implications of the current study are twofold. Firstly, when conducting an 
eating disorder assessment, clinicians must be cognisant of assessing for anxiety 
symptoms and where relevant, establishing a temporal chronology of onset of both 
disorders. Secondly, the possible etiological and maintenance factors must be considered 
when undertaking a clinical formulation and planning treatment.  
 
This thesis has also highlighted that eating pathology may be common in women 
presenting for treatment of anxiety disorders. Clinically, this is extremely important, as 
an individual presenting for treatment of an anxiety disorder may not necessarily disclose 
eating pathology. Nevertheless, it is clear from the current research that eating pathology 
and anxiety disorders often co-occur and therefore, eating pathology must also be 
assessed in order to adequately formulate and provide treatment for the individual 
presenting for anxiety treatment. Consequently, it is recommended that all future 
assessments of anxiety disorders include screening for eating disorder pathology. Given 
that the ADIS-IV does not include an assessment for eating pathology, it may be useful to 
follow Black-Becker et al. (2004) and incorporate a skip out condition on the EDE-Q to 
reduce the burden on patients. It is noted that the EDE-Q demonstrates high sensitivity 
and specificity for detecting eating disorder case status (Black-Becker et al., 2004) 
suggesting that the use of the EDE-Q, which is a relatively time efficient self-report 
questionnaire to complete, may be useful as a screening measure for eating disorder 
pathology.  
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One important clinical issue which has been highlighted in this research (although not 
included in the aims and objectives of the current study) is the possibility that the present 
DSM-IV classification system for the eating disorders is insufficient. Our findings, in line 
with previous research and clinical settings, found that a significant number of 
participants were diagnosed with the residual EDNOS category. Given that this is 
currently considered a category for atypical eating pathology, the fact that 40% of our 
sample was comprised of this diagnosis, suggests that the present DSM-IV classification 
system for eating disorders is not functioning as intended. In our study, the women 
diagnosed with EDNOS did not necessarily demonstrate less severe eating disorder 
symptoms or experience less distress, nevertheless, their symptoms did not fit the criteria 
for AN or BN. This is of particular concern as generally, a DSM-IV Not Otherwise 
Specified Category is indicative of a less severe form of a disorder. Thus, individuals 
with EDNOS may be overlooked in treatment planning or the provision of services, in 
circumstances where their symptoms and distress warrant as much priority as an AN or 
BN patient. With the planned publication of DSM-V imminent, this is clearly an 
extremely important aspect to address. Suggestions may include greater flexibility in 
criteria, removing the amenorrhea criteria for AN and the removal of criteria for 
minimum binge episodes per week for BN. Furthermore, as has been previously 
discussed elsewhere, differences between binge/purge and restricting patients within the 
ED categories, in terms of treatment and outcome, may suggest that diagnostic criteria 
should reflect these differences. The findings of the current study indicate that there is a 
need to consider alternatives to the current diagnostic classification system for eating 
disorders. This may include making the criteria for existing categories more flexible or 
moving to a transdiagnostic approach.  
 
9.7 Directions for Future Research  
The findings of the current study raise important questions regarding the etiological and 
prognostic factors associated with eating disorders, which should be addressed in future 
research. A number of potential directions for future research are discussed below.  
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Firstly, our study has raised the possibility that the diagnosis and treatment of anxiety 
pathology in patients with eating disorders may be crucial for successful treatment of the 
eating pathology. In order to address this, future studies should focus on investigating 
treatment response amongst individuals with comorbid anxiety and eating disorders. Of 
particular interest would be whether individuals respond better to treatment when 
treatment includes addressing both eating and anxiety disorders, compared with treatment 
focusing on the eating pathology only. Furthermore, research should also follow up 
patients to assess anxiety symptoms over time and post treatment.  
 
Secondly, one of the strengths of our study was that all anxiety disorders were thoroughly 
investigated across all eating disorder subtypes. Although we did not find support for the 
prevalence of OCD amongst eating disorder populations, we did find that PTSD was 
prevalent. Further research should aim to investigate this further, and in particular, 
research investigating PTSD and eating disorder comorbidity should examine the type of 
trauma experienced, to see whether certain types of trauma are more likely to be 
associated with eating pathology. In this regard, it would be particularly interesting to test 
the possibility that certain eating disorder behaviours (such as bingeing and purging) are 
used to regulate affect, or as a coping strategy for anxiety symptoms, such as intrusive 
memories.  
 
In addition to the suggestions above, it is clear from the current study that anxiety 
disorders are prevalent across the full spectrum of eating disorders. Given the more recent 
emphasis on transdiagnostic approaches to the treatment of eating pathology, further 
research investigating anxiety presentations irrespective of eating disorder diagnosis may 
assist in broadening our current understanding of comorbidity between anxiety and eating 
disorders.  
 
Furthermore, in order to obtain a thorough understanding of the etiological and 
prognostic relationship between eating and anxiety disorders, it is necessary not only to 
investigate the prevalence in eating disorder populations but also anxiety populations. 
The current study has provided support for the suggestion that comorbidity may be high 
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in anxiety populations and it is clear that future research into the prevalence of eating 
pathology amongst anxiety populations would be very informative.  
 
Finally, our study has provided the rationale for using standardized structured assessment 
instruments to thoroughly investigate the prevalence of anxiety and eating disorder 
comorbidity. Questions have clearly been raised regarding the methodological limitations 
inherent in previous research and the possibility that this has resulted in distorted 
prevalence rates, in particular amongst certain anxiety disorders. Future research should 
avoid these limitations by only using sound methodological procedures and instruments. 
Having consistent standards across studies will improve the ability to compare results 
across studies, thus improving clinical understanding of this important area.   
 
9.8 Conclusion  
To the best of the author’s knowledge, the current study is the largest to date on an 
Australian sample investigating comorbidity patterns in anxiety and eating disorders. It is 
the only Australian study, and one of a few worldwide, to consider the prevalence of 
eating disorders amongst an anxiety population. It is also one of the few such studies 
worldwide to include assessment for all DSM-IV anxiety disorders. 
 
The current study adds to previous research in this area by investigating the full range of 
DSM-IV anxiety disorders, using thorough assessment measures to distinguish between 
anxiety and eating pathology, and by considering the temporal relationship between 
comorbid disorders.  
 
The aims and objectives, to investigate the comorbidity and temporal relationship 
between anxiety and eating disorders, were accomplished. 
 
The author hopes that this study will improve clinical understanding of the etiological, 
maintenance and prognostic factors associated with eating disorders thereby significantly 
improving treatment and therapeutic outcomes. Such improved clinical understanding 
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should reduce the devastating health consequences and high mortality rates currently 
associated with the eating disorders.  
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Psychology Clinic 
School of Psychology 
University of Sydney 
___________________________________________________ 
PARTICIPANT INFORMATION SHEET 
Research Project 
The Comorbidity Between Eating Disorders and Anxiety Disorders 
 
The focus of this research is on the prevalence of people who have both an eating disorder and an 
anxiety disorder. Specifically, this study will focus on the severity of symptoms in people with 
both an eating disorder and an anxiety disorder, and whether there is a difference depending on 
whether they present to an anxiety unit or an eating disorder unit.  
 
This study is being conducted by Jessica Swinbourne, Psychologist, and will form the basis for 
the degree of Doctorate of Psychology / Masters of Science at The University of Sydney under 
the supervision of Professor Stephen Touyz, Professor of Clinical Psychology at the University of 
Sydney. 
 
The study will involve an assessment of anxiety and eating disorders and may require you to 
complete some questionnaires. It is anticipated that the time taken for the assessment and 
questionnaires will be between 2 – 3 hours.  
 
Being in this study is completely voluntary and you are not under any obligation to consent. You 
are free to withdraw at any time, and there is no penalty should you decide to do so.  
 
All aspects of this study, including results, will be strictly confidential and only the researchers 
and treatment providers will have access to information on participants, except as required by 
law. A report of the study may be submitted for publication, but individual participants will not 
be identifiable in such a report.  
 
Should you have any questions or concerns regarding this research please contact  
Jessica Swinbourne, Psychologist, on Ph: (02) 9351 5952.  
 
Any person with concerns or complaints about the conduct of this research study 
can contact Ms Gail Briody, Manager, Ethics Administration, University of Sydney on  
(02) 9351 4811 or email gbriody@mail.usyd.edu.au. 
This information sheet is for you to keep 
 
 
Version 1 
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Psychology Clinic 
School of Psychology 
University of Sydney 
___________________________________________________________________ 
PARTICIPANT CONSENT FORM 
 
I, ________________________, give consent to my participation in the research project 
           Name (please print) 
 
The Comorbidity Between Eating Disorders and Anxiety Disorders.  
 
In giving my consent I acknowledge that: 
 
1. The procedures required for the project and the time involved have been explained to me, 
and any questions I have about the project have been answered to my satisfaction. 
2. I have read the Participant Information Sheet and have been given the opportunity to 
discuss the information and my involvement in the project with the researcher/s. 
3. I understand that my participation in this study is voluntary and I can withdraw at 
any time, without affecting my relationship with the researcher(s) or treatment 
providers now or in the future. 
4. I understand that my involvement is strictly confidential and no information about 
me will be used in any way that reveals my identity. 
 
 
Signed:   
 
Name:   ..............................................................................................................................................  
 
Date:   ..............................................................................................................................................  
 
 
Should you have any questions or concerns regarding this research please contact  
Jessica Swinbourne, Psychologist, on Ph: (02) 9351 5952.  
 
 
Any person with concerns or complaints about the conduct of this research study 
can contact Ms Gail Briody, Manager, Ethics Administration, University of Sydney on  
(02) 9351 4811 or email gbriody@mail.usyd.edu.au. 
 
Version 1 
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Psychology Clinic 
School of Psychology 
University of Sydney 
PARTICIPANT INFORMATION SHEET 
Research Project 
The Comorbidity Between Eating Disorders and Anxiety Disorders 
 
The focus of this research is on the prevalence of women who have both an eating disorder and an 
anxiety disorder. This study will consider the symptoms of eating and anxiety disorder, the 
treatment received and treatment outcome and whether there is a difference depending on 
whether someone has a comorbid disorder or not.  
 
This study is being conducted by Jessica Swinbourne, Psychologist, and will form the basis for 
the degree of Doctorate of Psychology / Doctor of Philosophy at The University of Sydney under 
the supervision of Professor Stephen Touyz, Professor of Clinical Psychology at the University of 
Sydney. 
 
The study will involve an assessment of anxiety and eating disorders and may require you to 
complete some questionnaires. The study will also involve a 6 month follow up after completing 
treatment, and will involve further assessment of anxiety and eating disorders  and the completion 
of questionnaires. It is anticipated that the time taken for the assessment and questionnaires will 
be between 1½  – 3 hours on both occasions.  
 
This study would also involve review of medical records during your treatment to investigate the 
treatment you received and treatment outcome.  
 
Being in this study is completely voluntary and you are not under any obligation to consent. You 
are free to withdraw at any time, and there is no penalty should you decide to do so.  
All aspects of this study, including results, will be strictly confidential and only the researchers 
and treatment providers will have access to information on participants, except as required by 
law. A report of the study may be submitted for publication, but individual participants will not 
be identifiable in such a report.  
 
Should you have any questions or concerns regarding this research please contact  
Jessica Swinbourne, Psychologist, on Ph: (02) 9351 5952.  
Any person with concerns or complaints about the conduct of this research study 
can contact Ms Gail Briody, Manager, Ethics Administration, University of Sydney on (02) 
9351 4811 or email gbriody@mail.usyd.edu.au. 
 
This information sheet is for you to keep 
 
Version 2 
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Psychology Clinic 
School of Psychology 
University of Sydney 
______________________________________________________________________________ 
PARTICIPANT CONSENT FORM 
I, ________________________, give consent to my participation in the research project 
           Name (please print) 
 
The Comorbidity Between Eating Disorders and Anxiety Disorders.  
 
In giving my consent I acknowledge that: 
 
1. The procedures required for the project and the time involved have been 
explained to me, and any questions I have about the project have been answered 
to my satisfaction. 
2. I have read the Participant Information Sheet and have been given the opportunity 
to discuss the information and my involvement in the project with the 
researcher/s. 
3. I understand that my participation in this study is voluntary and I can withdraw at 
any time, without affecting my relationship with the researcher(s) or treatment 
providers now or in the future. 
4. I understand that my involvement is strictly confidential and no information about 
me will be used in any way that reveals my identity. 
 
 
Signed:  ....................................................................................................................................  
 
Name:   .................................................................................................................................... 
 
Date:   .................................................................................................................................... 
 
 
Should you have any questions or concerns regarding this research please contact  
Jessica Swinbourne, Psychologist, on Ph: (02) 9351 5952.  
 
 
Any person with concerns or complaints about the conduct of this research study 
can contact Ms Gail Briody, Manager, Ethics Administration, University of Sydney on (02) 
9351 4811 or email gbriody@mail.usyd.edu.au. 
 
Version 2 
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Psychology Clinic 
School of Psychology 
University of Sydney 
___________________________________________________ 
PARTICIPANT INFORMATION SHEET 
Research Project 
The Comorbidity Between Eating Disorders and Anxiety Disorders 
 
The focus of this research is on the prevalence of people who have both an eating disorder and an 
anxiety disorder. Specifically, this study will focus on the severity of symptoms in people with 
both an eating disorder and an anxiety disorder, and whether there is a difference depending on 
whether they present to an anxiety unit or an eating disorder unit.  
 
This study is being conducted by Jessica Swinbourne, Psychologist, and will form the basis for 
the degree of Doctorate of Psychology / Doctor of Philosophy at The University of Sydney under 
the supervision of Professor Stephen Touyz, Professor of Clinical Psychology at the University of 
Sydney. 
 
The study will involve an assessment of anxiety and eating disorders and may require you to 
complete some questionnaires. It is anticipated that the time taken for the assessment and 
questionnaires will be between 2 – 3 hours.  
 
Being in this study is completely voluntary and you are not under any obligation to consent. You 
are free to withdraw at any time, and there is no penalty should you decide to do so.  
 
All aspects of this study, including results, will be strictly confidential and only the researchers 
and treatment providers will have access to information on participants, except as required by 
law. A report of the study may be submitted for publication, but individual participants will not 
be identifiable in such a report.  
 
Should you have any questions or concerns regarding this research please contact  
Jessica Swinbourne, Psychologist, on Ph: (02) 9351 5952.  
 
Any person with concerns or complaints about the conduct of this research study 
can contact Ms Gail Briody, Manager, Ethics Administration, University of Sydney on  
(02) 9351 4811 or email gbriody@mail.usyd.edu.au. 
This information sheet is for you to keep 
 
Version 3 
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Psychology Clinic 
School of Psychology 
University of Sydney 
___________________________________________________________________ 
PARTICIPANT CONSENT FORM 
 
I, ________________________, give consent to my participation in the research project 
           Name (please print) 
 
The Comorbidity Between Eating Disorders and Anxiety Disorders.  
 
In giving my consent I acknowledge that: 
 
5. The procedures required for the project and the time involved have been explained to me, 
and any questions I have about the project have been answered to my satisfaction. 
6. I have read the Participant Information Sheet and have been given the opportunity to 
discuss the information and my involvement in the project with the researcher/s. 
7. I understand that my participation in this study is voluntary and I can withdraw at 
any time, without affecting my relationship with the researcher(s) or treatment 
providers now or in the future. 
8. I understand that my involvement is strictly confidential and no information about 
me will be used in any way that reveals my identity. 
 
 
Signed:   
 
Name:   ..............................................................................................................................................  
 
Date:   ..............................................................................................................................................  
 
 
Should you have any questions or concerns regarding this research please contact  
Jessica Swinbourne, Psychologist, on Ph: (02) 9351 5952.  
 
 
Any person with concerns or complaints about the conduct of this research study 
can contact Ms Gail Briody, Manager, Ethics Administration, University of Sydney on  
(02) 9351 4811 or email gbriody@mail.usyd.edu.au. 
 
Version 3 
 277 
 
 
 
 
 
 
 
 
APPENDIX B 
 
 
Northside Clinic Participant Information Sheet 
Northside Clinic Participant Consent Form 
 
 278 
 
 
Psychology Clinic 
School of Psychology 
University of Sydney 
___________________________________________________ 
PARTICIPANT INFORMATION SHEET 
Research Project 
The Dual Diagnosis of Eating Disorders and Anxiety Disorders 
 
The focus of this research is on the prevalence of people who have both an eating disorder and an 
anxiety disorder (dual diagnosis). Specifically, this study will focus on the severity of symptoms 
in people with both an eating disorder and an anxiety disorder, and whether there is a difference 
depending on whether they present to an anxiety unit or an eating disorder unit.  
 
This study is being conducted by Jessica Swinbourne, Psychologist, and will form the basis for 
the degree of Doctorate of Psychology / Doctor of Philosophy at The University of Sydney under 
the supervision of Professor Stephen Touyz, Professor of Clinical Psychology at the University of 
Sydney. 
 
The study will involve an assessment of anxiety and eating disorders and may require you to 
complete some questionnaires. It is anticipated that the time taken for the assessment and 
questionnaires will be between 2 – 3 hours.  
 
Being in this study is completely voluntary and you are not under any obligation to consent. You 
are free to withdraw at any time, and there is no penalty should you decide to do so.  
 
All aspects of this study, including results, will be strictly confidential and only the researchers 
and treatment providers will have access to information on participants, except as required by 
law. A report of the study may be submitted for publication, but individual participants will not 
be identifiable in such a report.  
 
Should you have any questions or concerns regarding this research please contact  
Jessica Swinbourne, Psychologist, on Ph: (02) 9351 5952.  
 
Any person with concerns or complaints about the conduct of this research study 
can contact Ms Gail Briody, Manager, Ethics Administration, University of Sydney on  
(02) 9351 4811 or email gbriody@mail.usyd.edu.au. 
This information sheet is for you to keep 
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Psychology Clinic 
School of Psychology 
University of Sydney 
___________________________________________________________________ 
PARTICIPANT CONSENT FORM 
 
I, ________________________, give consent to my participation in the research project 
           Name (please print) 
 
The Dual Diagnosis of Eating Disorders and Anxiety Disorders.  
 
In giving my consent I acknowledge that: 
 
1. The procedures required for the project and the time involved have been explained to 
me, and any questions I have about the project have been answered to my 
satisfaction. 
2. I have read the Participant Information Sheet and have been given the opportunity to 
discuss the information and my involvement in the project with the researcher/s. 
3. I understand that my participation in this study is voluntary and I can 
withdraw at any time, without affecting my relationship with the researcher(s) 
or treatment providers now or in the future. 
4. I understand that my involvement is strictly confidential and no information 
about me will be used in any way that reveals my identity. 
 
 
Signed:   
 
Name:   ..............................................................................................................................................  
 
Date:   ..............................................................................................................................................  
 
 
Should you have any questions or concerns regarding this research please contact  
Jessica Swinbourne, Psychologist, on Ph: (02) 9351 5952.  
 
 
Any person with concerns or complaints about the conduct of this research study 
can contact Ms Gail Briody, Manager, Ethics Administration, University of Sydney on  
(02) 9351 4811 or email gbriody@mail.usyd.edu.au. 
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SWAHS Anxiety Clinic Participant Information Sheet 
SWAHS Anxiety Clinic Participant Consent Form 
SWAHS Eating Disorders Day Program Participant Information Sheet 
SWAHS Eating Disorders Day Program Clinic Participant Consent Form 
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University of Sydney Ethical Approval for Research 23/5/2005 
University of Sydney Ethical Approval of modification 7/9/2005 
University of Sydney Ethical Approval of modification 19/5/2006 
University of Sydney Ethical Approval of modification 19/4/2007 
University of Sydney Ethical Approval of modification 22/6/2007 
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SWHAS HREC Approval for Research 29/3/2006 
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Assessment Measures 
Demographics Questionnaire 
Depression Anxiety Stress Scale  (DASS-21) 
Eating Disorder Examination Questionnaire (EDE-Q) 
Eating Disorder Inventory -3 (EDI-3) 
Eating Attitude Test (EAT-40) 
Eating Disorder Examination (EDE) 
Anxiety Disorder Interview Schedule (ADIS-IV) 
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DEMOGRAPHICS 
 
 
     Date of Interview:___________________ 
 
Name:  __________________________________ 
Date of birth:  __________________________________ 
Ethnic Origin: __________________________________  
Sex: M  /  F 
Marital Status: __________________________________  
Children:  __________________________________ 
  Age   Sex 
  ____  ____ 
  ____  ____ 
  ____  ____ 
  ____  ____ 
 
Occupational History:  
Current:  __________________________________ 
Prior:   __________________________________ 
 
Education:  __________________________________ 
Medication  
NAME FOR DOSE 
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DASS - 21 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement applied 
to you over the past week.  There are no right or wrong answers.  Do not spend too much time on any 
statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
1 I found it hard to wind down 0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I found it difficult to work up the initiative to do things 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I experienced trembling (eg, in the hands) 0      1      2      3 
8 I felt that I was using a lot of nervous energy 0      1      2      3 
9 I was worried about situations in which I might panic and make a fool of myself 0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting agitated 0      1      2      3 
12 I found it difficult to relax 0      1      2      3 
13 I felt down-hearted and blue 0      1      2      3 
14 I was intolerant of anything that kept me from getting on with what I was doing 0      1      2      3 
15 I felt I was close to panic 0      1      2      3 
16 I was unable to become enthusiastic about anything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 
19 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
20 I felt scared without any good reason 0      1      2      3 
21 I felt that life was meaningless 0      1      2      3 
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Instructions  
The following questions are concerned with the PAST FOUR WEEKS ONLY (28 days). 
Please read each question carefully and circle the appropriate number on the right. Please 
answer all the questions.  
On how many days out of the past 
28 days…… 
No 
Days 
1 – 5 
days 
6 – 12 
days 
13 – 15 
days 
16 – 22 
days 
23-27 
days 
Every 
day 
1. Have you been deliberately 
trying to limit the amount of food 
you eat to influence your shape or 
weight?  
0 1 2 3 4 5 6 
2. Have you gone for long periods 
of time (8 hours or more) without 
eating anything in order to 
influence your shape or weight?  
0 1 2 3 4 5 6 
3. Have you tried to avoid eating 
any foods which you like in order 
to influence your shape or weight? 
0 1 2 3 4 5 6 
4. Have you tried to follow definite 
rules regarding your eating in order 
to influence your shape or weight; 
for example, a calorie limit, a set 
amount of food, or rules about what 
or when you should eat?  
0 1 2 3 4 5 6 
5. Have you wanted your stomach 
to be empty?  
0 1 2 3 4 5 6 
6. Has thinking about food or its 
calorie content made it much more 
difficult to concentrate on things 
you are interested in; for example, 
read, watch TV or follow a 
conversation?   
0 1 2 3 4 5 6 
EDE-Q 
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On how many days out of the past 
28 days…… 
No 
Days 
1 – 5 
days 
6 – 12 
days 
13 – 15 
days 
16 – 22 
days 
23-27 
days 
Every 
day 
7. Have you been afraid of losing 
control over your eating? 
0 1 2 3 4 5 6 
8. Have you had episodes of binge 
eating?  
0 1 2 3 4 5 6 
9. Have you eaten in secret? (do not 
count binges.) 
0 1 2 3 4 5 6 
10. Have you definitely wanted 
your stomach to be flat? 
0 1 2 3 4 5 6 
11. Has thinking about shape or 
weight made it much more difficult 
to concentrate on things you are 
interested in; for example, read, 
watch TV or follow a conversation?   
0 1 2 3 4 5 6 
12. Have you had a definite fear 
that you might gain weight or 
become fat?  
0 1 2 3 4 5 6 
13. Have you felt fat?  0 1 2 3 4 5 6 
14. Have you had a strong desire to 
lose weight?  
0 1 2 3 4 5 6 
 
OVER THE PAST FOUR WEEKS (28 DAYS) 
15. On what proportion of times that you have eaten 
have you felt guilty because of the effect on your shape 
or weight? (Do not count binges.) (Circle the number 
which applies.)  
 
0 – None of the times 
1 – A few of the times  
2 – Less than half the times  
3 – Half the times 
4 – More than half the times  
5 – Most of the time  
6 – Every time  
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16. Over the past four weeks (28 days), have there been any time when you have felt that 
you have eaten what other people would regard as an unusually large amount of food 
given the circumstances? (Please put appropriate number in box.) 
 
                                  0 – No         [  ] 
                       1 – Yes        [  ] 
17. How many such episodes have you had over the past four weeks?  
          [  ] [  ] [  ] 
 
18 During how many of these episodes of overeating did you have a sense of having lost 
control over your eating?  
[  ] [  ] [  ] 
_______________________________________________________________________ 
19. Have you had other episodes of eating in which you have had a sense of having lost 
control and eaten too much, but have not eaten an unusually large amount of food given 
the circumstances?  
   0 – No         [  ] 
                       1 – Yes        [  ] 
 
20. How many such episodes have you had over the past four weeks?  
          [  ] [  ] [  ] 
 
 
21. Over the past four weeks have you made yourself sick (vomit) as a means of 
controlling your shape or weight?  
                                                                                                               0 – No         [  ] 
                       1 – Yes        [  ] 
 
22. How many times have you done this over the past four weeks?  
          [  ] [  ] [  ] 
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23. Have you taken laxatives as a means of controlling your shape or weight?  
                                                                                                               0 – No         [  ] 
                       1 – Yes        [  ] 
 
24. How many times have you done this over the past four weeks?  
          [  ] [  ] [  ] 
 
 
25. Have you taken diuretics (water tablets) as a means of controlling your shape or 
weight?  
                                                                                                               0 – No         [  ] 
                       1 – Yes        [  ] 
 
26. How many times have you done this over the past four weeks?  
          [  ] [  ] [  ] 
 
 
27. Have you exercised hard as a means of controlling your shape or weight?  
   0 – No         [  ] 
                       1 – Yes        [  ] 
 
28. How many times have you done this over the past four weeks?  
          [  ] [  ] [  ] 
 
 
 
 291 
 
OVER THE PAST FOUR WEEKS 
(28 DAYS) (please circle the number 
which best describes your behaviour  
N
O
T A
T A
LL 
 
SLIG
H
TLY
 
 
M
O
D
ER
A
TELY
 
 
M
A
R
K
ED
LY
 
29. Has your weight influenced how 
you think about (judge) yourself as a 
person? 
0 1 2 3 4 5 6 
30. Has your shape influenced how 
you think about (judge) yourself as a 
person? 
0 1 2 3 4 5 6 
31. How much would it upset you if 
you had to weigh yourself once a week 
for the next four weeks?  
0 1 2 3 4 5 6 
32. How dissatisfied have you felt 
about your weight? 
0 1 2 3 4 5 6 
33. How dissatisfied have you felt 
about your shape? 
0 1 2 3 4 5 6 
34. How concerned have you been 
about other people seeing you eat? 
0 1 2 3 4 5 6 
35. How uncomfortable have you felt 
seeing your body; for example in the 
mirror, in shop window reflections, 
while undressing or taking a bath or 
shower? 
0 1 2 3 4 5 6 
35. How uncomfortable have you felt 
about others seeing your body; for 
example in communal changing 
rooms, when swimming or wearing 
tight clothes?  
0 1 2 3 4 5 6 
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EAT – 40 
Instructions: Please place an (X) in the column which applies best to each of the numbered statements 
. Most of the questions directly relate to food or eating, although other types of questions have been 
included. Please answer each question carefully.  
 Always Very 
Often 
Often Sometimes Rarely Never 
1. Like eating with other people                     
2. Prepare foods for others but do not eat what I 
cook  
      
3. Become anxious prior to eating       
4. Am terrified about being overweight       
5. Avoid eating when I am hungry        
6. Find myself preoccupied with food       
7. Have gone on eating binges where I feel that I 
may not be able to stop 
      
8. Cut my food into small pieces        
9. Aware of the calorie content of foods that I eat        
10.Particularly avoid foods with a high 
carbohydrate content (eg. bread, potatoes, rice etc)  
      
11.Feel bloated after meals        
12. Feel that others would prefer if I ate more       
13.Vomit after I have eaten        
14. Feel extremely guilty after eating        
15. Am preoccupied with a desire to be thinner        
16. Exercise strenuously to burn off calories        
17. Weigh myself several times a day        
18. Like my clothes to fit tightly        
19. Enjoy eating meat        
20. Wake up early in the morning        
21. Eat the same food day after day        
22. Think about burning up calories when I exercise        
23. Have regular menstrual periods        
25. Am preoccupied with the thought of having fat 
on my body  
 
 
     
26. Take longer than others to eat my meals        
27. Enjoy eating at restaurants        
28. Take laxatives        
29. Avoid foods with sugar in them        
30. Eat diet foods  
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 Always Very 
Often 
Often Sometimes Rarely Never 
31. Feel that food controls my life        
32. Display self control around food        
33.Feel that others pressure me to eat        
34. Give too much time and thought to food        
35. Suffer from constipation        
36. Feel uncomfortable after eating sweets        
37. Engage in dieting behaviour        
38. Like my stomach to be empty        
39. Enjoy trying new rich foods        
40. Have the impulse to vomit after meals        
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APPENDIX H 
 
 
Excluded Assessment Measures 
Beck Depression Inventory – II (BDI-II) 
Anorexia Nervosa Stages Of Change –Questionnaire (ANSOC-Q) 
Eating Disorder Belief Questionnaire (EDBQ) 
Metacognitions questionnaire (MCQ) 
Penn State Worry questionnaire (PSWQ) 
Social interaction anxiety scale (SIAS) 
Social phobia scale (SPS) 
Fear of negative evaluation scale (FNE) 
Agoraphobic cognitions questionnaire (ACQ) 
Body sensations questionnaire (BCQ) 
Padua Inventory (PI-WSUR)  
Yale – Brown obsessive compulsive scale (Y-BOCS) 
Maudsley Obsessional Compulsive inventory (MOCI) 
Posttraumatic diagnostic scale (PDS) 
Impact of Events Scale Revised (IES-R) 
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ANSOC – Q 
Instructions: Each of the items below is made up of 5 statements. For each item, please 
read the five statements carefully. Then select the statement (or statements) which best 
describe/s your current attitude or behavior (not how you have been in the past or how 
you would like to be).  
1.The following statements refer to gaining weight: 
a) as far as I am concerned, I do not need to gain weight 
b) In some ways I think that I might be better off if I gained weight 
c) I have decided that I will attempt to gain weight  
d) At the moment I am putting in a lot of effort into gaining weight 
e) I am working to maintain the weight gains I have made 
2.The following statements refer to body weight:  
a) as far as I am concerned, I do not need to weigh at least _____kg (insert your 
minimal normal weight)  
b) In some ways I think that I might be better off if I weighed at least _____kg 
c) I have decided that I will attempt to reach at least _____kg 
d) At the moment I am putting in a lot of effort to reach at least _____kg 
e) I am working to maintain a weight of at least _____kg 
3. The following statements refer to parts of the body which may particularly 
concern you in terms of weight gain (such as hips, thighs, stomach, or buttocks):  
a) There is not way I would be prepared to gain weight on these body parts 
b) Sometimes I think I would be prepared to gain weight on these body parts 
c) I have decided that I am prepared to gain weight on these body parts  
d) I am presently trying to gain weight on these body parts  
e) I am working to maintain the weight I gained on these body parts  
4. The following statements refer to your appearance:  
a) I do not want to be a normal weight because I would be less satisfied with my 
appearance at a weight of at least _____kg (insert your minimal normal weight) 
b) I have occasionally thought about being a normal weight because in some ways I 
would be more satisfied with my appearance at a weight of at least _____kg 
c) I have decided to reach a normal weight because I would be more satisfied with 
my appearance at a weight of at least _____kg 
d) I am presently trying to reach a normal weight because I will be more satisfied 
with my appearance at a weight of at least _____kg 
e) I am working to maintain a normal weight because I am more satisfied with my 
appearance at a weight of at least _____kg 
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5. The following statements refer to your health:  
a) I do not need to be a normal weight because there are no risks to my health when I 
weigh below _____kg (insert your minimal normal weight) 
b) I have occasionally thought about being a normal weight because of the risks to 
my health when I weigh below _____kg 
c) I have decided to reach a normal weight because of the risks to my health when I 
weigh below _____kg 
d) I am presently trying to reach a normal weight because of the risks to my health 
when I weigh below _____kg 
e) I am working to maintain a normal weight because of the risks to my health when 
I weigh below _____kg 
6. The following statements refer to the importance of body shape and weight:  
a) I do not exaggerate the importance of my body shape or weight in determining my 
happiness and success 
b) Sometimes I think that I exaggerate the importance of my body shape or weight in 
determining my happiness and success 
c) I have decided that I need to reduce the importance that I place on my body shape 
or weight in determining my happiness and success 
d) I often try to challenge the importance that I place on my body shape or weight in 
determining my happiness and success 
e) I have succeeded in reducing my tendency to place too much importance on my 
body shape or weight in determining my happiness and success and want it to stay 
this way 
7. The following statements refer to a fear of fatness:  
a) My fear of becoming fat is not excessive 
b) I occasionally think that my fear of becoming fat is excessive 
c) I have decided that I need to do something about the fear I have of becoming fat 
because it is controlling me 
d) I know that my fear of becoming fat has caused problems and now I am trying to 
correct this 
e) I have succeeded in reducing my fear of becoming fat and I want it to stay this 
way 
8. The following statements refer to weight loss:  
a) I would prefer to lose more weight 
b) Sometimes I think that it might be time to stop losing weight 
c) I have decided that it is time to stop losing weight 
d) I am trying to stop losing weight 
e) I have managed to stop losing weight and hope to stay this way 
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9. The following statements refer to body fat versus muscle:  
a) I might think about gaining muscle on purpose, but I would never think of gaining 
fat on purpose  
b) Sometimes I think that I may need to gain some fat even though I would prefer to 
have only muscle 
c) I have decided that to be healthy I need to have some fat on my body  
d) I realize that I need to have some fat on my body and I am working to achieve this  
e) I have managed to increase the level of fat on my body which I am trying to 
maintain 
10. The following statements refer to the rate of weight gain:  
a) There is no way I would be prepared to gain at least 1kg a week  
b) Sometimes I think I would be prepared to gain at least 1kg a week 
c) I have decided that in general it would be best for me to gain at least 1kg a week 
d) I am putting in a lot of effort to gain at least 1kg a week  
e) I am working to maintain my weight by would be prepared to gain at least 1kg a 
week if necessary  
11. The following statements refer to certain shape and weight standards which you 
may have for evaluating your body (such as only being satisfied with your body 
when your stomach is flat or when you are below a certain weight):  
a) The standards I use to evaluate my body are not too strict 
b) Sometimes I think that the standards I use to evaluate my body may be too strict  
c) I have decided that the standards I use to evaluate my body are too strict and need 
to be changed 
d) I am putting in a lot of effort to change the strict standards which I use to evaluate 
my body  
e) I have managed to let go of the strict standards which I used in the past to 
evaluate my body and am hoping to keep it this way 
12. The following statements refer to certain foods which you may avoid eating 
(such as food high in calories or fat, red meat or dairy products):  
a) There are certain foods which I strictly avoid and would not even consider eating  
b) There are certain foods which I try to avoid, although sometimes I think that it 
might be okay to eat them occasionally  
c) I think that I am too strict in the foods which I allow myself to eat and have 
decided that I will attempt to eat foods which I usually avoid 
d) I am putting in a lot of effort to regularly eat foods which I usually avoid 
e) I used to avoid eating certain foods which I now eat regularly  
13. The following statements refer to daily food consumption:  
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a) There is not need for me to eat 3 standard-size meals and a snack each day  
b) Sometimes I think that I should eat 3 standard-size meals and a snack each day 
c) I have decided that I need to eat 3 standard-size meals and a snack each day 
d) I am putting in a lot of effort to eat 3 standard-size meals and a snack each day 
e) I am working to maintain a current eating pattern which includes 3 standard-size 
meals and a snack each day 
14. The following statements refer to time spent thinking about food and your 
weight (such as thoughts about becoming fat, counting the calories or fat content of 
food, or calculating the amount of energy used when exercising):  
a) There is nothing wrong with the amount of time I spend thinking about food and 
my weight 
b) The amount of time I spend thinking about food and my weight is a problem 
sometimes  
c) I have decided that I need to use strategies to help me reduce the amount of time I 
spend thinking about food and my weight 
d) I am using strategies to help me reduce the amount of time I spend thinking about 
food and my weight 
e) I used to spend too much time thinking about food and my weight which I have 
managed to reduce and am working to keep it this way 
15. The following statements refer to certain eating behaviors (such as needing to eat 
food at a specific rate or time, moving around on the plate, being unable to eat all 
food on a plate, taking longer than others to eat meals, having difficulty eating with 
others, needing to chew food a certain number of times or needing to stick to the 
same food plan each day):  
a) There is nothing that I need to change about the way I eat my meals 
b) I sometimes think that I need to change aspects of the way I eat my meals 
c) I have decided that I will try to change aspects of the way I eat my meals  
d) I am putting a lot of effort to change aspects of the way I eat my meals  
e) I have succeeded in changing aspects of the way I eat my meals and want it to 
stay this way  
16. The following statements refer to feelings associated with eating (such as feeling 
guilty) and not eating (such as feeling in control):  
a) There is no need for me to change the feelings I associate with eating and not 
eating  
b) I sometimes think that I need to change the feelings I associate with eating and 
not eating  
c) I have decide that I will try to change the feelings I associate with eating and not 
eating  
d) I am putting in a lot of effort to change the feelings I associate with eating and not 
eating  
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e) I have succeeded in changing the feelings I associate with eating and not eating 
and want it to stay this way  
18.The following statements refer to methods which you may use to control your 
weight (such as restricting your eating, exercising, vomiting, taking laxatives or 
other pills). You may select more than one statement for the different methods you 
use to control your weight. Please indicate which weight control method/s you are 
referring to in the blank space/s provided.  
a) There is nothing seriously wrong with the methods (_______________) I use to 
control my weight 
b) I have been thinking that there may be problems associated with the methods 
(_______________) I use to control my weight 
c) I have decide that I will attempt to stop using certain methods 
(_______________) to control my weight 
d) I am putting in a lot of effort to stop using certain methods (_______________) to 
control my weight  
e) I have managed to stop using certain methods (_______________) to control my 
weight and I would like it to stay this way 
19.The following statements refer to certain characteristics (such as perfectionism, 
low self esteem or feeling a need for control):  
a) I do not have any problems in the way I approach life which I need to work on  
b) I sometimes think that I may have certain problems in the way I approach life 
which I need to work on 
c) I have certain problems in the way I approach life which I have decided to work 
on  
d) I am actively working on problems in the way I approach life  
e) The problems in the way I approach life I have improved and I am trying to keep 
it this way  
20. The following statements refer to relationship problems (such as relationships 
with family or friends):  
a) I do not have any problems in my relationships with others which I need to work 
on 
b) I sometimes think that I may have certain problems in my relationships with 
others which I need to work on  
c) I have certain problems in my relationships with others which I have decided to 
work on  
d) I am actively working on problems in my relationships with others  
e) The problems in my relationships with others have improved and I am trying to 
keep it this way 
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EDBQ 
Instructions: Choose the rating (place a mark on the line) that best describes what you 
usually believe or what you believe most of the time. Base your response of what you 
emotionally feel or believe and not on what you rationally believe to be true. 
 
0------------------------------------------------------------------------100 
I don’t usually                                                    I am usually completely  
believe this at all                                                     convinced that this is true 
 
1. I’m stupid    
0------------------------------------------------------------------------100 
2. I’m no good  
0------------------------------------------------------------------------100 
3. I’m a failure  
0------------------------------------------------------------------------100 
4. I’m useless  
0------------------------------------------------------------------------100 
5. I’m dull  
0------------------------------------------------------------------------100 
6. I’m not a likeable person  
0------------------------------------------------------------------------100 
7. I’m all alone  
0------------------------------------------------------------------------100 
8. I don’t like myself very much  
0------------------------------------------------------------------------100 
9. I’m unlovable  
0------------------------------------------------------------------------100 
10. I’m ugly  
0------------------------------------------------------------------------100 
11. If my thighs are firm it means I’m a better person  
0------------------------------------------------------------------------100 
12. If my hips are narrow it means I’m successful  
0------------------------------------------------------------------------100 
13. If my bottom is small people will take me seriously  
0------------------------------------------------------------------------100 
14. If I gain weight it means I’m a bad person  
0------------------------------------------------------------------------100 
15. If I gain weight I’m nothing 
0------------------------------------------------------------------------100 
16. If my body shape is in proportion people will love me  
0------------------------------------------------------------------------100 
17. If my hips are thin people will approve of me  
0------------------------------------------------------------------------100 
18. If I lose weight people will be friendly and want to get to know me  
0------------------------------------------------------------------------100 
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19. If I lose weight people will care about me  
0------------------------------------------------------------------------100 
20. If I lose weight I’ll count more in the world 
0------------------------------------------------------------------------100 
21. If my stomach is flat I’ll be more desirable 
0------------------------------------------------------------------------100  
22. If my flesh is firm I’m more attractive  
0------------------------------------------------------------------------100 
23. If my body is lean I can feel good about myself  
0------------------------------------------------------------------------100 
24. If I eat desserts or puddings I’ll get fat  
0------------------------------------------------------------------------100 
25. Body fat/flabbiness is disgusting  
0------------------------------------------------------------------------100 
26. If I eat bad foods such as fats, sweets, bread and cereals they will turn into fat 
0------------------------------------------------------------------------100 
27. If I’ve eating something I have to get rid of it as soon as possible  
0------------------------------------------------------------------------100 
28. If I binge and vomit I can stay in control  
0------------------------------------------------------------------------100 
29. If I eat three meals a day like other people I’ll gain weight  
0------------------------------------------------------------------------100 
30. If I eat normally I’ll gain weight   
0------------------------------------------------------------------------100 
31. If I stay hungry I can guard against losing control and getting fat  
0------------------------------------------------------------------------100 
32. If I eat a forbidden food I won’t be able to stop  
0------------------------------------------------------------------------100 
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MCQ 
 
Instructions: This questionnaire is concerned with beliefs people have about their 
thinking. Listed below are a number of beliefs that people have expressed. Please read 
each item and say how much you generally agree with it by colouring in the circle under 
the appropriate number. Please respond to all the items, there are no right or wrong 
answers. 
 1   2   3   4 
    Do not agree            Agree slightly          Agree moderately      Agree very much 
1. Worrying helps me to avoid problems in the future………………….. 
 
    
2. My worrying is dangerous for me…………………………………….. 
 
    
3. l have difficulty knowing if I have actually done something or just       
imagined it………………………………………………………………. 
 
    
4. I think a lot about my thoughts……………………………………….. 
 
    
5. l could make myself sick with worrying………………………….…... 
 
    
6. I am aware of the way my mind works when l am thinking through a 
problem………………………………………………………………….. 
 
    
7. If I did not control a worrying thought, and then it happened, it would be 
my fault………………………………………………………………. 
 
    
8. If I let my worrying thoughts get out of control, they will end up 
controlling me…………………………………………………………… 
 
    
9. l need to worry in order to remain organised…………………………. 
 
    
10. I have little confidence in my memory for words and names……….. 
 
    
11. My worrying thoughts persist, no matter how I try to stop 
them……………………………………………………………………... 
 
    
12. Worrying helps me to get things sorted out in my mind……………. 
 
    
13. I cannot ignore my worrying thoughts………………………………. 
 
    
14. I monitor my thoughts……………………………………………….. 
 
    
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15. I should be in control of my thoughts all of the time………………... 
 
    
16. My memory can mislead me at times……………………………….. 
 
    
17. I could be punished for not having certain thoughts………….……... 
 
    
18. My worrying could make me go mad……………………………….. 
 
    
19. If I do not stop my worrying thoughts, they could come true………. 
 
    
20. I rarely question my thoughts……………………………………….. 
 
    
21. Worrying puts my body under a lot of stress………………………... 
 
    
22. Worrying helps me to avoid disastrous situations…………………... 
 
    
23. l am constantly aware of my thinking……………………………….. 
 
    
24. I have a poor memory……………………………………………….. 
 
    
25. l pay close attention to the way my mind works…………………….. 
 
    
26. People who do not worry, have no depth……………………………. 
 
    
27. Worrying helps me cope…………………………………………….. 
 
    
28. I imagine having not done things and then doubt my memory for doing 
them………………………………………………………………. 
 
    
29. Not being able to control my thoughts is a sign of weakness.………. 
 
    
30. If l did not worry, I would make more mistakes…………………….. 
 
    
31. I find it difficult to control my thoughts………………………….…. 
 
    
32. Worrying is a sign of a good person………………………………… 
 
    
33. Worrying thoughts enter my head against my will………………….. 
 
    
34. If I could not control my thoughts I would go crazy………………... 
 
    
35. l will lose out in life if l do not worry…………………………….…. 
 
    
36. When l start worrying I cannot stop…………………………………. 
 
    
37. Some thoughts will always need to be controlled……………………     
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38. I need to worry, in order to get things done…………………………. 
 
    
39. I will be punished for not controlling certain thoughts……………… 
 
    
40. My thoughts interfere with my concentration……………………….. 
 
    
41. It is alright to let my thoughts roam free……………………………. 
 
    
42. I worry about my thoughts…………………………………………... 
 
    
43. I am easily distracted………………………………………………... 
 
    
44. My worrying thoughts are not productive…………………………... 
 
    
45. Worry can stop me from seeing a situation clearly…………………. 
 
    
46. Worrying helps me to solve problems………………………………. 
 
    
47. I have little confidence in my memory for places…………………... 
 
    
48. My worrying thoughts are uncontrollable…………………………... 
 
    
49. It is bad to think certain thoughts……………………………….…… 
 
    
50. If I do not control my thoughts, I may end up embarrassing myself... 
 
    
51. I do not trust my memory…………………………………………… 
 
    
52. I do my clearest thinking when I am worrying……………………… 
 
    
53. My worrying thoughts appear automatically………………………... 
 
    
54. l would be selfish if I never worried………………………………… 
 
    
55. If l could not control my thoughts, I would not be able to function… 
 
    
56. I need to worry, in order to work well………………………………. 
 
    
57. l have little confidence in my memory for actions………………….. 
 
    
58. I have difficulty keeping my mind focused on one thing for a long 
time……………………………………………………………………… 
 
    
59. If a bad thing happens which I have not worried about, I feel 
responsible……………………………………………………………….     
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60. It would not be normal, if I did not worry……………………….….. 
 
    
61. I constantly examine my thoughts…………………………………... 
 
    
62. If I stopped worrying, l would become glib, arrogant and 
offensive…………………………………………………………………. 
 
    
63. Worrying helps me to plan the future more effectively……………... 
 
    
64. I would be a stronger person if I could worry less…………………... 
 
    
65. It would be stupid and complacent not to worry…………………….     
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PSWQ 
 
Instructions: Listed below are a number of statements about how much and under what 
circumstances you find that you worry.  Using the 5-point scale shown below, please rate 
the extent to which the behaviour described by each statement has been typical of you by 
colouring in the circle that best reflects your response. 
 
1        2        3               4         5 
                                    not at all                  very typical 
                                typical of me                                         of me 
  
       
1. If I do not have enough time to do everything, I do 
not worry about it………………………………… 
 
 
     
2. My worries overwhelm me……………………….. 
 
      
3. I do not tend to worry about things……………….. 
 
      
4. Many situations make me worry………………….. 
 
      
5. I know I should not worry about things, but I just 
cannot help it……………………………………… 
 
 
     
6. When I am under pressure I worry a lot…………... 
 
      
7. I am always worrying about something…………... 
 
      
8. I find it easy to dismiss worrisome thoughts……… 
 
      
9. As soon as I finish one task, I start to worry about 
everything else I have to do………………………. 
 
 
     
10. I never worry about anything……………………... 
 
      
11. When there is nothing more I can do about a 
concern, I do not worry about it anymore………… 
 
 
     
12. I have been a worrier all my life………………….. 
 
      
13. I notice that I have been worrying about things….. 
 
      
14. Once I start worrying I cannot stop………………. 
 
      
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15. I worry all the time………………………………... 
 
      
16. I worry about projects until they are all done….…. 
 
      
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SIAS 
 
Instructions: For each question please colour in a circle to indicate the degree to which 
you feel the statement is characteristic or true of you. DO NOT tick, cross or circle your 
answer.  Please use a blue or black pen. DO NOT use a pencil. The rating scale is as 
follows: 
 
0                            1                            2         3             4 
Not at all true              Slightly characteristic                  Moderately                  Very characteristic   Extremely true or   
characteristic                      or true of me.                          characteristic or                    or true of me               characteristic of 
of me                        true of me                   me 
 
1. I get nervous if I have to speak to someone in authority (eg, 
teacher, boss)……………………………………      
2. I have difficulty making eye-contact with others……………      
3. I become tense if I have to talk about myself or my feelings……      
4. I find it difficult mixing comfortably with the people I work with      
5. I find it easy to make friends of my own age…………………….      
6. I tense-up if I meet an acquaintance in the street……...……      
7. When mixing socially, I am uncomfortable………………..….      
8. I feel tense if I am alone with just one person……………...…      
9. I am at ease meeting people at parties, etc…………….………      
10. I have difficulty talking with other people…………………….      
11. I find it easy to think of things to talk about…………………..      
12. I worry about expressing myself in case I appear awkward...……      
13. I find it difficult to disagree with another’s point of view……      
14. I have difficulty talking to an attractive person of the opposite 
sex.… 
     
15. I find myself worrying that I won’t know what to say in social 
situations……………………………………………      
16. I am nervous mixing with people I don’t know well…………      
17. I feel I’ll say something embarrassing when talking……………      
18. When mixing in a group I find myself worrying I will be 
ignored…………………………………………………………. 
     
19. I am tense mixing in a group…….................................................      
20. I am unsure whether to greet someone I know only slightly……      
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SPS 
 
Instructions: For each question, please colour in a circle to indicate the degree to which 
you feel the statement is characteristic or true of you. DO NOT tick, cross or circle your 
answer. Please use a blue or black pen.  DO NOT use a pencil. The rating scale is as 
follows: 
 
          0                            1                            2         3             4 
   Not at all true        Slightly characteristic           Moderately              Very characteristic   Extremely true or 
characteristic                      or true of me.                          characteristic or                    or true of me               characteristic of  
        of me                        true of me                   me     
 
1. I become anxious if I have to write in front of other people……      
2. I become self-conscious when using public toilets…………….      
3. I can suddenly become aware of my own voice and of others 
listening to me … 
     
4. I get nervous that people are staring at me as I walk down the 
street...  
     
5. I fear I may blush when I am with others......................       
6. I feel self-conscious if I have to enter a room where others are 
already seated … 
     
7. I worry about shaking or trembling when I’m watched by other 
people ……… 
     
8. I would get tense if I had to sit facing people on a bus or a 
train……. 
     
9. I get panicky that others might see me faint, or get sick or 
ill…….…. 
     
10. I would find it difficult to drink something if in a group of 
people….. 
     
11. It would make me feel self-conscious to eat in front of a stranger at 
a restaurant 
     
12. I am worried people will think my behaviour odd ...........      
13. I would get tense if I had to carry a tray across a crowded 
cafeteria…  
     
14. I worry I’ll lose control of myself in front of other people ........      
15. I worry I might do something to attract the attention of other 
people...       
16. When in an elevator, I am tense if people look at me ....………      
17. I can feel conspicuous standing in a line………………      
18. I can get tense when speaking in front of other 
people………………. 
     
19. I worry my head will shake or nod in front of others ................      
20. I feel awkward and tense if I know people are watching me..      
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FNE  
Instructions: read each of the following statements carefully and in each case indicate 
whether or not the statement applies to you by circling either “T” for true or “F” for false. 
There are no right or wrong answers, and no trick questions. Please answer every 
question, even if you are not completely sure of the answer. 
 
1. I rarely worry about seeming foolish to others……………………..      T     F  
2. I worry about what people will think of me even when I know it doesn’t make any 
difference…………………………………………………….…       T     F 
3. I become tense and jittery if I know someone is sizing me up……...      T     F 
4. I am unconcerned even if I know people are forming an unfavourable impression of 
me……………………………………………………………..….       T     F 
5. I feel very upset when I commit some social error…………….……      T     F  
6. The opinions that important people have of me cause me little               
concern……………………………………………………………….     T     F 
7. I am often afraid that I may look ridiculous or make a fool of                  
myself…………………………………………………………………    T     F  
8. I react very little when other people disapprove of me……………….    T     F 
9. I am frequently afraid of other people noticing my shortcomings….…   T     F  
10. The disapproval of others would have little effect on me………..…...   T     F 
11. If someone is evaluating me I tend to expect the worst…………..…..    T     F   
12. I rarely worry about what kind of impression I am making on 
someone………………………………………………………..….     T     F  
13. I am afraid that others will not approve of me……………………...…    T     F  
14. I am afraid that people will find fault with me……………………...…    T     F  
15. Other people’s opinions of me do not bother me………………….….      T     F  
16. I am not usually upset if I do not please someone…………………....      T     F   
17. When I am talking to someone, I worry about what they may be thinking  
about me……………………………………………………………..…       T     F     
18. I feel that you can’t help making social errors sometimes, so why worry   
about it…………………………………………………………..…….…     T     F 
19. I am usually worried about what kind of impression I make……….…     T     F  
20. I worry a lot about what my superiors think of me…………………….    T     F  
21. If I know someone is judging me, it has little effect on me………….…   T     F 
22. I worry that others will think I am not worthwhile………………….…..  T     F  
23. I worry very little about what others may think of me……………….…  T     F 
24. Sometimes I think I am too concerned with what other people  
      think of me……………………………………………………………....  T     F 
25. I often worry that I will say or do the wrong things…………………..… T     F  
26. I am often indifferent to the opinion others have of me……………….... T     F  
27. I am usually confident that others will have a favourable impression of 
me………………………………………………………...   T     F  
28. I often worry that people who are important won’t think very much of 
me……………………………………………………………...    T     F   
29. I brood about the opinions my friends have about me………………..… T     F 
30. I become tense and jittery if I know I am being judged by my 
superiors………………………………………………………..……   T     F  
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ACQ 
 
Instructions: This questionnaire contains a list of thoughts people might have at times 
when they are feeling nervous, frightened or anxious. Using the 5-point scale shown 
below rate the degree to which you experience each thought when you are in situations 
where you have been very nervous, frightened or anxious. 
        1               2            3                   4                   5 
|__________|__________|__________|__________| 
                 The thought                      Occurs about                   The thought 
                never occurs               half the time                 always occurs 
 
Again, please colour in the circle next to your response. DO NOT tick, cross or circle 
your answer.  Use a blue or black pen.  DO NOT use a pencil or liquid paper.  
1. I am going to throw up 
 
     
2. I am going to pass out 
 
     
3. I must have a brain tumour 
 
     
4. I must have a brain tumour 
 
     
5. I will choke to death   
 
     
6. I am going to act foolishly   
 
     
7. I am going blind 
 
     
8. I will not be able to control myself 
 
     
9. I will hurt someone   
 
     
10. I am going to have a stroke   
 
     
11. I am going to go crazy  
 
     
12. I am going to scream  
 
     
13. I am going to babble or talk funny  
  
     
14. I will be paralyzed by fear   
 
     
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BSQ 
Instructions: this questionnaire contains a list of sensations people might have at times 
when they are feeling nervous, frightened or anxious. Using the 5 – point scale shown 
below rate the degree to which you are worried or frightened by the sensations when you 
are in situations where you have been very nervous, frightened or anxious.  
 
 
1     2      3   4    5  
Not frightened or                                Extremely frightened 
Worried by this                         by this sensation  
Sensation  
 
 
1. Heart palpitations………………………………………….1     2     3     4     5 
2. Pressure in your chest……………………………………..1     2     3     4     5 
3. Numbness in your arms or legs……………………………1     2     3     4     5 
4. Tingling in your fingertips……………………………….   1     2     3     4     5 
5. Numbness in another part of your body …………………..1     2     3     4     5 
6. Feeling short of breath……………………………………..1     2     3     4     5 
7. Dizziness……………………………………………………1     2     3     4     5 
8. Blurred or distorted vision………………………………….1     2     3     4     5 
9. Nausea………………………………………………………1     2     3     4     5 
10. Butterflies in your stomach ………………………………...1     2     3     4     5 
11. Knots in your stomach ……………………………………..1     2     3     4     5 
12. A lump in your throat ………………………………………1     2     3     4     5 
13. Wobbly or rubber legs ……………………………………...1     2     3     4     5 
14. Sweating ……………………………………………………1     2     3     4     5 
15. Dry throat ……………………………………………….….1     2     3     4     5 
16. Feeling disoriented and confused ………………………….1     2     3     4     5 
17. Feeling disconnected from your body ……………………..1     2     3     4     5 
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PI-WSUR 
 
Instructions: The following statements refer to thoughts and behaviours which may 
occur to everyone in everyday life. For each statement, colour in the circle under the 
number which best seems to fit you and the degree of disturbance which such thoughts or 
behaviours may create. Rate your replies as follows: 
 
                     0                         1                           2                          3                       4 
               Not at all             A little             Quite a lot               A lot             Very much 
 
1 I feel my hands are dirty when I touch money………………………       
2 I think even slight contact with bodily secretions (perspiration, 
saliva, urine, etc.) may contaminate my clothes or somehow harm 
me . . . . . …………………………………………………………….. 
 
     
3 I find it difficult to touch an object when I know it has been touched 
by strangers or by certain people …………………………………… 
      
4 I find it difficult to touch garbage or dirty things..  …………………       
5 I avoid using public toilets because I am afraid of disease and 
contamination………………………………………………………
… 
 
     
6 I avoid using public telephones because I am afraid of contagion and 
disease  ……………………………………………………………… 
      
7 I wash my hands more often and longer than necessary  ……………       
8 I sometimes have to wash or clean myself simply because I think I 
may be dirty or ‘contaminated’……………………………………… 
      
9 If I touch something I think is ‘contaminated’ I immediately have to 
wash or clean myself  ……………………………………………….. 
      
10 If an animal touches me I feel dirty and immediately have to wash 
myself or change my clothing……………………………………….. 
      
11 I feel obliged to follow a particular order in dressing, undressing and 
washing 
myself……………………………………………………….. 
 
     
12 Before going to sleep I have to do certain things in a certain order….       
13 Before going to bed I have to hang up or fold my clothes in a special 
way.………………………………………………………………….. 
      
 
14 I have to do things several times before I think they are properly 
done………………………………………………………………….. 
      
15 I tend to keep on checking things more often than necessary………..       
16 I check and re-check gas and water taps and light switches after 
turning them off……………………………………………………… 
      
17 I return home to check doors, windows, drawers, etc. to make sure       
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they are properly shut. ………………………………….…… 
18 I keep on checking forms, documents, cheques in detail to make 
sure I have filled them in correctly…………………………………  
      
19 I keep on going back to see that matches, cigarettes, etc. are 
properly extinguished………………………………………. 
 
 
     
20 When I handle money I count and recount it several times ……….       
21 I check letters carefully many times before posting them 
…………… 
      
22 Sometimes I am not sure I have done things which in fact I know I 
have done ……………………..……………………………. 
      
23 When I read, I have the impression I have missed something 
important and must go back and re-read the passage at least two or 
three times…………………………………………………………… 
 
     
24 I imagine catastrophic consequences as a result of absent-
mindedness or minor errors which I make ………………………….. 
      
25 I think or worry at length about having hurt someone without 
knowing it……………………………………………………………. 
      
26 When I hear about a disaster, I think somehow it is my 
fault………………………………………………………………….. 
      
27 I sometimes worry at length for no reason that I have hurt myself or 
have some disease…………………………………………………… 
      
28 I get upset or worried at the sight of knives, daggers, and other 
pointed objects……………………………………………….……… 
      
29 When I hear about suicide or crime, I am upset for a long time and 
find it difficult to stop thinking about 
it……………………………… 
      
 
30 I invent useless worries about germs and disease……………………       
31 When I look down from a bridge or a very high window, I feel an 
impulse to throw myself into space………………………………….. 
      
32 When I see a train approaching, I sometimes think I could throw 
myself under it’s 
wheels……………………………………………… 
 
     
33 At certain moments, I am tempted to tear my clothes off in 
public…….…………………………………………………………
… 
 
     
34 While driving I sometimes feel an impulse to drive the car into 
someone or something……………………………………………….. 
      
35 Seeing weapons excites me and makes me think violent 
thoughts……………………………………………………………… 
      
36 I sometimes feel the need to break or damage things for no 
reason…. 
      
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37 I sometimes have an impulse to steal other people’s belongings, 
even if they are of no use to me…………………………..…………. 
      
38 I am sometimes almost irresistibly tempted to steal something from 
the supermarket……………………………………………………… 
      
39 I sometimes have an impulse to hurt defenseless children or 
animals….…………………………………………………………… 
      
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Y-BOCS 
Instructions: Please complete the following questions, choosing only one number per item. 
Scores should reflect the composite effect of all obsessive compulsive symptoms. Rate the 
average occurrence of each item during the prior week up to and including now by colouring in 
the appropriate circle. 
Your most frequent obsessions: 
………………………………………………………………………………………………
………………………………………………………………………………… … 
Your most frequent compulsions: 
………………………………………………………………………………………………
…………………………………………………………………………………… 
Obsession Rating Scale  
- Range of Severity - 
 Item  0hrs / 
day  
0 –
1hrs/day  
1 – 3hrs/day  3 – 8hrs/day  8+ hrs/day  
1 Time spent 
on 
obsessions  
     
  None  Mild  Definite but 
manageable  
Substantial 
impairment 
Incapacitating  
2 Interference 
from 
obsessions  
     
  None  Little Moderate  Severe Near constant  
3 Distress 
from 
obsessions 
     
  Always 
resist  
Much 
resistance  
Some 
resistance  
Often yield  Completely 
yield  
4 Resistance to 
obsessions       
  Comple
te 
control 
Much 
control  
Some control  Little control  No control  
5 Control over 
obsessions       
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Compulsion Rating Scale  
- Range of Severity - 
 Item  0hrs / day  0 –
1hrs/day  
1 – 3hrs/day  3 – 8hrs/day  8+ hrs/day  
1 Time spent 
on 
compulsions  
     
  None  Mild  Definite but 
manageable  
Substantial 
impairment 
Incapacitating  
2 Interference 
from 
compulsions  
     
  None  Little Moderate  Severe Near constant  
3 Distress 
from 
compulsions 
     
  Always 
resist  
Much 
resistance  
Some 
resistance  
Often yield  Completely 
yield  
4 Resistance to 
compulsions       
  Complete 
control 
Much 
control  
Some control  Little control  No control  
5 Control over 
compulsions       
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MOCI 
Instructions: Please answer each question by putting a circle around the “True” or the 
“False” following the question. There are no right or wrong answers, and no trick 
questions. Work quickly and do not think too long about the exact meaning of the 
question.  
1. I avoid using public telephone because of possible contamination  True False 
2. I frequently get nasty thoughts and have difficulty getting rid of 
them  
True False 
3. I am more concerned than most people about honesty True False 
4. I am often late because I can’t seem to get through everything on 
time  
True False 
5. I don’t worry unduly about contamination if I touch an animal  True False 
6. I frequently have to check things (eg. gas or water taps, doors etc) 
several times 
True False 
7. I have a very strict conscience  True False 
8. I find that almost every day I am upset by unpleasant thoughts that 
come into my mind against my will  
True False 
9. I do not worry unduly if I accidentally bump into somebody  True False 
10. I usually have serious doubts about the simple everyday things I 
do  
True False 
11.Neither of my parent was very strict during my childhood True False 
12.I tend to get behind in my work because I repeat things over and 
over again 
True False 
13. I use an average amount of soap True False 
14. Some numbers are extremely unlucky  True False 
15.I do not check letters over and over again before posting them True False 
16.I do not take a long time to dress in the morning  True False 
17. I am not excessively concerned about cleanliness  True False 
18.One of my major problems is that I pay too much attention to 
detail  
True False 
19. I can use well-kept toilets without any hesitation  True False 
20.My major problem is repeated checking  True False 
21.I am not unduly concerned about germs and diseases  True False 
22.I do not tend to check things more than once True False 
23.I do not stick to a very strict routine when doing ordinary things  True False 
24.My hands do not feel dirty after touching money  True False 
25.I do not usually count when doing a routine task True False 
26. I take a rather long time to complete my washing in the morning  True False 
27.I do not use a great deal of antiseptics  True False 
28.I spend a lot of time every day checking things over and over 
again  
True False 
29. Hanging and folding my clothes at night does not take a long time  True False 
30. Even when I do something very carefully I often feel that it is not 
right 
True False 
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PDS 
 
Please indicate how many of the following events you have witnessed or 
experienced:  
 Accident or fire       
 Natural diaster       
 Nonsexual assault (known assailant)     
 Nonsexual assault (unknown assailant)    
 Sexual assault (known assailant)    
 Sexual assault (unknown assailant)    
 Combat or war zone       
 Sexual abuse        
 Imprisonment        
 Torture       
 Life-threatening illness      
 Other         
 
Please indicate which of the above events has disturbed you most in the past month and 
briefly describe the event in the space provided.  
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
______________________________________________________ 
 
Please refer to the above event when answering the following questions.  
1. Was there any physical injury to yourself as a result of the event?  Yes / No  
2. Was there any physical injury to someone else as a  result of the event?  Yes / No 
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3. Did you feel that your life or someone else’s life was in danger at  
    the time of this event?        Yes / No 
4. Did you have a feeling of helplessness or terror at the time of the event? Yes / No 
  
The following items refer to the frequency with which you have experienced these 
symptoms in the past month:  
 0   1   2   3 
 Once in a while        Some of the time           Half the time                Almost always  
 Once a week or less     2 times / week       3 – 4 times / week         5 + times / week 
               
1. Having upsetting thoughts or images about the traumatic event that came 
into your head when you didn’t want them to 
2. Having bad dreams or nightmares about the traumatic event  
3. Reliving the traumatic event, acting or feeling as if it was happening again  
4. Feeling emotionally upset when you were reminded of the traumatic event 
(eg feeling scared, sad, angry, guilty etc)  
5. Experiencing physical reactions when you were reminded of the traumatic 
event (eg breaking out in a sweat, heart beating fast)  
6. Trying not to think about, or have feelings about the traumatic event 
7. Trying to avoid activities, people or places that remind you of the 
traumatic event  
8. In ability to recall an important aspect of the trauma  
9. Having much less interest or participating much less often in important 
activities  
10. Feeling distant or cut off from people around you  
11. Feeling emotionally numb (for example being unable to cry or unable to 
have loving feelings)  
12. Feeling as if your future plans or hopes will not come true (for example 
you will not have a career, marriage, children or a long life)  
13. Having trouble falling or staying asleep  
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14. Feeling irritable or having fits of anger  
15. Having trouble concentrating (for example drifting in and out of 
conversations, losing track of a story on television, forgetting what you 
read)  
16. Being overly alert (for example checking to see who is around you , being 
uncomfortable with your back to a door etc)  
17. Being jumpy and easily startled (for example when someone walks up 
behind you)  
 
Please indicate whether your symptoms have interfered with the following areas within 
the past month :  
 
1. Work      Yes / No  
2. Household duties    Yes / No 
3. Friendships    Yes / No 
4. Family relationships    Yes / No 
5. Fun and leisure activities   Yes / No 
6. Schoolwork     Yes / No 
7. Sex life    Yes / No 
8. General satisfaction with life   Yes / No 
9. Overall level of functioning   Yes / No 
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IES – Revised 
 
Instructions: Below is a list of difficulties people sometimes have after stressful life 
events. Please read each item, and then indicate how distressing each difficulty has been 
for you DURING THE PAST SEVEN DAYS with respect to _______________, how 
much were you distressed or bothered by these difficulties? 
 Not at all 
A little 
bit Moderately 
Quite a 
bit Extremely 
Any reminder brought back 
feelings about it 0 1 2 3 4 
I had trouble staying asleep 0 1 2 3 4 
Other things kept making 
me think about it 0 1 2 3 4 
I felt irritable and angry 0 1 2 3 4 
I avoided letting myself get 
upset when I thought about 
it or was reminded of it 
0 1 2 3 4 
I thought about it when I 
didn’t mean to 0 1 2 3 4 
I felt as if it hadn’t 
happened or wasn’t real 0 1 2 3 4 
I stayed away from 
reminders about it 0 1 2 3 4 
Pictures about it popped 
into my mind 0 1 2 3 4 
I was jumpy and easily 
startled 0 1 2 3 4 
I tried not to think about it 0 1 2 3 4 
I was aware that I still had a 
lot of feelings about it, but I 
didn’t deal with them 
0 1 2 3 4 
My feelings about it were 
kind of numb 0 1 2 3 4 
I found myself acting or 
feeling as though I was 
back at that time 
0 1 2 3 4 
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 Not at all 
A little 
bit Moderately 
Quite a 
bit Extremely 
I had trouble falling asleep 0 1 2 3 4 
I had waves of strong 
feelings about it 0 1 2 3 4 
I tried to remove it from my 
memory 0 1 2 3 4 
I had trouble concentrating 0 1 2 3 4 
Reminders of it caused me 
to have physical reactions, 
such as sweating, trouble 
breathing, nausea, or a 
pounding heart 
0 1 2 3 4 
I had dreams about it 0 1 2 3 4 
I felt watchful or on-guard 
  
0 1 2 3 4 
I tried not to talk about it 0 1 2 3 4 
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APPENDIX I 
 
 
Statistical Analyses 
 
 
All statistical analyses may be found on the disc located in the sleeve on the back cover 
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1. DEMOGRAPHIC STATISTICS & CLINICAL CHARACTERISTICS   
1.1 DESCRIPTIVE STATISTICS  
 
INPATIENT ED WHOLE SAMPLE  
 
Statistics
50 50 50 49 50 49
0 0 0 1 0 1
25.38 .26 14.20 88.29 17.2698 17.96
8.263 .922 2.030 78.481 3.23910 6.324
18 0 11 3 12.55 11
56 4 20 276 25.50 43
Valid
Missing
N
Mean
Std. Deviation
Minimum
Maximum
Age
Children
(number)
Education
(Years)
ED Length
(Months) BMI
ED Onset
Age (Years)
 
 
 
Statistics
50 50 37 24
0 0 13 26
93.70 54.96 15.19 89.42
88.939 97.219 9.015 59.598
0 0 5 12
288 360 43 264
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
Anxiety Length
(Months)
Secondary
Anxiety Length
(Months)
Anxiety Onset
Age (Years)
Time Between
Anxiety Dx and
ED (Months)
 
 
Statistics
50 50 50 50 50 50
0 0 0 0 0 0
5.38 13.42 9.22 36.30 52.00 11.00
9.659 28.912 11.710 73.544 84.201 13.482
0 0 0 0 0 0
28 140 28 280 400 30
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
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Children (number)
46 92.0 92.0 92.0
1 2.0 2.0 94.0
1 2.0 2.0 96.0
2 4.0 4.0 100.0
50 100.0 100.0
0
2
3
4
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Marital Status
5 10.0 10.0 10.0
36 72.0 72.0 82.0
2 4.0 4.0 86.0
1 2.0 2.0 88.0
2 4.0 4.0 92.0
4 8.0 8.0 100.0
50 100.0 100.0
Married
Single
cohabiting
Separated
Divorced
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Employment Status
23 46.0 46.0 46.0
15 30.0 30.0 76.0
12 24.0 24.0 100.0
50 100.0 100.0
employed
unemployed
F/T Student
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Depression Levels
6 12.0 13.6 13.6
4 8.0 9.1 22.7
10 20.0 22.7 45.5
7 14.0 15.9 61.4
17 34.0 38.6 100.0
44 88.0 100.0
6 12.0
50 100.0
Normal
Mild
Moderate
Severe
Ex Severe
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
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Antidepressant Medication
37 74.0 74.0 74.0
13 26.0 26.0 100.0
50 100.0 100.0
Antidepressant
Medication
No Antidepressant
Medication
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Eating Disorder Diagnosis
19 38.0 38.0 38.0
14 28.0 28.0 66.0
6 12.0 12.0 78.0
11 22.0 22.0 100.0
50 100.0 100.0
ANR
ANBP
BN
EDNOS
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Binging
31 62.0 62.0 62.0
19 38.0 38.0 100.0
50 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Laxative Use
38 76.0 76.0 76.0
12 24.0 24.0 100.0
50 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
28 56.0 56.0 56.0
22 44.0 44.0 100.0
50 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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INPATIENT ED COMORBID AD & ED ONLY 
 
Statistics
37 37 37 37 37 37
0 0 0 0 0 0
25.70 .19 14.24 92.49 126.62 17.5662
7.356 .811 1.992 77.714 80.513 3.27953
18 0 11 8 5 12.55
46 4 19 276 288 25.50
Valid
Missing
N
Mean
Std. Deviation
Minimum
Maximum
Age
Children
(number)
Education
(Years)
ED Length
(Months)
Anxiety Length
(Months) BMI
 
Statistics
37 37 37 24
0 0 0 13
74.27 17.95 15.19 89.42
106.727 6.472 9.015 59.598
0 11 5 12
360 43 43 264
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
Secondary
Anxiety Length
(Months)
ED Onset
Age (Years)
Anxiety Onset
Age (Years)
Time Between
Anxiety Dx and
ED (Months)
 
 
Statistics
37 37 37 37 37 37
0 0 0 0 0 0
5.16 13.59 9.51 39.51 61.35 11.78
9.625 31.756 11.357 81.351 93.338 13.505
0 0 0 0 0 0
28 140 28 280 400 30
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
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Children (number)
35 94.6 94.6 94.6
1 2.7 2.7 97.3
1 2.7 2.7 100.0
37 100.0 100.0
0
3
4
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Marital Status
3 8.1 8.1 8.1
26 70.3 70.3 78.4
2 5.4 5.4 83.8
1 2.7 2.7 86.5
2 5.4 5.4 91.9
3 8.1 8.1 100.0
37 100.0 100.0
Married
Single
cohabiting
Separated
Divorced
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Employment Status
16 43.2 43.2 43.2
13 35.1 35.1 78.4
8 21.6 21.6 100.0
37 100.0 100.0
employed
unemployed
F/T Student
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Antidepressant Medication
30 81.1 81.1 81.1
7 18.9 18.9 100.0
37 100.0 100.0
Antidepressant
Medication
No Antidepressant
Medication
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Depression Levels
2 5.4 6.3 6.3
3 8.1 9.4 15.6
6 16.2 18.8 34.4
5 13.5 15.6 50.0
16 43.2 50.0 100.0
32 86.5 100.0
5 13.5
37 100.0
Normal
Mild
Moderate
Severe
Ex Severe
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Eating Disorder Diagnosis
12 32.4 32.4 32.4
11 29.7 29.7 62.2
6 16.2 16.2 78.4
8 21.6 21.6 100.0
37 100.0 100.0
ANR
ANBP
BN
EDNOS
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
ED Onset Age (Years)
1 2.7 2.7 2.7
1 2.7 2.7 5.4
5 13.5 13.5 18.9
11 29.7 29.7 48.6
3 8.1 8.1 56.8
2 5.4 5.4 62.2
4 10.8 10.8 73.0
4 10.8 10.8 83.8
2 5.4 5.4 89.2
1 2.7 2.7 91.9
1 2.7 2.7 94.6
1 2.7 2.7 97.3
1 2.7 2.7 100.0
37 100.0 100.0
11
12
14
15
16
17
18
19
20
25
30
38
43
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Binging
23 62.2 62.2 62.2
14 37.8 37.8 100.0
37 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Vomiting
16 43.2 43.2 43.2
21 56.8 56.8 100.0
37 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Laxative Use
25 67.6 67.6 67.6
12 32.4 32.4 100.0
37 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
19 51.4 51.4 51.4
18 48.6 48.6 100.0
37 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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INPATIENT ED NO ANXIETY  
Statistics
12 13 12 13 13 13 13 13 13
1 0 1 0 0 0 0 0 0
75.33 16.4262 18.00 3.85 10.77 8.38 27.15 25.38 8.77
82.880 3.08762 6.120 7.755 19.430 13.112 45.927 42.154 13.700
3 14.02 13 0 0 0 0 0 0
240 24.60 36 28 58 28 125 120 30
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
ED Length
(Months) BMI
ED Onset
Age (Years)
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
 
 
Eating Disorder Diagnosis
7 53.8 53.8 53.8
3 23.1 23.1 76.9
3 23.1 23.1 100.0
13 100.0 100.0
ANR
ANBP
EDNOS
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Laxative Use
13 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
9 69.2 69.2 69.2
4 30.8 30.8 100.0
13 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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OUTPATIENT ED WHOLE SAMPLE  
 
Statistics
50 50 50 50 50 50
0 0 0 0 0 0
25.04 .38 13.60 20.4196 99.08 95.04
6.398 .923 2.050 3.17167 76.771 108.281
27 4 9 13.51 330 480
18 0 10 15.44 6 0
45 4 19 28.95 336 480
Valid
Missing
N
Mean
Std. Deviation
Range
Minimum
Maximum
Age
Children
(number)
Education
(Years) BMI
ED Length
(Months)
Anxiety Length
(Months)
 
 
Statistics
50 50 28 21
0 0 22 29
41.28 16.78 12.25 88.71
94.742 4.713 7.250 52.927
480 25 35 216
0 9 5 24
480 34 40 240
Valid
Missing
N
Mean
Std. Deviation
Range
Minimum
Maximum
Secondary
Anxiety Length
(Months)
ED Onset
Age (Years)
Anxiety Onset
Age (Years)
Time Between
Anxiety Dx and
ED (Months)
 
Statistics
50 50 50 50 50 50
0 0 0 0 0 0
9.94 15.08 9.88 22.60 27.90 9.08
11.506 21.824 12.257 45.648 42.858 12.383
28 84 28 280 150 28
0 0 0 0 0 0
28 84 28 280 150 28
Valid
Missing
N
Mean
Std. Deviation
Range
Minimum
Maximum
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
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Children (number)
40 80.0 80.0 80.0
6 12.0 12.0 92.0
3 6.0 6.0 98.0
1 2.0 2.0 100.0
50 100.0 100.0
0
1
3
4
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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OUTPATIENT ED – COMORBID AD & ED  
 
 
Statistics
28 28 28 28 28 28
0 0 0 0 0 0
26.29 .46 13.89 116.04 169.71 20.4139
6.782 1.071 2.061 86.864 90.198 2.74228
18 0 10 6 12 16.45
45 4 18 336 480 28.95
Valid
Missing
N
Mean
Std. Deviation
Minimum
Maximum
Age
Children
(number)
Education
(Years)
ED Length
(Months)
Anxiety Length
(Months) BMI
 
 
Statistics
ED Onset Age (Years)
28
0
16.64
4.724
10
33
Valid
Missing
N
Mean
Std. Deviation
Minimum
Maximum
 
Statistics
Anxiety Onset Age (Years)
28
0
12.25
7.250
Valid
Missing
N
Mean
Std. Deviation
 
 
 
 
 
 
Children (number)
22 78.6 78.6 78.6
3 10.7 10.7 89.3
2 7.1 7.1 96.4
1 3.6 3.6 100.0
28 100.0 100.0
0
1
3
4
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Statistics
28 28 28 28 28 28
0 0 0 0 0 0
6.86 9.75 9.61 16.32 32.14 8.36
10.550 18.360 12.282 25.456 50.943 12.221
0 0 0 0 0 0
28 84 28 84 150 28
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
 
 
Marital Status
6 21.4 21.4 21.4
15 53.6 53.6 75.0
3 10.7 10.7 85.7
1 3.6 3.6 89.3
3 10.7 10.7 100.0
28 100.0 100.0
Married
Single
cohabiting
Divorced
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Employment Status
11 39.3 39.3 39.3
4 14.3 14.3 53.6
13 46.4 46.4 100.0
28 100.0 100.0
employed
unemployed
F/T Student
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Antidepressant Medication
14 50.0 50.0 50.0
14 50.0 50.0 100.0
28 100.0 100.0
Antidepressant
Medication
No Antidepressant
Medication
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Eating Disorder Diagnosis
4 14.3 14.3 14.3
9 32.1 32.1 46.4
15 53.6 53.6 100.0
28 100.0 100.0
ANR
BN
EDNOS
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Depression Levels
5 17.9 18.5 18.5
3 10.7 11.1 29.6
5 17.9 18.5 48.1
6 21.4 22.2 70.4
8 28.6 29.6 100.0
27 96.4 100.0
1 3.6
28 100.0
Normal
Mild
Moderate
Severe
Ex Severe
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
 
 
Binging
17 60.7 60.7 60.7
11 39.3 39.3 100.0
28 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Vomiting
14 50.0 50.0 50.0
14 50.0 50.0 100.0
28 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Laxative Use
26 92.9 92.9 92.9
2 7.1 7.1 100.0
28 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
18 64.3 64.3 64.3
10 35.7 35.7 100.0
28 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
 
 
OUTPATIENT ED – NO ANXIETY GROUP 
Statistics
22 22 22 22 22 22
0 0 0 0 0 0
77.50 20.4268 16.95 21.86 30.59 22.50
56.390 3.71528 4.806 24.328 62.525 29.911
6 15.44 9 0 0 0
192 28.67 34 84 280 90
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
ED Length
(Months) BMI
ED Onset
Age (Years)
No of
Episodes
Binging
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
 
 
 
 
Laxative Use
22 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
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Eating Disorder Diagnosis
1 4.5 4.5 4.5
1 4.5 4.5 9.1
6 27.3 27.3 36.4
14 63.6 63.6 100.0
22 100.0 100.0
ANR
ANBP
BN
EDNOS
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
 
 
 ENTIRE ED SAMPLE (INPATIENT AND OUTPATIENT)  
 
Marital Status
12 12.0 12.0 12.0
66 66.0 66.0 78.0
7 7.0 7.0 85.0
2 2.0 2.0 87.0
3 3.0 3.0 90.0
10 10.0 10.0 100.0
100 100.0 100.0
Married
Single
cohabiting
Separated
Divorced
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Employment Status
41 41.0 41.0 41.0
26 26.0 26.0 67.0
33 33.0 33.0 100.0
100 100.0 100.0
employed
unemployed
F/T Student
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Antidepressant Medication
57 57.0 57.0 57.0
43 43.0 43.0 100.0
100 100.0 100.0
Antidepressant
Medication
No Antidepressant
Medication
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Eating Disorder Diagnosis
24 24.0 24.0 24.0
15 15.0 15.0 39.0
21 21.0 21.0 60.0
40 40.0 40.0 100.0
100 100.0 100.0
ANR
ANBP
BN
EDNOS
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Depression Levels
16 16.0 17.2 17.2
8 8.0 8.6 25.8
22 22.0 23.7 49.5
14 14.0 15.1 64.5
33 33.0 35.5 100.0
93 93.0 100.0
7 7.0
100 100.0
Normal
Mild
Moderate
Severe
Ex Severe
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Binging
54 54.0 54.0 54.0
46 46.0 46.0 100.0
100 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Vomiting
49 49.0 49.0 49.0
51 51.0 51.0 100.0
100 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Laxative Use
86 86.0 86.0 86.0
14 14.0 14.0 100.0
100 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
59 59.0 59.0 59.0
41 41.0 41.0 100.0
100 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Statistics
100 100 100 99 100 100
0 0 0 1 0 0
25.21 .32 13.90 93.74 18.8447 94.37
7.354 .920 2.052 77.415 3.56050 98.584
38 4 10 333 16.40 480
18 0 10 3 12.55 0
56 4 20 336 28.95 480
Valid
Missing
N
Mean
Std. Deviation
Range
Minimum
Maximum
Age
Children
(number)
Education
(Years)
ED Length
(Months) BMI
Anxiety Length
(Months)
 
 
 
Children (number)
86 86.0 86.0 86.0
6 6.0 6.0 92.0
1 1.0 1.0 93.0
4 4.0 4.0 97.0
3 3.0 3.0 100.0
100 100.0 100.0
0
1
2
3
4
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Statistics
100 99 65 45
0 1 35 55
48.12 17.36 13.92 89.09
95.750 5.572 8.369 55.948
480 34 38 252
0 9 5 12
480 43 43 264
Valid
Missing
N
Mean
Std. Deviation
Range
Minimum
Maximum
Secondary
Anxiety Length
(Months)
ED Onset
Age (Years)
Anxiety Onset
Age (Years)
Time Between
Anxiety Dx and
ED (Months)
 
 
Statistics
100 100 100 100 100 100
0 0 0 0 0 0
7.66 14.25 9.55 29.45 39.95 10.04
10.815 25.498 11.930 61.285 67.564 12.915
0 0 0 0 0 0
28 140 28 280 400 30
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
 
 
 
 
DEPRESSION LEVELS COMORBID ED & AD vs ED ONLY  
9 7
2 6
11 11
3 11
9 24
Normal
Mild
Moderate
Severe
Ex Severe
Count
Depression
Levels
No
Count
Depression
Levels
Yes
Anxiety Dx
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TRAUMA ACROSS ED SUBTYPES  
27 16 25
12 5 15
No Trauma Reported
Trauma Reported
Count
Trauma
AN
Count
Trauma
BN
Count
Trauma
EDNOS
Eating Disorder Diagnos is
 
 
OCPD ACROSS ED SUBTYPES  
 
36 21 37
3  3
No
Yes
Count
Possible
OCPD
Diagnosis
AN
Count
Possible
OCPD
Diagnosis
BN
Count
Possible
OCPD
Diagnosis
EDNOS
Eating Disorder Diagnos is
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ENTIRE ED SAMPLE – COMORBID AD & ED GROUP  
Statistics
65 65 65 65 65 65 65 65
0 0 0 0 0 0 0 0
2.69 102.63 18.7929 17.38 12.37 29.52 .22 48.77
1.198 81.967 3.35291 5.779 26.735 64.265 .414 78.790
1 6 12.55 10 0 0 0 0
4 336 28.95 43 140 280 1 400
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
Eating
Disorder
Diagnosis
ED Length
(Months) BMI
ED Onset
Age (Years)
No of
Episodes
Binging
per Month
No of
Episodes
vomiting
per month Laxative Use
Exercise Per
Day (Minutes)
 
 
Eating Disorder Diagnosis
16 24.6 24.6 24.6
11 16.9 16.9 41.5
15 23.1 23.1 64.6
23 35.4 35.4 100.0
65 100.0 100.0
ANR
ANBP
BN
EDNOS
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Laxative Use
51 78.5 78.5 78.5
14 21.5 21.5 100.0
65 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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ENTIRE ED SAMPLE – NO ANXIETY GROUP  
Statistics
35 34 35 34 35 35 35 35
0 1 0 1 0 0 0 0
2.91 76.74 18.9409 17.32 17.74 29.31 23.57 .00
1.245 65.683 3.96698 5.238 22.986 56.231 34.376 .000
1 3 14.02 9 0 0 0 0
4 240 28.67 36 84 280 120 0
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
Eating
Disorder
Diagnosis
ED Length
(Months) BMI
ED Onset
Age (Years)
No of
Episodes
Binging
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes) Laxative Use
 
 
Eating Disorder Diagnosis
8 22.9 22.9 22.9
4 11.4 11.4 34.3
6 17.1 17.1 51.4
17 48.6 48.6 100.0
35 100.0 100.0
ANR
ANBP
BN
EDNOS
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Laxative Use
35 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
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ENTIRE ED SAMPLE ACROSS ED SUBTYPES  
 
Report
26.28 14.13 89.10 15.5841 18.82
39 39 39 39 39
9.055 2.028 80.948 1.05975 6.893
23.67 13.90 87.33 21.4276 16.38
21 21 21 21 21
4.351 1.841 54.777 2.78233 2.924
24.98 13.68 101.82 20.6678 16.44
40 40 39 40 39
6.723 2.200 84.926 3.07958 4.946
25.21 13.90 93.74 18.8447 17.36
100 100 99 100 99
7.354 2.052 77.415 3.56050 5.572
Mean
N
Std. Deviat ion
Mean
N
Std. Deviat ion
Mean
N
Std. Deviat ion
Mean
N
Std. Deviat ion
Eating Disorder
Diagnosis
AN
BN
EDNOS
Total
Age
Education
(Years)
ED Length
(Months) BMI
ED Onset
Age (Years)
 
Marital Status
12 12.0 12.0 12.0
66 66.0 66.0 78.0
7 7.0 7.0 85.0
2 2.0 2.0 87.0
3 3.0 3.0 90.0
10 10.0 10.0 100.0
100 100.0 100.0
Married
Single
cohabiting
Separated
Divorced
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Children (number)
86 86.0 86.0 86.0
6 6.0 6.0 92.0
1 1.0 1.0 93.0
4 4.0 4.0 97.0
3 3.0 3.0 100.0
100 100.0 100.0
0
1
2
3
4
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Employment Status
41 41.0 41.0 41.0
26 26.0 26.0 67.0
33 33.0 33.0 100.0
100 100.0 100.0
employed
unemployed
F/T Student
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Depression Levels
16 16.0 17.2 17.2
8 8.0 8.6 25.8
22 22.0 23.7 49.5
14 14.0 15.1 64.5
33 33.0 35.5 100.0
93 93.0 100.0
7 7.0
100 100.0
Normal
Mild
Moderate
Severe
Ex Severe
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Binging
54 54.0 54.0 54.0
46 46.0 46.0 100.0
100 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Vomiting
49 49.0 49.0 49.0
51 51.0 51.0 100.0
100 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Laxative Use
86 86.0 86.0 86.0
14 14.0 14.0 100.0
100 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
59 59.0 59.0 59.0
41 41.0 41.0 100.0
100 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
AN  
Marital Status
4 10.3 10.3 10.3
25 64.1 64.1 74.4
4 10.3 10.3 84.6
2 5.1 5.1 89.7
2 5.1 5.1 94.9
2 5.1 5.1 100.0
39 100.0 100.0
Married
Single
cohabiting
Separated
Divorced
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Children (number)
33 84.6 84.6 84.6
3 7.7 7.7 92.3
1 2.6 2.6 94.9
1 2.6 2.6 97.4
1 2.6 2.6 100.0
39 100.0 100.0
0
1
2
3
4
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Employment Status
17 43.6 43.6 43.6
13 33.3 33.3 76.9
9 23.1 23.1 100.0
39 100.0 100.0
employed
unemployed
F/T Student
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Depression Levels
5 12.8 14.3 14.3
3 7.7 8.6 22.9
8 20.5 22.9 45.7
5 12.8 14.3 60.0
14 35.9 40.0 100.0
35 89.7 100.0
4 10.3
39 100.0
Normal
Mild
Moderate
Severe
Ex Severe
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Binging
31 79.5 79.5 79.5
8 20.5 20.5 100.0
39 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Vomiting
24 61.5 61.5 61.5
15 38.5 38.5 100.0
39 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Laxative Use
33 84.6 84.6 84.6
6 15.4 15.4 100.0
39 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Exercise Use
24 61.5 61.5 61.5
15 38.5 38.5 100.0
39 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
BN  
Marital Status
2 9.5 9.5 9.5
15 71.4 71.4 81.0
1 4.8 4.8 85.7
3 14.3 14.3 100.0
21 100.0 100.0
Married
Single
Divorced
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Children (number)
21 100.0 100.0 100.00Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Employment Status
10 47.6 47.6 47.6
4 19.0 19.0 66.7
7 33.3 33.3 100.0
21 100.0 100.0
employed
unemployed
F/T Student
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Depression Levels
3 14.3 14.3 14.3
1 4.8 4.8 19.0
6 28.6 28.6 47.6
4 19.0 19.0 66.7
7 33.3 33.3 100.0
21 100.0 100.0
Normal
Mild
Moderate
Severe
Ex Severe
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Binging
21 100.0 100.0 100.0YesValid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Vomiting
3 14.3 14.3 14.3
18 85.7 85.7 100.0
21 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Laxative Use
18 85.7 85.7 85.7
3 14.3 14.3 100.0
21 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
16 76.2 76.2 76.2
5 23.8 23.8 100.0
21 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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EDNOS 
 
Marital Status
6 15.0 15.0 15.0
26 65.0 65.0 80.0
3 7.5 7.5 87.5
5 12.5 12.5 100.0
40 100.0 100.0
Married
Single
cohabiting
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Children (number)
32 80.0 80.0 80.0
3 7.5 7.5 87.5
3 7.5 7.5 95.0
2 5.0 5.0 100.0
40 100.0 100.0
0
1
3
4
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Employment Status
14 35.0 35.0 35.0
9 22.5 22.5 57.5
17 42.5 42.5 100.0
40 100.0 100.0
employed
unemployed
F/T Student
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Depression Levels
8 20.0 21.6 21.6
4 10.0 10.8 32.4
8 20.0 21.6 54.1
5 12.5 13.5 67.6
12 30.0 32.4 100.0
37 92.5 100.0
3 7.5
40 100.0
Normal
Mild
Moderate
Severe
Ex Severe
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
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Binging
23 57.5 57.5 57.5
17 42.5 42.5 100.0
40 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Vomiting
22 55.0 55.0 55.0
18 45.0 45.0 100.0
40 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Laxative Use
35 87.5 87.5 87.5
5 12.5 12.5 100.0
40 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
19 47.5 47.5 47.5
21 52.5 52.5 100.0
40 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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ENTIRE ED SAMPLE PURGATIVE ABUSE  
 
1 1  1 12 21 8 12 2 3 1 1 6 12
  1  15 6 7 3 1    11 5
No
Yes
Count
Vomiting
Count
Laxative
Use
Panic with Ag
Count
Vomiting
Count
Laxative
Use
Panic w/o Ag
Count
Vomiting
Count
Laxative
Use
Social Phobia
Count
Vomiting
Count
Laxative
Use
GAD
Count
Vomiting
Count
Laxative
Use
OCD
Count
Vomiting
Count
Laxative
Use
Specific Phobia
Count
Vomiting
Count
Laxative
Use
PTSD
Anxiety Disorder Diagnos is
 
 
ENTIRE ED SAMPLE TABLES OF MEANS  
 
 
 
 
Report
90.04 83.50 15.3083 19.42 16.94
24 24 24 24 16
87.392 92.984 1.19604 7.306 12.546
87.60 108.00 16.0253 17.87 14.45
15 15 15 15 11
72.349 100.502 .59936 6.300 7.891
87.33 102.29 21.4276 16.38 12.00
21 21 21 21 15
54.777 84.736 2.78233 2.924 4.209
101.82 91.63 20.6678 16.44 12.83
39 40 40 39 23
84.926 109.901 3.07958 4.946 6.807
93.74 94.37 18.8447 17.36 13.92
99 100 100 99 65
77.415 98.584 3.56050 5.572 8.369
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Eating Disorder
Diagnosis
ANR
ANBP
BN
EDNOS
Total
ED Length
(Months)
Anxiety Length
(Months) BMI
ED Onset
Age (Years)
Anxiety Onset
Age (Years)
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Report
.00 .00 .08 .08 43.75 9.33
24 24 24 24 24 24
.000 .000 .408 .408 84.843 13.483
7.73 24.00 15.67 63.73 59.33 11.47
15 15 15 15 15 15
10.977 35.189 10.588 82.948 104.092 13.341
22.52 38.76 21.71 64.33 22.86 4.86
21 21 21 21 21 21
7.954 32.221 10.330 78.026 45.403 9.891
4.43 6.28 6.55 15.90 39.38 12.65
40 40 40 40 40 40
7.442 11.099 10.382 45.996 45.660 13.400
7.66 14.25 9.55 29.45 39.95 10.04
100 100 100 100 100 100
10.815 25.498 11.930 61.285 67.564 12.915
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Eating Disorder
Diagnosis
ANR
ANBP
BN
EDNOS
Total
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
 
 
 
 
 
Report
2.97 9.23 6.08 24.56 49.74 10.15
39 39 39 39 39 39
7.676 24.416 10.019 59.322 91.694 13.293
22.52 38.76 21.71 64.33 22.86 4.86
21 21 21 21 21 21
7.954 32.221 10.330 78.026 45.403 9.891
4.43 6.28 6.55 15.90 39.38 12.65
40 40 40 40 40 40
7.442 11.099 10.382 45.996 45.660 13.400
7.66 14.25 9.55 29.45 39.95 10.04
100 100 100 100 100 100
10.815 25.498 11.930 61.285 67.564 12.915
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Eating Disorder
Diagnosis
AN
BN
EDNOS
Total
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
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 OUTPATIENT ANXIETY - WHOLE SAMPLE  
 
Statistics
52 52 44
0 0 8
34.67 .96 13.45
12.309 1.400 2.444
52 6 14
18 0 7
70 6 21
Valid
Missing
N
Mean
Std. Deviation
Range
Minimum
Maximum
Age
Children
(number)
Education
(Years)
 
 
 
 
Statistics
52 52 52 52 52 52 52
0 0 0 0 0 0 0
2.62 1.62 1.69 3.79 2.71 .94 .12
6 4 1 7 4 7 1
1 0 1 1 1 0 0
7 4 2 8 5 7 1
Valid
Missing
N
Mean
Range
Minimum
Maximum
Marital Status
Employment
Status
Antidepressa
nt Medicat ion
Anxiety
Disorder
Diagnosis
Depression
Levels
Secondary
Anxiety
Diagnosis Trauma
 
 
 
Children (number)
30 57.7 57.7 57.7
6 11.5 11.5 69.2
9 17.3 17.3 86.5
5 9.6 9.6 96.2
1 1.9 1.9 98.1
1 1.9 1.9 100.0
52 100.0 100.0
0
1
2
3
5
6
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Marita l Status
11 21.2 21.2 21.2
26 50.0 50.0 71.2
6 11.5 11.5 82.7
1 1.9 1.9 84.6
2 3.8 3.8 88.5
1 1.9 1.9 90.4
5 9.6 9.6 100.0
52 100.0 100.0
Married
Single
cohabiting
Separated
Divorced
Widowed
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Employment Status
2 3.8 3.8 3.8
25 48.1 48.1 51.9
17 32.7 32.7 84.6
7 13.5 13.5 98.1
1 1.9 1.9 100.0
52 100.0 100.0
0
employed
unemployed
F/T Student
Retired
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Antidepressant Medication
16 30.8 30.8 30.8
36 69.2 69.2 100.0
52 100.0 100.0
Antidepressant
Medication
No Antidepressant
Medication
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Depression Levels
21 40.4 40.4 40.4
4 7.7 7.7 48.1
9 17.3 17.3 65.4
5 9.6 9.6 75.0
13 25.0 25.0 100.0
52 100.0 100.0
Normal
Mild
Moderate
Severe
Ex Severe
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Anxie ty Disorder Diagnosis
9 17.3 17.3 17.3
15 28.8 28.8 46.2
9 17.3 17.3 63.5
12 23.1 23.1 86.5
3 5.8 5.8 92.3
3 5.8 5.8 98.1
1 1.9 1.9 100.0
52 100.0 100.0
Panic with Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
ASD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Secondary Anxiety Diagnosis
39 75.0 75.0 75.0
1 1.9 1.9 76.9
2 3.8 3.8 80.8
5 9.6 9.6 90.4
1 1.9 1.9 92.3
1 1.9 1.9 94.2
1 1.9 1.9 96.2
2 3.8 3.8 100.0
52 100.0 100.0
None
Panic with AG
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Trauma
46 88.5 88.5 88.5
6 11.5 11.5 100.0
52 100.0 100.0
No Trauma Reported
Trauma Reported
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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OUTPATIENT ANXIETY - ED ONLY GROUP  
 
 
Statistics
7 7 7 7 7 7
0 0 0 0 0 0
31.29 .86 13.00 27.6686 147.43 197.14
12.829 1.215 1.155 12.44426 105.916 161.125
19 0 11 17.60 72 24
47 3 15 51.15 348 504
Valid
Missing
N
Mean
Std. Deviation
Minimum
Maximum
Age
Children
(number)
Education
(Years) BMI
ED Length
(Months)
Anxiety Length
(Months)
 
 
 
Statistics
7 7 7 5
0 0 0 2
25.71 19.00 14.86 96.00
68.034 9.933 9.227 49.477
0 9 5 36
180 40 32 156
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
Secondary
Anxiety Length
(Months)
ED Onset
Age (Years)
Anxiety Onset
Age (Years)
Time Between
Anxiety Dx and
ED (Months)
 
 
 
 
Statistics
7 7 7 7 7 7
0 0 0 0 0 0
8.86 9.29 .14 .57 22.86 9.71
13.120 12.867 .378 1.512 29.277 13.238
0 0 0 0 0 0
28 28 1 4 60 28
Valid
Missing
N
Mean
Std. Deviat ion
Minimum
Maximum
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
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Age
1 14.3 14.3 14.3
1 14.3 14.3 28.6
1 14.3 14.3 42.9
1 14.3 14.3 57.1
1 14.3 14.3 71.4
2 28.6 28.6 100.0
7 100.0 100.0
19
20
22
24
40
47
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Children (number)
4 57.1 57.1 57.1
1 14.3 14.3 71.4
1 14.3 14.3 85.7
1 14.3 14.3 100.0
7 100.0 100.0
0
1
2
3
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Marita l Status
2 28.6 28.6 28.6
4 57.1 57.1 85.7
1 14.3 14.3 100.0
7 100.0 100.0
Married
Single
Partner (non cohabiting)
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Employment Status
4 57.1 57.1 57.1
1 14.3 14.3 71.4
2 28.6 28.6 100.0
7 100.0 100.0
employed
unemployed
F/T Student
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Depression Levels
2 28.6 28.6 28.6
2 28.6 28.6 57.1
1 14.3 14.3 71.4
2 28.6 28.6 100.0
7 100.0 100.0
Normal
Moderate
Severe
Ex Severe
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Antidepressant Medication
2 28.6 28.6 28.6
5 71.4 71.4 100.0
7 100.0 100.0
Antidepressant
Medication
No Antidepressant
Medication
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
OUTPATIENT ANXIETY - ED ONLY GROUP 
Eating Disorder Diagnosis
7 100.0 100.0 100.0EDNOSValid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Anxiety Disorder Diagnosis
1 14.3 14.3 14.3
1 14.3 14.3 28.6
3 42.9 42.9 71.4
1 14.3 14.3 85.7
1 14.3 14.3 100.0
7 100.0 100.0
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Temporal Relationship between ED and Anxiety
5 71.4 71.4 71.4
2 28.6 28.6 100.0
7 100.0 100.0
Anxiety before ED
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Secondary Anxiety Diagnosis
6 85.7 85.7 85.7
1 14.3 14.3 100.0
7 100.0 100.0
None
Social Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Secondary Anxiety Length (Months)
6 85.7 85.7 85.7
1 14.3 14.3 100.0
7 100.0 100.0
0
180
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Temporal Relationship secondary anxiety and ED
6 85.7 85.7 85.7
1 14.3 14.3 100.0
7 100.0 100.0
N/A
Anxiety before ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Subclinical AD
7 100.0 100.0 100.0NoneValid
Frequency Percent Valid Percent
Cumulative
Percent
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Binging
2 28.6 28.6 28.6
5 71.4 71.4 100.0
7 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Vomiting
6 85.7 85.7 85.7
1 14.3 14.3 100.0
7 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Laxative Use
7 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
4 57.1 57.1 57.1
3 42.9 42.9 100.0
7 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Trauma
4 57.1 57.1 57.1
3 42.9 42.9 100.0
7 100.0 100.0
No Trauma Reported
Trauma Reported
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Possible OCPD Diagnosis
7 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
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ENTIRE SAMPLE TABLES OF MEANS  
 
 
Report
25.38 .26 14.20
50 50 50
8.263 .922 2.030
25.04 .38 13.60
50 50 50
6.398 .923 2.050
34.67 .96 13.45
52 52 44
12.309 1.400 2.444
28.45 .54 13.76
152 152 144
10.340 1.144 2.181
Mean
N
Std. Deviat ion
Mean
N
Std. Deviat ion
Mean
N
Std. Deviat ion
Mean
N
Std. Deviat ion
Facility
ED Inpatient
ED Outpat ient
Anxiety Patient
Total
Age
Children
(number)
Education
(Years)
 
 
 
Report
88.29 93.70 17.2698 17.96 15.19
49 50 50 49 37
78.481 88.939 3.23910 6.324 9.015
99.08 95.04 20.4196 16.78 12.25
50 50 50 50 28
76.771 108.281 3.17167 4.713 7.250
19.85 27.96 6.3562 19.00 14.86
52 52 52 7 7
62.462 87.550 12.70985 9.933 9.227
68.29 71.65 14.5723 17.47 14.01
151 152 152 106 72
80.517 99.799 9.90993 5.898 8.391
Mean
N
Std. Deviat ion
Mean
N
Std. Deviat ion
Mean
N
Std. Deviat ion
Mean
N
Std. Deviat ion
Facility
ED Inpatient
ED Outpatient
Anxiety Patient
Total
ED Length
(Months)
Anxiety Length
(Months) BMI
ED Onset
Age (Years)
Anxiety Onset
Age (Years)
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Report
5.38 13.42 9.22 36.30 52.00 11.00
50 50 50 50 50 50
9.659 28.912 11.710 73.544 84.201 13.482
9.94 15.08 9.88 22.60 27.90 9.08
50 50 50 50 50 50
11.506 21.824 12.257 45.648 42.858 12.383
1.19 1.25 .02 .08 3.08 1.31
52 52 52 52 52 52
5.438 5.452 .139 .555 12.763 5.641
5.45 9.80 6.29 19.40 27.34 7.05
152 152 152 152 152 152
9.805 21.785 10.673 51.556 57.930 11.721
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Facility
ED Inpatient
ED Outpatient
Anxiety Patient
Total
No of Days
Binging
per Month
No of
Episodes
Binging
per Month
No of Days
Vomiting
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Exercise Days
Per Month
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2. THE PREVALENCE OF ANXIETY DISORDERS    
2.1 DESCRIPTIVE STATISTICS  
 
INPATIENT ED WHOLE SAMPLE  
 
Secondary Anxiety Diagnosis
45 90.0 90.0 90.0
1 2.0 2.0 92.0
2 4.0 4.0 96.0
1 2.0 2.0 98.0
1 2.0 2.0 100.0
50 100.0 100.0
None
Social Phobia
GAD
OCD
Specific Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Secondary Anxiety Diagnosis
29 58.0 58.0 58.0
1 2.0 2.0 60.0
10 20.0 20.0 80.0
7 14.0 14.0 94.0
2 4.0 4.0 98.0
1 2.0 2.0 100.0
50 100.0 100.0
None
Panic with AG
Social Phobia
GAD
OCD
PTSD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Primary Anxiety Disorder Diagnosis 
13 26.0 26.0 26.0 
1 2.0 2.0 28.0 
1 2.0 2.0 30.0 
14 28.0 28.0 58.0 
8 16.0 16.0 74.0 
2 4.0 4.0 78.0 
1 2.0 2.0 80.0 
10 20.0 20.0 100.0 
50 100.0 100.0 
None 
Panic with Ag 
Panic w/o Ag 
Social Phobia 
GAD 
OCD 
Specific Phobia 
PTSD 
Total 
Valid 
Frequency Percent Valid Percent 
Cumulative 
Percent 
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Subclinical AD
44 88.0 88.0 88.0
1 2.0 2.0 90.0
3 6.0 6.0 96.0
2 4.0 4.0 100.0
50 100.0 100.0
None
GAD
OCD
Specific Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Trauma
34 68.0 68.0 68.0
16 32.0 32.0 100.0
50 100.0 100.0
No Trauma Reported
Trauma Reported
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Possible OCPD Diagnosis
47 94.0 94.0 94.0
3 6.0 6.0 100.0
50 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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INPATIENT ED COMORBID AD & ED ONLY  
 
Secondary Anxiety Diagnosis
16 43.2 43.2 43.2
1 2.7 2.7 45.9
10 27.0 27.0 73.0
7 18.9 18.9 91.9
2 5.4 5.4 97.3
1 2.7 2.7 100.0
37 100.0 100.0
None
Panic with AG
Social Phobia
GAD
OCD
PTSD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Anxie ty Disorder Diagnosis
1 2.7 2.7 2.7
1 2.7 2.7 5.4
14 37.8 37.8 43.2
8 21.6 21.6 64.9
2 5.4 5.4 70.3
1 2.7 2.7 73.0
10 27.0 27.0 100.0
37 100.0 100.0
Panic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Secondary Anxiety Diagnosis
32 86.5 86.5 86.5
1 2.7 2.7 89.2
2 5.4 5.4 94.6
1 2.7 2.7 97.3
1 2.7 2.7 100.0
37 100.0 100.0
None
Social Phobia
GAD
OCD
Specific Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Subcl inica l AD
32 86.5 86.5 86.5
3 8.1 8.1 94.6
2 5.4 5.4 100.0
37 100.0 100.0
None
OCD
Specific Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Trauma
22 59.5 59.5 59.5
15 40.5 40.5 100.0
37 100.0 100.0
No Trauma Reported
Trauma Reported
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Possible OCPD Diagnosis
36 97.3 97.3 97.3
1 2.7 2.7 100.0
37 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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OUTPATIENT ED – COMORBID AD & ED  
 
 
Anxiety Disorder Diagnosis
13 46.4 46.4 46.4
7 25.0 25.0 71.4
1 3.6 3.6 75.0
7 25.0 25.0 100.0
28 100.0 100.0
Social Phobia
GAD
OCD
PTSD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Secondary Anxiety Diagnosis
15 53.6 53.6 53.6
1 3.6 3.6 57.1
8 28.6 28.6 85.7
3 10.7 10.7 96.4
1 3.6 3.6 100.0
28 100.0 100.0
None
Panic w/o Ag
Social Phobia
GAD
OCD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Secondary Anxiety Diagnosis
27 96.4 96.4 96.4
1 3.6 3.6 100.0
28 100.0 100.0
None
Specific Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
 
 
Subclinica l AD
25 89.3 89.3 89.3
2 7.1 7.1 96.4
1 3.6 3.6 100.0
28 100.0 100.0
None
Panic with AG
Social Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 373 
 
 
 
Trauma
16 57.1 57.1 57.1
12 42.9 42.9 100.0
28 100.0 100.0
No Trauma Reported
Trauma Reported
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Possible OCPD Diagnosis
27 96.4 96.4 96.4
1 3.6 3.6 100.0
28 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Secondary Anxiety Diagnosis
28 100.0 100.0 100.0NoneValid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
 
 
ENTIRE ED SAMPLE (INPATIENT AND OUTPATIENT)  
 
 
Anxiety Disorder Diagnosis
35 35.0 35.0 35.0
1 1.0 1.0 36.0
1 1.0 1.0 37.0
27 27.0 27.0 64.0
15 15.0 15.0 79.0
3 3.0 3.0 82.0
1 1.0 1.0 83.0
17 17.0 17.0 100.0
100 100.0 100.0
None
Panic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Secondary Anxiety Diagnosis
66 66.0 66.0 66.0
1 1.0 1.0 67.0
1 1.0 1.0 68.0
18 18.0 18.0 86.0
10 10.0 10.0 96.0
3 3.0 3.0 99.0
1 1.0 1.0 100.0
100 100.0 100.0
None
Panic with AG
Panic w/o Ag
Social Phobia
GAD
OCD
PTSD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Secondary Anxiety Diagnosis
94 94.0 94.0 94.0
1 1.0 1.0 95.0
2 2.0 2.0 97.0
1 1.0 1.0 98.0
2 2.0 2.0 100.0
100 100.0 100.0
None
Social Phobia
GAD
OCD
Specific Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Subclinical AD
85 85.0 85.0 85.0
2 2.0 2.0 87.0
2 2.0 2.0 89.0
4 4.0 4.0 93.0
5 5.0 5.0 98.0
2 2.0 2.0 100.0
100 100.0 100.0
None
Panic with AG
Social Phobia
GAD
OCD
Specific Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Trauma
68 68.0 68.0 68.0
32 32.0 32.0 100.0
100 100.0 100.0
No Trauma Reported
Trauma Reported
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Possible OCPD Diagnosis
94 94.0 94.0 94.0
6 6.0 6.0 100.0
100 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
OUTPATIENT ANXIETY - ED ONLY GROUP 
Eating Disorder Diagnosis
7 100.0 100.0 100.0EDNOSValid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Anxiety Disorder Diagnosis
1 14.3 14.3 14.3
1 14.3 14.3 28.6
3 42.9 42.9 71.4
1 14.3 14.3 85.7
1 14.3 14.3 100.0
7 100.0 100.0
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Temporal Relationship between ED and Anxiety
5 71.4 71.4 71.4
2 28.6 28.6 100.0
7 100.0 100.0
Anxiety before ED
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 376 
Secondary Anxiety Diagnosis
6 85.7 85.7 85.7
1 14.3 14.3 100.0
7 100.0 100.0
None
Social Phobia
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Secondary Anxiety Length (Months)
6 85.7 85.7 85.7
1 14.3 14.3 100.0
7 100.0 100.0
0
180
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Temporal Relationship secondary anxiety and ED
6 85.7 85.7 85.7
1 14.3 14.3 100.0
7 100.0 100.0
N/A
Anxiety before ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Subclinical AD
7 100.0 100.0 100.0NoneValid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Binging
2 28.6 28.6 28.6
5 71.4 71.4 100.0
7 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Vomiting
6 85.7 85.7 85.7
1 14.3 14.3 100.0
7 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Laxative Use
7 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Exercise Use
4 57.1 57.1 57.1
3 42.9 42.9 100.0
7 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Trauma
4 57.1 57.1 57.1
3 42.9 42.9 100.0
7 100.0 100.0
No Trauma Reported
Trauma Reported
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Possible OCPD Diagnosis
7 100.0 100.0 100.0NoValid
Frequency Percent Valid Percent
Cumulative
Percent
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3. THE TEMPORAL RELATIONSHIP BETWEEN ED & AD    
3.1 DESCRIPTIVE STATISTICS  
 
INPATIENT ED WHOLE SAMPLE  
 
Temporal Relationship between ED and Anxiety
13 26.0 26.0 26.0
24 48.0 48.0 74.0
7 14.0 14.0 88.0
6 12.0 12.0 100.0
50 100.0 100.0
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Temporal Relationship secondary anxiety and ED
29 58.0 58.0 58.0
11 22.0 22.0 80.0
6 12.0 12.0 92.0
4 8.0 8.0 100.0
50 100.0 100.0
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Temporal  Relationship secondary anxiety and ED
45 90.0 90.0 90.0
3 6.0 6.0 96.0
2 4.0 4.0 100.0
50 100.0 100.0
N/A
Anxiety before ED
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Temporal Relationship between ED and Anxiety
24 64.9 64.9 64.9
7 18.9 18.9 83.8
6 16.2 16.2 100.0
37 100.0 100.0
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
Temporal Relationship secondary anxiety and ED
16 43.2 43.2 43.2
11 29.7 29.7 73.0
6 16.2 16.2 89.2
4 10.8 10.8 100.0
37 100.0 100.0
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Temporal  Relationship secondary anxiety and ED
32 86.5 86.5 86.5
3 8.1 8.1 94.6
2 5.4 5.4 100.0
37 100.0 100.0
N/A
Anxiety before ED
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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INPATIENT ED AGE OF ONSET FOR AD ACROSS WHOLE SAMPLE AND ED 
SUBTYPES   
 
 
Case Processing Summary
37 100.0% 0 .0% 37 100.0%
Anxiety Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
 
 
Report
Anxiety Onset Age (Years)
35.00 1 . 35 35
19.00 1 . 19 19
12.71 14 6.707 5 30
15.38 8 12.258 5 43
11.50 2 7.778 6 17
5.00 1 . 5 5
17.90 10 7.680 10 34
15.19 37 9.015 5 43
Anxiety Disorder
Di iPanic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Mean N Std. Deviat ion Minimum Maximum
 
 
 
AN  
 
Case Processing Summary
23 69.7% 10 30.3% 33 100.0%
Anxiety Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
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Report
Anxiety Onset Age (Years)
35.00 1 . 35 35
10.89 9 4.567 5 16
20.50 4 16.114 5 43
11.50 2 7.778 6 17
5.00 1 . 5 5
18.17 6 8.681 10 34
15.30 23 10.088 5 43
Anxiety Disorder
Panic with Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Mean N Std. Deviation Minimum Maximum
 
 
EDNOS  
 
Case Processing Summary
8 72.7% 3 27.3% 11 100.0%
Anxiety Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
 
 
Report
Anxiety Onset Age (Years)
19.00 1 . 19 19
20.00 3 9.539 11 30
5.00 1 . 5 5
20.00 3 6.245 15 27
18.00 8 8.053 5 30
Anxiety Disorder
Di iPanic w/o Ag
Social Phobia
GAD
PTSD
Total
Mean N Std. Deviat ion Minimum Maximum
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BN ONLY  
 
 
Case Processing Summary
6 100.0% 0 .0% 6 100.0%
Anxiety Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
 
 
Report
Anxiety Onset Age (Years)
10.00 2 5.657 6 14
12.00 3 3.606 8 15
10.00 1 . 10 10
11.00 6 3.578 6 15
Anxiety Disorder
Di iSocial Phobia
GAD
PTSD
Total
Mean N Std. Deviat ion Minimum Maximum
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INPATIENT ED TEMPORAL RELATIONSHIP AD & ED ACROSS THE ED 
SUBTYPES  
 
AN  
 
10       
  8 2 2 1 5
  1 2    
 1     1
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Count
Temporal
Relationship
between ED
and Anxiety
None
Count
Temporal
Relationship
between ED
and Anxiety
Panic with Ag
Count
Temporal
Relationship
between ED
and Anxiety
Social Phobia
Count
Temporal
Relationship
between ED
and Anxiety
GAD
Count
Temporal
Relationship
between ED
and Anxiety
OCD
Count
Temporal
Relationship
between ED
and Anxiety
Specific
Phobia
Count
Temporal
Relationship
between ED
and Anxiety
PTSD
Anxiety Disorder Diagnos is
 
 
 
BN  
1 2 1
1 1  
Anxiety before ED
Anxiety and ED
same time
Count
Temporal
Relationship
between ED
and Anxiety
Social Phobia
Count
Temporal
Relationship
between ED
and Anxiety
GAD
Count
Temporal
Relationship
between ED
and Anxiety
PTSD
Anxiety Disorder Diagnosis
 
 
EDNOS  
 
3     
  1 1  
  1  1
 1 1  2
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Count
Temporal
Relationship
between ED
and Anxiety
None
Count
Temporal
Relationship
between ED
and Anxiety
Panic w/o Ag
Count
Temporal
Relationship
between ED
and Anxiety
Social Phobia
Count
Temporal
Relationship
between ED
and Anxiety
GAD
Count
Temporal
Relationship
between ED
and Anxiety
PTSD
Anxiety Disorder Diagnosis
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OUTPATIENT ED – COMORBID AD & ED 
Temporal Relationship between ED and Anxiety
21 75.0 75.0 75.0
3 10.7 10.7 85.7
4 14.3 14.3 100.0
28 100.0 100.0
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Temporal Relationship secondary anxiety and ED
15 53.6 53.6 53.6
10 35.7 35.7 89.3
1 3.6 3.6 92.9
2 7.1 7.1 100.0
28 100.0 100.0
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Temporal Relationship secondary anxiety and ED
27 96.4 96.4 96.4
1 3.6 3.6 100.0
28 100.0 100.0
N/A
Anxiety before ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
 
 
 
OUTPATIENT ED ONSET AGE FOR EACH AD ACROSS ED SUBTYPES  
 
AN  
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Report
Anxiety Onset Age (Years)
6.00 1 . 6 6
31.50 2 12.021 23 40
9.00 1 . 9 9
19.50 4 15.546 6 40
Anxiety Disorder
Di iSocial Phobia
GAD
PTSD
Total
Mean N Std. Deviat ion Minimum Maximum
 
 
BN  
 
Case Processing Summary
9 60.0% 6 40.0% 15 100.0%
Anxiety Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
 
 
Report
Anxiety Onset Age (Years)
12.60 5 4.393 6 17
8.50 2 4.950 5 12
17.00 2 .000 17 17
12.67 9 4.664 5 17
Anxiety Disorder
Di iSocial Phobia
GAD
PTSD
Total
Mean N Std. Deviat ion Minimum Maximum
  
 
EDNOS  
 
 
Case Processing Summary
15 51.7% 14 48.3% 29 100.0%
Anxiety Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
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Report
Anxiety Onset Age (Years)
11.86 7 5.080 5 18
7.33 3 2.517 5 10
6.00 1 . 6 6
10.00 4 1.633 8 12
10.07 15 4.114 5 18
Anxiety Disorder
Social Phobia
GAD
OCD
PTSD
Total
Mean N Std. Deviat ion Minimum Maximum
 
 
 
WHOLE SAMPLE    
 
Case Processing Summary
28 100.0% 0 .0% 28 100.0%
Anxiety Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
 
 
Report
Anxiety Onset Age (Years)
11.69 13 4.733 5 18
14.57 7 12.817 5 40
6.00 1 . 6 6
11.86 7 3.716 8 17
12.25 28 7.250 5 40
Anxiety Disorder
Social Phobia
GAD
OCD
PTSD
Total
Mean N Std. Deviat ion Minimum Maximum
 
 
 
 
 
 
 387 
OUTPATIENT ED TEMPORAL RELATIONSHIP FOR AD & ED   
 
AN  
 
2    
 1 1 1
  1  
N/A
Anxiety before ED
Anxiety after ED
Count
Temporal
Relationship
between ED
and Anxiety
None
Count
Temporal
Relationship
between ED
and Anxiety
Social Phobia
Count
Temporal
Relationship
between ED
and Anxiety
GAD
Count
Temporal
Relationship
between ED
and Anxiety
PTSD
Anxiety Disorder Diagnosis
 
 
BN  
 
6    
 3 2  
 2   
   2
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Count
Temporal
Relationship
between ED
and Anxiety
None
Count
Temporal
Relationship
between ED
and Anxiety
Social Phobia
Count
Temporal
Relationship
between ED
and Anxiety
GAD
Count
Temporal
Relationship
between ED
and Anxiety
PTSD
Anxiety Disorder Diagnosis
 
 
EDNOS  
14     
 6 3 1 3
 1    
    1
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Count
Temporal
Relationship
between ED
and Anxiety
None
Count
Temporal
Relationship
between ED
and Anxiety
Social Phobia
Count
Temporal
Relationship
between ED
and Anxiety
GAD
Count
Temporal
Relationship
between ED
and Anxiety
OCD
Count
Temporal
Relationship
between ED
and Anxiety
PTSD
Anxiety Disorder Diagnosis
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ENTIRE ED SAMPLE (INPATIENT AND OUTPATIENT)  
 
Temporal Relationship between ED and Anxiety
35 35.0 35.0 35.0
45 45.0 45.0 80.0
10 10.0 10.0 90.0
10 10.0 10.0 100.0
100 100.0 100.0
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Temporal Relationship secondary anxiety and ED
66 66.0 66.0 66.0
21 21.0 21.0 87.0
7 7.0 7.0 94.0
6 6.0 6.0 100.0
100 100.0 100.0
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
Temporal  Relationship secondary anxiety and ED
94 94.0 94.0 94.0
4 4.0 4.0 98.0
2 2.0 2.0 100.0
100 100.0 100.0
N/A
Anxiety before ED
Anxiety after ED
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
 
ENTIRE ED SAMPLE AGE OF ONSET OF AD ACROSS THE ED SUBTYPES 
 
AN  
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Case Processing Summary
27 69.2% 12 30.8% 39 100.0%
Anxiety Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
 
 
Report
Anxiety Onset Age (Years)
35.00 1 . 35 35
10.40 10 4.575 5 16
24.17 6 14.730 5 43
11.50 2 7.778 6 17
5.00 1 . 5 5
16.86 7 8.649 9 34
15.93 27 10.784 5 43
Anxiety Disorder
Di iPanic with Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Mean N Std. Deviation Minimum Maximum
 
 
BN 
 
 
Report
Anxiety Onset Age (Years)
11.86 7 4.451 6 17
10.60 5 4.037 5 15
14.67 3 4.041 10 17
12.00 15 4.209 5 17
Anxiety Disorder
Di iSocial Phobia
GAD
PTSD
Total
Mean N Std. Deviat ion Minimum Maximum
 
 
  
 
 
 
 
 
 
EDNOS  
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Case Processing Summary
39 97.5% 1 2.5% 40 100.0%
ED Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
 
 
Report
ED Onset Age (Years)
17.19 16 5.504 9 34
16.00 1 . 16 16
18.50 10 5.543 12 33
15.00 4 2.828 11 17
15.00 1 . 15 15
12.86 7 1.952 10 15
16.44 39 4.946 9 34
Anxiety Disorder
Di iNone
Panic w/o Ag
Social Phobia
GAD
OCD
PTSD
Total
Mean N Std. Deviation Minimum Maximum
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ENTIRE ED SAMPLE  
 
Case Processing Summary
65 100.0% 0 .0% 65 100.0%
Anxiety Onset Age
(Years)  * Anxiety
Disorder Diagnosis
N Percent N Percent N Percent
Inc luded Excluded Total
Cases
 
 
Report
Anxiety Onset Age (Years)
35.00 1 . 35 35
19.00 1 . 19 19
12.22 27 5.753 5 30
15.00 15 12.071 5 43
9.67 3 6.351 6 17
5.00 1 . 5 5
15.41 17 6.911 8 34
13.92 65 8.369 5 43
Anxiety Disorder
Panic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Mean N Std. Deviat ion Minimum Maximum
 
 
 
 
 
 
 
ENTIRE ED SAMPLE TEMPORAL RELATIONSHIP AD & ED ACROSS ED 
SUBTYPES  
12 6 17
21 9 15
3 4 3
3 2 5
N/A
Anxiety before ED
Anxiety and ED
same time
Anxiety after ED
Count
Temporal
Relationship
between ED
and Anxiety
AN
Count
Temporal
Relationship
between ED
and Anxiety
BN
Count
Temporal
Relationship
between ED
and Anxiety
EDNOS
Eating Disorder Diagnosis
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4. COMPARISONS ACROSS THE SAMPLE  
4.1 CHI- SQUARE ANALYSES  
 
 
ENTIRE ED SAMPLE COMPARISON OF FREQUNCIES OF AD  
 
Type Of Treatment
37 32.5 4.5
28 32.5 -4.5
65
Inpatient
Outpatient
Total
Observed N Expected N Residual
 
 
Test Statistics
1.246
1
.264
Chi-Squarea
df
Asymp. Sig.
Type Of
Treatment
0 cells  (.0%) have expected frequencies less than
5. The minimum expected cell frequency is 32.5.
a. 
 
 
ENTIRE ED SAMPLE COMPARISON OF FREQUENCY OF AD ACROSS ED 
SUBTYPES 
 
EDTYPE
27 21.7 5.3
15 21.7 -6.7
23 21.7 1.3
65
AN
BN
EDNOS
Total
Observed N Expected N Residual
 
 
Test Statistics
3.446
2
.179
Chi-Squarea
df
Asymp. Sig.
EDTYPE
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 21.7.
a. 
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COMPARISON OF DIFFERNECES BETWEEN INPATIENT AND 
OUTPATIENT ED TEMPORAL RELATIONSHIP BETWEEN AD & ED   
 
 
Type of Treatment
24 22.5 1.5
21 22.5 -1.5
45
Inpatient
Outpatient
Total
Observed N Expected N Residual
 
 
Test Statistics
.200
1
.655
Chi-Squarea
df
Asymp. Sig.
Type of
Treatment
0 cells  (.0%) have expected frequencies less than
5. The minimum expected cell frequency is 22.5.
a. 
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ED INPATIENT AND OUTPATIENT EMPLOYMENT COMPARISONS 
 
 
Case Processing Summary
100 100.0% 0 .0% 100 100.0%
TREATMENT  *
Employment
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
TREATMENT  * Employment  Crosstabulation
23 15 12 50
20.5 13.0 16.5 50.0
46.0% 30.0% 24.0% 100.0%
56.1% 57.7% 36.4% 50.0%
23.0% 15.0% 12.0% 50.0%
18 11 21 50
20.5 13.0 16.5 50.0
36.0% 22.0% 42.0% 100.0%
43.9% 42.3% 63.6% 50.0%
18.0% 11.0% 21.0% 50.0%
41 26 33 100
41.0 26.0 33.0 100.0
41.0% 26.0% 33.0% 100.0%
100.0% 100.0% 100.0% 100.0%
41.0% 26.0% 33.0% 100.0%
Count
Expected Count
% within TREATMENT
% within Employment
% of Total
Count
Expected Count
% within TREATMENT
% within Employment
% of Total
Count
Expected Count
% within TREATMENT
% within Employment
% of Total
Inpatient
Outpatient
TREATMENT
Total
Employed Unemployed FT Student
Employment
Total
 
 
Chi-Square Tests
3.680a 2 .159
3.715 2 .156
2.645 1 .104
100
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
0 cells  (.0%) have expected count less than 5. The
minimum expected count is  13.00.
a. 
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Symmetric Measures
.192 .159
.192 .159
100
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptotic standard error assuming the null
hypothesis.
b. 
 
 
 
ED INPATIENT AND OUTPATIENT TREATMENT COMPARISONS  
 
Case Processing Summary
100 100.0% 0 .0% 100 100.0%
TREATMENT  *
Employment
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
TREATMENT  * Employment  Crosstabulation
23 15 12 50
20.5 13.0 16.5 50.0
46.0% 30.0% 24.0% 100.0%
56.1% 57.7% 36.4% 50.0%
23.0% 15.0% 12.0% 50.0%
18 11 21 50
20.5 13.0 16.5 50.0
36.0% 22.0% 42.0% 100.0%
43.9% 42.3% 63.6% 50.0%
18.0% 11.0% 21.0% 50.0%
41 26 33 100
41.0 26.0 33.0 100.0
41.0% 26.0% 33.0% 100.0%
100.0% 100.0% 100.0% 100.0%
41.0% 26.0% 33.0% 100.0%
Count
Expected Count
% within TREATMENT
% within Employment
% of Total
Count
Expected Count
% within TREATMENT
% within Employment
% of Total
Count
Expected Count
% within TREATMENT
% within Employment
% of Total
Inpatient
Outpatient
TREATMENT
Total
Employed Unemployed FT Student
Employment
Total
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Chi-Square Tests
3.680a 2 .159
3.715 2 .156
2.645 1 .104
100
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
0 cells  (.0%) have expected count less than 5. The
minimum expected count is  13.00.
a. 
 
 
Symmetric Measures
.192 .159
.192 .159
100
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptotic standard error assuming the null
hypothesis.
b. 
 
 
 
ED INPATIENT AND OUTPATIENT MARITAL COMPARISONS 
 
Case Processing Summary
95 100.0% 0 .0% 95 100.0%TREATMENT  * MARITAL
N Percent N Percent N Percent
Valid Missing Total
Cases
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TREATMENT  * MARITAL Crosstabulation
11 36 47
14.3 32.7 47.0
23.4% 76.6% 100.0%
37.9% 54.5% 49.5%
11.6% 37.9% 49.5%
18 30 48
14.7 33.3 48.0
37.5% 62.5% 100.0%
62.1% 45.5% 50.5%
18.9% 31.6% 50.5%
29 66 95
29.0 66.0 95.0
30.5% 69.5% 100.0%
100.0% 100.0% 100.0%
30.5% 69.5% 100.0%
Count
Expected Count
% within TREATMENT
% within MARITAL
% of Total
Count
Expected Count
% within TREATMENT
% within MARITAL
% of Total
Count
Expected Count
% within TREATMENT
% within MARITAL
% of Total
Inpatient
Outpatient
TREATMENT
Total
Married Single
MARITAL
Total
 
 
Chi-Square Tests
2.225b 1 .136
1.610 1 .205
2.242 1 .134
.182 .102
2.201 1 .138
95
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less  than 5. The minimum expected count is  14.
35.
b. 
 
 
Symmetric Measures
-.153 .136
.153 .136
95
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptotic standard error assuming the null
hypothesis.
b. 
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ED INPATIENT AND OUTPATIENT CHILDREN COMPARISONS  
 
TREATMENT
4 7.0 -3.0
10 7.0 3.0
14
Inpatient
Outpatient
Total
Observed N Expected N Residual
 
 
Test Statistics
2.571
1
.109
Chi-Squarea
df
Asymp. Sig.
TREATMENT
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 7.0.
a. 
 
 
 
ED INPATIENT AND OUTPATIENT MEDICATION COMPARISONS 
TREATMENT
37 28.5 8.5
20 28.5 -8.5
57
Inpatient
Outpatient
Total
Observed N Expected N Residual
 
 
Test Statistics
5.070
1
.024
Chi-Squarea
df
Asymp. Sig.
TREATMENT
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 28.5.
a. 
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ED INPATIENT AND OUTPATIENT DEPRESSION COMPARISONS 
Case Processing Summary
93 100.0% 0 .0% 93 100.0%
TREATMENT  *
DEPRESSION SCORE
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
TREATMENT  * DEPRESSION SCORE Crosstabulation
6 14 24 44
7.6 14.2 22.2 44.0
13.6% 31.8% 54.5% 100.0%
37.5% 46.7% 51.1% 47.3%
6.5% 15.1% 25.8% 47.3%
10 16 23 49
8.4 15.8 24.8 49.0
20.4% 32.7% 46.9% 100.0%
62.5% 53.3% 48.9% 52.7%
10.8% 17.2% 24.7% 52.7%
16 30 47 93
16.0 30.0 47.0 93.0
17.2% 32.3% 50.5% 100.0%
100.0% 100.0% 100.0% 100.0%
17.2% 32.3% 50.5% 100.0%
Count
Expected Count
% within TREATMENT
% within DEPRESSION
SCORE
% of Total
Count
Expected Count
% within TREATMENT
% within DEPRESSION
SCORE
% of Total
Count
Expected Count
% within TREATMENT
% within DEPRESSION
SCORE
% of Total
Inpatient
Outpatient
TREATMENT
Total
Normal Mild - Mod Sev - Ex Sev
DEPRESSION SCORE
Total
 
 
Chi-Square Tests
.888a 2 .641
.896 2 .639
.837 1 .360
93
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
0 cells  (.0%) have expected count less than 5. The
minimum expected count is  7.57.
a. 
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Symmetric Measures
.098 .641
.098 .641
93
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptotic standard error assuming the null
hypothesis.
b. 
 
 
 
 
ED INPATIENT AND OUTPATIENT BINGEING AND PURGING 
COMPARISONS 
 
TREATMENT
19 23.0 -4.0
27 23.0 4.0
46
Inpatient
Outpatient
Total
Observed N Expected N Residual
 
 
Test Statistics
1.391
1
.238
Chi-Squarea
df
Asymp. Sig.
TREATMENT
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 23.0.
a. 
 
 
 
VOMITING  
 
 
TREATMENT
25 25.5 -.5
26 25.5 .5
51
Inpatient
Outpatient
Total
Observed N Expected N Residual
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Test Statistics
.020
1
.889
Chi-Squarea
df
Asymp. Sig.
TREATMENT
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 25.5.
a. 
 
 
 
 
LAXATIVE ABUSE  
 
 
TREATMENT
12 7.0 5.0
2 7.0 -5.0
14
Inpatient
Outpatient
Total
Observed N Expected N Residual
 
 
Test Statistics
7.143
1
.008
Chi-Squarea
df
Asymp. Sig.
TREATMENT
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 7.0.
a. 
 
 
 
EXCESSIVE EXERCISE  
 
TREATMENT
22 20.5 1.5
19 20.5 -1.5
41
Inpatient
Outpatient
Total
Observed N Expected N Residual
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Test Statistics
.220
1
.639
Chi-Squarea
df
Asymp. Sig.
TREATMENT
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 20.5.
a. 
 403 
 
ED SUBTYPE EMPLOYMENT COMPARISONS 
 
 
Case Processing Summary
100 100.0% 0 .0% 100 100.0%ED * EMPLOYMENT
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
ED * EMPLOYMENT Crosstabulation
17 13 9 39
16.0 10.1 12.9 39.0
43.6% 33.3% 23.1% 100.0%
41.5% 50.0% 27.3% 39.0%
17.0% 13.0% 9.0% 39.0%
10 4 7 21
8.6 5.5 6.9 21.0
47.6% 19.0% 33.3% 100.0%
24.4% 15.4% 21.2% 21.0%
10.0% 4.0% 7.0% 21.0%
14 9 17 40
16.4 10.4 13.2 40.0
35.0% 22.5% 42.5% 100.0%
34.1% 34.6% 51.5% 40.0%
14.0% 9.0% 17.0% 40.0%
41 26 33 100
41.0 26.0 33.0 100.0
41.0% 26.0% 33.0% 100.0%
100.0% 100.0% 100.0% 100.0%
41.0% 26.0% 33.0% 100.0%
Count
Expected Count
% within ED
% within EMPLOYMENT
% of Total
Count
Expected Count
% within ED
% within EMPLOYMENT
% of Total
Count
Expected Count
% within ED
% within EMPLOYMENT
% of Total
Count
Expected Count
% within ED
% within EMPLOYMENT
% of Total
AN
BN
EDNOS
ED
Total
EMPLOYED UNEMPLOED FT STUDENT
EMPLOYMENT
Total
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Chi-Square Tests
4.283a 4 .369 .377
4.318 4 .365 .382
4.202 .384
2.097
b
1 .148 .151 .084 .018
100
Pearson Chi-Square
Likelihood Ratio
Fisher's Exact  Test
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Point
Probability
0 cells  (.0%) have expected count less  than 5. The minimum expected count is 5.46.a. 
The standardized s tatis tic is 1.448.b. 
 
 
Symmetric Measures
.207 .369 .377
.146 .369 .377
100
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig. Exact Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptot ic standard error assuming the null hypothesis.b. 
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ED SUBTYPE MARITAL COMPARISONS 
 
Case Processing Summary
100 100.0% 0 .0% 100 100.0%ED * MARITAL
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
ED * MARITAL  Crosstabulation
10 29 39
11.3 27.7 39.0
25.6% 74.4% 100.0%
34.5% 40.8% 39.0%
10.0% 29.0% 39.0%
5 16 21
6.1 14.9 21.0
23.8% 76.2% 100.0%
17.2% 22.5% 21.0%
5.0% 16.0% 21.0%
14 26 40
11.6 28.4 40.0
35.0% 65.0% 100.0%
48.3% 36.6% 40.0%
14.0% 26.0% 40.0%
29 71 100
29.0 71.0 100.0
29.0% 71.0% 100.0%
100.0% 100.0% 100.0%
29.0% 71.0% 100.0%
Count
Expected Count
% within ED
% within MARITAL
% of Total
Count
Expected Count
% within ED
% within MARITAL
% of Total
Count
Expected Count
% within ED
% within MARITAL
% of Total
Count
Expected Count
% within ED
% within MARITAL
% of Total
AN
BN
EDNOS
ED
Total
MARRIED SINGLE
MARITAL
Total
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Chi-Square Tests
1.188a 2 .552
1.179 2 .555
.838 1 .360
100
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
0 cells  (.0%) have expected count less than 5. The
minimum expected count is  6.09.
a. 
 
 
Symmetric Measures
.109 .552
.109 .552
100
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptotic standard error assuming the null
hypothesis.
b. 
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ED SUBTYPE BINGEING AND PURGING COMPARISONS 
 
BINGEING  
 
ED
8 15.3 -7.3
21 15.3 5.7
17 15.3 1.7
46
AN
BN
EDNOS
Total
Observed N Expected N Residual
 
 
Test Statistics
5.783
2
.056
Chi-Squarea
df
Asymp. Sig.
ED
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 15.3.
a. 
 
 
 
 
VOMITING  
 
ED
15 17.0 -2.0
18 17.0 1.0
18 17.0 1.0
51
AN
BN
EDNOS
Total
Observed N Expected N Residual
 
 
Test Statistics
.353
2
.838
Chi-Squarea
df
Asymp. Sig.
ED
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 17.0.
a. 
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LAXATIVE ABUSE  
 
ED
6 4.7 1.3
3 4.7 -1.7
5 4.7 .3
14
AN
BN
EDNOS
Total
Observed N Expected N Residual
 
 
Test Statistics
1.000
2
.607
.710
.211
Chi-Squarea
df
Asymp. Sig.
Exact Sig.
Point Probability
ED
3 cells (100.0%) have expected frequencies  less
than 5. The minimum expected cell frequency is  4.7.
a. 
 
 
 
PURGATIVE ABUSE TOTAL  
 
Type Of Treatment
49 32.5 16.5
16 32.5 -16.5
65
Comorbid ED and AD
ED Only
Total
Observed N Expected N Residual
 
 
Test Statistics
16.754
1
.000
Chi-Squarea
df
Asymp. Sig.
Type Of
Treatment
0 cells  (.0%) have expected frequencies less than
5. The minimum expected cell frequency is 32.5.
a. 
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EXCESSIVE EXERCISE  
 
ED
15 13.7 1.3
5 13.7 -8.7
21 13.7 7.3
41
AN
BN
EDNOS
Total
Observed N Expected N Residual
 
 
Test Statistics
9.561
2
.008
Chi-Squarea
df
Asymp. Sig.
ED
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 13.7.
a. 
 
 
 
ED
15 18.0 -3.0
21 18.0 3.0
36
AN
EDNOS
Total
Observed N Expected N Residual
 
 
Test Statistics
1.000
1
.317
Chi-Squarea
df
Asymp. Sig.
ED
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 18.0.
a. 
 
 
ED
15 10.0 5.0
5 10.0 -5.0
20
AN
BN
Total
Observed N Expected N Residual
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Test Statistics
5.000
1
.025
Chi-Squarea
df
Asymp. Sig.
ED
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 10.0.
a. 
 
 
 
 
ENTIRE ED SAMPLE COMPARISON OF AD FREUQENCY  
 
Type Of Treatment
37 32.5 4.5
28 32.5 -4.5
65
Inpatient
Outpatient
Total
Observed N Expected N Residual
 
 
Test Statistics
1.246
1
.264
Chi-Squarea
df
Asymp. Sig.
Type Of
Treatment
0 cells  (.0%) have expected frequencies less than
5. The minimum expected cell frequency is 32.5.
a. 
 
 
 
Social Phobia  
 
 
Type Of Treatment
14 13.5 .5
13 13.5 -.5
27
Inpatient
Outpatient
Total
Observed N Expected N Residual
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Test Statistics
.037
1
.847
Chi-Squarea
df
Asymp. Sig.
Type Of
Treatment
0 cells  (.0%) have expected frequencies less than
5. The minimum expected cell frequency is 13.5.
a. 
 
 
PTSD 
 
Type Of Treatment
10 8.5 1.5
7 8.5 -1.5
17
Inpatient
Outpatient
Total
Observed N Expected N Residual
 
 
Test Statistics
.529
1
.467
Chi-Squarea
df
Asymp. Sig.
Type Of
Treatment
0 cells  (.0%) have expected frequencies less than
5. The minimum expected cell frequency is 8.5.
a. 
 
 
GAD  
 
Type Of Treatment
8 7.5 .5
7 7.5 -.5
15
Inpatient
Outpatient
Total
Observed N Expected N Residual
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Test Statistics
.067
1
.796
Chi-Squarea
df
Asymp. Sig.
Type Of
Treatment
0 cells  (.0%) have expected frequencies less than
5. The minimum expected cell frequency is 7.5.
a. 
 
 
OCD 
Type Of Treatment
2 1.5 .5
1 1.5 -.5
3
Inpatient
Outpatient
Total
Observed N Expected N Residual
 
 
Test Statistics
.333
1
.564
1.000
.750
Chi-Squarea
df
Asymp. Sig.
Exact Sig.
Point Probability
Type Of
Treatment
2 cells (100.0%) have expected frequencies  less
than 5. The minimum expected cell frequency is  1.5.
a. 
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ENTIRE ED SAMPLE COMPARISON OF TEMPORAL RELATIONSHIP 
BETWEEN AD AND ED  
 
 
Case Processing Summary
65 100.0% 0 .0% 65 100.0%TREATMENT  * TempRel
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
TREATMENT  * TempRel Crosstabulation
24 7 6 37
25.6 5.7 5.7 37.0
64.9% 18.9% 16.2% 100.0%
53.3% 70.0% 60.0% 56.9%
36.9% 10.8% 9.2% 56.9%
21 3 4 28
19.4 4.3 4.3 28.0
75.0% 10.7% 14.3% 100.0%
46.7% 30.0% 40.0% 43.1%
32.3% 4.6% 6.2% 43.1%
45 10 10 65
45.0 10.0 10.0 65.0
69.2% 15.4% 15.4% 100.0%
100.0% 100.0% 100.0% 100.0%
69.2% 15.4% 15.4% 100.0%
Count
Expected Count
% within TREATMENT
% within TempRel
% of Total
Count
Expected Count
% within TREATMENT
% within TempRel
% of Total
Count
Expected Count
% within TREATMENT
% within TempRel
% of Total
Inpatient
Outpatient
TREATMENT
Total
Before Same Time After
TempRel
Total
 
 
Chi-Square Tests
.972a 2 .615 .645
.998 2 .607 .645
.955 .645
.411
b
1 .522 .620 .321 .109
65
Pearson Chi-Square
Likelihood Ratio
Fisher's Exact  Test
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Point
Probability
2 cells  (33.3%) have expected count less than 5. The minimum expected count is 4.31.a. 
The standardized s tatis tic is -.641.b. 
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Symmetric Measures
.122 .615 .645
.122 .615 .645
65
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig. Exact Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptot ic standard error assuming the null hypothesis.b. 
 
 
 
 
COMPARISON OF PURGATIVE ABUSE FOR SOCIAL PHOBIA, GAD & PTSD  
 
AD
21 15.7 5.3
10 15.7 -5.7
16 15.7 .3
47
Social Phobia
PTSD
GAD
Total
Observed N Expected N Residual
 
 
Test Statistics
3.872
2
.144
Chi-Squarea
df
Asymp. Sig.
AD
0 cells  (.0%) have expected frequencies  less than
5. The minimum expected cell frequency is 15.7.
a. 
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ENTIRE ED SAMPLE COMPARISON OF  TEMPORAL RELATIONSHIP OF 
AD AND ED ACROSS ED SUBTYPES (ALL AD) 
 
 
 
Case Processing Summary
65 100.0% 0 .0% 65 100.0%ED DX * TEMP REL
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
ED DX * TEMP REL Crosstabulation
21 3 3 27
18.7 4.2 4.2 27.0
77.8% 11.1% 11.1% 100.0%
46.7% 30.0% 30.0% 41.5%
32.3% 4.6% 4.6% 41.5%
9 4 2 15
10.4 2.3 2.3 15.0
60.0% 26.7% 13.3% 100.0%
20.0% 40.0% 20.0% 23.1%
13.8% 6.2% 3.1% 23.1%
15 3 5 23
15.9 3.5 3.5 23.0
65.2% 13.0% 21.7% 100.0%
33.3% 30.0% 50.0% 35.4%
23.1% 4.6% 7.7% 35.4%
45 10 10 65
45.0 10.0 10.0 65.0
69.2% 15.4% 15.4% 100.0%
100.0% 100.0% 100.0% 100.0%
69.2% 15.4% 15.4% 100.0%
Count
Expected Count
% within ED DX
% within TEMP REL
% of Total
Count
Expected Count
% within ED DX
% within TEMP REL
% of Total
Count
Expected Count
% within ED DX
% within TEMP REL
% of Total
Count
Expected Count
% within ED DX
% within TEMP REL
% of Total
AN
BN
EDNOS
ED
DX
Total
Before Same time After
TEMP REL
Total
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Chi-Square Tests
3.132a 4 .536 .571
2.912 4 .573 .610
3.064 .572
1.216
b
1 .270 .303 .158 .041
65
Pearson Chi-Square
Likelihood Ratio
Fisher's Exact  Test
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Point
Probability
6 cells  (66.7%) have expected count less than 5. The minimum expected count is 2.31.a. 
The standardized s tatis tic is 1.103.b. 
 
 
Symmetric Measures
.220 .536 .571
.155 .536 .571
65
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig. Exact Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptot ic standard error assuming the null hypothesis.b. 
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ENTIRE ED SAMPLE COMPARISON OF DEPRESSION ACROSS ED 
SUBTYPES 
 
 
Case Processing Summary
93 100.0% 0 .0% 93 100.0%
ED Type *
DEPRESSION SCORE
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
 
Chi-Square Tests
.978a 4 .913 .919
.966 4 .915 .919
1.008 .928
.780
b
1 .377 .394 .211 .042
93
Pearson Chi-Square
Likelihood Ratio
Fisher's Exact  Test
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Point
Probability
1 cells  (11.1%) have expected count less than 5. The minimum expected count is 3.61.a. 
The standardized s tatis tic is -.883.b. 
 
 
Symmetric Measures
.103 .913 .919
.073 .913 .919
93
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig. Exact Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptot ic standard error assuming the null hypothesis.b. 
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ENTIRE ED SAMPLE COMPARISON OF  DEPRESSION FOR COMORBID ED 
& AD AND ED ONLY GROUPS  
Case Processing Summary
93 100.0% 0 .0% 93 100.0%
ED Type *
DEPRESSION SCORE
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
ED Type * DEPRESSION SCORE Crosstabulation
7 17 35 59
10.2 19.0 29.8 59.0
11.9% 28.8% 59.3% 100.0%
43.8% 56.7% 74.5% 63.4%
7.5% 18.3% 37.6% 63.4%
-1.8 -.9 2.2
9 13 12 34
5.8 11.0 17.2 34.0
26.5% 38.2% 35.3% 100.0%
56.3% 43.3% 25.5% 36.6%
9.7% 14.0% 12.9% 36.6%
1.8 .9 -2.2
16 30 47 93
16.0 30.0 47.0 93.0
17.2% 32.3% 50.5% 100.0%
100.0% 100.0% 100.0% 100.0%
17.2% 32.3% 50.5% 100.0%
Count
Expected Count
% within ED Type
% within DEPRESSION
SCORE
% of Total
Adjusted Residual
Count
Expected Count
% within ED Type
% within DEPRESSION
SCORE
% of Total
Adjusted Residual
Count
Expected Count
% within ED Type
% within DEPRESSION
SCORE
% of Total
Comorb ED and Anxiety
ED Only
ED Type
Total
Normal Mild - Mod Sev - Ex Sev
DEPRESSION SCORE
Total
 
 
Chi-Square Tests
5.732a 2 .057
5.736 2 .057
5.624 1 .018
93
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
0 cells  (.0%) have expected count less than 5. The
minimum expected count is  5.85.
a. 
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Symmetric Measures
.248 .057
.248 .057
93
Phi
Cramer's V
Nominal by
Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a. 
Us ing the asymptotic standard error assuming the null
hypothesis.
b. 
 
 
 
 
ENTIRE ED SAMPLE COMPARISON OF TRAUMA ACROSS ED SUBTYPES 
Type Of Treatment
12 10.7 1.3
5 10.7 -5.7
15 10.7 4.3
32
AN
BN
EDNOS
Total
Observed N Expected N Residual
 
 
Test Statistics
4.938
2
.085
Chi-Squarea
df
Asymp. Sig.
Type Of
Treatment
0 cells  (.0%) have expected frequencies less than
5. The minimum expected cell frequency is 10.7.
a. 
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4.2 INDEPENDENT SAMPLES T -TESTS  
 
INPATIENT ED COMPARED WITH OUTPATIENT ED  
 
 
AGE /EDUCATION 
 
Group Sta tistics
50 25.38 8.263 1.169
50 25.04 6.398 .905
50 14.20 2.030 .287
50 13.60 2.050 .290
Facility
ED Inpatient
ED Outpatient
ED Inpatient
ED Outpatient
Age
Education (Years)
N Mean Std. Deviat ion
Std. Error
Mean
 
 
Independent Samples Test
2.802 .097 .230 98 .819 .340 1.478 -2.593 3.273
.230 92.220 .819 .340 1.478 -2.595 3.275
.461 .499 1.470 98 .145 .600 .408 -.210 1.410
1.470 97.991 .145 .600 .408 -.210 1.410
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Age
Education (Years)
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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ED LENGTH / BMI / ED ONSET AGE  
 
Group Statistics
49 88.29 78.481 11.212
50 99.08 76.771 10.857
50 17.2698 3.23910 .45808
50 20.4196 3.17167 .44854
49 17.96 6.324 .903
50 16.78 4.713 .667
Facility
ED Inpatient
ED Outpatient
ED Inpatient
ED Outpatient
ED Inpatient
ED Outpatient
ED Length (Months)
BMI
ED Onset Age (Years)
N Mean Std. Deviation
Std. Error
Mean
 
 
Independent Samples Test
.220 .640 -.692 97 .491 -10.794 15.603 -41.763 20.174
-.692 96.826 .491 -10.794 15.607 -41.770 20.182
.001 .980 -4.913 98 .000 -3.14980 .64111 -4.42207 -1.87753
-4.913 97.957 .000 -3.14980 .64111 -4.42207 -1.87753
.626 .431 1.053 97 .295 1.179 1.119 -1.043 3.401
1.050 88.725 .296 1.179 1.123 -1.052 3.410
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
ED Length (Months)
BMI
ED Onset Age (Years)
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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INPATIENT ED COMORBID AD & ED COMPARED WITH ED ONLY  
 
 
 
Group Sta tistics
37 92.49 77.714 12.776
12 75.33 82.880 23.925
37 17.95 6.472 1.064
12 18.00 6.120 1.767
37 17.5662 3.27953 .53915
13 16.4262 3.08762 .85635
37 14.35 31.756 5.221
13 10.77 19.430 5.389
37 39.51 81.351 13.374
13 27.15 45.927 12.738
37 61.35 93.338 15.345
13 25.38 42.154 11.691
Comorbid ED and AD
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
ED Length (Months)
ED Onset Age (Years)
BMI
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
N Mean Std. Deviat ion
Std. Error
Mean
 
 
Independent Samples Test
.110 .741 .654 47 .516 17.153 26.229 -35.612 69.919
.632 17.727 .535 17.153 27.123 -39.893 74.199
.066 .798 -.025 47 .980 -.054 2.123 -4.325 4.217
-.026 19.637 .979 -.054 2.062 -4.361 4.253
.545 .464 1.094 48 .279 1.14006 1.04224 -.95550 3.23562
1.127 22.234 .272 1.14006 1.01194 -.95729 3.23741
.436 .512 .381 48 .705 3.582 9.404 -15.326 22.490
.477 34.860 .636 3.582 7.503 -11.652 18.816
.714 .402 .517 48 .607 12.360 23.891 -35.676 60.396
.669 37.749 .507 12.360 18.469 -25.038 49.757
2.548 .117 1.335 48 .188 35.967 26.933 -18.186 90.119
1.864 44.719 .069 35.967 19.291 -2.894 74.828
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
ED Length (Months)
ED Onset Age (Years)
BMI
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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OUTPATIENT ED COMORBID AD & ED COMPARED WITH ED ONLY 
 
Mann-Whitney Test 
 
Ranks
28 28.32 793.00
22 21.91 482.00
50
28 25.75 721.00
22 25.18 554.00
50
28 21.29 596.00
22 30.86 679.00
50
28 24.71 692.00
22 26.50 583.00
50
28 25.68 719.00
22 25.27 556.00
50
Comorbid ED and AD
Comorbid ED and AD
ED Only
Total
Comorbid ED and AD
ED Only
Total
Comorbid ED and AD
ED Only
Total
Comorbid ED and AD
ED Only
Total
Comorbid ED and AD
ED Only
Total
ED Length (Months)
BMI
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
N Mean Rank Sum of Ranks
 
 
Test Statisticsa
229.000 301.000 190.000 286.000 303.000
482.000 554.000 596.000 692.000 556.000
-1.548 -.137 -2.429 -.456 -.112
.122 .891 .015 .648 .911
.124 .896 .015 .654 .917
.062 .448 .007 .327 .461
.001 .004 .000 .004 .004
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. (2-tailed)
Exact Sig. (1-tailed)
Point Probability
ED Length
(Months) BMI
No of
Episodes
Binging
per Month
No of
Episodes
vomiting
per month
Exercise Per
Day (Minutes)
Grouping Variable: Comorbid ED and ADa. 
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Group Sta tistics
28 116.04 86.864 16.416
22 77.50 56.390 12.022
28 16.64 4.724 .893
22 16.95 4.806 1.025
28 20.4139 2.74228 .51824
22 20.4268 3.71528 .79210
28 9.75 18.360 3.470
22 21.86 24.328 5.187
28 16.32 25.456 4.811
22 30.59 62.525 13.330
28 32.14 50.943 9.627
22 22.50 29.911 6.377
Comorbid ED and AD
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
ED Length (Months)
ED Onset Age (Years)
BMI
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
N Mean Std. Deviat ion
Std. Error
Mean
 
 
Independent Samples Test
2.748 .104 1.802 48 .078 38.536 21.387 -4.467 81.538
1.894 46.523 .064 38.536 20.347 -2.409 79.480
.004 .948 -.230 48 .819 -.312 1.356 -3.038 2.415
-.229 44.873 .820 -.312 1.359 -3.049 2.425
3.172 .081 -.014 48 .989 -.01289 .91298 -1.84855 1.82277
-.014 37.484 .989 -.01289 .94657 -1.92999 1.90421
1.365 .248 -2.008 48 .050 -12.114 6.034 -24.246 .018
-1.941 38.071 .060 -12.114 6.240 -24.746 .518
3.493 .068 -1.100 48 .277 -14.269 12.977 -40.362 11.823
-1.007 26.477 .323 -14.269 14.172 -43.375 14.836
5.401 .024 .787 48 .435 9.643 12.258 -15.004 34.289
.835 44.801 .408 9.643 11.548 -13.619 32.904
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
ED Length (Months)
ED Onset Age (Years)
BMI
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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ENTIRE ED SAMPLE COMORBID AD & ED COMPARED WITH ED ONLY 
 
 
 
Group Sta tistics
65 102.63 81.967 10.167
34 76.74 65.683 11.265
65 17.38 5.779 .717
34 17.32 5.238 .898
65 18.7929 3.35291 .41588
35 18.9409 3.96698 .67054
65 12.37 26.735 3.316
35 17.74 22.986 3.885
65 29.52 64.265 7.971
35 29.31 56.231 9.505
65 48.77 78.790 9.773
35 23.57 34.376 5.811
Anxiety
Comorb ED & AD
ED Only
Comorb ED & AD
ED Only
Comorb ED & AD
ED Only
Comorb ED & AD
ED Only
Comorb ED & AD
ED Only
Comorb ED & AD
ED Only
ED Length (Months)
ED Onset Age (Years)
BMI
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
N Mean Std. Deviat ion
Std. Error
Mean
 
 
Independent Samples Test
3.167 .078 1.593 97 .114 25.895 16.258 -6.372 58.163
1.707 80.959 .092 25.895 15.174 -4.296 56.087
.099 .754 .052 97 .959 .061 1.185 -2.292 2.414
.053 73.116 .958 .061 1.149 -2.229 2.351
2.395 .125 -.197 98 .844 -.14793 .75013 -1.63655 1.34068
-.187 60.437 .852 -.14793 .78904 -1.72601 1.43014
.144 .705 -1.005 98 .317 -5.374 5.346 -15.982 5.234
-1.052 79.236 .296 -5.374 5.108 -15.541 4.793
.005 .945 .016 98 .987 .209 12.914 -25.419 25.836
.017 78.116 .987 .209 12.405 -24.487 24.904
8.783 .004 1.799 98 .075 25.198 14.008 -2.601 52.996
2.216 94.920 .029 25.198 11.370 2.626 47.770
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
ED Length (Months)
ED Onset Age (Years)
BMI
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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INPATIENT ED LENGTH OF ED COMORBID AD & ED COMPARED WITH 
ED ONLY  
 
Group Sta tistics
37 92.49 77.714 12.776
12 75.33 82.880 23.925
37 17.95 6.472 1.064
12 18.00 6.120 1.767
Comorbid ED and AD
Comorbid ED and AD
ED Only
Comorbid ED and AD
ED Only
ED Length (Months)
ED Onset Age (Years)
N Mean Std. Deviat ion
Std. Error
Mean
 
 
Independent Samples Test
.110 .741 .654 47 .516 17.153 26.229 -35.612 69.919
.632 17.727 .535 17.153 27.123 -39.893 74.199
.066 .798 -.025 47 .980 -.054 2.123 -4.325 4.217
-.026 19.637 .979 -.054 2.062 -4.361 4.253
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
ED Length (Months)
ED Onset Age (Years)
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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INPATIENT & OUTPATIENT ED COMPARISON BETWEEN ED & AD 
LENGTH / ONSET  
 
 
 
Group Sta tistics
37 92.49 77.714 12.776
28 116.04 86.864 16.416
37 126.62 80.513 13.236
28 169.71 90.198 17.046
37 17.95 6.472 1.064
28 16.64 4.724 .893
37 15.19 9.015 1.482
28 12.25 7.250 1.370
Facility
ED Inpatient
ED Outpat ient
ED Inpatient
ED Outpat ient
ED Inpatient
ED Outpat ient
ED Inpatient
ED Outpat ient
ED Length (Months)
Anxiety Length (Months)
ED Onset Age (Years)
Anxiety Onset Age (Years)
N Mean Std. Deviat ion
Std. Error
Mean
 
 
Independent Samples Test
.040 .842 -1.150 63 .255 -23.549 20.480 -64.475 17.376
-1.132 54.593 .263 -23.549 20.802 -65.244 18.145
.353 .554 -2.029 63 .047 -43.093 21.241 -85.539 -.647
-1.997 54.512 .051 -43.093 21.581 -86.351 .166
.443 .508 .899 63 .372 1.303 1.450 -1.594 4.200
.938 62.939 .352 1.303 1.389 -1.472 4.079
.914 .343 1.413 63 .163 2.939 2.080 -1.218 7.096
1.456 62.733 .150 2.939 2.018 -1.095 6.973
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
ED Length (Months)
Anxiety Length (Months)
ED Onset Age (Years)
Anxiety Onset Age (Years
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
 
 
 
 
 
 
 428 
ED ENTIRE SAMPLE EDE SCORES COMPARISON (comorbid AD & ED vs ED 
only)  
 
 
Group Statistics
35 4.034 .9647 .1631
65 4.311 1.1220 .1392
35 3.823 1.3362 .2259
65 3.951 1.1495 .1426
35 4.471 1.2963 .2191
65 4.594 1.2176 .1510
35 4.434 1.4279 .2414
65 4.412 1.3536 .1679
35 4.214 1.0327 .1746
65 4.329 .9858 .1223
Anxiety Diagnos is
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
Restraint Concern Score
Eating Concern Score
Shape Concern Score
Weight Concern Score
Global Score
N Mean Std. Deviation
Std. Error
Mean
 
 
Independent Samples Test
1.110 .295 -1.232 98 .221 -.2765 .2243 -.7217 .1687
-1.290 79.236 .201 -.2765 .2144 -.7032 .1502
1.676 .198 -.501 98 .617 -.1279 .2553 -.6345 .3786
-.479 61.324 .634 -.1279 .2671 -.6619 .4061
.049 .825 -.469 98 .640 -.1224 .2611 -.6406 .3958
-.460 66.057 .647 -.1224 .2661 -.6537 .4089
.120 .729 .076 98 .940 .0220 .2893 -.5521 .5961
.075 66.586 .941 .0220 .2940 -.5649 .6089
.000 .993 -.547 98 .586 -.1149 .2101 -.5320 .3021
-.539 66.981 .591 -.1149 .2131 -.5404 .3105
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Restraint Concern Score
Eating Concern Score
Shape Concern Score
Weight Concern Score
Global Score
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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4.3 ANALYIS OF VARIANCE (ANOVA)  
 
 
INPATIENT AND OUTPATIENT ED SAMPLE COMPARISONS ACROSS THE 
ED SUBTYPES  
 
 
Descriptives
39 26.28 9.055 1.450 23.35 29.22 18 56
21 23.67 4.351 .950 21.69 25.65 18 32
40 24.98 6.723 1.063 22.82 27.13 18 45
100 25.21 7.354 .735 23.75 26.67 18 56
39 15.5841 1.05975 .16970 15.2406 15.9276 12.55 17.10
21 21.4276 2.78233 .60715 20.1611 22.6941 17.80 28.95
40 20.6678 3.07958 .48692 19.6829 21.6526 15.44 28.67
100 18.8447 3.56050 .35605 18.1382 19.5512 12.55 28.95
AN
BN
EDNOS
Total
AN
BN
EDNOS
Total
Age
BMI
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
95% Confidence Interval for
Mean
Minimum Maximum
 
 
Test of Homogeneity of Variances
4.624 2 97 .012
16.064 2 97 .000
Age
BMI
Levene
Statistic df1 df2 Sig.
 
 
ANOVA
97.051 2 48.525 .895 .412
5257.539 97 54.201
5354.590 99
687.670 2 343.835 58.783 .000
567.371 97 5.849
1255.041 99
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Age
BMI
Sum of
Squares df Mean Square F Sig.
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Post Hoc Tests 
 
Multiple Comparisons
Games-Howell
2.615 1.733 .294 -1.55 6.79
1.307 1.798 .748 -3.00 5.61
-2.615 1.733 .294 -6.79 1.55
-1.308 1.425 .631 -4.74 2.12
-1.307 1.798 .748 -5.61 3.00
1.308 1.425 .631 -2.12 4.74
-5.84352* .63042 .000 -7.4215 -4.2655
-5.08365* .51565 .000 -6.3305 -3.8368
5.84352* .63042 .000 4.2655 7.4215
.75987 .77829 .595 -1.1270 2.6468
5.08365* .51565 .000 3.8368 6.3305
-.75987 .77829 .595 -2.6468 1.1270
(J) Eat ing Disorder
Diagnosis
BN
EDNOS
AN
EDNOS
AN
BN
BN
EDNOS
AN
EDNOS
AN
BN
(I) Eating Disorder
Diagnosis
AN
BN
EDNOS
AN
BN
EDNOS
Dependent  Variable
Age
BMI
Mean
Difference
(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval
The mean difference is significant at  the .05 level.*. 
 
 
 
BMI ACROSS ED SUBTYPES 
 
Between-Subjects Factors
AN 39
BN 21
EDNOS 40
1
3
4
Eating Disorder
Diagnosis
Value Label N
 
 
Descriptive Statistics
Dependent  Variable: BMI
15.5841 1.05975 39
21.4276 2.78233 21
20.6678 3.07958 40
18.8447 3.56050 100
Eating Disorder
AN
BN
EDNOS
Total
Mean Std. Deviat ion N
 
 
Levene's Test of Equa lity of Error Variancesa
Dependent  Variable: BMI
16.064 2 97 .000
F df1 df2 Sig.
Tests the null hypothes is that the error variance o
the dependent variable is equal across groups.
Design: Intercept+EDa. 
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Tests of Betw een-Subjects Effects
Dependent  Variable: BMI
687.670b 2 343.835 58.783 .000 .548 117.567 1.000
33858.324 1 33858.324 5788.549 .000 .984 5788.549 1.000
687.670 2 343.835 58.783 .000 .548 117.567 1.000
567.371 97 5.849
36767.313 100
1255.041 99
Source
Correc ted Model
Intercept
ED
Error
Total
Correc ted Total
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Powera
Computed using alpha = .05a. 
R Squared = .548 (Adjusted R Squared = .539)b. 
 
 
Estimated Marginal Means 
 
Eating Disorder Diagnosis
Dependent  Variable: BMI
15.584 .387 14.815 16.353
21.428 .528 20.380 22.475
20.668 .382 19.909 21.427
Eating Disorder
Diagnosis
AN
BN
EDNOS
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
 
Post Hoc Tests 
 
Eating Disorder Diagnosis 
 
Multiple Comparisons
Dependent  Variable: BMI
Games-Howell
-5.8435* .63042 .000 -7.4215 -4.2655
-5.0836* .51565 .000 -6.3305 -3.8368
5.8435* .63042 .000 4.2655 7.4215
.7599 .77829 .595 -1.1270 2.6468
5.0836* .51565 .000 3.8368 6.3305
-.7599 .77829 .595 -2.6468 1.1270
(J) Eat ing Disorder
Diagnosis
BN
EDNOS
AN
EDNOS
AN
BN
(I) Eating Disorder
Diagnosis
AN
BN
EDNOS
Mean
Difference
(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval
Based on observed means.
The mean difference is significant at  the .05 level.*. 
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Descriptives
39 14.13 2.028 .325 13.47 14.79 11 20
21 13.90 1.841 .402 13.07 14.74 11 19
40 13.68 2.200 .348 12.97 14.38 10 19
100 13.90 2.052 .205 13.49 14.31 10 20
39 89.10 80.948 12.962 62.86 115.34 7 288
21 87.33 54.777 11.953 62.40 112.27 6 216
39 101.82 84.926 13.599 74.29 129.35 3 336
99 93.74 77.415 7.781 78.30 109.18 3 336
39 18.82 6.893 1.104 16.59 21.06 13 43
21 16.38 2.924 .638 15.05 17.71 12 22
39 16.44 4.946 .792 14.83 18.04 9 34
99 17.36 5.572 .560 16.25 18.48 9 43
AN
BN
EDNOS
Total
AN
BN
EDNOS
Total
AN
BN
EDNOS
Total
Education (Years)
ED Length (Months)
ED Onset Age (Years)
N Mean Std. Deviat ion Std. Error Lower Bound Upper Bound
95% Confidence Interval for
Mean
Minimum Maximum
 
 
Test of Homogeneity of Variances
.360 2 97 .699
1.803 2 96 .170
2.109 2 96 .127
Education (Years)
ED Length (Months)
ED Onset Age (Years)
Levene
Statistic df1 df2 Sig.
 
 
ANOVA
4.057 2 2.028 .476 .622
412.943 97 4.257
417.000 99
4247.172 2 2123.586 .350 .706
583080.0 96 6073.750
587327.2 98
136.623 2 68.312 2.256 .110
2906.286 96 30.274
3042.909 98
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Education (Years)
ED Length (Months)
ED Onset Age (Years)
Sum of
Squares df Mean Square F Sig.
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Post Hoc Tests 
 
Multiple Comparisons
Tukey HSD
.223 .558 .916 -1.11 1.55
.453 .464 .594 -.65 1.56
-.223 .558 .916 -1.55 1.11
.230 .556 .910 -1.09 1.55
-.453 .464 .594 -1.56 .65
-.230 .556 .910 -1.55 1.09
1.769 21.094 .996 -48.45 51.99
-12.718 17.649 .752 -54.73 29.30
-1.769 21.094 .996 -51.99 48.45
-14.487 21.094 .772 -64.70 35.73
12.718 17.649 .752 -29.30 54.73
14.487 21.094 .772 -35.73 64.70
2.440 1.489 .235 -1.11 5.98
2.385 1.246 .140 -.58 5.35
-2.440 1.489 .235 -5.98 1.11
-.055 1.489 .999 -3.60 3.49
-2.385 1.246 .140 -5.35 .58
.055 1.489 .999 -3.49 3.60
(J) Eating Disorder
Diagnosis
BN
EDNOS
AN
EDNOS
AN
BN
BN
EDNOS
AN
EDNOS
AN
BN
BN
EDNOS
AN
EDNOS
AN
BN
(I) Eating Disorder
Diagnosis
AN
BN
EDNOS
AN
BN
EDNOS
AN
BN
EDNOS
Dependent Variable
Education (Years)
ED Length (Months)
ED Onset Age (Years)
Mean
Difference
(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval
 
 
Homogeneous Subsets 
 
Educa tion (Years)
Tukey HSDa,b
40 13.68
21 13.90
39 14.13
.668
Eating Disorder
Diagnosis
EDNOS
BN
AN
Sig.
N 1
Subset
for alpha
= .05
Means for groups in homogeneous subsets are displayed.
Uses Harmonic  Mean Sample Size = 30.531.a. 
The group sizes are unequal. The harmonic mean
of the group sizes is used. Type I error levels are
not guaranteed.
b. 
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ED Length (Months)
Tukey HSDa,b
21 87.33
39 89.10
39 101.82
.750
Eating Disorder
Diagnosis
BN
AN
EDNOS
Sig.
N 1
Subset
for alpha
= .05
Means for groups in homogeneous subsets are displayed.
Uses Harmonic  Mean Sample Size = 30.333.a. 
The group sizes are unequal. The harmonic mean
of the group sizes is used. Type I error levels are
not guaranteed.
b. 
 
 
ED Onset Age  (Years)
Tukey HSDa,b
21 16.38
39 16.44
39 18.82
.201
Eating Disorder
Diagnosis
BN
EDNOS
AN
Sig.
N 1
Subset
for alpha
= .05
Means for groups in homogeneous subsets are displayed.
Uses Harmonic  Mean Sample Size = 30.333.a. 
The group sizes are unequal. The harmonic mean
of the group sizes is used. Type I error levels are
not guaranteed.
b. 
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ENTIRE ED SAMPLE COMPARISON BETWEEN ED SYMPTOMS  ACROSS   
ALL AD DIAGNOSES 
 
 
Descriptives
1 16.5500 . . . . 16.55 16.55
1 17.8200 . . . . 17.82 17.82
27 18.5037 2.98146 .57378 17.3243 19.6831 12.55 24.20
15 19.5087 3.96999 1.02505 17.3102 21.7072 13.99 28.95
3 16.7033 1.82511 1.05373 12.1695 21.2372 15.60 18.81
1 13.8000 . . . . 13.80 13.80
17 19.4724 3.52899 .85591 17.6579 21.2868 14.43 25.50
65 18.7929 3.35291 .41588 17.9621 19.6237 12.55 28.95
1 252.00 . . . . 252 252
1 36.00 . . . . 36 36
27 84.74 69.116 13.301 57.40 112.08 6 276
15 94.40 93.599 24.167 42.57 146.23 24 336
3 52.00 13.856 8.000 17.58 86.42 36 60
1 144.00 . . . . 144 144
17 139.94 84.140 20.407 96.68 183.20 15 300
65 102.63 81.967 10.167 82.32 122.94 6 336
1 18.00 . . . . 18 18
1 16.00 . . . . 16 16
27 18.04 5.687 1.095 15.79 20.29 12 38
15 18.33 7.678 1.982 14.08 22.59 11 43
3 16.00 1.732 1.000 11.70 20.30 15 18
1 14.00 . . . . 14 14
17 16.00 4.924 1.194 13.47 18.53 10 30
65 17.38 5.779 .717 15.95 18.82 10 43
1 .00 . . . . 0 0
1 .00 . . . . 0 0
27 17.67 36.102 6.948 3.39 31.95 0 140
15 16.00 23.213 5.994 3.14 28.86 0 84
3 .00 .000 .000 .00 .00 0 0
1 .00 . . . . 0 0
17 5.12 9.823 2.382 .07 10.17 0 36
65 12.37 26.735 3.316 5.74 18.99 0 140
1 .00 . . . . 0 0
1 25.00 . . . . 25 25
27 46.33 92.566 17.814 9.72 82.95 0 280
15 19.07 34.483 8.903 -.03 38.16 0 112
3 3.00 5.196 3.000 -9.91 15.91 0 9
1 .00 . . . . 0 0
17 20.47 25.373 6.154 7.43 33.52 0 84
65 29.52 64.265 7.971 13.60 45.45 0 280
1 .00 . . . . 0 0
1 .00 . . . . 0 0
27 37.78 56.795 10.930 15.31 60.25 0 150
15 26.00 47.929 12.375 -.54 52.54 0 150
3 70.00 45.826 26.458 -43.84 183.84 30 120
1 120.00 . . . . 120 120
17 84.12 120.834 29.306 21.99 146.24 0 400
65 48.77 78.790 9.773 29.25 68.29 0 400
Panic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Panic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Panic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Panic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Panic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
Panic with Ag
Panic w/o Ag
Social Phobia
GAD
OCD
Specific Phobia
PTSD
Total
BMI
ED Length (Months)
ED Onset Age (Years)
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
95% Confidence Interval for
Mean
Minimum Maximum
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Test of Homogeneity of Variances
1.048a 3 58 .378
1.470b 3 58 .232
.599c 3 58 .618
3.110
d
3 58 .033
4.691
e
3 58 .005
2.625
f
3 58 .059
BMI
ED Length (Months)
ED Onset Age (Years)
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
Levene
Statistic df1 df2 Sig.
Groups with only one case are ignored in computing the test of
homogeneity of variance for BMI.
a. 
Groups with only one case are ignored in computing the test of
homogeneity of variance for ED Length (Months) .
b. 
Groups with only one case are ignored in computing the test of
homogeneity of variance for ED Onset Age (Years).
c. 
Groups with only one case are ignored in computing the test of
homogeneity of variance for No of Episodes Binging per Month .
d. 
Groups with only one case are ignored in computing the test of
homogeneity of variance for No of Episodes vomiting per month .
e. 
Groups with only one case are ignored in computing the test of
homogeneity of variance for Exercise Per Day (Minutes) .
f. 
 
ANOVA
61.796 6 10.299 .908 .495
657.691 58 11.339
719.487 64
69475.412 6 11579.235 1.863 .103
360509.7 58 6215.685
429985.1 64
77.088 6 12.848 .362 .900
2060.296 58 35.522
2137.385 64
2767.374 6 461.229 .622 .712
42975.765 58 740.961
45743.138 64
14537.047 6 2422.841 .563 .758
249781.2 58 4306.572
264318.2 64
43463.107 6 7243.851 1.187 .326
353838.4 58 6100.663
397301.5 64
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
BMI
ED Length (Months)
ED Onset Age (Years)
No of Episodes
Binging per Month
No of Episodes
vomiting per month
Exercise Per Day
(Minutes)
Sum of
Squares df Mean Square F Sig.
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ENTIRE SAMPLE COMPARISON OF EDE SCORES  
 
Descriptives
50 4.492 .9435 .1334 4.224 4.760 1.8 6.0
50 3.936 1.1302 .1598 3.615 4.257 1.6 6.0
7 3.743 1.0114 .3823 2.808 4.678 1.8 4.8
107 4.183 1.0708 .1035 3.978 4.388 1.6 6.0
50 3.916 1.1118 .1572 3.600 4.232 1.4 6.0
50 3.896 1.3175 .1863 3.522 4.270 1.4 6.0
7 2.457 1.3986 .5286 1.164 3.751 1.0 4.6
107 3.811 1.2705 .1228 3.568 4.055 1.0 6.0
50 4.454 1.2418 .1756 4.101 4.807 1.3 5.9
50 4.648 1.2441 .1759 4.294 5.002 1.0 6.0
7 3.971 .7588 .2868 3.270 4.673 2.8 5.0
107 4.513 1.2209 .1180 4.279 4.747 1.0 6.0
50 4.288 1.5692 .2219 3.842 4.734 1.0 6.0
50 4.552 1.1447 .1619 4.227 4.877 1.6 6.0
7 3.629 .6370 .2407 3.039 4.218 2.6 4.2
107 4.368 1.3498 .1305 4.110 4.627 1.0 6.0
50 4.298 .9747 .1378 4.021 4.575 2.4 5.7
50 4.280 1.0321 .1460 3.987 4.573 1.7 5.9
7 3.471 .5707 .2157 2.944 3.999 2.8 4.4
107 4.236 .9957 .0963 4.045 4.426 1.7 5.9
ED Inpatient
ED Outpat ient
Anxiety Patient
Total
ED Inpatient
ED Outpat ient
Anxiety Patient
Total
ED Inpatient
ED Outpat ient
Anxiety Patient
Total
ED Inpatient
ED Outpat ient
Anxiety Patient
Total
ED Inpatient
ED Outpat ient
Anxiety Patient
Total
Restraint Concern Score
Eating Concern Score
Shape Concern Score
Weight Concern Score
Global Score
N Mean Std. Deviat ion Std. Error Lower Bound Upper Bound
95% Confidence Interval for
Mean
Minimum Maximum
 
 
Test of Homogeneity of Variances
1.238 2 104 .294
1.324 2 104 .271
1.164 2 104 .316
5.753 2 104 .004
1.087 2 104 .341
Restraint Concern Score
Eating Concern Score
Shape Concern Score
Weight Concern Score
Global Score
Levene
Statistic df1 df2 Sig.
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ANOVA
9.181 2 4.590 4.249 .017
112.349 104 1.080
121.530 106
13.743 2 6.871 4.541 .013
157.364 104 1.513
171.107 106
3.138 2 1.569 1.054 .352
154.863 104 1.489
158.002 106
5.840 2 2.920 1.621 .203
187.292 104 1.801
193.132 106
4.381 2 2.190 2.262 .109
100.704 104 .968
105.085 106
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Restraint Concern Score
Eating Concern Score
Shape Concern Score
Weight Concern Score
Global Score
Sum of
Squares df Mean Square F Sig.
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Post Hoc Tests 
Multiple Comparisons
LSD
.5560* .2079 .009 .011 1.101
.7491 .4194 .077 -.351 1.850
-.5560* .2079 .009 -1.101 -.011
.1931 .4194 .646 -.907 1.294
-.7491 .4194 .077 -1.850 .351
-.1931 .4194 .646 -1.294 .907
.0200 .2460 .935 -.626 .666
1.4589* .4964 .004 .156 2.761
-.0200 .2460 .935 -.666 .626
1.4389* .4964 .005 .136 2.741
-1.4589* .4964 .004 -2.761 -.156
-1.4389* .4964 .005 -2.741 -.136
-.1940 .2441 .428 -.834 .446
.4826 .4924 .329 -.810 1.775
.1940 .2441 .428 -.446 .834
.6766 .4924 .172 -.616 1.969
-.4826 .4924 .329 -1.775 .810
-.6766 .4924 .172 -1.969 .616
-.2640 .2684 .328 -.968 .440
.6594 .5416 .226 -.762 2.080
.2640 .2684 .328 -.440 .968
.9234 .5416 .091 -.498 2.344
-.6594 .5416 .226 -2.080 .762
-.9234 .5416 .091 -2.344 .498
.0180 .1968 .927 -.498 .534
.8266 .3971 .040 -.215 1.869
-.0180 .1968 .927 -.534 .498
.8086 .3971 .044 -.233 1.851
-.8266 .3971 .040 -1.869 .215
-.8086 .3971 .044 -1.851 .233
(J) Facility
ED Outpatient
Anxiety Patient
ED Inpatient
Anxiety Patient
ED Inpatient
ED Outpatient
ED Outpatient
Anxiety Patient
ED Inpatient
Anxiety Patient
ED Inpatient
ED Outpatient
ED Outpatient
Anxiety Patient
ED Inpatient
Anxiety Patient
ED Inpatient
ED Outpatient
ED Outpatient
Anxiety Patient
ED Inpatient
Anxiety Patient
ED Inpatient
ED Outpatient
ED Outpatient
Anxiety Patient
ED Inpatient
Anxiety Patient
ED Inpatient
ED Outpatient
(I) Facility
ED Inpatient
ED Outpatient
Anxiety Patient
ED Inpatient
ED Outpatient
Anxiety Patient
ED Inpatient
ED Outpatient
Anxiety Patient
ED Inpatient
ED Outpatient
Anxiety Patient
ED Inpatient
ED Outpatient
Anxiety Patient
Dependent Variable
Restraint Concern Score
Eating Concern Score
Shape Concern Score
Weight Concern Score
Global Score
Mean
Difference
(I-J) Std. Error Sig. Lower Bound Upper Bound
99% Confidence Interval
The mean difference is s ignificant at the .01 level.*. 
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4.4 LOGISTIC REGRESSION ANALYSES  
 
 
Case Processing Summary
100 100.0
0 .0
100 100.0
0 .0
100 100.0
Unweighted Casesa
Included in Analysis
Missing Cases
Total
Selected Cases
Unselected Cases
Total
N Percent
If weight is in effect, see class ification table for the total
number of cases.
a. 
 
 
Dependent Variable  Encoding
0
1
Original Value
No
Yes
Internal Value
 
 
Block 0: Beginning Block 
 
Classification Table a,b
0 35 .0
0 65 100.0
65.0
Observed
No
Yes
Anxiety Diagnos is
Overall  Percentage
Step 0
No Yes
Anxiety Diagnos is Percentage
Correct
Predicted
Constant is  included in the model.a. 
The cut value is  .500b. 
 
 
Variables in the Equation
.619 .210 8.718 1 .003 1.857ConstantStep 0
B S.E. Wald df Sig. Exp(B)
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Variables not in the Equation
1.526 1 .217
.256 1 .613
.224 1 .636
.006 1 .939
.304 1 .581
5.842 5 .322
RESTRAINT
EATING
SHAPE
WEIGHT
GLOBAL
Variables
Overall Statistics
Step
0
Score df Sig.
 
 
Block 1: Method = Enter 
 
Omnibus Tests of Model Coefficients
5.936 5 .313
5.936 5 .313
5.936 5 .313
Step
Block
Model
Step 1
Chi-square df Sig.
 
 
Model Summary
123.553a .058 .079
Step
1
-2 Log
likelihood
Cox & Snell
R Square
Nagelkerke
R Square
Estimation terminated at iteration number 4 because
parameter estimates changed by less than .001.
a. 
 
 
Classification Table a
3 32 8.6
7 58 89.2
61.0
Observed
No
Yes
Anxiety Diagnos is
Overall  Percentage
Step 1
No Yes
Anxiety Diagnos is Percentage
Correct
Predicted
The cut value is  .500a. 
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Variables in the Equation
3.968 2.166 3.355 1 .067 52.874 .757 3692.064
3.658 2.166 2.853 1 .091 38.792 .556 2706.218
4.047 2.246 3.245 1 .072 57.215 .700 4673.592
3.451 2.259 2.333 1 .127 31.537 .376 2642.997
-14.943 8.798 2.885 1 .089 .000 .000 9.973
.067 1.035 .004 1 .948 1.070
RESTRAINT
EATING
SHAPE
WEIGHT
GLOBAL
Constant
Step
1
a
B S.E. Wald df Sig. Exp(B) Lower Upper
95.0% C.I.for EXP(B)
Variable(s) entered on step 1: RESTRAINT, EATING, SHAPE, WEIGHT, GLOBAL.a. 
 
 
 
 
 
 
 
 
 
 
 
 
